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Abstract 
Discrimination may contribute to poorer health outcomes experienced by non-dominant social 
groups. While discrimination and health research has flourished over the past two decades, little 
attention has been paid to the assessment of multiple forms of discrimination, nor to the health 
effects of discrimination for transgender persons in Canada. Therefore, this thesis examines the 
impacts of discrimination on health behaviours among transgender persons in Ontario and 
develops a new instrument set for evaluating self-reported discrimination irrespective of 
attribution, the Intersectional Discrimination Index (InDI). The first four manuscripts draw on 
data from the Trans PULSE Project, a respondent-driven sampling survey of transgender 
Ontarians aged 16+ conducted in 2009-2010 (n=433). Analyses were weighted using RDS-II 
methods, and odds ratios or prevalence ratios were estimated from logistic regression models to 
identify the impacts of discrimination, social exclusion, and gender transition. The first 
manuscript investigates correlates of both past-year HIV-related sexual risk and sexual inactivity 
among transfeminine (male-to-female spectrum) persons. Genital surgery for gender transition 
was independently associated with lower odds of both outcomes. Discrimination was not 
associated with sexual risk overall, but sensitivity analyses found that correlates differed by type 
of sexual risk behaviour. The second manuscript examines HIV-related sexual risk among 
transmasculine (female-to-male spectrum) persons who are gay, bisexual, or have sex with men. 
Known correlates of sexual risk among cisgender gay and bisexual men were similarly predictive 
of risk in this population, including sexual abuse, stimulant use, and depressive symptoms. The 
third and fourth manuscripts focus on heavy episodic drinking (HED) and illicit drug use, 
respectively, among all transgender Ontarians. HED, cocaine use, and amphetamine use were 
more common among transgender Ontarians than expected based on the age-standardized 
reference population. HED was associated with transmasculine gender and sex work, but not 
with discrimination. Illicit drug use was associated with anti-transgender violence, homelessness 
or underhousing, and sex work. The final manuscript describes the development and validation 
of the InDI, which includes three components measuring anticipated, day-to-day, and major 
discrimination. The bi-national validity and reliability study found consistent evidence of 
construct validity and test-retest reliability. Finally, implications and future research directions 
are discussed.  
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1 Chapter 1: Introduction and Objectives 
1.1 Thesis Objectives 
This thesis aimed to explore the impacts of discrimination on health behaviours (substance use 
and HIV risk) within a Canadian transgender population, and to contribute to the improved 
measurement of discrimination in population health research. Specifically, the thesis had three 
primary objectives: 
Objective 1: To examine discrimination and gender transition factors associated with human 
immunodeficiency virus (HIV)-related sexual risk behaviour among transgender persons in 
Ontario, Canada, including: 
a. transfeminine (male-to-female spectrum transgender) persons. Considering the high 
prevalence of sexual abstinence in this group, associations with both high-risk sexual 
behaviour and abstinence (versus low risk sex) were identified. 
b. transmasculine (female-to-male spectrum transgender) persons who identify as gay, 
bisexual, queer, or who have sex with men. 
Objective 2: To describe the prevalence of hazardous substance use among transgender persons 
in Ontario, Canada in comparison to the age-standardized reference population, and to examine 
associations with discrimination and gender transition. Two outcomes were examined: 
a. Past-year heavy episodic drinking.  
b. Past-year illicit drug use. Based on data availability, disparities with the Ontario reference 
population were estimated for past-year use of cocaine or amphetamines, while predictors 
of illicit drug use were examined within the trans population.  
Objective 3: To develop and evaluate the validity and reliability of the Intersectional 
Discrimination Index, a set of self-report measures of anticipated and enacted discrimination for 
use in intersectional population health research.  
2 
1.2 Thesis organization
The remainder of Chapter 1 consists of a review of literature pertinent to the thesis objectives. 
Chapters 2 and 3 address Objective 1, for transfeminine and transmasculine persons, 
respectively. A version of Chapter 2 is under revision with The Journal of Sex Research. A 
version of Chapter 3 was published in the Journal of Acquired Immune Deficiency Syndromes.1 
Objectives 2a and 2b are satisfied in Chapters 4 (heavy episodic drinking) and 5 (illicit drug use). 
Versions of Chapters 4 and 5 have been published in Drug and Alcohol Dependence2 and 
Addictive Behaviors,3 respectively. Chapter 6 describes the development and evaluation of the 
Intersectional Discrimination Index, as per Objective 3. A version of this chapter will be 
submitted for publication. Finally, Chapter 7 provides an integrated discussion and conclusion.  
Questionnaires, letters of invitation and consent, and Research Ethics Board approval documents 
are included as appendices.  
1.3 Introduction
1.3.1 Defining discrimination 
Public health interest in the impacts of stigma, prejudice, and discrimination on health has 
increased in the past two decades,4 and various definitions and theoretical models of these 
concepts have been developed, often in parallel. According to Link and Phelan,5 stigma involves 
labeling of human differences, cultural beliefs that relate those labels to negative stereotypes, and 
categorization of labeled persons to distinguish "us" from "them," followed by status loss and 
discrimination. They also highlight the role of differential access to power and resources in 
producing stigmatization. While theories of stigma have tended to focus on individual 
characteristics (e.g., deviant behaviour, disease, disability), prejudice frameworks have more 
commonly been applied to race/ethnicity, and other stigmas related to group (i.e., shared within 
family) characteristics.6 These concepts have much in common, and can be subsumed under the 
umbrella of stigma.  
Phelan and colleagues6 developed a typology of functions of stigma that is informative for 
studies of its manifestations and consequences: exploitation and domination (keeping people 
3 
down), norm enforcement (keeping people in), and disease avoidance (keeping people away). 
Others prefer to frame social inequities in health in terms of ‘oppression,’ but these definitions 
also overlap greatly with the stigma concept. For example, Paradies defines privilege/oppression 
as “a societal system in which actors are divided along socially constructed dimensions with 
power unevenly distributed (or produced) based on these dimensions.”7 pg. 144  
Stigma can be considered a fundamental cause of health inequalities8: one that (a) affects 
multiple diseases via multiple pathways in a large number of people; (b) concerns access to 
health-promoting resources; and (c) is robustly related to health inequities across time and 
setting.9 Because new pathways arise to reproduce the relationship between the fundamental 
cause and multiple outcomes, a fundamental cause approach suggests that intervening on those 
mediators will not resolve health inequities over the long-term. Moreover, focusing on estimating 
the impact of one type of stigma on one health outcome is likely to underestimate its effects.8 
However, this does not imply that stigma universally leads to health inequalities between 
dominant and non-dominant groups. For example, studies have repeatedly failed to find evidence 
of mental health disparities between African-Americans and white Americans, despite robust 
findings of mental health-harming effects among African-Americans.10 
Enacted stigma (i.e., inequitable interpersonal or institutional treatment based on stigma) is most 
often referred to as discrimination. Put differently, discrimination has been defined as “all means 
of expressing and institutionalizing social relationships of dominance and oppression”,4 pg. 650 
incorporating institutionalized oppression of social groups, direct or indirect discrimination in 
law and policy, and subtle interpersonal slights. Multiple pathways link stigma and 
discrimination to poor health outcomes. Krieger lists six primary pathways: economic and social 
deprivation; excess exposure to toxins and pathogens; social trauma; health-harming responses to 
discrimination; targeted marketing of harmful commodities; inadequate medical care; and 
ecosystem degradation.4  
1.3.2 Conceptualizing self-reported discrimination and its health impacts 
 Although ecological and multi-level data are increasingly being used to identify the impacts of 
institutional and structural discrimination on population health,11 most research on discrimination 
4 
and health has focused on self-reported discrimination, which is generally interpersonal, direct, 
and overt.4 Such reported discrimination is necessarily perceived discrimination, most often in 
the absence of a visible counterfactual contrast (i.e., knowledge of the treatment one would 
receive in the same situation were all factors but minority group membership held constant).7,12 
Moreover, even perceived discrimination may not be self-reported due to impression 
management and internalized stigma (e.g., the belief that discrimination is just).12,13 Irrespective 
of whether it coincides with objective discrimination, perceived discrimination communicates to 
a target that they are unworthy, threatens their sense of belonging, stigmatizes potentially salient 
group identities, and can contribute to feelings of powerlessness.14 Thus, perceived 
discrimination represents a potential mechanism in the development and maintenance of health 
inequalities within and across population groups, and an important exposure to investigate in 
population health research aiming to ameliorate inequalities.15,16  
Self-reported discrimination is most often conceptualized as a psychosocial stressor,17 informed 
by Lazarus and Folkman’s Transactional Model and Stress and Coping18 and Pearlin et al.’s 
stress process model.19 The Transactional stress model encompasses two primary stages: 
appraisal and coping. The model posits cognitive appraisal processes following an experience, 
wherein an individual first assesses a situation as potentially stressful (e.g., as a threat or loss), 
and then assesses the availability of coping resources. Next, they will enact cognitive and 
behavioural coping efforts to regulate their emotional response to the experience and/or to try 
and change the stressful situation. Pearlin’s stress process model and its more recent 
elaborations20 include three key domains: sources of stress (e.g., discrete event versus ongoing, 
seriousness of threat) that negatively impact self-concept and sense of mastery; social and 
personal resources which mediate the impacts of stress; and finally, symptoms of stress (i.e., 
distress). In addition to precipitating emotional, cognitive, and behavioural responses, chronic 
discrimination may have negative physiologic effects (e.g., elevated cortisol levels).20 
Discrimination is also a key stressor within minority stress theory,21,22 which builds on social 
stress theories by describing the additional burden of stress experienced by sexual and gender 
minorities, and potentially others with concealable stigmas. Meyer21,22 identified four 
interconnected minority stress processes for gay, lesbian, and bisexual individuals, which have 
  
 
5 
 
been extended to transgender persons23 They are (1) external, objective stressors (e.g., acts of 
discrimination), (2) expectations of such stressful events (i.e., anticipated discrimination), (3) 
internalized stigma (negative attitudes towards one’s own sexual or gender identity), and (4) 
concealment of sexuality or gender identity to mitigate stigma.  
Each of these frameworks posit that, as a stressor, discrimination may contribute to distress or 
maladaptive coping strategies, depending on the availability of coping resources such as a 
personal sense of mastery, social supports, or pride in minority identity. Self-reported 
discrimination may also impact health directly or through mechanisms other than stress,4 for 
instance, economic deprivation related to job loss, injury due to hate violence, or lack of medical 
treatment due to discriminatory refusal of care.  
1.3.3 Discrimination and intersectionality  
Intersectionality is a theoretical framework based in African-American feminist scholarship, 
particularly the work of legal scholar Kimberlé Crenshaw.24  She argued that various forms of 
discrimination act in tandem and cannot be understood in isolation from each other, pointing to 
how legal frameworks requiring discrimination claims based on gender or based on race could 
not address experiences of African-American women that were both gendered and racialized. 
Crenshaw argued that single-axis analyses of discrimination distort the experiences of Black 
women whose experiences cannot be reduced to the "sum of their parts" (racism and sexism). In 
a single-axis framework, discrimination is conceptualized by the experiences of otherwise-
privileged group members (e.g., defining sexism as the experiences of white women), through a 
counterfactual definition of discrimination as a situation in which, "but for" a single given 
characteristic, the individual would have had a different outcome. Over the past twenty-five 
years, intersectionality has “travelled” extensively beyond its disciplinary origins,25 including 
applications in qualitative and quantitative public health research.26 
McCall27 has delineated three distinct intersectionality frameworks. Some intersectionality 
scholars reject categories of social difference altogether (“anti-categorical”) while others prefer 
to focus on heterogeneity within a single defined group, such as African-American women 
(“intracategorical”). The version of intersectionality adopted within population health research 
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tends to be the third approach (“intercategorical”), which recognizes categories of social 
difference as socially constructed – yet real in their effects –  and examines relationships and 
inequities between groups defined by multiple categories of difference. In the context of 
population health research, intersectionality frameworks highlight that effects of multiple social 
positions (e.g., race, class, gender), and the bio-psycho-social processes associated with them 
(e.g., racism, sexism) cannot be assumed to reflect simple “addition” of the effects observed for 
each position or process individually. Rather, intersectionality researchers consider the potential 
for qualitative and quantitative interaction between social positions and/or processes in their 
effects on population health.15,28,29  
Despite increasing interest in intersectional frameworks across diverse fields of scholarship,30-33 
quantitative studies of discrimination and health have primarily examined one form of 
discrimination at a time.30,34 Instead, intersectional discrimination research has largely been 
qualitative, with some even arguing that quantitative methods are poorly suited to the study of 
intersectionality.29 As in health inequities research more broadly, quantitative intersectionality 
studies, when conducted, have often been limited by a focus on documenting inequalites across 
groups cross-stratified by social position (i.e., socio-demographic characteristics) rather than on 
understanding modifiable processes that lead to such inequalites.15,16,28,29 More recently, methods 
for quantitative intersectionality research have been identified and summarized,28 and Bauer has 
proposed a research agenda to advance analytic intersectional population health research, 
including the development of intersectional measures of discrimination.15 
1.4 Health impacts of discrimination
In 1999, a systematic review by Krieger35 found only 20 reports in the public health literature 
that assessed self-reported discrimination as a determinant of health. Most studies examined 
impacts of racial discrimination among African Americans, and focused on mental health 
outcomes. A few considered physical health outcomes, chiefly hypertension. Negative 
associations between discrimination and health were most consistent for mental health outcomes, 
but conclusions were limited by heterogeneity in exposure operationalization and measurement. 
By 2014, the field had burgeoned to the extent that Krieger was able to conduct a ‘review of 
reviews’ on associations between discrimination and health,4 finding that evidence of the 
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deleterious effects of discrimination has remained strongest for the impacts of racial and ethnic 
discrimination on negative mental health outcomes. A 2015 meta-analysis of 333 studies on 
racism and health published between 1983-2013 found that racial discrimination was associated 
with negative effects on (in order of effect size) negative mental health, positive mental health, 
general health, and negative physical health.36  
The robustness of findings related to racial/ethnic discrimination is in part a function of research 
focus: most discrimination and health research has examined racial discrimination, primarily 
among African-Americans.4 However, meta-analyses of correlational and experimental data of 
studies examining multiple bases of discrimination published through 2012 found that effects of 
reported discrimination were larger for discrimination based on concealable stigma (e.g., sexual 
orientation, mental illness) than based on visible non-dominant group membership (e.g. racial 
minority status).14 This suggests that focus is warranted on a broader range of discrimination 
experiences (including other forms of discrimination experienced by individuals who also report 
racial/ethnic discrimination).  
In addition to negative mental health, associations between discrimination and health risk 
behaviours have been observed in many studies.4,37-40 However, associations with health risk 
behaviours appear population-, behaviour-, and measure-dependent. For instance, a recent 
systematic review of discrimination and alcohol use highlights that global associations are 
inconsistent, with conclusions depending on the groups being compared, choice of exposure and 
outcome measure, and moderating/mediating factors.40 The authors note that lack of standardized 
discrimination measurement is a substantial obstacle to advancing scientific knowledge in the 
area—if studies using inconsistent measures reach different conclusions, it is impossible to 
determine whether the disagreement is due to differences in casual processes, or simply to 
variation in operationalization of the exposure. The difficulty research participants may have in 
attributing perceived discrimination to specific bases (e.g., race versus gender) also challenges 
the validity of findings that are purportedly specific to each discrimination type.15
Another limitation of the discrimination and health literature is reliance on self-report and cross-
sectional data, which are subject to confounding by personality traits and to reverse-causation 
(e.g., for those with poor health to perceive more discrimination).34 However, evidence to date 
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suggests that while personality traits (e.g., neuroticism) are associated with reporting 
discrimination, associations with health remain robust after control for personality 
characteristics,34 and that discrimination may actually impact health through impacts on 
personality.41 Further, documented prospective associations of discrimination with objective 
clinical end-points and asymptomatic preclinical end-points (e.g., all-cause mortality,42,43 
inflammation12) provide evidence against reverse causality as an explanation for this pattern of 
findings.34 
1.5 Discrimination and health behaviours in transgender populations
1.5.1 Who are transgender persons? 
Transgender (trans) persons are those with a gender identity that differs from their birth-assigned 
sex. This includes individuals who identify as transgender men or women, as well as those who 
consider themselves neither male nor female, and who may use terms such as genderqueer, non-
binary, or Two Spirit.44 To be concise and respectful, this thesis refers to individuals who were 
assigned a female sex at birth but who have a male or masculine gender identity as 
transmasculine, and to those who were assigned male at birth but who have a female or feminine 
gender identity as transfeminine. In the United States, an estimated 0.6% of the adult population 
can be classifed as transgender.45 As no population-based survey in Canada currently includes 
measures to ascertain transgender status, comparable figures are not available in the Canadian 
context.  
Historically, trans identities were pathologized within medicine, and trans people were labelled 
with the psychiatric diagnosis of Gender Identity Disorder. In recent years trans identity has 
increasingly come to be seen as part of a spectrum of gender diversity, that is sometimes, but not 
always, associated with a need for medical or mental health care.46 Reflecting this understanding, 
the most recent edition of the Diagnostic and Statistical Manual of the American Psychiatric 
Association47 replaced Gender Identity Disorder with a diagnosis of Gender Dysphoria. This 
nosologic change places the locus of “disorder” in clinically significant distress or impairment 
related to an incongruence between one’s gender identity and birth-assigned sex or sexed 
embodiment, rather than in the gender identity itself. Gender dysphoria is thus a condition that 
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some trans people will have, at some points in their lives, and for which social and/or medical 
transition is the standard of care. 48,49 However, whether due to personal choice or social 
circumstances, trans people may not take steps to socially or medically transition. An estimated 
30% of trans Ontarians continue to live day-to-day in their birth-assigned gender role.50 Among 
those who do medically transition sex, treatment decisions are individualized. For instance, even 
among those trans Ontarians who described themselves as having completed medical transition, 
only 59% of transfeminine persons and 1% of transmasculine persons had undergone genital 
reconstruction.50 
Although trans people have often been overlooked in health and social research,51,52 there has 
been a rapid growth in scientific interest in transgender health. A review of published 
quantitative trans health research from 2008-2014 found approximately 10 articles per year from 
2008 through 2012, approximately 30 in 2013, and 50 in 2014.44 
1.5.2 Experiences of discrimination among transgender persons 
The growing evidence base on trans health and well-being indicates that trans populations 
experience high levels of stigma, discrimination, and violence.53 For example, in a 2015 survey 
of over 27,000 transgender Americans,54 14% reported being denied equal treatment or service, 
46% reported verbal harassment, and 9% reported physical assault due to transgender status, in 
the past year alone. In Ontario, 98% of trans persons reported any lifetime experiences of anti-
trans stigma (transphobia),55 while lifetime verbal harassment and physical assault related to 
being trans were reported by an estimated 35% and 21%, respectively.56 Stigma and 
discrimination are also evident in primary and emergency healthcare settings, which can lead 
trans people to avoid seeking care.57,58  
In addition, as will be discussed in greater detail later in this thesis, a number of studies have 
found inequalities in the mental, sexual, and behavioural health of trans persons relative to the 
broader population, particularly related to depression, suicidality, HIV/AIDS, and substance 
use.51,59 Within a minority stress framework, a causal link between stigma, discrimination, and 
health inequalities has been proposed.23 A number of recent North American studies have 
evaluated associations between discrimination and health outcomes in trans samples.53 Related to 
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Objectives 1 and 2 of this thesis, the following sections review the literature pertaining to HIV 
and substance use within trans populations, with particular emphasis on the roles of stigma and 
discrimination.  
1.5.3 HIV in transgender populations 
Alarming HIV prevalence levels have been reported among transfeminine persons in some 
settings. A 2012 meta-analysis60 combined seroprevalence estimates from 39 studies in 10 
middle-income and 5 high-income countries (n=11,066) to estimate pooled seroprevalence at 
19% globally, and 22% in high-income countries (n=3,869). These estimates correspond to odds 
of HIV infection 48.8 times higher than the corresponding country-specific estimates for the 
overall population. Behaviourally, this high prevalence has been attributed to frequent 
engagement in condomless receptive anal intercourse with non-trans (cisgender) men.60 As 
discussed in the following section, such behaviour is less common in the Ontario transgender 
population. Studies of transmasculine persons have reported HIV prevalence rates of 0-4%,44,61-67 
with most relying on self-reported status in small samples.  
It is important to note that sampling bias appears endemic to seroprevalence studies in trans 
populations.68 In the aforementioned meta-analysis of transfeminine persons, 32% of all 
participants from high-income countries were sampled in San Francisco or Los Angeles, 
California. Also, most transfeminine studies have oversampled communities disproportionately 
impacted by HIV such as survival sex workers and African-Americans.69-71 Recent studies of 
trans people in the United States employing large, broad convenience samples have found 
reported HIV prevalences ranging from 2-8%.71-74 In Ontario, self-reported HIV prevalence was 
estimated to be 3% among transfeminine persons and 0.6% among transmasculine persons, but 
46% had never been tested.44 In comparison, HIV seroprevalence among all Canadians was 0.2% 
in 2011.75 
1.5.4 HIV-related sexual risk in transgender populations 
In Ontario, HIV risk attributable to injection behaviours appears negligible among trans 
persons.76 Thus, this thesis will focus exclusively on HIV-related sexual risk, which is quite 
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heterogeneous among trans Ontarians.44 An estimated 19% of transfeminine persons and 7% of 
transmasculine persons had engaged in any HIV-related high-risk sexual activity in the past year. 
Sexual risk largely attributable to insertive genital sex among transfeminine persons and almost 
exclusively attributable to receptive genital sex among transmasculine persons. Only an 
estimated 4% of transfeminine persons reported high-risk receptive anal intercourse.  
Prior research has found most HIV-related sexual risk among transmasculine persons to result 
from vaginal intercourse.66,77,78 Among transfeminine persons, however, most studies have 
focused exclusively on anal intercourse with cisgender men, and sometimes only receptive anal 
intercourse.79-81 Where HIV risk attributable to insertive genital sex among transfeminine 
persons has been measured, rates were low. For example, in one study, 2 of 392 transfeminine 
participants reported condomless insertive genital sex.63 Although condomless receptive anal sex 
poses the highest risk for HIV transmission, other forms of unprotected intercourse still present a 
substantial risk for HIV transmission and acquisition,82 as well as for other sexually transmitted 
infections (STIs). The unique sexual risk behaviour profile of Ontario’s trans population, as 
compared to previous samples from the urban United States, highlights the need for research in 
the local context. This variation in patterns of sexual risk may be accompanied by variation in 
contributors to risk behaviour.   
1.5.5 Substance use in transgender populations 
Unlike the relatively straightforward HIV-related outcomes, describing the burden of substance 
use and misuse among trans persons is complicated by the range of outcomes, variable 
definitions, and reporting timeframes employed.51  Further, much published research on 
substance use among trans persons has been conducted in the context of HIV prevention 
research,83-87 in which higher-risk samples are purposefully recruited. These studies have found 
high levels of heavy episodic (binge) drinking and illicit drug use among transfeminine persons. 
For example, in samples recruited New York, Los Angeles, and San Francisco respectively, 25% 
used cocaine use and 60% drank heavily the past six months,84 22% reported past-month 
methamphetamine use,88 and 20% reported past-year methamphetamine use while 30% drank 
heavily in the past six months.83  
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More heterogeneous, mixed-gender convenience samples of trans persons have found higher 
levels of binge drinking and/or illicit drug use among trans persons as compared to cisgender 
survey participants or reference populations, particularly among youth.89-91 Among over 75,000 
college students in the United States, cisgender males were more likely to report any heavy 
episodic drinking, but trans students reported a greater number of recent heavy drinking days 
(incidence-rate ratios comparing cisgender females and males to trans persons were 0.43 and 
0.28, both p< 0.001).89 Compared to cisgender boys and adjusting for other socio-demographic 
characteristics, trans adolescents in a national U.S. online survey were more likely to report any 
use and regular use of alcohol and illicit drugs (adjusted odds ratios [AORs] ranging from 1.42-
1.75, all p<0.01).91  
Less research has focused on substance use disparities between cisgender and transgender adults. 
However, in the 2014 Behavioral Risk Factor Surveillance System (BRFSS) survey, the only 
population-based source of data on substance use among trans adults (in 19 U.S. states),92 they 
were no more likely than cisgender persons to report binge drinking, confirming an earlier 
finding from the 2007-2009 Massachusetts BRFSS.93 However, as alcohol use behaviours vary 
by both sex and gender,94 overall transgender-cisgender comparisons may obscure disparities. 
Methodologically, the BRFSS and other household probability surveys studies may 
systematically under-recruit more marginalized trans persons (e.g., homeless individuals) and 
will misclassify those who are uncomfortable disclosing transgender status to an interviewer.92 A 
recent Canadian survey of gay and bisexual men—a population that is arguably less stigmatized 
than trans persons in the United States—found that 30% would not disclose sexual orientation as 
part of an interviewer-administered population survey.95 Further, BRFSS data pertaining to other 
forms of substance use among trans people have not been published, leaving questions about 
disparities in drug use unanswered.  Related to the objectives of this thesis, the burdens of heavy 
drinking and illicit drug use, as well as disparities with the cisgender population, have not been 
characterized among trans Canadians.   
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1.5.6 Understanding health behaviour disparities in transgender populations 
1.5.6.1 Minority stress  
As described in Section 1.3.2, minority stress theory posits that members of gender minority 
groups will experience a higher burden of negative mental and behavioral health outcomes 
related to social stigma.21,22 The framework also asserts that minority identity and within-group 
solidarity can have protective mental health effects and foster resilience.23  
Empirical research to date, primarily conducted in the United States, has associated exposure to 
transphobia with greater substance use and HIV risk. Scores on a transphobia scale were 
positively associated with condomless receptive anal intercourse with commercial (sex work) 
partners among transfeminine persons in San Francisco (AOR= 2.56, 95% CI: 1.12- 5.87).96 
Again among transfeminine San Franciscans, another study found that higher scores on a 
transphobia measure were correlated with both recent condomless anal intercourse (AOR=1.45; 
95% CI: 1.04, 2.00) and illicit drug use (AOR=1.47, 95% CI: 1.05, 2.04).97 Two studies found 
interactions between youth status and transphobia, such that reporting high versus low levels 
predicted HIV-related sexual risk behaviour among transfeminine youth of colour in San 
Francisco (AOR=3.2; 95% CI: 0.9, 12.8)81 and among trans youth in Ontario (AOR=1.14, 95% 
CI: 1.00-1.20).98 Results in both studies had borderline statistical significance, however sample 
sizes were small (57-113 youth). Among adolescents, transphobic bullying mediated the 
association between transgender status and alcohol or illicit drug use.91 For example, such 
bullying mediated 32.9% (95% CI: 15.8, 50.1) of the effect of trans status on the odds of regular 
non-cannabis illicit drug use. Finally, in a rare longitudinal study of transfeminine adults 
conducted in New York City, transphobic harassment and/or violence was prospectively 
associated with greater substance use (e.g., OR for any cocaine use was 3.17, 95% CI: 2.44, 
4.11),84 HIV-related sexual risk behaviour (e.g., hazard ratio with casual partners= (HR 2.55; 
95% CI: 1.73, 3.75),99 and incident HIV or other sexually transmitted infections (adjusted hazard 
ratio, lagged effect=1.64; 95% CI: 1.02, 2.63).99  
As suggested by the framework of intersectionality, stigma and discrimination based on 
transgender status may act in concert with other forms to potentiate poorer health outcomes for 
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transgender persons who are also racial/ethnic minorities. In the United States, estimates of HIV 
prevalence among African-American and other transfeminine persons of colour are higher than 
among white transfeminine persons—and all other at-risk groups.64,100 Some have speculated that 
transfeminine persons of colour may be more likely to have sex with cisgender men and 
therefore to be at higher risk of HIV acquisition.101 Supporting this hypothesis, one study found 
that the higher HIV incidence among Black and Latina (relative to white) transfeminine persons 
was largely mediated by sexual orientation.102 However, a minority stress approach suggests that 
experiences of racism may also contribute to HIV-related sexual risk. In Ontario, while 
Aboriginal and/or racialized trans persons were less likely than whites to report high-risk sex, 
self-reported racism increased the odds of having had high-risk sex among racialized persons.55 
However, the study’s use of parallel (and potentially overlapping) measures of transphobia and 
racism limited the potential for an integrated analysis of the total effect of discrimination.  
In addition to self-reported stigma and discrimination, research on health behaviours among trans 
people must consider the indirect effects of stigma via experiences of social exclusion and socio-
economic marginalization. For example, approximately half of trans Ontarians reported annual 
incomes under $15,000 CDN,44 and 33% were underhoused,103 while 13% reported being fired 
from a job, and 18% not being hired, due to being trans.104 Unstable housing80 and extremely low 
incomes105 have been associated with sexual risk among transfeminine persons.  In this context, 
trans people report high levels of engagement in sex work,106 including 15% of trans Ontarians 
who reported lifetime engagement in sex work or exchange sex, and 2% who reported current 
employment as a sex worker.44 A meta-analysis found that transfeminine sex workers were more 
likely to be HIV-positive than non-transgender male or female sex workers, but not non-sex 
working transfeminine persons.107 Sex work may not be an independent risk factor for HIV 
acquisition, but rather an indicator of the presence of proximal risk factors related to 
marginalization.107,108 Sex work has also consistently been associated with substance use among 
transgender persons.84,109-111  
1.5.6.2 Syndemics 
Singer112,113 developed the concept of syndemics to describe the interaction among substance 
use, violence, and HIV/AIDS resulting from social marginalization among low-income substance 
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users. He argued that these conditions were not simply co-occurring, but mutually re-inforcing 
(i.e., that they interact synergistically), or in some cases, mutually causal. Syndemics in sexual 
and gender minority communities are theorized to result from minority stress processes that 
unfold over the life course and show associations with perceived stigma.97,114 Although 
syndemics and intersectionality research have largely developed in parallel, they are highly 
compatible. For instance, an intersectional syndemics approach could hypothesize and 
investigate the concentration of interacting health conditions at the intersection of sexual 
orientation, race/ethnicity, and HIV status.115  Syndemic theory has primarily been applied to 
research on HIV infection or transmission risk as a primary outcome, particularly among gay 
men and other men who have sex with men. Clustering psychosocial health problems (polydrug 
use, depressive symptomatology, intimate partner violence, and childhood sexual abuse) have 
been found to be associated with increased rates of HIV infection and HIV-related sexual risk 
behaviour among gay men.116  
Given evidence of high levels of psychosocial health problems and experiences of violence 
amongst trans persons, Operario and Nemoto117 argue that syndemic conditions exist among 
transfeminine persons and must be addressed in efforts to reduce their HIV vulnerability and 
improve their overall health. Little research has specifically sought to test the applicability of 
syndemic theory to HIV risk or substance use in trans populations, with a 2015 review 
identifying 8 studies purporting to employ syndemic theory in trans samples globally.59 One 
study of transfeminine youth found that having two or more potentially syndemic conditions 
(polysubstance use, intimate partner violence, victimization, low self-esteem) was associated 
with increased odds of unprotected anal intercourse (e.g., OR for 2 versus 0 conditions=5.46; 
95% CI: 1.55, 19.12).118 For each additional condition reported by transmasculine persons who 
have sex with men in a Massachusetts study (heavy drinking, polydrug use, depression, anxiety, 
partner violence, childhood sexual abuse), the odds of condomless intercourse were higher, but 
only among those who had socially transitioned gender (AOR=1.79; 95% CI: 1.42, 2.25).119  
Despite the high level of interest and uptake of syndemic theory in the HIV research literature, 
recent work by Tsai has drawn attention to some important conceptual and methodologic 
problems.120,121 The “syndemic count” score approach described above – and used in most 
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published syndemics research – captures neither synergistic interaction nor mutual causation 
between health conditions, but rather, the cumulative effects of an increasing number of 
adversity or health risk indicators.121,122 Further, effects attributed to the number of “syndemic” 
conditions could in fact be driven by the difference between zero conditions and one 
condition.123  
1.5.6.3 Gender affirmation 
Gender affirmation refers to the psychological, social, medical, and legal processes of validating 
one’s own gender identity and acquiring social validation of that identity.51 Research to date, 
almost entirely qualitative, suggests that gender affirmation may contribute to health risk 
behaviours in a number of ways. First, to achieve gender affirmation, trans persons may strive to 
conform to gendered norms of (health) behaviour.124,125 To date, this process has primarily been 
investigated for transfeminine persons, among whom acquiescence in relationships with 
cisgender men124,126 and disordered eating behaviours127 have emerged as risk behaviours related 
to gender norms. Similarly, qualitative studies have identified a need for gender-related 
validation or affirmation from sexual and romantic partners as a potential contributor to HIV-
related sexual risk.124,126,128-130 Sevelius126 argues that transfeminine persons have limited access 
to gender affirmation, yet have increased need for it because of enacted and internalized 
transphobia. Therefore, they may engage in behaviours that increase their access to gender 
affirmation despite health risks, including condomless sex with male partners who provide 
gender validation. For transfeminine persons in primary relationships with female partners who 
are not accepting of their trans identities, outside partners may be an important source of gender 
affirmation.131 Gay and bisexual-identified transmasculine persons have also described seeking 
gender affirmation through sex with men; acceptance and desirability as a gay man is seen by 
some as particularly validating of male identity.66,77 
Lack of social and medical gender affirmation may also contribute to substance use and other 
health risk behaviours as a coping strategy. Medical transition (hormones and/or surgery) is 
associated with reduced mental health symptomology and suicide attempts among trans 
persons.56,132,133 Evidence regarding the impact on both HIV risk and substance use behaviour 
has been more mixed.   
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Among transfeminine persons, two studies reported negative and positive relationships, 
respectively, between transition and substance use.  The first, in San Francisco, found that 
hormone therapy was associated with less non-injection illicit drug use (OR=0.2; 95% CI: 0.1, 
0.4), while hormone therapy (OR=0.4; 95% CI: 0.3, 0.7), breast augmentation surgery (OR=0.2; 
95% CI: 0.2, 0.3), and genital surgery (OR=0; 95% CI: 0, 0.2) were associated with less binge 
drinking.134 However, among cohort participants in New York, both social transition (presenting 
in felt gender) and hormone therapy were associated with any substance use, the number of 
substances used, and the number of past-month substance use days.84 For example, the odds of 
any substance use were 1.29 times as high among those presenting in their felt gender (95% CI: 
1.20, 1.38), and 3.08 times as high (95% CI: 2.10, 4.51) among those on hormone therapy. In the 
same cohort, sexual risk behaviour was more common among those presenting in their felt 
gender (OR for condomless intercourse with commercial partners= 1.22; 95% CI: 1.12, 1.33) and 
those on hormone therapy (OR for condomless intercourse with casual partners= 2.97; 95% CI: 
1.84, 4.79).99 In the San Francisco study, neither hormones nor surgeries were associated with 
sexual risk behaviour.134   
Finally, the social and physiological effects of gender transition may potentiate health risks. For 
example, transmasculine persons frequently report a perception that testosterone use leads to 
increased sex drive, and increased interest in sex with men.74,77,135,136 Among transfeminine 
persons, feminizing hormones may cause erectile difficulties and thus challenges with condom 
use,131,137,138 but can also contribute to reduced sex drive and activity.136,138  
1.5.6.4 Rationale for examining the impacts of discrimination and gender transition on 
transgender health behaviours in Canada 
As summarized above, trans persons face high levels of discrimination and social exclusion 
globally. In the United States and in other countries for which data are available, inequities in 
mental, sexual, and behavioural health are evident. However, little is known about the prevalence 
of substance use risks among trans people in the Canadian and Ontario contexts. Further, 
predictors of both substance use and HIV risks have not been evaluated in a Canadian trans 
population (with the exception of a previous thesis by Marcellin which focused on self-reported 
racism and transphobia as predictors of HIV risk55,98). In the United States, observed inequities 
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have been linked to experiences of stigma and discrimination. Within trans populations, access to 
gender transition and affirmation may also play a role in shaping health behaviour. Yet, these 
factors have seldom been analyzed in an integrative manner. Moreover, trans people’s 
experiences in Ontario, relative to the United States, may be differentially shaped by access to 
publicly insured health care, as well as human rights protections (e.g., under the Ontario Human 
Rights Code139). Thus, the current thesis seeks to fill these gaps in knowledge pertaining to the 
health of trans Ontarians, with the aim of informing interventions to prevent hazardous substance 
use and new HIV infections.  
1.6 The need for intersectional discrimination measures 
1.6.1 Current approaches to measuring discrimination  
Objective 3 of this thesis addresses the measurement of discrimination from an intersectional 
perspective. Corresponding to the proliferation of discrimination research is a growing set of 
instruments to measure discrimination, primarily focused on racial/ethnic discrimination. A 2006 
review identified 152 self-report instruments for racism.38 Most (86%) were developed in the 
United States, and 69% focused exclusively on African-Americans, limiting utility for research 
with ethnically diverse samples globally. Highlighting the importance of appropriate 
measurement of the discrimination construct, among the three most commonly used measures 
(representing about one-quarter of studies), the proportion of statistically significant findings 
ranged from 30-86%.38 
In recognition of the need for instruments suitable to population health research with ethnically 
diverse samples, efforts have been made to develop and evaluate the validity of measures for 
racial/ethnic discrimination experiences across ethno-racial groups, including immigrant 
populations,140,141 who may attribute discrimination to language rather than race/ethnicity.4 
However, these efforts have rarely extended to creating instruments that can tap multiple forms 
of discrimination.142  
Single-item measures of intersectional discrimination have been described in the literature (i.e., 
in which either the base question or the sole question directly asks if the respondent has 
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experienced discrimination143). Single-item measures that leave time and space unspecified, 
however, will contribute to poor recall and under-reporting.144 To our knowledge, only one multi-
item instrument has been developed specifically to assess discrimination across stigmatized 
social groups from an intersectional perspective. Bastos et al.145 developed such a measure for 
use in the Brazillian context, and evaluated its validity in a university student sample in Brazil. It 
assesses so-called “explicit” interpersonal discrimination, ranging from minor interpersonal 
slights to events that may affect life chances, such as employment discrimination. After each of 
18 questions that ask about unfair treatment (without language regarding social position or 
discrimination) a sub-item asks if the respondent attributes the experience to discrimination 
based on several listed social positions. While this measure makes an important contribution, a 
few key limitations are evident for adaptation in the Canadian context, including generic 
language that encourages reporting of non-discriminatory unfair treatment, items specific to the 
student context, and items that appear intended to tap experiences based primarily on 
race/ethnicity or class (e.g., being mistaken for an employee rather than a customer). 
Beyond this example, when investigating discrimination based on multiple social positions, 
researchers have employed attribution-specific scales, parallel versions of the same scale with 
multiple attribution-specific stems, or adaptations of popular measures that were developed to 
assess race/ethnicity-based discrimination (without attribution in the stem). In the following 
sections, each approach is briefly described.  
1.6.1.1 Attribution-specific discrimination measures 
Attribution-specific discrimination measures abound, including those related to discrimination 
against specific ethno-racial groups,146,147 ethno-racial minorities overall,140,148 women,149 sexual 
minorities,150-152 gender minorities (i.e., transgender persons),55,153 and people living with mental 
illness or substance use disorders.154-156 To examine the effects of intersecting forms of 
discrimination, some studies have employed two or more such measures. 
For example, in the area of trans health, two recent studies employed non-parallel measures of 
transphobia and racism on HIV risk behaviour 55 and mental health.157 In the study of HIV risk 
among trans Ontarians, Marcellin et al. examined the interaction between racism and 
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transphobia, using continuous scale scores.55 In the latter mental health study, the combined 
effects of racism and transphobia were of interest. Given the different items and response scales, 
this required categorizing respondents into those experiencing high versus low levels of each 
racism and/or transphobia. In both cases, the scales included overlapping items (e.g., sexual 
objectification, health care discrimination), and thus the independence of these exposures is 
unclear. In addition, such measures are clearly unsuitable for use in broader population surveys 
in which a small minority of respondents will be transgender. 
1.6.1.2 Parallel, attribution-specific versions of the same discrimination measure 
Bogart and colleagues developed the Multiple Discrimination Scale158 to assess race/ethnicity, 
HIV, and sexual orientation discrimination concurrently among Black and Latino men who have 
sex with men living with HIV. It includes ten binary items regarding interpersonal discrimination 
and violence which are asked repeatedly, with each of the three scales employing a different 
stem. Each scale is scored independently, to create separate but comparable measures of each 
discrimination type. Another study of intersecting race/ethnicity, HIV, and gender stigma among 
women living with HIV employed parallel measures of race and gender discrimination adapted 
by Clark et al.159 from Williams’ Everyday Discrimination Scale,160 along with a separate 
measure of HIV stigma.161 Following a similar approach, some investigators have adapted 
Krieger et al.'s Experiences of Discrimination (EOD) questionnaire,162 a popular38,40 measure 
designed to assess racial/ethnic discrimination among working-class Black, Latino, and White 
U.S. adults, to investigate multiple forms of discrimination. The EOD asks respondents: “Have 
you ever experienced discrimination, been prevented from doing something, or been hassled or 
made to feel inferior in any of the following situations because of your race, ethnicity, or color?” 
across nine situations (e.g., seeking employment, healthcare, or housing; in public spaces).162 
When adapted, the end of the question has been modified to ask about discrimination based on 
gender, sexual orientation, or other factors, with respondents asked to complete the measure for 
each social position. 163-165  
Such measures suffer from a few important limitations. The response burden of being asked to 
answer the same questions multiple times (for each social position of interest) must be 
considered. This approach also assumes that respondents can clearly identify and report the 
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reason for being discriminated against,142 contrary to the expectations of intersectionality 
theory.29 Further, to an even greater extent than the use of multiple, non-parallel discrimination 
measures, this approach may facilitate reporting of a single event or experience multiple times 
(e.g., being denied employment based on race and based on gender). Thus, the validity of 
treating the subscales as independent exposures is questionable, as is summing responses to 
estimate the overall frequency of discrimination. Indeed, in recent research using adapted EOD 
items to explore the effects of race/ethnicity, gender, and sexual orientation discrimination on 
mental health and substance use outcomes,163,164 discrimination was coded as experiencing 
sexual orientation discrimination only, experiencing two types of discrimination, or experiencing 
three types. Given that the original items included frequency information, this represents a 
substantial loss of information.  
1.6.1.3 Adapting “unfair treatment” race/ethnicity-based discrimination measures 
The Everyday Discrimination Scale (EDS) by Williams et al.160 inquires about unfair treatment 
in interpersonal contexts. A sample item asks respondents how often they “…are treated with 
less respect than other people are”. Rather than inquiring about unfair treatment based on social 
status or position initially, a follow-up item asks the respondent “what do you think was the main 
reason for these experiences”, with a list of options. However, some surveys have modified the 
original wording with a preface that primes the respondent to answer with respect to 
discrimination (e.g., “how often have you experienced each of the following types of 
discrimination”).166,167 Specific reference to discrimination in the stem may be important, as a 
study of Asian-Americans found that almost 1/3 of respondents reporting no generic “unfair 
treatment” did report racial/ethnic discrimination when more specific language was used.168 
Williams et al. also developed a measure of major discrimination, with nine items probing 
“unfair” treatment in specified contexts (e.g., “…have you ever been unfairly fired”), followed 
by the same attribution question as the EDS. However, the EDS is often used in isolation, 
without the corresponding major discrimination questions.34,169 This is problematic, as major 
discrimination events must be understood in concert with more chronic, ‘everyday' stressors in 
order to fully comprehend the impact of discrimination on health.39  
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As the base questions do not refer to social position, the Williams Everyday and Major 
discrimination items have been adapted for studies of multiple forms of discrimination by 
revising the attribution question to allow or encourage multiple attributions167,170 (e.g., “what do 
you think are the main reasons…”167). In other cases, the stem is not altered but interviewers 
record additional attributions if they are provided.166,171 Irrespective of the exact wording, the 
measures’ format allows investigators to model the effects of (a) total discrimination burden 
irrespective of attribution,166,170,172 (b) the number of grounds discrimination is attributed to,171,173 
and/or (c) variation in the effects of discrimination based on the grounds it is attributed 
to.166,168,174 However, with respect to the third approach, evidence indicates that the health effects 
of discrimination (when measurement is standardized) do not necessarily depend on the grounds 
to which it is attributed.34 
1.6.1.4 The need for intersectionality in the development of multiple-basis discrimination 
measures   
This overview of current practices in measuring discrimination has shown that developers of 
discrimination measures have infrequently taken an intersectional perspective.15 Intersectional 
population health research has sometimes drawn on secondary data sources in which 
discrimination was assessed via multiple, non-intersectional indices, with associated analytic 
limitations. In other cases, a single instrument has been employed, but one which was not 
initially intended to demonstrate content validity across different kinds of discrimination. Thus, 
both analytic flexibility and content validity may be improved if new measures are developed 
within an intersectional framework.  
Considering evidence of attributional ambiguity among members of groups who experience 
multiple forms of stigma,29,175 intersectional measures would ideally not require participants to 
disaggregate discrimination experiences based on the attribute being targeted. Whether posed in 
the stem or in a follow-up question, these attribution items pose a high cognitive and 
psychological burden, and measures that require attribution in the stem may lead to under-
reporting.176 Moreover, single-axis or select-axes measures will underestimate the overall 
prevalence of discrimination experiences and their health effects. Instead, global measures of 
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discrimination could be used, with social status and position data cross-stratified to analyze the 
intersectional distribution and effects of discrimination.15 
To ensure construct validity across intersecting groups, global discrimination measures require 
attention to the commonalities, as well as the differences, in experiences of discrimination across 
stigmatized groups. This is evident from the literature on developing race/ethnicity-based 
discrimination measures for use with multiple ethnic groups. In some cases, measures developed 
for use with African-Americans have been adopted for other populations without changing any 
of the items.141,177,178 This is problematic as such measures (e.g., the Williams Everyday 
Discrimination Scale160) do not include items addressing common manifestations of 
discrimination for non-African-American and/or immigrant ethno-racial minority groups, 
including discrimination related to language or accent, nativity, and “positive” stereotypes.177 
Conversely, measures designed for Asian-Americans, for example, would be too specific and 
thus unsuitable for comparative research or population health surveys.141,177 
Even within a single target ethno-racial group, these measures may exhibit bias related to 
intersectional social positions. The Williams Everyday and Major discrimination measures were 
developed with the intention of measuring racial discrimination experienced by African-
Americans.160 “Everyday” items probe disrespectful or discourteous treatment; being treated as 
frightening, unintelligent, inferior, or dishonest; and being called names or threatened. Among 
African-Americans, a study found evidence of gender bias.179 Most items were endorsed by a 
higher percentage of men versus women, and the proportion of variance explained by a latent 
discrimination variable was higher for men. The authors note that some items are specific to 
stigmas against African-American men (e.g., being perceived as frightening or criminal), while 
none refer to gendered forms of racism that may be more commonly experienced by women 
(e.g., in romantic relationships).  
More broadly, to be applicable to discrimination based on a range of social statuses or positions, 
items should sample from within all dimensions of the typology of stigma described in Section 
1.1.1. Race/ethnicity-based discrimination items, as described above, appear to reflect 
exploitation and domination to a greater extent than norm enforcement or disease avoidance. The 
latter are particularly salient for stigmas related to characteristics considered voluntary and 
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mutable (e.g., sexual orientation, transgender identity), or threatening to the perpetrator’s sense 
of well-being (e.g., mental illness, infectious disease).5  
1.6.2 The need to consider multiple dimensions of discrimination 
Scholars of stress have emphasized the need to measure stressors comprehensively to identify 
their full effects on health,180 including those that differ with respect to chronicity, viewed on a 
spectrum from continuous to discrete events, and with respect to level, from micro to macro (e.g. 
interpersonal slights to structural impediments).181 As different types of discrimination may 
produce different psychophysiological responses, and in turn different health outcomes, some 
have cautioned against combining multiple types of discrimination into a single measure.41  
1.6.2.1 Day-to-day and major discrimination 
Following the classification scheme within social stress theory, major discrimination events 
might be considered acute stressors – discrete events that are ‘objectively’ stressful – while day-
to-day discrimination is akin to a chronic stressor – a subjective experience that lacks a clear 
time frame and may be either ongoing or repeating.182 The measures developed by Williams et 
al.160 are unique in separating major and everyday discrimination into separate scales. Consistent 
with the prediction of social stress theory that chronic stressors are particularly pernicious,183-185 
when employing both major and day-to-day discrimination components, the latter has been 
found to more strongly predict psychological distress.37,160,166 However, this could also reflect the 
stronger impact of more recent experiences, as the Williams measure assesses major 
discrimination over the lifetime and everyday discrimination over an unspecified timeframe, 
which is likely to be perceived as contemporaneous.166 Regardless, these findings highlight the 
importance of considering both chronicity and timing in developing discrimination measures. 
Domains in which discrimination occurs should also be incorporated in measurement (e.g., 
home, justice system, health care, in public). This is critical for cognitively grounding survey 
items.4 In addition, a meta-analysis of experimental studies that manipulated perceived 
discrimination (e.g., by telling subjects that a confederate was motivated by racial prejudice) 
revealed that only studies assessing repeated (versus single-event) discrimination had a 
  
 
25 
 
significant effect on mental health.14 This indicates that discrimination measures should include 
assessment of frequency. Knowledge about the domains in which discrimination occurs is also 
needed to inform efforts to prevent discrimination, and to monitor trends over time. Researchers 
are advised to consider both domains and junctures at which discrimination may occur within 
institutions (access, functioning, and movement, e.g., getting a job, evaluation within the 
workplace, promotion).4,35,144 When multi-item measures are being used, adequate coverage of 
domains is required to avoid underestimating discrimination by sampling from a small frame of 
the discrimination ‘universe’.186 Finally, measurement should include traumatic or violent events 
based on social position, which are often excluded from discrimination measures.34,39,176  
1.6.2.2 Anticipated discrimination 
As posited by social and minority stress theories, discrimination can constitute a chronic stressor 
in the lives of stigmatized persons even without direct experience of discrimination events, 
because of stress related to the possibility of experiencing it in the future.21,22,181 Anticipated 
discrimination may lead minority group members to experience anxiety and/or a high level of 
vigilance in interactions with dominant group members or institutions, taxing coping 
resources.21,176 Correlational and experimental studies have found that anticipated discrimination 
is associated with psychological distress and cardiovascular stress responses.187,188  
Of the limited number of studies related to anticipated discrimination,176 some have investigated 
impacts of stigma consciousness or awareness.88,189 While stigma consciousness is also related to 
distress among members of target groups,189 one can be aware of stigma against members of 
one’s group without worrying about facing discrimination personally.190,191 Anticipated 
discrimination also differs from internalization of stigmatizing attitudes about one’s own group, 
which has been measured and studied extensively in sexual minorities.152 An individual can 
anticipate stigma without having a negative self-image related to the stigmatized status.187 
Further, in some cases anticipated discrimination is conflated with responses to anticipation, or is 
assumed to result only from experienced discrimination. For example, Williams et al.160 assessed 
vigilance and consequent behaviour alteration only among respondents who reported 
experiencing enacted discrimination. Considering these research gaps, stress related to 
anticipated discrimination has been identified as an emerging research priority.34  
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1.7 Data sources
This thesis employs three datasets to achieve its objectives. Each data source is described briefly 
below; additional details are provided in the respective manuscripts.  
1.7.1 Trans PULSE Project 
Chapters 2 through 5 draw on data from the Trans PULSE Project, a community-based, mixed 
methods research project that began in 2005. Project partners included unaffiliated community 
members, The University of Western Ontario, Wilfred Laurier University, Sherbourne Health 
Centre, Rainbow Health Ontario, and The 519 Church Street Community Centre. This thesis 
focuses on the Trans PULSE respondent-driven sampling survey funded by the Canadian 
Institutes of Health Research. Ethics approval was obtained from The University of Western 
Ontario and Wilfred Laurier University. In 2009-2010, 433 trans Ontarians participated in the 
cross-sectional survey through a self-administered questionnaire, completed online or using a 
visually identical paper copy (see Appendix A).  
Participants were recruited through respondent-driven sampling (RDS), an innovative method for 
sampling hidden populations, for whom a sampling frame cannot be enumerated.192,193 RDS is a 
modified chain-referral sampling method, in which participants recruit their peers. This aids in 
the recruitment of stigmatized populations, which may be unwilling to identify themselves to 
researchers. In addition to facilitating recruitment of hidden populations, RDS analytic methods 
allow for the generation of asymptotically unbiased estimates and confidence intervals for the 
networked target population through weighing on recruitment probabilities.194 RDS II weights 
are based on personal network size (the number of eligible persons known, representing the 
number of possible recruitment paths).195 Eligible participants needed to be 16 years of age or 
older; living, working, or receiving health care in Ontario; and identify as trans following a broad 
definition. Recruitment began with 16 diverse seed participants, who were each given three 
coupons for recruitment of their peers. Upon completing the survey, participants were given 
three coupons for further recruitment.  
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1.7.2 Canadian Community Health Survey 
In Chapters 4 and 5, data on the past-year prevalence of heavy episodic drinking, cocaine use, 
and amphetamine use among Ontarians aged 16+ in 2009-2010 were obtained from Statistics 
Canada’s Canadian Community Health Survey.196 The CCHS is an ongoing multi-stage, multi-
mode, stratified, cluster sampling cross-sectional survey of Canadians aged 12 and above. The 
sampling frame covers approximately 97% the Canadian population (excluding institutionalized 
persons and those living on First Nations reserves). To date, measures of transgender status or 
identity have not been included in the CCHS. Respondent sex/gender is classified as male or 
female, usually classified based on the interviewer’s assumption. 
1.7.3 Understanding Social Experiences and Health Survey 
Chapter 6 reports on partial findings of the Understanding Social Experiences and Health 
Survey. The survey’s primary objective was to evaluate the validity and reliability of the 
Intersectional Discrimination Index (InDI). A secondary objective was to collect additional data 
on indicators of social status and position, targetable attributes (i.e., visibility of minority status) 
and mental and behavioural health outcomes (psychological distress, smoking, anxiety, and 
hazardous drinking) for proof-of-concept analyses demonstrating the potential uses of the InDI. 
Legerweb, a market and academic research firm, was hired to collect data through their online 
survey panels in both Canada and the United States. Baseline data were collected between 
August and November 2016 from 2642 adults aged 18+, including 1065 in Canada and 1577 in 
the United States. As described in Chapter 6, quota sampling was employed with the aim of 
achieving approximately equal numbers of participants from six major ethno-racial groups, and 
an oversample of sexual and/or gender minorities. To assess test-retest reliability of the InDI, a 
subsample of 150 participants (83 in Canada and 67 in the United States) completed a follow-up 
survey between three and six weeks after baseline. Ethical approval was obtained from the Non-
Medical Research Ethics Board at the University of Western Ontario (see Appendix E).  
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2 Chapter 2: HIV/STI risk and sexual inactivity among transfeminine 
persons: A Canadian respondent-driven sampling survey 
2.1 Introduction
Available data indicate an extremely high burden of HIV infection among transfeminine (i.e., 
male-to-female spectrum transgender) persons. A 2012 meta-analysis1 found pooled HIV 
seroprevelance of 19% among 11,066 transfeminine persons in 15 countries. Sampling bias 
appears endemic to seroprevalence studies in urban North American transfeminine 
communities;2 however, studies of more heterogeneous and geographically dispersed transgender 
(trans) populations have been limited to self-reported HIV status. In previously published results 
from the Trans PULSE study, 3% of transfeminine persons identified as HIV-positive, but 42% 
had never been tested; only 19% had engaged in any HIV-related high-risk sexual activity in the 
past year, with insertive vaginal intercourse (i.e., a transfeminine person using her penis for 
vaginal penetration) being the largest contributor.3  
Minority stress theory4 posits that health risk behaviors among sexual and gender minorities are 
attributable to the additional burden of stigma-related stress these groups face. Exposure to anti-
trans stigma and violence has been associated with condomless anal intercourse5,6 and incident 
HIV/STI.7 Coping responses such as substance use can further increase sexual risk.8,9 
Discrimination in education and employment contribute to high levels of poverty, unstable 
housing, and survival sex work, which in turn exacerbate HIV/STI vulnerability.3,8 In addition, 
sexual relationships can offer affirmation of gender identity for transfeminine individuals who 
often face invalidation, and the need for such affirmation may take precedence over HIV/STI 
prevention.10  
Although public health research has emphasized the role of stigma in potentiating sexual risk, 
stigma may also serve to limit sexual engagement. In Ontario, half of transfeminine persons 
reported no past-year sex partners: more than twice the proportion who had HIV 
transmission/acquisition risk.3 Periods of abstinence have been associated with health-promoting 
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behaviors among adults.11 However, determinants and consequences of sexual inactivity in a 
population with average levels of sexual activity are unlikely to reflect the experiences of 
sexually stigmatized groups. Transfeminine persons face threats of rejection, stigma, and 
violence when disclosing trans status to potential sexual partners, as well as fetishization.12 Body 
image concerns related to gender incongruence can also lead to avoidance of sex,13 as can 
reduced sexual desire or function related to feminizing hormone therapy and surgical 
complications.13,14 In the cisgender (non-trans) population, female sex,15 higher education,15 
depression,16 and sexual abuse17  are associated with low desire and inactivity.  
Sexual health studies among transfeminine persons have primarily sampled patients accessing 
hormonal and surgical treatments, while HIV/STI studies have primarily sampled trans women 
who have sex with men. These two groups do not represent Ontario’s transfeminine population, 
among whom only 23% had sex with a cisgender man in the past year12 and 47% had never used 
feminizing hormones.18 Addressing the limitations of both urban convenience and clinical 
samples for understanding the spectrum of sexual health, the present study draws on a 
respondent-driven sampling study of trans people in Ontario. Extending our team’s past 
descriptive research on transfeminine sexualities12 and trans persons’ HIV risk,3 we sought to 
identify factors associated with both past-year HIV/STI-related sexual risk and inactivity among 
transfeminine persons. Of primary interest were the potential impacts of discrimination and 
other forms of social exclusion on these outcomes, however, for this first exploratory analysis of 
these outcomes in a Canadian population we also examined associations with gender transition 
and other potential socio-demographic and psychological determinants of trans sexual health. 
2.2 Methods
2.2.1  Study Design and Participants 
The Trans PULSE community-based participatory research project surveyed 433 trans Ontarians 
in 2009-2010 using respondent-driven sampling (RDS). RDS is a modified chain-referral 
sampling method for hidden populations.19,20 In addition to facilitating recruitment of hidden 
populations through the use of peers, RDS analytic methods can produce asymptotically unbiased 
point estimates for the networked target population.21 We used RDS II weights, which are 
estimated as the inverse of the number of target population members known, to adjust for unequal 
recruitment probabilities due to personal network size.  
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Participants completed a self-administered questionnaire, using visually identical online or paper 
versions. Eligible participants needed to be 16 years of age or older; live, work, or receive health 
care in Ontario; and identify as trans following an inclusive definition.  Recruitment began with 
16 diverse seed participants selected from the study’s community advisory committee who were 
each given three coupons for recruitment of their peers. Upon completing the survey, participants 
were given three coupons for further recruitment. Twenty-two seeds were added after 4 to 5 
waves of recruitment were obtained; maximum chain length was ten waves beyond the seeds. All 
but seven seeds were productive (i.e., recruited at least one participant). A recruitment network 
diagram has been published previously.3 
Ethics approval was obtained from The University of Western Ontario and Wilfrid Laurier 
University. Gender spectrum was classified as transmasculine (i.e., assigned female at birth; 
n=227) or transfeminine (i.e., assigned male at birth=205), including individuals who identified as 
neither men nor women. This analysis includes 171 transfeminine participants who had ever had 
sex and provided sufficient data (17 participants had no sexual experience and 17 were missing 
data).  
2.2.2 Measures 
Demographic and background factors. Participants indicated their age, education, social 
transition status (living in felt gender full-time, part-time, or not at all), surgical history, hormone 
use, and the frequency with which they were socially perceived as cisgender. Ethnoracial group 
was coded as Aboriginal, non-Aboriginal racialized (i.e. person of color), or white based on 
answers to multiple check-all-that-apply items. Residence in metropolitan Toronto (Ontario’s 
largest urban center) was ascertained by the first letter of the respondent’s postal code. Income-to-
needs ratio was calculated by dividing the mid-point of household income categories by the 
number of household members being supported. Sexual attraction was dichotomized as primarily 
attracted to men versus primarily attracted to women, multiple genders, or not sexually attracted 
to others. Background variables included sexual abuse (any unwanted sexual contact before age 
16) and religiosity of upbringing (quite or extremely versus fairly or less). Self-reported HIV
status was measured, but not included in analyses because of small cell sizes. As previously
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reported, an estimated 3% of transfeminine Ontarians reported being HIV-positive, although only 
40% had been tested in the previous two years.3  
Social exclusion and inclusion. A scale of perceived transphobia (Cronbach’s a= 0.81) included 
items pertaining to external (e.g. employment discrimination) and internalized (e.g. fear of dying 
young) dimensions of trans-related discrimination.22 Participants indicated lifetime experiences 
of transphobic physical or sexual assault, and harassment or threats. Social support was measured 
with the Medical Outcomes Study scale;23 a= 0.97 in our data). Perceived parental support for 
gender identity or expression was dichotomized to reflect the presence of potentially protective 
strong support, including expected support for those who had not yet disclosed their gender 
identity. Involvement in the local lesbian, gay, bisexual, and transgender (LGBT) community was 
coded dichotomously based on participant report of past-year LGBT event attendance or group 
membership. Attendance at a trans-specific bar or club night was included as a separate variable, 
as these events more often emphasize sexual partner seeking.   
Substance use, mental health, and sexual agency. Problematic alcohol use was operationalized 
as a score of 2 or greater on the CAGE short screener.24 Stimulant use was defined as any past-
year use of cocaine, crack, crystal methamphetamine, or other amphetamines. Center for 
Epidemiological Studies Depression scale25 scores were categorized into low (<16), moderate 
(16-26), and high (27-60) symptomatology (a= 0.93 in our data).  Sexual anxiety, fear, and 
satisfaction (a= 0.92; 0.84; 0.96) were assessed with the relevant subscales of the 
Multidimensional Sexual Self-concept Questionnaire.26 The research team developed a seven-
item measure of trans-related body image worries (a=0.80), and an eight-item trans-specific 
condom/barrier self-efficacy scale (a=0.92) including items such as “…how certain are you that 
you could ask a non-trans partner to use a protective barrier [for example, a condom, dental dam, 
glove, or plastic wrap]?”. 
HIV/STI-related sexual risk and sexual inactivity.  Past-year sexual risk behaviour was 
categorized as no risk (abstinent), low risk (only oral sex, vaginal/anal sexual activities without 
fluid exposure, or fluid-exposed vaginal/anal sex with an HIV-seroconcordant spouse or long-
term partner in a monogamous relationship), or high risk (fluid-exposed vaginal/anal sex outside 
of a seroconcordant, monogamous relationship).  
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2.2.3 Statistical analysis 
Weighted frequencies and associated 95% confidence intervals were calculated in SAS 9.3.1.27 
Confidence intervals were estimated using Taylor linearization and adjustment for clustering by 
shared recruiter. Odds ratios were estimated with weighted logistic regression models using a 
domain analysis in SAS PROC SURVEYLOGISTIC. Polytomous models estimated effects for 
past-year sexual inactivity or (separately) high-risk sex, with low-risk sex as the referent. After 
estimating bivariate associations, we built a model containing all demographic and background 
variables to identify independent demographic predictors.  Next, we estimated adjusted odds 
ratios separately for each of the social exclusion/inclusion and mental health, substance use, and 
sexual agency variables of interest.  To control for non-modifiable factors and to reduce 
confounding, these models were adjusted for variables with p<0.25 in the demographic and 
background model.28 Social transition status was included as a covariate regardless of p-value, 
because of its potential to confound associations between trans-specific experiences and the 
outcomes.  
We did not enter all variables into a multivariable model because of the exploratory nature of the 
analysis, the multitude of potential mediated pathways and consequent risk of adjusting for 
mediators, multicollinearity, and the relatively small sample size. For multivariable analyses 
only, simple imputation of the mean or mode was used for independent variables with less than 
10% missingness. One variable (childhood sexual abuse) had 12.2% missing, and was imputed 
using individual marginal predicted risks of sexual abuse (rounded to 0 or 1) generated from a 
logistic regression model.  
Approximately half of sexual risk was attributable to condomless vaginal intercourse as the 
insertive partner, and we hypothesized that predictors of this behavior could diverge from other 
forms of sexual risk. Therefore, we conducted a sensitivity analysis by repeating regression 
analyses with a more narrowly defined risk outcome, reclassifying condomless insertive vaginal 
intercourse into the “low risk” category (for proof-of-concept, not to imply that such behavior 
necessarily presents low HIV/STI risk). Adjusted odds ratios were estimated using the same set 
of adjustment variables as in primary analyses.   
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2.3 Results
Among transfeminine people in Ontario age 16 and over, 11.7% (95% CI: 5.0, 18.4) had never 
engaged in partnered sex (and were excluded from the following analysis). Of those who had 
ever had sex, 40.8% (95% CI: 28.9, 52.6) reported no past-year sex partners, 38.3% (95% CI: 
26.7, 49.9) engaged in low-risk sex, and 20.9% (95% CI: 11.7, 30.2) had at least one sexual 
encounter that could pose high HIV/STI-related risk. Approximately half of high HIV/STI-
related sexual risk was attributable solely to vaginal intercourse as the insertive partner: 9.9% 
(95% CI: 3.0, 16.9) had sexual risk related to anal intercourse or receptive vaginal intercourse. 
Data on HIV testing and self-reported status have been previously published;3 in this analytic 
subgroup three-quarters identified as HIV-negative (75.2%, 95% CI: 64.2, 86.2) and 1.2% (95% 
CI: 0.0, 3.0%) as HIV-positive, while 23.6% (95% CI: 12.7, 34.6) did not know their status. 
While analyzed as a single set of polytomous models (n=171), results for the two outcomes are 
presented in separate tables for clarity. Findings for the first outcome – HIV/STI-related risk 
behaviour– as well as weighted variable frequencies are presented in Tables 2.1 and 2.2. Crude 
odds of sexual risk were higher among those not living in their felt gender. In the multivariable 
model including all demographic and background variables, living in Toronto (AOR= 0.25, 95% 
CI: 0.07, 0.93) and having completed genital surgery (AOR=0.08, 95% CI: 0.02, 0.46), were 
statistically significantly associated with lower odds of HIV/STI risk behaviour. After adjusting 
for demographic and background factors, attending trans-specific club or bar nights (AOR=5.11, 
95% CI: 1.46, 17.94) was associated with sexual risk, while greater sexual anxiety (AOR=0.59, 
95% CI: 0.35, 0.97) and higher condom self-efficacy (AOR=0.54, 95% CI: 0.34, 0.88) were 
associated with lower odds of HIV/STI risk behaviour. Neither transphobia scale scores nor 
transphobic violence were associated with HIV/STI risk behaviour. 
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Table 2.1: Weighted demographic and background characteristics of transfeminine persons in Ontario, Canada and 
associations with high HIV/STI sexual risk versus low-risk sex (n=171) 
Weighted frequencies Bivariate associations Full modela 
% or x̄     95% CI OR† 95% CI† AOR† 95% CI 
Age (years) 38.7 (34.8, 42.6) 1.05 (0.99, 1.10) 1.04 (0.99, 1.11) 
Ethnoracial group 
    Aboriginal 
    Non-Aboriginal white 
    Non-Aboriginal racialized 
 9.6 
84.3 
 6.1 
(2.6, 16.6) 
(76.7, 92.0) 
(2.2, 10.0) 
0.14 
1.00 
1.03 
(0.02, 1.17) 
(0.24, 4.46) 
0.26 
1.00 
1.89 
(0.01, 11.33) 
(0.36, 9.97) 
Residence in metropolitan Toronto 27.6 (17.4, 37.9) 0.56 (0.15, 2.13) 0.25 (0.07, 0.93)* 
Education 
    Less than high school 
    High school diploma 
   Some postsecondary  
   Postsecondary graduate 
 6.1 
 6.6 
29.0 
58.4 
(1.8, 10.3) 
(2.0, 11.1) 
(17.7, 40.2) 
(46.6, 70.2) 
0.61 
0.58 
0.29 
1.00 
(0.12, 3.15) 
(0.10, 3.25) 
(0.08, 1.10) 
1.27 
0.49 
0.09 
1.00 
(0.18, 8.76) 
(0.06, 4.14) 
(0.02, 0.50)* 
Income-to-needs ratio 
    <$10,000 CAD 
     $10,000-19,999 
     $20,000-29,999 
     >$30,000  
21.5 
25.9 
 9.7 
42.9 
(11.0, 32.0) 
(14.8, 37.0) 
(2.7, 16.7) 
(30.0, 55.8) 
0.76 
1.31 
4.30 
1.00 
(0.16, 3.68) 
(0.24, 7.02) 
(0.67, 27.8) 
1.84 
1.96 
3.62 
1.00 
(0.30, 11.39) 
(0.27, 14.22) 
(0.94, 13.91) 
Primarily attracted to men 17.2 (8.9, 25.6) 0.51 (0.12, 2.22) 1.05 (0.16, 6.78) 
Experienced childhood sexual abuse 37.8 (25.6, 50.0) 0.26 (0.07, 0.96)* 0.16 (0.02, 1.27) 
Quite/extremely religious upbringing 29.0 (17.3, 40.8) 2.02 (0.52, 7.80) 4.52 (0.96, 21.32) 
Social transition status 
   Living in felt gender full-time 
   Living in felt gender part-time 
   Not living in felt gender 
53.3 
22.3 
24.4 
(40.8, 65.8) 
(12.8, 31.8) 
(12.6, 36.1) 
1.00 
1.30 
5.31 
(0.37, 4.54) 
(1.12, 25.06)* 
1.00 
0.48 
1.86 
(0.09, 2.57) 
(0.34, 10.24) 
Perceived as cisgender (almost) always 36.5 (24.3, 48.7) 1.62 (0.44, 5.99) 1.22 (0.36, 4.10) 
Completed genital surgery 14.8 (6.9, 22.8) 0.22 (0.03, 1.49) 0.08 (0.02, 0.46)* 
Using feminizing hormones 59.6 (47.0, 72.1) 0.32 (0.10, 1.04) 0.48 (0.10, 2.32) 
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† OR = odds ratio; CI = confidence interval; AOR= adjusted odds ratio.   
*Association statistically significant at p<0.05.    
.  a Nagelkerke R2=0.5302 
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Table 2.2.2: High HIV/STI sexual risk versus low-risk sex: Crude and demographic-adjusted correlates and their frequencies 
among transfeminine persons in Ontario, Canada (n=171) 
Weighted frequencies Bivariate 
associations 
Demographic-
adjusted associationsa 
% or x̄ 95% CI OR† 95% CI† AOR† 95% CI 
Lifetime transphobia scale score (range= 0-33) 15.3 (13.9, 16.7) 0.94 (0.85, 1.03) 1.01 (0.90, 1.14) 
Lifetime transphobic violence 
   None 
   Verbal harassment or threats 
   Physical or sexual assault 
36.6 
42.1 
21.2 
(24.8, 48.5) 
(30.2, 54.1) 
(12.2, 30.2) 
1.00 
0.17 
0.26 
(0.04, 0.70)* 
(0.07, 0.95)* 
1.00 
0.55 
0.82 
(0.12, 2.47) 
(0.20, 3.35) 
Social support (range=0-5)  3.3 (3.1, 3.6) 0.98 (0.55, 1.72) 0.86 (0.46, 1.60) 
Strong parental support for gender 34.8 (22.9, 46.7) 0.72 (0.20, 2.63) 0.48 (0.12, 2.02) 
LGBT community involvement 34.3 (23.2, 45.3) 0.85 (0.25, 2.93) 1.31 (0.36, 4.80) 
Attended trans bar or club night event 33.9 (22.8, 45.0) 4.82 (1.41, 16.40)* 5.11 (1.46, 17.94)* 
Problem drinking (CAGE ≥ 2) 18.2 (9.0, 27.4) 0.43 (0.12, 1.57) 1.18 (0.24, 5.75) 
Past-year stimulant use  6.9 (3.0, 10.8) 0.81 (0.21, 3.04) 3.17 (0.36, 28.22) 
Depressive symptoms 
   Low: CESD score <16 
   Moderate: CESD score 16-26 
   High: CESD score 27-60 
38.1 
23.7 
38.3 
(25.8. 50.3) 
(13.6, 33.7) 
(26.7, 49.8) 
1.00 
0.65 
0.21 
(0.15, 2.88) 
(0.05, 0.81)* 
1.00 
0.85 
0.27 
(0.21, 3.45) 
(0.06, 1.27) 
Sexual body image worries (range=0-4) 2.0 (1.8, 2.3) 0.48 (0.27, 0.89)* 0.48 (0.23, 1.01) 
Sexual anxiety (range= 0-4) 2.1 (1.8, 2.4) 0.58 (0.36, 0.92)* 0.59 (0.35, 0.97)* 
Fear of sex (range= 0-4;) 1.7 (1.4, 2.0) 0.76 (0.44, 1.30) 0.82 (0.44, 1.52) 
Sexual satisfaction (range= 0-4) 1.3 (1.0, 1.6) 1.64 (1.10, 2.45)* 1.53 (1.00, 2.34) 
Condom self-efficacy (range= 0-6) 5.0 (4.8, 5.3) 0.74 (0.49, 1.13) 0.54 (0.34, 0.88)* 
† OR = odds ratio; CI = confidence interval; AOR= adjusted odds ratio.  
*Association statistically significant at p<0.05.
a Adjusted for social transition status and demographic/background variables significant at p<0.25: age, Toronto residence, education, income-to-needs ratio,
attraction, childhood sexual abuse and religiosity, genital surgery, and hormone use.
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Findings for the second outcome—past-year sexual inactivity—are presented in Tables 2.3 and 
2.4. In the multivariable model including all demographic and background variables, higher age 
(AOR for 1 year=1.11, 95% CI: 1.04, 1.19) was associated with greater odds of inactivity, and 
Toronto residence (AOR=0.06, 95% CI: 0.01, 0.29) and genital surgery (AOR=0.01, 95% CI: 
0.00, 0.09) with lesser odds. Sexual inactivity was inversely associated with education. 
Childhood sexual abuse was positively associated with sexual inactivity (AOR=11.64, 95% CI: 
2.02, 67.09), while primary attraction to men was negatively associated (AOR=0.10, 95% CI: 
0.01, 0.97). As shown in Table 2.4, adjusting for demographic and background factors, social 
support (AOR=0.53, 95% CI: 0.29, 0.95) and moderate depressive symptoms (AOR=0.18, 95% 
CI: 0.03, 0.97) were negatively associated with sexual inactivity.  
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Table 2.3: Past-year sexual inactivity versus low-risk sex: Associations with demographic 
and background factors among transfeminine persons in Ontario, Canada (n=171) 
Bivariate associations Full modela 
OR† 95% CI† AOR† 95% CI 
Age (1 year) 1.06 (1.01, 1.11)* 1.11 (1.04, 1.19)* 
Ethnoracial group 
    Aboriginal 
    Non-Aboriginal white 
    Non-Aboriginal racialized 
0.29 
1.00 
0.06 
(0.05, 1.60) 
(0.01, 0.63) 
1.49 
1.00 
0.10 
(0.10, 23.00) 
(0.00, 4.60) 
Residence in metropolitan Toronto 0.10 (0.03, 0.31)* 0.06 (0.01, 0.29)* 
Education 
    Less than high school 
    High school diploma 
   Some postsecondary  
   Postsecondary graduate 
0.46 
0.61 
0.73 
1.00 
(0.06, 3.55) 
(0.10, 3.80) 
(0.21, 2.53) 
0.03 
0.02 
0.17 
1.00 
(0.00, 0.44)* 
(0.00, 0.19)* 
(0.04, 0.77)* 
Income-to-needs ratio 
    <$10,000 CAD 
     $10,000-19,999 
     $20,000-29,999 
     >$30,000  
1.23 
1.84 
0.54 
1.00 
(0.26, 5.69) 
(0.42, 8.01) 
(0.11, 2.70) 
5.54 
1.57 
1.30 
1.00 
(0.91, 33.67) 
(0.24, 10.38) 
(0.15, 11.06) 
Primarily attracted to men 0.27 (0.06, 1.16) 0.10 (0.01, 0.97)* 
Experienced childhood sexual abuse 2.66 (0.87, 8.17) 11.64 (2.02, 67.09)* 
Quite or extremely religious upbringing 2.04 (0.52, 8.08) 3.04 (0.43, 21.42) 
Social transition status 
   Living in felt gender full-time 
   Living in felt gender part-time 
   Not living in felt gender 
1.00 
1.06 
2.73 
(0.28, 4.00) 
(0.60, 12.38) 
1.00 
0.38 
3.18 
(0.06, 2.40) 
(0.48, 21.28) 
Perceived as cisgender (almost) always 0.95 (0.28, 3.28) 1.14 (0.24, 5.50) 
Completed genital surgery 0.09 (0.03, 0.34)* 0.01 (0.00, 0.09)* 
Using feminizing hormones 1.14 (0.32, 4.12) 8.03 (0.98, 65.77) 
† OR = odds ratio; CI = confidence interval; AOR= adjusted odds ratio.  
*Association statistically significant at p<0.05.
a Nagelkerke R2=0.5302
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Table 2.4: Past-year sexual inactivity versus low-risk sex: Crude and demographic-
adjusted correlates among transfeminine persons in Ontario, Canada (n=171) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
† OR = odds ratio; CI = confidence interval; AOR= adjusted odds ratio.   
*Association statistically significant at p<0.05. 
a Adjusted for social transition status and demographic/background variables significant at p<0.25: age, Toronto   
residence, education, income-to-needs ratio, attraction, childhood sexual abuse and religiosity, genital surgery, and 
hormone use.  
 
 
Sensitivity analyses (results not shown) revealed changes in the magnitude, statistical 
significance, and direction of some associations when insertive vaginal intercourse was recoded 
into the category for “low risk” sexual activity. In bivariate analyses, living part-time (versus 
full-time) in one’s felt gender (OR=0.13, 95% CI: 0.02, 0.75) became associated with reduced 
sexual risk.  Income-to-needs ratios of $10-29,999 CAD (versus $30,000 or above) were crudely 
 Bivariate associations Demographic-adjusted 
associationsa 
OR† 95% CI† AOR† 95% CI 
Lifetime transphobia scale score  0.95 (0.87, 1.03) 0.94 (0.83, 1.05) 
Lifetime transphobic violence  
   None 
   Verbal harassment or threats 
   Physical or sexual assault 
 
1.00 
0.87 
0.20 
 
 
(0.25, 3.08) 
(0.05, 0.76)* 
 
1.00 
3.36 
0.16 
 
 
(0.60, 18.94) 
(0.02, 1.19) 
Social support  0.56 (0.33, 0.94)* 0.53 (0.29, 0.95)* 
Strong parental support for gender  0.59 (0.19, 1.89) 0.90 (0.16, 5.06) 
LGBT community involvement  0.39 (0.12, 1.27) 0.28 (0.07, 1.16) 
Attended trans bar or club night event 0.71 (0.24, 2.09) 0.39 (0.10, 1.53) 
Problem drinking 0.56 (0.13, 2.38) 0.58 (0.11, 3.15) 
Past-year stimulant use  0.20 (0.05, 0.90)* 0.36 (0.03, 4.50) 
Depressive symptoms  
   Low: CESD score <16 
   Moderate: CESD score 16-26 
   High: CESD score 27-60 
 
1.00 
0.83 
0.84 
 
 
(0.18, 3.77) 
(0.22, 3.17) 
 
1.00 
0.18 
0.24 
 
 
(0.03, 0.97)* 
(0.05, 1.23) 
Sexual body image worries  1.31 (0.69, 2.48) 1.00 (0.48, 2.09) 
Sexual anxiety  0.95 (0.62, 1.46) 0.86 (0.53, 1.37) 
Fear of sex  1.27 (0.74, 2.19) 1.08 (0.62, 1.90) 
Sexual satisfaction  0.72 (0.46, 1.12) 0.64 (0.36, 1.13) 
Condom self-efficacy  0.98 (0.64, 1.51) 1.21 (0.70, 2.10) 
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associated with higher odds of sexual risk, and this association persisted for incomes between 
$10-19,999 when adjusting for other demographics (AOR= 10.70, 95% CI: 1.02, 112.65). In the 
multivariable demographic model, the positive association between childhood religiosity and 
HIV/STI risk behaviour became statistically significant (AOR=7.39, 95% CI: 1.48, 36.93). 
Finally, adjusting for the same demographic and background variables as in the primary 
analyses, higher transphobia scale scores (AOR=1.39, CI: 1.10, 1.76) and past-year attendance at 
LGBT events (AOR=16.07, 95% CI: 1.91, 135.40) became significantly associated with HIV/
STI risk behaviour. Other findings remained consistent. 
2.4  Discussion
We estimated the prevalence and correlates of both past-year HIV/STI-related sexual risk and 
inactivity in the transfeminine population (age 16+) of Canada’s most populous province. To the 
best of our knowledge, this is the first study to explore sexual inactivity among transfeminine 
persons. Previously published results from our dataset indicated that 51% had no partnered sex in 
the past year,3 and this proportion remains high (41%) when considering only those who had 
ever had sex. Demographic and background correlates were similar to those identified as 
predictive of low sexual desire and/or inactivity in cisgender populations, including older age, 
higher education, and childhood sexual abuse (CSA). The prevalence of CSA in this population 
(37.8%, 95% CI: 26.50, 50.0) appears higher than meta-analytic estimates for sexual minority 
natal males (21% for gay men, 25% for bisexual men29). For transfeminine persons, CSA was 
associated with sexual inactivity, but not HIV/STI risk behaviour. Residence outside 
metropolitan Toronto was strongly associated with inactivity, which may reflect a smaller pool 
of potential sexual partners, and fewer venues in which to meet potential partners. However, 
sexual satisfaction scores were not significantly associated with sexual inactivity. As intentions 
or desires for sexual behavior were not measured, our measure of past-year inactivity includes 
intentionally chosen, involuntary, and circumstantial abstinence.  
Having completed genital surgery had the largest magnitude of effect in independently 
predicting both reduced sexual inactivity and HIV/STI risk behaviour, despite the fact that the 
reference group included individuals with no desire for vaginoplasty, in contrast to clinical 
research that has focused on trans women needing surgery.30 With respect to genital surgery and 
HIV/STI risk behaviour, previous studies have largely found no association.7,31,32 
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However, access to surgery was somewhat less common in these samples (7-10%); some 
primarily sampled sex workers or trans women in primary partnerships, and definitions of 
surgery were sometimes unclear. Future research in this area should capture detail on surgical 
status, and neovaginal sexual risk, to inform behavioral and biomedical prevention interventions. 
Aside from surgical status, other trans-specific background variables were largely unassociated 
with HIV/STI risk behaviour, with the exception that before adjustment, sexual risk was 
elevated among those not living in their felt gender.  
Our findings were largely inconsistent with previous research on HIV-related risk among 
transfeminine persons. We found little evidence to support minority stress or gender affirmation 
theories of HIV/STI risk in this broad transfeminine population. However, lower income and 
experiences of discrimination were positively, independently associated with high sexual risk in 
sensitivity analyses (when risk solely attributable to insertive vaginal intercourse was coded as 
“low risk”). This suggests that the factors that predict sexual risk for transfeminine persons 
differ by the natal sex of their partners, contributing to the discrepancy between findings from 
this sexually diverse population and from previous studies of trans women sexually active with 
cisgender men.  The use of respondent-driven sampling across a large geographic region, in the 
context of a study not focused primarily on HIV risk, may also account for these differences.  
Further research, including qualitative work, is needed to understand potential social and 
psychosocial drivers of sexual risk among transfeminine persons who are not primarily sexually 
active with cisgender men. In addition, data on sexual partner and network characteristics would 
enhance understanding of the likelihood of HIV/STI exposure via reported condomless sexual 
activity, particularly for sex with cisgender women, given low HIV prevalence among most 
female population subgroups in Canada and countries with similar HIV epidemic profiles.  
These findings also suggest that in future research with transfeminine persons, behavioral 
components of sexual risk should be treated as separate outcomes where possible and that 
engagement in low-risk sex and sexual inactivity should be disentangled. Excluding sexually 
inactive participants could efficiently achieve this objective, but such an approach restricts 
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applicability of prevalence estimates to a subgroup that, per our findings, could constitute less 
than half of the transfeminine population.  
2.4.1 Strengths and limitations 
This study had several strengths including the use of respondent-driven sampling with a diverse 
province-wide population, a community-based participatory research approach, multi-mode data 
collection, and measures of sexual risk designed specifically to capture the diverse sexual 
behaviors and embodiments of transfeminine persons. The study also had some important 
limitations. Estimates are adjusted for bias related to network size, but RDS II weights do not 
account for unrelated sampling biases.33 Confidence intervals are often wide, and should be 
cautiously interpreted considering the wide range of plausible values. In addition, our cross-
sectional data preclude casual inference, although survey measures accounted for temporality to 
the extent possible through use of lifetime and past-year measures.  
We also note the small proportion (6% weighted) of non-Aboriginal racialized persons in this 
study and particularly the absence of Black transfeminine participants,22 in light of observed 
racial inequities in HIV infection among transfeminine Americans.34 Black people constitute 
4.3% of Ontario’s population.35 Given that Aboriginal persons, who are disproportionately 
impacted by HIV in Canada, were well represented (10% weighted) and that Black persons were 
well-represented among transmasculine participants,3 we believe this may represent network 
patterns that resulted in under-recruitment of Black transfeminine persons (approximately seven 
Black transfeminine participants would be expected). In light of differences between American 
and Canadian Black populations that are relevant to HIV (e.g., over half of Black people in 
Canada were born outside the country36), we would urge caution in generalizing findings from 
Black transfeminine persons in the United States to those in Canada.  
2.4.2 Conclusion 
Notwithstanding these limitations, our findings provide further evidence of the heterogeneity of 
HIV-related risk in trans Ontarians, adding to previously published descriptive analyses.3 Most 
prior research on HIV risk among transfeminine persons has focused on subgroups at increased 
vulnerability due to the confluence of biological (e.g., engaging in receptive anal sex), social-
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structural (e.g., racialized poverty), and sexual-network (e.g., partnering with men who have sex 
with men) factors. This emphasis is sensible and necessary given limited resources and evidence 
of HIV crises in these subgroups. Yet, it results in research with limited generalizability. This 
may be particularly true for high-income settings beyond the United States where HIV epidemics 
are patterned differently (e.g., where ethnic/racial disparities are differentially shaped by unique 
historical trajectories37), overall HIV prevalence is relatively low, explicit human rights 
protections for trans people exist, and trans communities are highly heterogeneous in terms of 
sexual attraction and behavior.  
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3 Chapter 3: HIV sexual risk among gay, bisexual, and other 
transgender men who have sex with men: A respondent-driven 
sampling survey1  
3.1 Introduction
Transgender men who have sex with men have been labeled a key population at disproportionate 
risk of sexually transmitted HIV.1 Yet, there is a dearth of research evidence regarding the HIV 
disease burden, prevalence of HIV-related sexual risk, and factors associated with sexual risk 
among transmasculine persons who are gay, bisexual, or who have sex with men (T-GBMSM). 
We use the term “transmasculine” to refer to individuals who were assigned a female sex at birth 
but identify as male or masculine. Contrary to traditional assumptions that most transmasculine 
persons identify as heterosexual and/or are exclusively sexually attracted to women, an estimated 
63% of transmasculine Ontarians identified as gay, bisexual, or queer and/or reported past-year 
sex with men, while 21% had a past-year cisgender (non-trans) male sex partner.2 Similarly, 
three-quarters of transmasculine participants in the largest United States transgender survey 
identified as sexual minorities.3  
A review of research published through 2014 found only ten studies with laboratory-confirmed 
HIV seroprevalence data for transmasculine persons,4 of which most found no HIV infections. 
Three studies documented HIV seroprevalence ranging from 2.0% to 4.3%.5-7 Self-reported HIV 
prevalence ranged from 0-10%.4 Most of these reports were based on small samples with one or 
two HIV-positive cases. The sole population-based estimate of HIV prevalence among 
transmasculine persons comes from Ontario, Canada, where an estimated 0.6% identified as 
HIV-positive; however, half had never been tested.8 Two recent estimates of self-reported HIV 
prevalence in the subgroup of transmasculine persons who have sex with men are available from 
1
 A version of this chapter has been published: Scheim AI, Bauer GR, Travers R. HIV-related sexual risk among 
transgender men who are gay, bisexual, or have sex with men. J Acquir Immune Defic Syndr. 2017;74(4):e89–e96. 
doi: 10.1097/QAI.0000000000001222 
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internet-based studies in the United States9 and globally10, finding 1.2% (1/81) and 1.4% (1/69) 
prevalence, respectively. 
Thus, limited available data suggest a low burden of HIV among T-GBMSM relative to 
cisgender (non-transgender) MSM and transgender women, though potentially higher than the 
broader population. In Ontario, seroprevalence among cisgender MSM was estimated to be 16% 
in 2011.11 Among transgender women, pooled seroprevalence from urban convenience samples 
in high-income countries was 22%,12 while self-reported prevalence was estimated at 4.3% in a 
broad, primarily online United States sample,3 and 3% across Ontario.8 
Despite consistent findings of relatively low HIV prevalence among transmasculine persons who 
have been tested for HIV, T-GBMSM are increasingly integrated in cisgender MSM sexual 
networks13 where HIV prevalence is high. Estimates of HIV-related sexual risk behavior among 
T-GBMSM are highly variable4 and most combine data from trans men of all sexual orientations,
including those at low risk of sexually transmitted HIV by definition (i.e., those who only have
sex with cisgender women).  In one small study of transmasculine persons reporting recent sex
with cisgender men, 45% had condomless vaginal or anal intercourse in the past three months.9
Sexual mixing with cisgender MSM, combined with such levels of sexual risk behavior, may
potentiate an increase in seroprevalence among T-GBMSM. Therefore, HIV prevention
interventions targeted to T-GBMSM appear timely.
Only one study to date has identified correlates of HIV-related sexual risk in T-GBMSM,14 
employing a syndemic framework, which posits that HIV risk is only one component of a set of 
co-occurring, mutually reinforcing epidemics resulting from social stigma and deprivation.15 
Reisner and colleagues14 found that among those living in their felt gender role, higher scores on 
an index of potentially syndemic conditions (summation of indicators for binge drinking, 
substance use, depression, anxiety, childhood abuse, and intimate partner violence) were 
associated with lifetime STI diagnosis, multiple recent sex partners, and condomless anal or 
vaginal intercourse at last sexual encounter. This suggests that T-GBMSM who are living in their 
felt gender role share pathways to sexual risk with cisgender MSM, among whom syndemic 
conditions have consistently been linked to HIV risk behaviour.16-18 
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Studies of urban transfeminine (i.e., male-to-female transgender) persons who have sex with men 
have found experiences of violence,19 transphobia or trans-related stigma,20 depressive 
symptoms,19 substance use,21,22 unstable housing,23 and extreme poverty24 to affect HIV-related 
sexual risk behaviour; in some cases these factors cluster together, suggesting syndemic 
production of HIV risk.20,25  
Specific to transmasculine persons, social and medical transition status may contribute to sexual 
risk via increased sex drive related to testosterone therapy26 or transition-related sexual 
experimentation,27 including perceived shifts in sexual desire and attraction.28 In addition, T-
GBMSM have described seeking gender validation and affirmation as a gay or bisexual man 
through sexual activity, thereby reducing agency in negotiating condom use.27,29 The need for 
gender affirmation may vary with transition status. As among transfeminine persons, experiences 
of stigma and violence related to trans status26,30,31 have also been posited to increase risk 
behaviour for T-GBMSM, but this relationship has not been empirically assessed.  
Building upon our previously published descriptive findings regarding gay, bisexual, queer, and 
other TMSM in Ontario,2 the current analysis sought to identify factors associated with past-year 
HIV-related sexual risk for T-GBMSM. Within a minority stress framework, we assessed the 
impacts of discrimination and other forms of social exclusion on sexual risk among T-GBMSM, 
while also considering the role of gender transition, in addition to known correlates of sexual risk 
among transfeminine persons and cisgender MSM.
3.2 Methods
3.2.1 Study Design and Participants 
Trans PULSE was a community-based research project that explored the health of trans people in 
Ontario, Canada’s most populous province. “Trans” was defined broadly for recruitment, and 
included anyone whose gender identity did not match the sex they were assigned at birth; having 
taken steps to socially transition (e.g., through changing one’s name) or medically transition 
(e.g., by taking hormones) was not required. In 2009-2010, 433 trans Ontarians aged 16 and 
above completed a respondent-driven sampling (RDS) survey via a self-administered 
questionnaire, online or using a visually identical paper copy. RDS is an adapted chain-referral 
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sampling method for hidden populations.32,33 Combining systematic recruitment through 
participants’ social networks with analytic methods that weight data on recruitment probability 
and account for non-independence within recruitment chains, RDS can generate estimates for all 
networked members of the target population. RDS II weights,34 based on personal network size, 
were used for this analysis. Recruitment began with 16 seeds; 22 were added after 4-5 waves of 
recruitment were obtained (to ensure adequate chain length). Each participant received three 
tracked (virtual or paper) coupons to recruit peers. Ethics approval was obtained from Research 
Ethics Boards at The University of Western Ontario and Wilfrid Laurier University.  
Of 227 transmasculine participants (i.e., those assigned a female sex a birth), 173 were coded as 
T-GBMSM, based on (a) endorsing a sexual minority identity (e.g., gay, bisexual, pansexual,
queer) while not reporting exclusive attraction to cisgender women, or (b) reporting past-year
sexual activity with a cisgender or trans man. T-GBMSM were excluded from this analysis if
they were missing data for the outcome (n=13), or were missing data for more than 20% of
covariates (n=2), resulting in an analytic sample of 158 participants.
3.2.2 Measures 
Network size (for RDS estimation). Participants completed three eligibility questions, 
indicating whether or not they were 16 years of age or older; considered themselves “trans,” of 
“trans experience,” or “trans-identified”; and currently lived, worked, or received healthcare in 
Ontario. Next, they were asked: “How many other people do you personally know who could 
answer yes to all three eligibility questions?”  
Demographics and background factors. Participants indicated their year of birth, educational 
attainment, lived gender (living in one’s felt gender full-time, part-time, or not at all, 
dichotomized as full-time versus not for regression analyses), sexual orientation identity, and use 
of masculinizing hormones. Ethnoracial group was coded as Aboriginal (First Nations, Inuit, 
Métis, or another Indigenous group), non-Aboriginal racialized (i.e., person of color), or white. 
Residence in Toronto, Ontario’s capital and most populous metropolitan area, was coded based 
on the first letter of the respondent’s postal code. Income-to-needs ratio was calculated by 
dividing the mid-point of reported household income categories (ranging from <$5000 CDN to 
>$100,000) by the number of household members being supported. Sexual attraction was 
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categorized as primarily attracted to men (including transmasculine persons); primarily attracted 
to women (including transfeminine persons); attracted to multiple genders; or not attracted to 
others, and dichotomized into primarily attracted to men versus not. Childhood sexual abuse was 
defined as any unwanted sexual contact before age 16. Self-reported HIV status was not included 
in regression analyses because no T-GBMSM participants reported being HIV-positive. 
Social exclusion and inclusion. An 11-item scale of self-reported transphobic discrimination 
(Cronbach’s a= 0.81) was adapted from a measure of homophobia,35 and assessed the frequency 
with which participants experienced enacted (e.g. being denied employment) and felt (e.g. 
hearing that trans people are not normal), trans-related stigma, with higher scores indicating 
greater exposure.36 Separately, participants indicated whether they had ever experienced physical 
or sexual violence related to being trans. The Medical Outcomes Study Social Support Scale was 
used to measure social support.37 The study team developed measures of perceived support for 
gender identity from a range of sources (or expected, for those who had not disclosed).  For this 
analysis, received or expected support from parents was included and dichotomized as strongly 
supportive versus not (including “not applicable”), given evidence that parental support is 
uniquely important for trans mental and behavioral health.38 Indication of past-year attendance at 
an LGBT community event or membership in an LGBT student or religious group, and 
attendance at a trans-specific bar or club night, were included as separate variables to reflect their 
potentially divergent relationships with sexual risk.  
Substance use and mental health. Those scoring 2 or greater on the CAGE screener39 were 
coded as having problematic alcohol use. Past-year stimulant use included any use of cocaine, 
crack, crystal methamphetamine, or other amphetamines. Center for Epidemiological Studies 
Depression scale40 scores were categorized into low (<16), moderate (16-26), and high (27-60) 
depressive symptomatology. A scale of self-efficacy for negotiating condom use41 was adapted 
to include other barrier methods and trans-specific situations (e.g., “how certain are you that you 
could ask a non-trans partner to use a protective barrier?”). This revised 8-item barrier 
negotiation scale had high internal consistency (Cronbach’s a=0.92). The research team 
developed a measure of trans-specific worries in sexual situations (7 items, Cronbach’s a=0.80), 
as a validated measure of this construct was not available. It includes items such as “I worry that 
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once I’m naked, people will not see me as the gender I am” and “I worry that there are very few 
people who would want to have sex with me”. 
HIV-related sexual risk. Participants reported whether they engaged in condomless receptive 
intercourse to ejaculation in the past year, for both vaginal and anal intercourse, and the type of 
partner involved (e.g., spouse, one-time partner, exchange partner).  Sexual risk was classified as 
high for participants reporting any such condomless intercourse, unless it occurred within a 
monogamous relationship with a sero-concordant partner (i.e., if they were reported to have 
received a negative HIV test result following their last sexual risk activity). Those who had any 
other kind of past-year sexual activity with a partner were classified as low risk, while those with 
no past-year sex partners were considered at no risk. 
3.2.3  Statistical analysis 
Weighted frequencies and their 95% confidence intervals were calculated in SAS 9.3.42 RDS II 
weights (inverse of network size, rescaled to the sample size)34 were used to account for 
differential recruitment probabilities. Confidence intervals were estimated using Taylor 
linearization and variances were adjusted for clustering by shared recruiter. Crude and adjusted 
prevalence ratios (PRs and APRs) for high sexual risk, versus low or no risk, were estimated 
using average marginal predictions from logistic regression models43 in SAS-callable SUDAAN 
11.44 For multivariable analyses only, simple imputation of the median, mean, or mode was used 
for variables with less than 10% missingness. Two variables had more than 10% missing: 
childhood sexual abuse (10.8%) and income-to-needs ratio (12.0%). These were multiply 
imputed using weighted sequential hot-deck imputation in SUDAAN, with 5 imputations.  
After identifying bivariate associations with socio-demographic and background variables, a 
model was built containing all with p<0.25. Next, both bivariate and adjusted prevalence ratios 
were estimated for each of the social exclusion/inclusion and substance use/mental health 
variables of interest.  These associations were adjusted for age, childhood sexual abuse, and 
lived gender, based on the potential for these variables to act as confounders. Presentation of 
prevalence ratios using average marginal predictions requires selection of reference values for 
continuous variables, therefore ratios for scale variables are presented as comparisons of the 
weighted 75th versus 25th percentiles and those aged 40 or 30 are compared to those aged 20. As 
68 
this analysis was exploratory, and the absolute number of outcome events was small, we did not 
enter all variables of interest into a single multivariable model.  
3.3 Results
Figure 3.1 is a recruitment network diagram for the full study sample (n=433) coded by T-
GBMSM status and past-year HIV-related sexual risk.  
Figure 3.1: Recruitment diagram for Trans PULSE respondent-driven sampling survey  
Triangles=T-GBMSM; squares= other transmasculine persons; circles=transfeminine persons. 
Red=high past-year HIV-related sexual risk; blue= low risk; grey=no past-year sex partners; 
white=missing.  
Characteristics of Ontario T-GBMSM are described in Table 3.1. A minority reported being 
primarily or exclusively attracted to men (9.1%, 95% CI: 0.9, 17.3); most were attracted to 
multiple genders (70.7%, 95% CI: 59.0, 82.4). Similar to previously published results for all 
transmasculine Ontarians,2 the most commonly endorsed sexual orientation identities were 
69 
queer, bisexual or pansexual, and gay. None reported being HIV-positive, but only 18.7% (95% 
CI: 9.2, 28.3) had tested for HIV in the past year; 39.3% (95% CI: 26.4, 52.2) had never been 
tested. An estimated 10.0% (95% CI: 1.5, 18.6) had past-year high sexual risk. Among the 34.2% 
(95% CI: 22.2, 46.3) with a past-year cisgender male sex partner (data not shown), this 
proportion rose to 29.3% (95% CI: 8.4, 50.2). Most risk was related to receptive vaginal 
intercourse: of those reporting any high-risk sexual activity, 64% (unweighted) reported 
condomless receptive vaginal intercourse only. 
Table 3.1: Weighted characteristics of gay, bisexual, and other transmasculine persons who 
have sex with men in Ontario, Canada (n=158) 
% or    
x̄
95% CI 
Sociodemographic and background factors 
Age, years (x̄) 29.8 (26.9, 32.7) 
Ethnoracial group (%) 
    Aboriginal 
    Non-Aboriginal white 
    Non-Aboriginal racialized 
 3.7 
74.9 
21.5 
(0.2, 7.2) 
(63.6, 86.1) 
(10.6, 32.4) 
Residence in Toronto area (%) 49.8 (36.2, 63.4) 
Education (%) 
   High school diploma or less 
   Some postsecondary  
   Postsecondary graduate 
25.8 
26.0 
48.2 
(12.7, 38.8) 
(15.3, 36.7) 
(35.3, 61.2) 
Income-to-needs ratio (%) 
    <$10,000 CDN per household member 
     $10,000-19,999 
     $20,000-29,999 
     >$30,000  
24.0 
33.6 
25.4 
17.0 
(13.5, 34.5) 
(23.0, 44.3) 
(12.5, 38..2) 
(9.3, 24.8) 
Sexual attraction (%) 
   Primarily to male-identified 
   Primarily to female-identified 
   Multiple genders 
   Not attracted to anyone 
9.1 
16.3 
70.7 
3.9 
(0.9, 17.3) 
(6.5, 26.0) 
(59.0, 82.4) 
(0.0, 9.9) 
Childhood sexual abuse (%) 58.6 (45.9, 71.4) 
Lived gender (%) 
   Living full-time in felt gender 
   Living part-time in felt gender 
   Not living in felt gender 
51.6 
36.7 
11.7 
(38.3, 64.8) 
(24.9, 48.6) 
(2.9, 20.5) 
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Currently using hormones (%) 39.0 (27.1, 51.0) 
Self-reported HIV status 
   Positive 
   Negative 
   Don’t know or prefer not to say 
0.0 
82.8 
17.2 
(--, --)a
(72.9, 92.6) 
(7.4, 27.1) 
Tested for HIV 
   Yes, in the past year 
   Yes, more than one year ago 
   Never 
18.7 
41.9 
39.3 
 (9.2, 28.3) 
(29.0, 54.8) 
(26.4, 52.2) 
Social exclusion and inclusion 
Lifetime transphobia scale score (range= 0-33; x̄) 13.3 (11.6, 14.9) 
Lifetime transphobic violence (%) 
   None 
   Verbal harassment or threats 
   Physical or sexual assault 
43.2 
37.6 
19.3 
(29.7, 56.7) 
(26.3, 48.8) 
(9.6, 29.0) 
Social support (range=0-5; x̄) 3.7 (3.5, 3.9) 
Strong received or expected parental support for gender 
identity (%) 
18.0 (10.9, 25.0) 
Attended LGBT community, student, or religious event in 
past year (%) 
38.4 (26.3, 50.5) 
Attended trans-specific bar or club night, past year (%) 27.3 (17.1, 37.5) 
Substance use and mental health 
Problem drinking (CAGE ≥ 2; %) 32.1 (20.2, 43.9) 
Past-year stimulant use (%) 12.9 (4.3, 21.5) 
Depressive symptoms (%) 
   Low: CESD score <16 
   Moderate: CESD score 16-26 
   High: CESD score 27-60 
31.8 
25.8 
42.4 
(20.7, 42.9) 
(14.5, 37.0) 
(29.2, 55.7) 
Sexual worries scale (range= 0-4; x̄) 1.7 (1.5, 2.0) 
Barrier negotiation scale (range= 0-6; x̄) 5.0 (4.7, 5.3) 
Past-year HIV/STI sexual risk 
No partnered sex (%) 
Low-risk 
High-risk 
15.0 
75.0 
10.0 
(6.3, 23.7) 
(64.2, 85.7) 
(1.5, 18.6) 
a Cannot be estimated using RDS methods because 0 T-GBMSM reported being HIV-positive. 
71 
Crude associations and a multivariable model for socio-demographic and background factors are 
displayed in Table 3.2.  Only childhood sexual abuse was associated with increased sexual risk 
in bivariate analyses. In the multivariable model, CSA remained associated with sexual risk 
behavior (APR=14.03, 95% CI: 2.32, 84.70). In addition, increasing age (APR for 40 years old 
versus 20= 4.02, 95% CI: 1.23, 13.14), having some post-secondary education versus graduating 
(APR=2.74, 95% CI: 1.18, 6.37), being primarily attracted to men (APR=5.54, 95% CI: 2.27, 
13.54), and living in one’s felt gender full time (APR=5.20, 95% CI: 1.11, 24.33) were 
associated with HIV-related sexual risk. Masculinizing hormone use was not associated with 
sexual risk.  
Table 3.2: Associations of sociodemographic and background factors with HIV-related 
sexual risk among gay, bisexual, and other transmasculine persons who have sex with men 
in Ontario (n=158) 
Crude associations Demographic/ 
background model 
PR† 95% CI† APR† 95% CI 
Age 
   30 versus 20 years old 
   40 versus 20 years old 
1.64 
2.61 
(0.61, 4.38) 
(0.40, 17.25) 
2.04 
4.02 
(0.98, 4.22) 
(1.23, 13.14) 
Ethnoracial group 
    Aboriginal or racialized, 
vs. white 
0.24 (0.05, 1.14) 0.37 (0.09, 1.54) 
Residence in Toronto area 0.86 (0.16, 4.72) --b --b
Education 
 High school diploma or less 
   Some postsecondary  
   Postsecondary graduate 
0.74 
1.51 
1.00 
(0.09, 6.01) 
(0.22, 10.35) 
1.01 
2.74 
1.00 
(0.23, 4.38) 
(1.18, 6.37) 
Income-to-needs ratio 
    <$10,000 CDN 
     $10,000-19,999 
     $20,000-29,999 
     >$30,000  
1.00 
1.06 
1.40 
0.33 
(0.15, 7.65)  
(0.19, 10.35) 
(0.05, 2.09) 
--b --b
Primarily attracted to men 4.36 (0.76, 24.92) 5.54 (2.27, 13.54) 
Childhood sexual abuse 18.78 (2.81, 125.35) 14.03 (2.32, 84.70) 
Living in felt gender 1.99 (0.27, 14.72) 5.20 (1.11, 24.33) 
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Crude associations Demographic/ 
background model
PR† 95% CI† APR† 95% CI 
Using masculinizing 
hormones  
1.45 (0.27, 7.79) 0.35 (0.11, 1.11) 
    † PR = prevalence ratio; CI = confidence interval; APR= adjusted prevalence ratio.  
    Associations statistically significant at p<0.05 are bolded.     
b Not retained in multivariable model because p>0.25. 
Crude and adjusted associations for social exclusion and inclusion, substance use, and mental 
health factors are displayed in Table 3.3. Past-year stimulant use (APR=4.02, 95% CI: 1.31, 
12.30) and moderate versus low depressive symptoms (APR=5.77, 95% CI: 1.14, 29.25) were 
associated with increased sexual risk after adjustment for age, childhood sexual abuse, and lived 
gender. Sexual body image worries were negatively associated with sexual risk for HIV 
(APR=0.43, 95% CI: 0.21, 0.90).  
Table 3.3: Crude and adjusted odds ratios for correlates of HIV-related sexual risk among 
gay, bisexual, and other transmasculine persons who have sex with men in Ontario (n=158) 
Crude associations Adjusted 
associationsa
  PR† 95% CI† APR† 95% CI 
Lifetime transphobia scale score, 75th versus 
25th percentile 
1.34 (0.43, 4.21) 1.13 (0.45, 2.84) 
Lifetime transphobic violence 
   None 
   Verbal harassment or threats 
   Physical or sexual assault 
1.00 
0.18 
1.89 
(0.03, 1.07) 
(0.33, 10.72) 
1.00 
0.34 
2.21 
(0.06, 2.02) 
(0.52, 9.43) 
Social support, 75th versus 25th percentile 0.99 (0.49, 2.01) 0.76 (0.43, 1.34) 
Strong received or expected parental support 
for gender  
0.19 (0.03, 1.12) 0.20 (0.03, 1.25) 
Attended LGBT community, student, or 
religious event in past year  
0.32 (0.09, 1.14) 0.49 (0.12, 1.97) 
Attended trans-specific bar or club night, 
past year 2.12 (0.41, 11.09) 
1.88 (0.52, 6.86) 
Problem drinking 4.11 (0.96, 17.66) 3.40 (0.88, 13.17) 
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Past-year stimulant use 3.96 (0.77, 20.45) 4.02 (1.31, 12.30) 
Depressive symptoms 
   Low: CESD score <16 
   Moderate: CESD score 16-26 
   High: CESD score 27-60 
1.00 
7.25 
1.73 
(1.54, 34.06) 
(0.31, 9.50) 
1.00 
5.77 
1.58 
(1.14, 29.25) 
(0.22, 11.45) 
Sexual worries, 75th versus 25th percentile 0.72 (0.42, 1.24) 0.43 (0.21, 0.90) 
Barrier negotiation, 75th versus 25th 
percentile 
0.61 (0.39, 0.94) 0.84 (0.52, 1.37) 
† PR = prevalence ratio; CI = confidence interval; APR= adjusted prevalence ratio.  
Associations statistically significant at p<.05 are bolded.  
 a Adjusted for age, lived gender, and childhood sexual abuse. 
3.4 Discussion
Drawing on data that are generalizable to the networked trans population of Canada’s most 
populous province, we found no self-reported HIV infections, but low uptake of HIV testing. 
Thus, undiagnosed HIV infections are possible and should not be ruled out. This was a 
population recruited based on trans identity and/or status and sampled through trans social 
networks; participants were not recruited for being GB-MSM and were not necessarily living 
their day-to-day lives as men or transmasculine. While the vast majority of Ontario T-GBMSM 
(an estimated 91%) were not primarily or exclusively attracted to men, HIV-related sexual risk 
was higher among those who were, suggesting need for interventions for this subgroup. 
Considering preferences expressed by T-GBMSM,29 interventions could be delivered not only 
through trans-specific initiatives, but also by meaningfully including interested transmasculine 
persons in existing services designed for cisgender gay and bisexual men.  
Our findings have additional implications for the development and tailoring of HIV and other 
STI prevention interventions for T-GBMSM. They suggest that interventions should not focus on 
youth to the exclusion of adults, nor on residents of major urban centres to the exclusion of those 
residing in other settings. Residence in Toronto was unassociated with sexual risk, while 
increasing age was positively associated. Older T-GBMSM, who will be more likely to have 
lived substantial portions of their lives as women (potentially as sexual minority women), may 
face unique challenges in negotiating (safer) sexual relationships with cisgender men that 
deserve further investigation.  
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Contrary to theories postulated by T-GBMSM themselves in the qualitative research 
literature,26,31 masculinizing hormone use did not impact HIV-related sexual risk in this analysis. 
While testosterone use may increase libido (and even sexual interest in cisgender men27,45), our 
results indicate that this does not necessarily equate to engagement in sexual risk behavior. 
Adjusting for other background and demographic factors, those living in their felt gender were 
more likely to have high HIV-related sexual risk. This difference does not appear attributable to 
being more likely to have any sexual partners (86% of T-GBMSM living in their felt gender had 
any past-year sex, versus 81% of those living in their felt gender part-time or less, p=0.57). 
Taken together, these findings suggest that social gender transition and affirmation may be more 
salient for understanding engagement in sexual risk behaviour among T-GBMSM.  
These analyses considered factors previously associated with HIV-related sexual risk behavior 
among both transgender women and cisgender men who have sex with men.  We found that 
social determinants of health associated with HIV risk behaviour among transgender women 
(low incomes,24 transphobia,20 and violence19) are not necessarily generalizable to T-GBMSM. 
These findings also challenge our minority stress hypothesis that discrimination would predict 
sexual risk. Rather, well-documented psychosocial correlates of sexual risk among cisgender 
MSM were associated with HIV risk for T-GBMSM, including childhood sexual abuse 
(CSA),46,47 moderate depression,48 and stimulant use.49  
The reported frequency of CSA (58.6%, 95% CI: 45.9, 71.4) in this population is alarming, and 
is higher than the already elevated levels reported by cisgender sexual minority females and 
males (in the United States, this ranges from 19% of gay men to 44% of bisexual women47). 
Gender variance in childhood is associated with increased risk of CSA,50,51 perhaps due to 
targeting of non-conforming children for abuse. Our finding of a strong (albeit imprecisely 
estimated) association between CSA and HIV-related sexual risk among T-GBMSM indicates 
that CSA should be considered in the design and delivery of HIV prevention, sexual health, and 
mental health initiatives. CSA is also related to increased risk of psychopathology and substance 
use,52,53 sexual compulsivity,54 and intimate partner violence.55 These conditions may mediate 
the association between CSA and HIV-related sexual risk,56 and CSA may confound associations 
between psychosocial conditions and sexual risk. Studies of HIV risk behavior among trans 
people have largely failed to collect data on CSA history. In light of these findings and the causal 
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importance of CSA for many health outcomes later in life, sensitive collection of CSA data 
should be considered in transgender sexual health research.  
To inform interventions, future research could explore pathways between CSA, depression, 
substance use, and HIV risk among T-GBMSM, and the extent to which they are shared with 
cisgender MSM. For instance, does use of stimulants specifically to enhance sexual sensation 
and libido contribute to HIV risk among T-GBMSM? Do these mental health and substance use 
conditions interact to intensify HIV risk (above and beyond their combined individual effects) as 
suggested by syndemic theory?57 
Finally, this study re-affirms previous findings4 that despite sharing social vulnerabilities with 
transgender women and cisgender MSM, T-GBMSM demonstrate comparatively low prevalence 
of HIV infection and related sexual risk. While the present study did not identify any 
intervenable protective factors, understanding of such factors could contribute to prevention 
efforts both for transmasculine persons, and other sexual and gender minorities. However, we 
note that two-thirds of T-GBMSM were at low sexual risk almost by definition, as they had no 
cisgender male sex partners (transgender female sex partners were relatively uncommon for 
transmasculine persons,2 and all HIV-related sexual risk was borne by the subgroup who had 
cisgender male sex partners). Qualitative research with Ontario T-GBMSM58 has pointed to a 
paradoxical role of the exclusion that some encounter from gay and bisexual men’s communities 
and sexual networks: while potentially harmful for their overall well-being, the limited sexual 
opportunities that result likely reduce HIV transmission risk. At the same time, trans men’s 
resilient strategies for navigating sexual partnerships in the face of such exclusion, such as 
clearly negotiating sexual activities online in advance of meeting partners, may contribute to 
lower sexual risk among those who do have sex with cisgender men.  
3.4.1 Strengths and Limitations 
This represents only the second study to explore correlates of HIV-related sexual risk behavior 
among T-GBMSM. It also represents one of the largest samples of this population to date (15 of 
27 studies in a 2015 review4 had n<50). In addition to improving on previous research in this 
area by drawing on respondent-driven sampling data collected across Canada’s most populous 
province, the present analysis benefited from the use of sexual behavior and risk measures 
76 
developed specifically for trans respondents, and from inclusion of key variables often excluded 
in transgender studies (e.g., childhood sexual abuse). Nevertheless, this study was not without 
limitations. First, the small number of outcome events (14, unweighted) limited statistical power. 
Confidence intervals were often wide, and care should be taken to interpret estimates in relation 
to the full range of plausible values.  
Second, although RDS represents the best available strategy for obtaining a population-based 
sample of transgender people, generalizability of estimates rests on assumptions that may not be 
met in practice, and biases unrelated to network size are unaccounted for.59 The survey 
questionnaire only inquired about condomless intercourse to ejaculation, and sexual risk was 
further defined as such activity outside a seroconcordant monogamous partnership. To the extent 
that delayed condom application,60 withdrawal before ejaculation, and inaccurate perceptions of 
mutual monogamy and seroconcordance are prevalent, this measure will underestimate actual 
HIV-related sexual risk. However, this definition will also misclassify some sexual activity as 
high risk by including condomless intercourse with casual or non-monogamous partners known 
to be seroconcordant (data on HIV status of non-primary partners were unavailable). Finally, 
biomedical HIV prevention technologies (e.g., undetectable viral load, pre-exposure prophylaxis; 
PrEP) were not captured in these data, which were collected before the introduction of PrEP as a 
recommended intervention for MSM and transgender people.  
3.4.2 Conclusion 
In summary, we found that past-year sexual behavior posing high risk for HIV acquisition was 
uncommon overall in this broad population of T-GBMSM, but this was largely because a 
minority had any cisgender male sexual partners. Childhood sexual abuse emerged as a key 
predictor of sexual risk behavior, and should be considered as a contributor to mental health and 
health behaviour challenges for transmasculine persons in future research and interventions. 
Continued research, focused on T-GBMSM sexually active with cisgender men, is required to 
better understand HIV risk and vulnerability in this group. In the context of a perceived increase 
in sexual mixing with cisgender MSM,13,31  identifying and intervening on predictors of sexual 
risk behavior among T-GBMSM is particularly timely.  
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4 Chapter 4: Heavy episodic drinking among transgender persons: 
Disparities and predictors1 
4.1 Introduction
Hazardous alcohol consumption contributes substantially to the global burden of morbidity and 
mortality.1 Negative health consequences of alcohol use disproportionately impact poor and 
socially marginalized groups,1 some of whom (e.g., sexual minorities2) also have higher rates of 
disordered and non-disordered use. Less is known about alcohol use among transgender (trans) 
people, those with a gender identity that differs from their birth-assigned sex. Trans people 
represent an estimated 0.6% of the adult population in the United States.3 In a random sample of 
substance use research published in 2007 and 2012, only 1.3% of articles reported data on 
transgender identities.4 Population-based estimates of alcohol use are particularly scarce due to 
the lack of measures to identify trans respondents in most population health surveys. 
Understanding of the epidemiology of alcohol use among trans people is further challenged by 
the limited and non-validated substance use measures often included in trans surveys, and 
absence of comparison groups.5 
Much trans substance use research has focused on urban trans women living with or at high risk 
for HIV, who frequently report heavy alcohol use.6,7 Findings from broader trans populations in 
the United States have been more mixed. In a population-based sample of Massachusetts adults 
including 131 transgender persons, no difference was found in the prevalence of past-month 
heavy episodic drinking (HED) by transgender status.8 Other studies have been limited to 
national samples of U.S. adolescents and college students. Reisner and colleagues9 found that 
trans youth reported higher past-year alcohol use than their cisgender (non-trans) peers, while 
Coulter et al.10 found that trans students were less likely to report HED than cisgender (non-
trans) males, but had a greater number of recent HED days. 
1
 A version of this chapter has been published: Scheim AI, Bauer GR, Shokoohi M. Heavy episodic drinking among 
transgender persons: Disparities and predictors. Drug Alcohol Depend. 2016; 167: 156-162. 
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Disparities in alcohol misuse between cisgender and trans populations may be mediated by social 
stigma.9 Associations between stigma and alcohol misuse are well-documented in non-trans 
minority populations.2 Among trans people, problematic substance use has been conceptualized 
as a consequence of minority stress processes that result from a stigmatizing social environment. 
These processes include external, stigma-related stressors (e.g., violence), anticipation of such 
stressors, internalized stigma, and concealment of gender identity.11,12 For example, violence and 
discrimination have been associated with increased risk of problematic alcohol use.6,10,13,14  
Trans people face systemic barriers to employment, and may rely on sex work for income.15 
Trans sex workers have reported higher levels of substance use than other trans people,5,6 
perhaps due to greater minority stress,6 exposure to violence, and social network norms.15 In 
addition to enacted stigma in adulthood, sexual and gender minority populations 
disproportionately experience childhood sexual abuse. Such abuse is linked to increased risk of 
problematic alcohol use later in life.16 However, while most trans people encounter some degree 
of stigma, negative coping responses are by no means inevitable. Potentially protective factors 
against alcohol misuse include family support.17 
Gender transition, including social, medical, psychological, and legal processes of gender 
affirmation,18 is associated with improved mental health for trans people19 and could also be 
protective against alcohol misuse. However, findings regarding gender transition and alcohol use 
have been inconsistent, which may reflect countervailing impacts of heightened exposure to 
stigma resulting from transition. Among trans women in San Francisco, hormone therapy and 
breast augmentation were associated with lower odds of past-year HED.20 Conversely, in a 
cohort of trans women in New York, heavy alcohol use was higher among those living full-time 
as women or taking hormones.6  
In summary, findings regarding both disparities and predictors of HED in trans communities 
have been somewhat inconsistent. To date, no published research has investigated alcohol use 
among trans people in Canada, where the social and health context for trans people varies from 
the United States by virtue of greater human rights protections and a universal health care 
system. The objectives of the current study were (1) to describe the prevalence of HED among 
trans people in Ontario, Canada; (2) to compare HED prevalence to the age-standardized 
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cisgender population of Ontario; and (3) to assess the impacts of socio-demographic 
characteristics, gender transition, and social exclusion (e.g., discrimination) on HED. 
4.2 Methods
4.2.1 Transgender study population 
The Trans PULSE community-based participatory research project recruited 433 trans Ontarians 
via respondent-driven sampling (RDS) in 2009-2010, including 404 who completed alcohol use 
measures. Eligible participants needed to be 16 years of age or older; live, work, or receive 
health care in Ontario; and indicate that they identified as transgender, transsexual, or 
transitioned. This definition included individuals who identified as genderqueer or another non-
binary gender identity, and participants were not required to have undergone any social or 
medical gender transition.  
RDS is a chain-referral sampling and analysis method for hidden populations.21 Beginning with 
16 participants (commonly referred to as seeds) selected for maximum diversity, each respondent 
was provided with three tracked recruitment coupons for recruiting their peers. Twenty-two 
additional seeds were added after 4-5 waves of recruitment. Maximum chain length was ten 
waves beyond the seeds. Respondents completed a 60-90-minute survey online or by visually-
identical paper copy. They were compensated with a $20 gift card, or could opt to donate the 
honorarium to a trans-related charity. Secondary incentives for recruitment of peers ($5 gift 
cards) were added in the final months of the study, with no perceptible impact on recruitment. 
Research ethics boards at The University of Western Ontario and Wilfrid Laurier University 
approved this study. Research procedures and demographic characteristics pertaining to the 
Trans PULSE study population have been described in greater detail previously.22 
4.2.2 Cisgender study population 
A portion of this analysis used data from the Canadian Community Health Survey (CCHS) from 
Ontarians aged 16+ (n=39,980). The 2009-2010 data cycles were used to match the time of 
recruitment of Trans PULSE data. CCHS is an ongoing cross-sectional survey of Canadians aged 
12 and above employing a multi-stage, stratified, cluster sampling approach, with coverage of 
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over 97% of the Canadian population (excluding institutionalized persons and those living on 
First Nations reserves). Additional information about the survey methodology is available from 
Statistics Canada.23 CCHS estimates describe the assumed cisgender population because the 
survey did not include measures to identify trans respondents. Under the reasonable assumption 
that the population prevalence of trans people in Ontario, Canada is relatively similar to that of 
the United States (about 0.6%3), the inclusion of trans persons within the assumed cisgender 
comparison group would not have a significant impact on results.  
4.2.3 Measures 
Heavy episodic drinking. Trans PULSE and CCHS participants were asked how often they 
consumed five or more alcoholic drinks on one occasion in the past year. Response options 
ranged from “never” to “more than once a week”. For comparisons between the two populations 
and regression analyses, HED was defined as reporting consuming five or more alcoholic drinks 
on one occasion at least monthly in the past year. 
Sociodemographic factors. Socio-demographic characteristics included age, gender spectrum 
(transfeminine or transmasculine, i.e. natal male or female respectively, including those who 
identify as neither men nor women), Toronto residence (Ontario’s capital and largest urban 
center, based on postal code), ethno-racial group (Aboriginal, white, or non-Aboriginal person of 
color), educational attainment, and sexual minority identity (coded as yes if the respondent 
endorsed any non-heterosexual identity). Reported childhood physical or sexual abuse was 
included as a background factor. 
Transition. Participants indicated how often they lived in their felt gender (dichotomized as full-
time versus part-time or less) and described their medical transition status as not planning, 
unsure, or not applicable; planning but not begun; in process; or complete based on self-
perceived needs.  
Social exclusion and inclusion, sex work, and depression. The research team developed an 11-
item scale measuring the frequency of lifetime experiences of both external and internalized anti-
trans discrimination,24 adapted from a measure of homophobia.25, Other social exclusion and 
inclusion variables included lifetime experience of physical or sexual assault related to being 
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trans (yes versus no), Medical Outcomes Study social support scale26 scores (Cronbach’s a in 
our data=0.97), employment status (full-time, part-time, student, or other), and low income status 
(Statistics Canada low-income cut-off; LICO27). Underhousing was defined as current 
homelessness, living in substandard or temporary housing, or trouble meeting housing costs in 
combination with household income below the LICO. Perceived or expected parental support for 
gender identity or expression was dichotomized as strongly supportive versus not. Both lifetime 
and current sex work were assessed in the questionnaire, and the latter was included in this 
analysis. Depressive symptoms were measured with the Center for Epidemiological Studies 
Depression scale28 (Cronbach’s a= 0.93).  
4.2.4 Statistical analysis 
Weighted frequencies and their associated 95% confidence intervals (CIs) for Ontario’s 
networked trans population were calculated in SAS version 9.4.29 RDS II weights were 
employed, which are estimated as the inverse of the number of target population members 
known, rescaled to sum to the sample size.30 These weights adjust for unequal recruitment 
probabilities due to personal network size, generating estimates for the networked target 
population. CIs were estimated using Taylor series linearization and variances were adjusted for 
clustering by shared recruiter to account for non-independence within recruitment chains.31  
For comparison with the trans population frequencies, overall and sex-specific past-year 
weighted prevalence estimates for HED among Ontarians aged 16+ (CCHS data) were directly 
standardized to the overall and gender-spectrum-specific age distributions of trans Ontarians. Six 
age categories were employed: 16-24, 25-34, 35-44, 45-54, 55-64, and 65+. This method 
(Giblon and Bauer, in preparation) enables comparisons of trans population prevalence with 
expected prevalence in the general population, were its age distribution to match the younger age 
distribution of the trans population, which is particularly pronounced among transmasculine 
persons.22 We did not standardize for (assigned) sex, as proportions within the Trans PULSE 
data were equivalent to the Ontario population. Comparisons of HED prevalence were made 
between each gender spectrum and both (assumed cisgender) males and females in the broader 
Ontario population (i.e., by both natal sex and group most closely aligned with current gender 
identity), as alcohol misuse may have both biological and social components.  
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Standardized prevalence differences (SPDs) were estimated by subtracting the expected 
prevalences (age-adjusted from CCHS data) from observed prevalences of HED in the trans 
population. Confidence intervals for differences between proportions were constructed from CIs 
for single proportions using the Method of Variance Estimates Recovery.32 The basic idea is to 
recover variance estimates needed for setting confidence limits for differences from CIs for 
single proportions. The resulting CIs for difference provide a means of testing for statistically 
significant differences between RDS-weighted proportions- for which standard statistical tests 
are inappropriate,22,33 as well as proportions arising from different data structures. By definition, 
values contained in a 95% CI will be not be rejected at the 5% significance level. Therefore, we 
can conclude a difference in proportions is statistically different from zero at the 5% significance 
level whenever the 95% CI for the difference excludes 0.  
Weighted logistic regression models were used to estimate prevalence ratios (PRs) via average 
marginal predictions34 in SAS-callable SUDAAN version 11.35 Age and scale scores were 
entered into regression models as continuous, but PRs are presented as comparisons of reference 
values, as required for their estimation. After estimating bivariate associations for all covariates, 
a multivariable socio-demographic model was fit to estimate adjusted prevalence ratios (APRs) 
for socio-demographic correlates. Next, a blockwise procedure was employed to fit multivariable 
models for other covariates of interest, adjusting for age and socio-demographic factors 
significant at p<.05 in the multivariable socio-demographic model. Blocks of variables related to 
transition, social exclusion/inclusion, sex work, and depression were entered in turn. For 
parsimony, variables were only retained in subsequent modeling steps if their p-value from a 
Wald F-test was <0.25. This modeling approach aimed (a) to account for temporal ordering to 
the extent possible with cross-sectional data and to control for non-modifiable demographic 
characteristics, (b) to avoid inappropriate adjustment for mediators, and (c) to assess the impacts 
of social exclusion above and beyond those of gender transition. Analyses were repeated with 
stratification by gender spectrum, but results did not substantively differ, and thus only analyses 
for the full sample are reported.  
Of the 404 participants who completed alcohol use measures, seven were excluded from 
regression analyses because they were missing data on more than 20% of covariates. Participants 
excluded due to missing data were not significantly different than other participants with respect 
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to the sociodemographic variables included in this analysis. For multivariable analyses only, 
simple imputation of the median, mean, or mode was used to avoid participant loss in a complete 
case analysis. Less than 2% of data were missing for all but three variables included in this 
analysis; no variables were missing more than 10% of data.  
4.3 Results
4.3.1 Prevalence of heavy episodic drinking 
Approximately one-third of trans Ontarians reported heavy episodic drinking at least monthly in 
the past year (33.2%, 95% CI: 26.3, 40.1), including 10.9% (95% CI: 5.8, 16.1) who engaged in 
HED weekly or more. As shown in Figure 4.1, this estimated prevalence of HED at least 
monthly was 1.5 times greater than the prevalence expected based on the age-standardized 
assumed cisgender population of Ontario (21.9%, 95% CI: 21.1, 22.7), with 11.3% of trans 
persons reporting HED beyond what would be expected (SPD=11.3%; 95% CI: 4.4, 18.2; 
p=.001).  
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Figure 4.1: Past-year heavy episodic drinking at least monthly among transgender 
Ontarians and the age-standardized Ontario population, 2009-2010.          
Note: Error bars indicate 95% confidence intervals. 
By gender spectrum, 22.7% (95% CI: 13.5, 32.0) of transfeminine persons and 42.2% (95% CI: 
32.3, 52.1) of transmasculine persons reported HED at least monthly, a prevalence difference of 
19.5% (95% CI: 5.9, 33.0; p=.005). This difference was attributable to higher levels of 
occasional binge drinking (one to three times per month) among transmasculine persons (31.1% 
versus 12.0%); equal proportions of transmasculine and transfeminine persons reported heavy 
drinking once a week or more (11.1% and 10.8% respectively). Transfeminine persons had a 
higher HED prevalence than female (SPD=10.1%; 95% CI: 0.9, 19.5; p=.033), but not male 
Ontarians (SPD= -6.4%; 95% CI: -15.7, 2.9; p=.177), age-standardized to the transfeminine age 
distribution. Transmasculine persons were 2.7 times more likely to report HED than the age-
standardized female population (SPD= 26.5%; 95% CI: 16.5, 36.5; p<.000). In addition, the 
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higher HED prevalence among transmasculine individuals as compared to Ontario males 
approached statistical significance (SPD= 9.8%; 95% CI: -0.2, 19.8; p=.055). 
4.3.2 Trans population characteristics and associations with HED  
Weighted frequencies for socio-demographic characteristics and their bivariate and adjusted 
associations with HED are displayed in Table 4.1. In crude and adjusted sociodemographic 
models, transmasculine gender remained associated with greater HED (APR= 1.82; 95% CI: 
1.09, 3.06). No other sociodemographic characteristics were associated with HED. 
Table 4.1: Weighted socio-demographic characteristics of transgender people in Ontario, 
Canada and associations with heavy episodic drinking (n=397) 
 
*= p<.05, **= p≤.001 for Wald F-test 
a Adjusted for all other variables in the table; Nagelkerke R2=0.15 
b Modeled as continuous in logistic regression, reference levels required for presentation of prevalence ratios.  
 Weighted 
frequencies 
Heavy episodic drinking 
Prevalence ratio 
(bivariate) 
Adjusted prevalence 
ratioa 
% or 
mean  
(95% CI) PR  (95% CI) PR  (95% CI) 
Age (years)b 
    30 versus 20 years old 
    40 versus 20 years old 
32.5 
-- 
-- 
(30.3, 34.7)  
0.88 
0.76 
 
(0.72, 1.07) 
(0.50, 1.16) 
 
0.98 
0.95 
 
(0.81, 1.17) 
(0.66, 1.37) 
Transmasculine 
spectrum 
 
55.5 
 
(47.6, 63.4) 
 
1.93** 
 
(1.19, 3.13) 
 
1.82* 
 
(1.09, 3.06) 
Toronto residence 38.8 (30.9, 46.6) 1.34 (0.88, 2.03) 1.39 (0.92, 2.11) 
Race/ethnicity 
    White 
   Aboriginal 
    Non-Aboriginal person   
of color 
 
77.6 
6.5 
15.9 
 
(71.5, 83.7) 
(3.2, 9.8) 
(10.5, 21.3) 
 
1.00 
0.60 
0.72 
 
 
(0.22, 1.60) 
(0.36, 1.44) 
 
1.00 
0.63 
0.58 
 
 
(0.24, 1.62) 
(0.29, 1.15) 
Childhood abuse  70.0 (62.8, 77.1) 0.89 (0.56, 1.42) 0.89 (0.58, 1.35) 
Education 
   Less than high school 
   High school diploma 
   Some college/university 
   College or university  
 
11.5 
16.1 
27.1 
45.3 
 
(6.8, 16.1) 
(10.4, 21.8) 
(20.1, 34.1) 
(37.6, 53.0) 
 
1.95 
1.17 
1.52 
1.00 
 
(1.09, 3.49) 
(0.58, 2.36) 
(0.92, 2.53) 
 
1.60 
0.91 
1.53 
1.00 
 
(0.90, 2.84) 
(0.46, 1.78) 
(0.98, 2.38) 
 
Sexual minority  64.3 (56.5, 72.1) 0.77 (0.50, 1.18) 0.75 (0.52, 1.09) 
 
91 
 
 
Weighted frequencies for potential predictors of HED and their bivariate associations are 
presented in Table 4.2, while results of blockwise regression analyses are presented in Table 4.3. 
All multivariable models in Table 4.3 were adjusted for age and gender spectrum. Across models 
1-4, the magnitude and statistical significance of the APR for gender spectrum varied little from 
the initial adjusted value in Table 4.1 (results not shown; APRs ranged from 1.70-1.87, p-values 
from .01-.03). This indicates that gender variation in heavy episodic drinking was not attributable 
to differences in transition and social exclusion between gender spectra. In crude and adjusted 
analyses, current sex workers had an approximately two-fold higher HED prevalence (APR in 
final model=2.19, 95% CI: 1.36, 3.55). Neither transition status nor social exclusion/inclusion 
variables were associated with HED. 
Table 4.2: Weighted frequencies and bivariate associations for potential predictors of 
heavy episodic drinking among transgender people in Ontario, Canada (n=397) 
 Weighted 
frequencies 
Prevalence ratio 
(bivariate) 
% or 
mean 
(95% CI) PR  (95% CI) 
Living full-time in felt 
gender  
51.9 (43.5, 60.3) 1.04 (0.69, 1.57) 
Medical transition status  
Complete 
In process 
Planning but not begun 
Not planning, unsure, N/A 
 
27.0 
24.3 
28.5 
20.2 
 
(20.4, 33.7) 
(18.1, 30.5) 
(21.1, 35.9) 
(13.1, 27.2) 
 
1.00 
0.93 
1.46 
0.85 
 
 
(0.51, 1.72) 
(0.87, 2.44) 
(0.41, 1.75) 
Transphobia 
Mean (range=0-33) 
75th versus 25th percentile 
 
13.8 
-- 
 
(12.8, 14.8) 
 
-- 
0.89 
 
-- 
(0.65, 1.22) 
Transphobic assault 20.3 (14.5, 26.1) 1.36 (0.87, 2.12) 
Social support 
Mean (range=0-5) 
75th versus 25th percentile 
 
3.5 
-- 
 
(3.3, 3.7) 
 
-- 
0.97 
 
-- 
(0.70, 1.36) 
Strong parental support 
for gender  
24.7 (18.5, 30.9) 0.86 (0.50, 1.49) 
Below low income cut-off 43.7 (35.7, 51.7) 1.31 (0.81, 2.11) 
Employment status 
Full time 
Part time 
 
34.7 
15.8 
 
(27.9, 41.4) 
(10.3, 21.3) 
 
1.00 
1.03 
 
 
(0.53, 2.00) 
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Student 
Other 
27.5 
22.1 
(20.5, 34.5) 
(15.3, 28.8) 
0.94 
0.84 
(0.53, 1.66) 
(0.42, 1.70) 
Underhoused or homeless 17.4 (11.5, 23.3) 1.26 (0.75, 2.11) 
Current sex work 2.2 (0.0, 4.6) 2.36* (1.33, 4.18) 
Depressive symptoms 
Mean (range=0-60) 
75th versus 25th percentile 
23.2 
-- 
(20.9, 25.4) -- 
1.19 
-- 
(0.85, 1.65) 
. 
*= p<.05, **= p≤.001 for Wald F-test
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Table 4.3: Blockwise logistic regression predicting past-year heavy episodic drinking among transgender people in Ontario, 
Canada (n=397) 
 Adjusted prevalence ratiosa 
Model 1b Model 2 Model 3 Model 4 
PR  (95% CI) PR  (95% CI) PR  (95% CI) PR  (95% CI) 
Living full-time in felt gender  1.09† (0.65, 1.83) -- -- -- -- -- -- 
Medical transition status  
Complete 
In process 
Planning but not begun 
Not planning, unsure, N/A 
 
1.00† 
1.02 
1.37 
0.95 
 
 
(0.56, 1.84) 
(0.74, 2.54) 
(0.43, 2.09) 
-- -- -- -- -- -- 
Transphobia: 75th vs. 25th percentile -- 0.80 (0.57, 1.13) 0.84† (0.61, 1.16) -- -- 
Transphobic assault -- 1.45 (0.97, 2.15) 1.36 (0.89, 2.09) 1.15 (0.76, 1.74) 
Social support: 75th vs. 25th percentile -- 0.90† (0.65, 1.26) -- -- -- -- 
Strong parental support for gender  -- 0.89† (0.54, 1.49) -- -- -- -- 
Below low income cut-off -- 1.18† (0.70, 1.97) -- -- -- -- 
Employment status 
Full time 
Part time 
Student 
Other 
--  
1.00† 
0.94 
0.78 
0.81 
 
 
(0.52, 1.69) 
(0.45, 1.38) 
(0.42, 1.56) 
-- -- -- -- 
Underhoused or homeless -- 1.19† (0.69, 2.04) -- -- -- -- 
Current sex work -- -- 2.19* (1.33, 3.60) 2.19* (1.33, 3.61) 
Depressive symptoms: 75th vs. 25th 
percentile 
-- -- -- 1.16 (0.86, 1.57) 
Nagelkerke R2 0.07 0.10 0.08 0.09 
aAll models control for age and gender spectrum. b Model 1=gender transition; Model 2= social exclusion/inclusion factors added; Model 3= sex work added; 
Model 4=depressive symptoms added.   
†p>.25, not included in subsequent models. *= p<.05, **= p≤.001 for Wald F-test. 
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4.4  Discussion
Despite the well-established public health impacts of alcohol use in Canada and the United 
States, and well-documented burden of alcohol misuse in marginalized populations, little 
research has addressed alcohol use among transgender adults. Drawing on data generalizable to 
the networked trans population of Canada’s most populous province, we found that the estimated 
prevalence of HED monthly or more (33.2%) exceeded what would be expected based on the age 
distribution of trans Ontarians, particularly in comparison to the background female population. 
With the exceptions of transmasculine gender identity and sex work, sociodemographic 
characteristics, gender transition, and social exclusion factors were not associated with HED.  
Transmasculine persons were more likely than transfeminine persons to engage in heavy 
episodic drinking at least monthly, and this effect was robust to adjustment for all other 
covariates in the regression models. Their HED prevalence far exceeded the age-standardized 
female population of Ontario, and was almost significantly higher than that of age-standardized 
males. This provocative finding indicates need for increased attention to the health behaviours of 
transmasculine persons, which have arguably been overshadowed to date by research and 
programmatic emphasis on substance use as it relates to HIV risk. The roles of gender 
expectations and beliefs on alcohol use and misuse among transmasculine persons are 
particularly worthy of further exploration. In the broader population, sex differences in alcohol 
use, misuse, and dependence have declined over time, but remain evident.36 These shrinking sex 
differences in alcohol behaviors are hypothesized to relate to shifting social norms related to 
gender, and indicate that greater susceptibility to alcohol misuse among cisgender males cannot 
be solely attributed to biological factors. Our findings similarly indicate that gender identity and 
lived gender play a large role in alcohol misuse among trans people.  
That gender disparities in the cisgender population are larger for heavy drinking behavior than 
for alcohol abuse or dependence36 may help to explain our finding of no gender spectrum 
difference in the prevalence of frequent HED (weekly or more). Occasional HED among 
transmasculine persons may be influenced by sociocultural beliefs that equate excessive drinking 
behaviour with masculinity, or alcohol use may represent a stress-coping response that is 
relatively socially normative for transmasculine persons. 
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Estimated HED prevalence among transfeminine Ontarians fell between that of the age-adjusted 
cisgender female and male populations, and was only significantly different from the female 
population prevalence. Regardless of whether alcohol use patterns are attributed to natal sex or 
gender socialization, we might expect transfeminine persons to demonstrate greater HED 
prevalence than cisgender females. The observed disparity may not, therefore, be indicative of a 
health inequity.  
With respect to other sociodemographic characteristics, age was, unexpectedly, not significantly 
associated with HED within the trans population. As has been shown for sexual minorities,37 
age-related declines in substance use may be less steep among trans people and therefore 
difficult to detect in this relatively young sample. We also did not find evidence for an effect of 
minority stress on HED, despite the frequency with which participants encountered transphobia, 
violence, and social exclusion. As some degree of exposure to transphobia is ubiquitous among 
trans people, we cannot conclude that minority stress does not play a role in hazardous alcohol 
use in this trans population. Self-reported stigma and discrimination may not contribute to intra-
population variation in alcohol misuse within the trans population, yet exposure to social-
structural transphobia could account for the inter-population disparities we have identified. 
Finally, consistent with previous research among cisgender and transgender sex workers,15 we 
found that current sex work was associated with HED,  despite the low frequency of sex work in 
this population (2.2% were current sex workers22). The small number of sex workers in our study 
precludes exploration of specific contributors to alcohol use for this population; however, 
drinking may represent a coping strategy in response to sex-work-specific stressors and one that 
is normative within some sex workplace cultures.38  
4.4.1 Strengths and limitations 
The Trans PULSE survey employed validated alcohol use measures, including an HED measure 
directly comparable with Statistics Canada data for the same time period. Our novel use of age-
standardized comparison data from the Canadian Community Health Survey overcame a 
consistent limitation of transgender health research, in which appropriate comparison groups are 
often lacking. Considering that trans people (particularly transmasculine persons) are younger 
than the background population, comparison of unstandardized prevalence can be misleading. 
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Bias can be compounded by comparison of population-based survey findings to results of urban, 
high-risk convenience samples that characterize many transgender substance use studies. In 
contrast, these data were obtained from across the one province that contains two-fifths of 
Canada’s population. Demographic characteristics largely mirrored the background population, 
with the exception of younger age and lower incomes.22  
Nevertheless, some limitations should be noted. CCHS data were standardized to RDS-weighted 
point estimates for the age distributions of trans Ontarians. Were trans status ascertained in the 
Canadian census, such census data would be preferable for standardization. However, given that 
we employed standardization to make comparisons to the same population that gave rise to the 
estimates, this limitation is unlikely to affect results. In addition, while these RDS II analyses 
account for bias related to personal network size, other sampling biases may persist. Homophily, 
the tendency to know and recruit like others, is of concern in chain-referral sampling, and 
alternative RDS estimators explicitly adjust for homophily in recruitment. However, previous 
unpublished sensitivity analyses with this data set revealed that with the exception of geographic 
variables, results were not impacted substantially by the choice of estimator. Ultimately, while 
respondent-driven sampling represents an improvement over convenience sampling, inclusion of 
questions to capture transgender status in population-based surveys will be necessary to 
overcome these limitations.  
4.4.2 Conclusion 
We identified disparities in heavy episodic drinking between transgender and cisgender residents 
of Canada’s most populous province, which were particularly pronounced for transmasculine 
persons. These results should stimulate development of public health interventions and further 
research to address alcohol use among transmasculine persons.  
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5 Chapter 5: Drug use among transgender people in Ontario, Canada1 
5.1 Introduction
Transgender (trans) persons are those with a gender identity that differs from their birth-assigned 
sex, including individuals who are transfeminine (male birth-assigned sex with female or 
feminine gender identity) or transmasculine (female birth-assigned sex with male or masculine 
gender identity). Although population size estimates are not available for Canada, data from the 
United States indicate that trans persons constitute an estimated 0.6% of the adult population.1  
Trans people continue to experience profound social stigma and exclusion, which contribute to 
institutional and interpersonal discrimination, violence, limited health care access, and 
internalization of anti-transgender attitudes.2-5 Little substance use research has explicitly 
included trans persons,6 and quantitative data on substance use among trans persons in Canada 
have been unavailable. However, limited existing evidence and the theory of minority stress7-10 
suggest that trans populations experience disparities in drug use related to social stigma and 
discrimination. Disparities in drug use may also be related to gender dysphoria, or psychological 
distress caused by lack of alignment between one’s physical sex characteristics and gender 
identity.  
Research to date on substance use in trans populations has primarily focused on urban 
transfeminine persons living with or at high risk of acquiring HIV, finding high levels of cocaine 
and methamphetamine use.11-13 However, samples from HIV prevention studies are 
representative of the broader transfeminine population in Ontario, among whom HIV risk is low 
overall.14 Moreover, drug use is an important outcome in its own right, irrespective of its 
association with sexually-transmitted HIV, given substantial impacts on morbidity and mortality 
related to mental health, suicide, and infectious disease.15 In addition, a respondent-driven 
1
 A version of this chapter has been published: Scheim AI, Bauer GR, Shokoohi M. Drug use among transgender 
people in Ontario, Canada: disparities and associations with social exclusion. Addict Behav. 2017; 72: 151-158. 
http://doi.org/10.1016/j.addbeh.2017.03.022 
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sampling survey (n=433) in Ontario, Canada, found that transmasculine persons had a higher 
prevalence of binge drinking than their transfeminine counterparts.16 These facts underscore the 
need to examine substance use in broader trans populations, inclusive of multiple gender 
identities.  
Data from mixed-gender convenience samples of trans adults indicate that drug use in these 
samples is lower than in HIV prevention research settings, but potentially higher than in the 
broader population. For example, one in five participants to a Massachusetts trans survey 
reported any past-year non-cannabis illicit drug use,17 while one in ten participants to an online 
survey of trans people in the United States reported any such drug use in the past three months.18 
In comparison, non-cannabis illicit drug use was reported by approximately 2% of all Canadians 
aged 15+ over the past year19 and 3% of all Americans aged 12+ over the past month20 in 2013. 
Few data are available from high-income country settings outside the United States. However, in 
a report from an Australian trans convenience sample, 29% reported past-year illicit drug use 
(including cannabis).21  
Discrimination and social exclusion have been associated with substance use among trans 
persons, and may partially account for the higher levels of use observed. For example, studies in 
the United States found that reported anti-transgender discrimination22,23 and violence11,24 
predicted increased drug use among transfeminine adults. Depression, as a consequence of 
exposure to discrimination, may mediate the association with drug use.11 Socio-economic 
marginalization (e.g., unemployment, poverty), which is common in trans populations,25,26 is 
associated with drug use in the broader population.27,28 In a context of barriers to formal 
employment, trans people report high levels of sex work involvement,29 and sex work has in turn 
been associated with greater drug use in trans samples.11,17 Conversely, social inclusion may be 
protective against substance use within trans populations. For instance, family support has been 
identified as a predictor of lower substance use among trans persons and sexual minority 
individuals.30,31 
In addition to discrimination and social exclusion, gender dysphoria may potentiate substance 
use as a coping strategy. By alleviating gender dysphoria, medical gender transition through 
hormones and/or surgery may contribute to improved mental health32 and reduced substance use. 
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However, gender transition may also increase exposure to minority stressors. Findings on the 
association between medical transition and substance use have been mixed, with one study of 
trans women in San Francisco finding lower drug use among those who have taken hormones 
and/or had surgery,33 and another in New York finding the opposite.11   
The present study draws on data from a respondent-driven sampling survey of 433 trans people 
in Ontario, Canada’s most populous province, and from the Canadian Community Health 
Survey. We sought to compare past-year use of select substances (cocaine or crack and 
amphetamines, based on data availability) to the age-standardized cisgender male and female 
population of Ontario, hypothesizing that past-year prevalence would be higher among trans 
persons overall. Considering that drug use may be impacted both by biological sex and social 
gender, we did not have a priori hypotheses regarding transgender-cisgender disparities by 
gender identity.  
Next, we built exploratory blockwise regression models to evaluate the impacts of socio-
demographic characteristics, gender transition, and discrimination or social exclusion factors on 
past-year use of drugs associated with high risk of physical, psychological, and social harm to 
users. Considering potential inter-relationships between discrimination and both sex work and 
depression, these were included as covariates. We hypothesized that indicators of discrimination 
and exclusion (transphobia, transphobic violence, lower social support, lack of parental support 
for gender, lack of employment, low income, and underhousing or homelessness), sex work, and 
depressive symptoms would be associated with higher prevalence of drug use.  
5.2 Methods
5.2.1 Transgender study population 
 The Trans PULSE community-based participatory research project recruited 433 trans Ontarians 
via respondent-driven sampling (RDS) in 2009–2010, including 406 who completed substance 
use measures. Eligible participants needed to be 16 years of age or older; live, work, or receive 
health care in Ontario; and consider themselves trans, based on self-identification. Participants 
were not required to have undergone any social or medical gender transition. RDS is a chain-
  
103 
 
referral sampling and analysis method developed for stigmatized populations lacking appropriate 
sampling frames.34  
Recruitment began with 16 seed participants selected for demographic diversity. Each 
respondent was provided with three tracked coupons for recruiting their peers. Twenty-two 
additional seeds were added after 4-5 waves of recruitment, and data collection continued until a 
maximum of 10 recruitment waves were obtained. Respondents completed the 60-90-minute 
questionnaire online or by visually identical paper copy. They were compensated with a $20 gift 
card, or could opt to donate the honorarium to a trans-related charity. Secondary incentives for 
recruitment of peers ($5 gift cards) were only offered in the final months of the study, and had no 
detectable impact on recruitment rates. The study received approval from Research Ethics 
Boards at The University of Western Ontario and Wilfrid Laurier University. Additional 
information about the Trans PULSE study has been published previously.25 
5.2.2 Cisgender study population 
Data on the prevalence of past-year cocaine or amphetamine use among Ontarians aged 16 and 
above (n = 39,980) were obtained from the 2009-2010 data cycles of the Canadian Community 
Health Survey (CCHS). Data on Trans PULSE-comparable items regarding use of other drugs 
(e.g., heroin) were not made available by Statistics Canada due to small cell sizes. CCHS is an 
annual multi-stage, stratified, cluster sampling cross-sectional survey of Canadians aged 12 and 
above employing both computer-assisted personal and telephone interviews. CCHS covers over 
97% of the Canadian population, excluding institutionalized persons and those living on First 
Nations reserves. Additional information about CCHS methodology has been previously 
published online.35 Measures to identify trans respondents are not currently included in CCHS, 
and therefore we have assumed respondents to be cisgender. Applying national U.S. estimates,1 
we would expect approximately 0.6% of this cisgender comparison group to be misclassified, 
with no anticipated substantive impact on results.  
5.2.3 Measures 
Past-year cocaine and amphetamine use. Separate CCHS items asked about use of “cocaine or 
crack” or “speed (amphetamines)” over the past year. Trans PULSE participants were provided 
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with a list of illicit substances and asked to indicate which they had used in the past year. 
Amphetamines were defined differently in the two surveys: in Trans PULSE use of crystal 
methamphetamine and “other amphetamines” were queried separately, while CCHS participants 
were only asked to report use of “speed (amphetamines)”. To be conservative (as CCHS 
respondents may not have reported crystal methamphetamine use when asked about “speed”), 
only reported use of “other amphetamines” in Trans PULSE data was compared to reported 
amphetamine use in CCHS data, excluding crystal methamphetamine.  
Past-year higher-risk drug use. A binary variable indicating any past-year drug use was created 
for regression analyses with Trans PULSE data. Given that an indicator of frequency or severity 
of use was not available, we limited attention to drugs posing significant risk of physical, 
psychological, and social harm to the user, based on Nutt et al.’s multi-criteria decision 
analysis.36 Evaluation criteria for their ranking of user-side harms included drug- specific and 
drug-related mortality, morbidity, and mental impairment; risk of dependence; loss of tangibles 
(including criminal justice involvement); and loss of relationships. While not included in the 
ranking by Nutt et al., non-medical use of prescription opioids is a major source of drug-related 
morbidity and mortality in Canada (e.g., related to overdose).37 Therefore, respondents were 
coded as engaging in higher-risk drug use if they reported any past year use of heroin, cocaine 
(crack or powder), crystal methamphetamine, other amphetamines, GHB, ketamine, or 
prescription narcotics not prescribed by a physician. Drug types queried in our survey but 
excluded from this outcome definition were cannabis, poppers (alkyl nitrites), hallucinogens, and 
ecstasy/MDMA.  
Personal network size. For RDS weighting, Trans PULSE participants were asked “How many 
other people do you personally know who could answer yes to all three eligibility questions?” 
These questions were the eligibility criteria listed above.  
Covariates. Socio-demographic and background characteristics included age, gender identity 
(transfeminine or transmasculine), ethno-racial group (Indigenous, white, or person of color), 
residence in Toronto (Ontario’s capital and major urban center), report of childhood physical or 
sexual abuse, educational attainment (dichotomized as high school completion or less, versus any 
post-secondary education), and sexual minority identity. Gender transition variables were social 
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transition (living in felt gender full-time, versus part-time or less) and medical transition. The 
latter was self-reported as complete; in process; planning but not begun; or not planning, unsure, 
or not applicable.  
Social stigma and exclusion factors included transphobia, operationalized with an 11-item scale 
of enacted and internalized transphobia (anti-transgender stigma; Cronbach’s α =0.813) and an 
indicator of experiencing transphobic physical or sexual violence, both over  a lifetime frame. 
Social support was measured with the Medical Outcomes Study scale38 (Cronbach’s α in our 
data=0.97). Participants reported whether a range of important people in their lives were 
supportive of their gender identity or expression, or anticipated to be supportive if disclosure had 
not taken place. Given evidence for a unique impact of strong parental support,32 a dichotomous 
measure of strong parental support (versus moderate or weak support) was included. Other 
factors indicating social exclusion were current employment status, low income status (below the 
Statistics Canada low income cut-off 39), and homelessness or underhousing (defined as living in 
temporary or substandard housing, or having low income in combination with trouble meeting 
housing costs). Current sex work was self-reported in response to a question about current 
sources of paid work. Finally, past-week depressive symptoms were measured with the Center 
for Epidemiological Studies scale40 (Cronbach’s a in our data= 0.93). 
5.2.4 Statistical analysis 
To adjust for unequal recruitment probabilities, Trans PULSE data were analyzed with RDS II 
weights, which are estimated as the inverse of network size, rescaled to sum to the sample size.41 
Estimates are thus for the networked trans population in Ontario. Weighted frequencies and their 
95% confidence intervals were calculated in SAS version 9.3,42 employing Taylor series 
linearization and adjusting variances for clustering by shared recruiter.43 Comparisons with 
CCHS data on the prevalence of past-year cocaine and amphetamine use were made by directly 
standardizing overall and sex-specific weighted estimates for Ontarians aged 16+ to the overall 
and gender-identity-specific age distributions of trans Ontarians. Six age categories were 
employed: 16–24, 25–34, 35–44, 45–54, 55–64, and 65+. Comparisons were made by both birth-
assigned sex and current gender identity (i.e., between both gender identity groups and both 
males and females in the broader Ontario population). This method has been used and described 
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previously to compare the prevalence of heavy episodic drinking among transgender versus 
cisgender Ontarians,16 while accounting for the substantially younger age distribution of the 
transgender population. Standardized prevalence differences (SPDs) were estimated by 
subtracting the age-standardized CCHS prevalence from observed prevalence in the trans 
population. This can be interpreted as the excess prevalence in the trans population as compared 
to what would be expected of the cisgender population, if the populations had the same age 
distribution. Confidence intervals around the SPD were constructed using the Method of 
Variance Estimates Recovery44 to allow for comparison given the different structures of the two 
data sources. Differences in proportions are significant at p < 0.05 where the CI around the SPD 
excludes 0.  
Predictors of higher-risk drug use were examined using Trans PULSE data. Prevalence ratios 
were estimated using average marginal predictions45 from weighted logistic regression models in 
SAS-callable SUDAAN.46 Bivariate associations were estimated for all covariates. Next, 
adjusted prevalence ratios (APRs) were estimated for socio-demographic and background 
factors. Finally, a series of blockwise multivariable models were fit, with variables entered in the 
following order: (1) gender transition, (2) social stigma and exclusion, (3) sex work, and (4) 
depressive symptoms. This exploratory modeling approach was intended to account for temporal 
ordering to the extent possible with cross-sectional data, and to assess the impacts of social 
exclusion factors while adjusting for gender transition. Each model was adjusted for age and for 
socio-demographic or background factors independently associated with the outcome at p<0.10 
(ethno-racial group, Toronto residence, and childhood abuse). For each block, all variables were 
entered simultaneously. Variables were excluded from the following modeling step only if their 
p-value (for a Wald test in the multivariable model) was >0.25.47 Results of analyses stratified by 
gender identity did not substantively differ and thus only analyses for the full sample are 
reported.  
All available outcome data (n=406) were used to generate prevalence estimates in Table 1. For 
regression analyses, respondents were excluded if they were missing data on more than 20% of 
covariates (n=7), resulting in an analytic sample of 399.  
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5.3 Results 
5.3.1 Drug use frequencies in the transgender population 
As shown in Table 5.1, an estimated 12.3% (95% CI: 7.7, 17.0) of trans Ontarians had used at 
least one higher-risk drug in the past year, with no significant difference detected by gender 
identity. Powder cocaine was the most frequently reported drug (7.3%; 95% CI: 3.3, 11.4), and 
crystal methamphetamine least common (0.4%, 95% CI: 0.0, 0.7). Only use of crack cocaine 
varied significantly by gender identity, with transfeminine persons being more likely to report 
use (4.5%, 95% CI: 0.0, 9.7 versus 0.7%, 95% CI: 0.0, 1.5).  
 
Table 5.1: Past-year drug use among transgender Ontarians, by gender identity (n=406) 
 
a Transmasculine= assigned female at birth and identifies as male or masculine; transfeminine= assigned male at 
birth and identifies as female or feminine.  
b Classes were defined as: cocaine (powder or crack), amphetamines, “club drugs” (Ketamine and GHB), and 
opiates (heroin, prescription narcotics).  
*= p<.05 for difference between transmasculine and transfeminine persons. 
5.3.2 Drug use frequencies in comparison to Ontarians overall 
Comparisons to the reference population data from CCHS are displayed in Figures 5.1 and 5.2. 
Compared to the age-standardized cisgender population, transgender Ontarians were more likely 
 All Trans People 
 
 
Transmasculinea 
 
Transfemininea 
 
% 95% CI % 95% CI % 95% CI 
 Crack cocaine 2.4 (0.0, 4.9) 0.7* (0.0, 1.5) 4.5* (0.0, 9.7) 
Powder cocaine 7.3 (3.3, 11.4) 9.4 (3.3, 15.5) 5.0 (0.0, 10.2) 
Crystal methamphetamine 0.4 (0.0, 0.7) 0.4 (0.0, 0.9) 0.4 (0.0, 0.9) 
Other amphetamine 1.6 (0.5, 2.7) 1.4 (0.0, 3.1) 1.9 (0.5, 3.4) 
Ketamine 2.6 (1.1, 4.2) 2.9 (0.6, 5.3) 2.3 (0.3, 4.3) 
Gamma Hydroxybutyrate (GHB) 0.6 (0.0, 1.4) 0.8 (0.0, 2.1) 0.4 (0.0, 1.0) 
Heroin 0.6 (0.0, 1.4) 0.8 (0.0, 2.2) 0.4 (0.0, 1.2) 
Non-medical use of prescription 
narcotics 
6.2 (2.9, 9.6) 7.5 (2.6, 12.5) 4.7 (0.0, 9.6) 
At least one of above  12.3 (7.7, 17.0) 13.2 (6.7, 19.7) 11.4 (4.3, 18.5)  
More than one class of drugb  4.1 (1.7, 6.5)   5.2 (1.1, 9.4)  2.8 (0.8, 4.8) 
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than expected to use both cocaine (powder or crack) and amphetamines. Specifically, the 
estimated prevalence of past-year cocaine use was 6.8% (95% CI for standardized prevalence 
differences; SPD= 1.6, 10.9) greater among trans persons, while estimated amphetamine use was 
1.6% (95% CI: 0.5, 2.7) greater. Put differently, there were an estimated 68 excess prevalent 
cases of past-year cocaine use per 1000 trans people, and 16 excess prevalent cases of 
amphetamine use, compared to what would be expected for the age-standardized reference 
population.  
Next, analyses were stratified by gender identity, with data from cisgender males and females 
age-standardized to the relevant transgender age distribution (e.g., for comparisons with 
transmasculine persons, both cisgender males and females were age-standardized to the 
transmasculine age distribution). Transmasculine persons were significantly more likely to use 
cocaine than the cisgender reference populations, but not amphetamines. Transmasculine persons 
had a higher past-year prevalence of cocaine use as compared to both Ontario males (SPD= 
7.2%, 95% CI: 1.0, 13.3) and females (SPD= 8.5%, 95% CI: 2.3, 14.6). In contrast, 
transfeminine persons were more likely to use amphetamines than both cisgender males (SPD= 
1.5%, 95% CI: 0.1, 3.0) and females (SPD= 1.8%, 95% CI: 0.4, 3.3). However, their prevalence 
of cocaine use varied only in comparison to cisgender females (SPD= 5.9%, 95% CI: 0.3, 11.4). 
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Figure 5.1: Past-year cocaine or crack use among transgender Ontarians and the age-
standardized Ontario population, 2009-2010 
 
Note: Error bars indicate 95% confidence intervals.  
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Figure 5.2: Past-year amphetamine use among transgender Ontarians and the age-
standardized Ontario population, 2009-2010 
 
Note: Error bars indicate 95% confidence intervals.  
5.3.3 Trans population characteristics and associations with drug use 
Weighted frequencies of socio-demographic characteristics and their associations with past-year 
drug use within the transgender population are shown in Table 5.2. In both crude and adjusted 
analyses, childhood physical or sexual abuse (APR=2.80, 95% CI: 1.18, 6.63), and Toronto 
residence (APR=3.15, 95% CI: 1.42, 6.99) were associated with higher prevalence of drug use, 
while people of color had a lower prevalence than whites (APR=0.24, 95% CI: 0.08, 0.65). 
1.6
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0.5
0.2
1.9
0.4
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Table 5.2: Weighted socio-demographic and background characteristics of transgender 
people in Ontario, Canada and associations with past-year drug use (n=399) 
*= p<.05, **= p≤.001 for Wald F-test  
a Nagelkerke R2=0.18 
bModeled as continuous in logistic regression, reference levels required for presentation of prevalence ratios. 
5.3.4  Predictors of drug use 
Results of blockwise logistic regression models predicting drug use are presented in Table 5.3, 
alongside bivariate prevalence ratios and weighted frequencies for each covariate. Experiences of 
transphobia, transphobic physical or sexual assault, homelessness or underhousing, and sex work 
were crudely associated with drug use. Multivariable models were adjusted for age, 
race/ethnicity, Toronto residence, and childhood abuse. In model 1, where transition status 
variables were added, neither social nor medical gender transition was significantly associated 
with drug use (results not shown). In model 2, including social stigma/exclusion variables, 
transphobic physical or sexual assault (APR= 2.11, 95% CI: 1.07, 4.17), greater social support 
(APR= 1.61, 95% CI: 1.11, 2.33), and being underhoused or homeless (APR= 2.34, 95% CI: 
1.02, 5.38) were positively associated with drug use. In model 3, adding current sex work to 
Weighted 
frequencies 
Prevalence ratio 
(bivariate) 
Adjusted prevalence 
ratioa
% (95% CI) PR (95% CI) PR (95% CI) 
Age (years)b 
Median, IQR 
30 versus 20 
40 versus 20 
28.7 
-- 
-- 
22.1- 38.7 
-- 
-- 
-- 
0.81 
0.65 
-- 
(0.62, 1.07) 
(0.37, 1.15) 
-- 
0.81 
0.66 
-- 
(0.59, 1.12) 
(0.33, 1.29) 
Gender identity 
Transmasculine 
Transfeminine 
55.6 
44.4 
(47.7, 63.4) 
(36.6, 52.3) 
1.31 
1.00 
(0.57, 2.97) 1.09 
1.00 
(0.49, 2.43) 
Toronto residence 38.8 (31.0, 46.7) 2.67* (1.13, 6.30) 3.15** (1.42, 6.99) 
Race/ethnicity 
White 
Indigenous 
Person of color 
77.6 
  6.5 
15.8 
(71.5, 83.8) 
(3.2, 9.8) 
(10.5, 21.2) 
1.00* 
0.79 
0.29 
(0.28, 2.23) 
(0.10, 0.79) 
1.00* 
0.63 
0.24 
(0.15, 2.62) 
(0.08, 0.65) 
Childhood abuse 69.5 (62.4, 76.6) 3.08* (1.29, 7.33) 2.80* (1.18, 6.63) 
High school education or 
less  
27.5 (20.1, 34.9) 0.55 (0.25, 1.20) 0.51 (0.20, 2.19) 
Sexual minority 64.3 (56.6, 72.1) 1.35 (0.59, 3.10) 0.95 (0.42, 2.19) 
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retained social stigma and exclusion variables, sex work was associated with greater drug use 
(APR=3.82, 95% CI: 1.22, 11.94). Social support remained positively correlated with drug use, 
while associations with transphobic assault and homelessness or underhousing were attenuated 
and lost statistical significance. In model 4, depressive symptoms were not associated with past-
year drug use.
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Table 5.3: Blockwise logistic regression predicting past-year drug use among transgender people in Ontario, Canada (n=399), 
controlling for socio-demographic and background characteristics 
 
 
Weighted 
frequencies 
Prevalence ratio 
(bivariate) 
Adjusted prevalence ratiosa 
Model 2b Model 3 Model 4 
% or 
median  
(95% CI) 
or IQR 
PR  (95% CI) PR  (95% CI) PR  (95% CI) PR  (95% CI) 
Living full-time in felt gender  52.0 (43.6, 60.4) 1.60 (0.68, 3.79) -- -- -- -- -- -- 
Medical transition status  
Complete 
In process 
Planning but not begun 
Not planning, unsure, N/A 
 
27.1 
24.3 
28.4 
20.1 
 
(20.4, 33.8) 
(18.2, 30.5) 
(21.1, 35.8) 
(13.1, 27.2) 
 
1.00 
0.64 
0.42 
0.83 
 
 
(0.29, 1.38) 
(0.11, 1.57) 
(0.31, 2.22) 
-- -- -- -- -- -- 
Transphobia 
Median, IQR 
75th versus 25th percentile 
 
12.8 
-- 
 
9.0-18.2 
-- 
 
 
1.69* 
 
 
(1.10, 2.60) 
 
 
1.08† 
 
 
(0.71, 1.67) 
-- -- -- -- 
Transphobic assault 20.3 (14.4, 26.1) 3.09** (1.47, 6.47) 2.11* (1.07, 4.17) 1.84 (0.94, 3.57) 1.82 (0.92, 3.61) 
Social support 
Median, IQR 
75th versus 25th percentile 
 
3.6 
-- 
 
2.8-4.3 
-- 
 
 
1.37 
 
 
(1.00, 1.90) 
 
 
1.61* 
 
 
(1.11, 2.33) 
 
 
1.59** 
 
 
(1.15, 2.19) 
 
 
1.61** 
 
 
(1.14, 2.27) 
Strong parental support for 
gender  
24.7 (18.5, 30.9) 0.49 (0.23, 1.05) 0.52 (0.25, 1.07) 0.55 (0.28, 1.07) 0.55 (0.29, 1.06) 
Below low income cut-off 43.8 (35.8, 51.8) 1.69 (0.78, 3.69) 0.95† (0.47, 1.92) -- -- -- -- 
Employment status 
Full or part-time 
Student 
Other 
 
50.5 
27.5 
22.0 
 
(42.9, 58.1) 
(20.5, 34.5) 
(15.3, 28.8) 
 
1.00 
1.16 
0.79 
 
 
(0.48, 2.81) 
(0.31, 2.03) 
 
1.00† 
1.01 
0.78 
 
 
(0.44, 2.31) 
(0.34, 1.80) 
-- -- -- -- 
Underhoused/ homeless 17.6 (11.7, 23.5) 2.74* (1.23, 6.08) 2.34* (1.02, 5.38) 1.83 (0.75, 4.44) 1.84 (0.77, 4.40) 
Current sex work 2.2 (0.0, 4.6) 7.48** (3.97, 14.08)  3.82* (1.22, 11.94) 3.82* (1.22, 11.99) 
Depressive symptoms 
Median, IQR 
75th versus 25th percentile 
 
22.5 
-- 
 
10.7-32.8 
-- 
 
 
1.06 
 
 
(0.67, 1.68) 
  
 
1.05 
 
 
(0.67, 1.63) 
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aAll models control for age, ethnoracial group, Toronto residence, and childhood sexual or physical abuse. 
b Model 1 (transition status variables) not displayed; p-values for all variables were > 0.25. Model 2= social exclusion/inclusion factors; Model 3= sex work 
added; Model 4=depressive symptoms added.   
†p>0.25, not included in subsequent models.  *= p<0.05, **= p≤0.001 for Wald F-test  
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5.4 Discussion
Drawing on data from a province-wide respondent-driven sampling survey, we found that an 
estimated 12.3% of trans Ontarians reported past-year use of illicit drugs associated with a high 
risk of harm to the user, most commonly cocaine or non-prescribed opioids. In comparison to the 
reference (cisgender) population in the same period, directly standardized to reflect the younger 
transgender age distribution, trans persons were five to six times more likely to report past-year 
use of cocaine and amphetamines. While data on non-medical prescription opioid use (NMPOU) 
in the cisgender population were not available for standardized comparisons, an estimated 2.0 % 
of Ontario adults reported NMPOU in 2008-9,48 as compared to the 6.2% we have estimated for 
the trans Ontario population. Drug use within the trans population was associated with socio-
demographic and background characteristics (white race, major urban residence, and childhood 
abuse), transphobic violence, homelessness or underhousing, and sex work.  
5.4.1 Strengths and limitations 
This is the first study to estimate the prevalence of drug use among trans Canadians, and draws 
on respondent-driven sampling data, which are, in theory, generalizable to the networked 
transgender population of Ontario (i.e., those knowing at least one other trans person). However, 
while RDS II weights adjust for unequal recruitment probabilities due to network size, other 
sampling biases may remain.49 For instance, specific groups may be consistently under- or over-
recruited, or be more likely to decline participation even if recruited. Ultimately, inclusion of 
measures to identify trans respondents in Canadian population health surveys will be will be 
critical to advancing understanding of health disparities. Comparison to CCHS was based on 
availability of data for the same categories of drugs as included in Trans PULSE. To be 
conservative, we compared reported use of “speed (amphetamines)” in CCHS to “other 
amphetamines” in Trans PULSE. This underestimate the disparity in use to the extent that crystal 
methamphetamine users responded affirmatively to the CCHS question.  
The Trans PULSE survey did not collect data on the frequency of drug use in the past year. 
Reported use may have been intermittent, or even a single event, and is not indicative of 
problematic use or dependence. To mitigate the limitations of the available outcome data, we 
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restricted attention to drugs posing higher risk of harms to users. Nevertheless, respondents may 
have experienced high risk related to problematic use of other drugs. Self-reporting of drug use is 
also subject to social desirability bias. While Trans PULSE was self-administered (with the 
option to retain anonymity), the CCHS was interviewer-administered, and therefore reporting 
bias may contribute to overestimation of prevalence differences.  In addition, the data are cross-
sectional and thus causality cannot be inferred. Further, some exposures were measured over the 
same time frame as drug use (e.g., sex work), and are potential effects of drug use.  
5.4.2 Implications 
Consistent with prior research, indicators of social stigma and exclusion were associated with 
drug use within the trans population.20-22  Interestingly, while discriminatory violence was 
related to drug use, transphobia overall was not. The addition of sex work to regression models 
attenuated the estimated prevalence ratios for transphobic assault and underhousing, suggesting 
that sex work may mediate and/or confound associations between these factors and drug use. A 
previous study in New York found that sex work was prospectively associated with transphobic 
violence, and in turn, with depressive symptoms and substance use.11 Research including larger 
numbers of transgender sex workers, ideally longitudinal, is required to elucidate the 
relationships between these factors over time and across geographic contexts.  
Greater social support was consistently positively associated with drug use. This unexpected 
finding warrants future investigation. As we examined any past-year drug use, much of which 
would be occasional recreational use, it is plausible that individuals engaging in such use are 
more socially well-connected.  
Gender identity was not associated with drug use among trans persons.  Few studies have 
directly compared substance use by gender identity, and those studies have had conflicting 
findings.17,18 In this same study population, transmasculine gender was robustly associated with 
heavy episodic drinking, while social exclusion variables—with the exception of sex work—
were unassociated.16 However, there was no gender identity difference in the prevalence of very 
frequent (weekly or more) binge drinking. Taken together, these findings suggest that the impact 
of gender norms on transgender substance use behavior may be stronger for more socially 
normative use (e.g., occasional heavy drinking), with social marginalization more salient for 
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predicting higher-risk substance use or dependence. Social and medical gender transition statuses 
were also not significantly associated with drug use, suggesting that factors other than gender 
dysphoria may account for the high prevalence of drug use in this population. Indeed, results 
indicate that drug use is particularly elevated among trans Ontarians who have experienced 
victimization (childhood abuse, transphobic assault), homelessness or underhousing, and sex 
work. Culturally competent substance use prevention and treatment services that consider the 
impact of these experiences are warranted.  
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6 Chapter 6: The intersectional discrimination index: Development 
and validation of measures of self-reported experienced and 
anticipated discrimination 
6.1 Introduction
6.1.1 Discrimination and health 
Discrimination refers to a range of explicit and implicit policies, practices, and behaviours that 
perpetuate inequities between socially defined groups, including institutionalized and legal 
subjugation, de facto discrimination by ostensibly neutral policies, and interpersonal slights.1 
Most research on discrimination and health has focused on perceived discrimination self-
reported by its targets.1 Such discrimination represents one mechanism by which non-dominant 
group membership may be linked to poorer health outcomes, and thus represents an important 
area of investigation for research aiming to intervene on the processes that maintain health 
disparaties.2,3 
Perceived discrimination is frequently understood as a psychosocial stressor that contributes to 
the higher overall burden of stress experienced by non-dominant social groups,4,5 within the 
psychological and sociological stress frameworks first elaborated by Lazarus and Folkman6 and 
Pearlin, respectively.7 Discrimination may also impact health via social resistance, whereby 
discriminated group members actively engage in risk behaviours as a means of expressing their 
dissatisfaction with discriminatory social arrangements, and alienation from dominant society 
and its norms.8,9 Further, discrimination events can diminish health directly when they involve 
loss of economic resources to maintain health, physical injury, or denial of health care.1 A 
growing body of research links self-reported discrimination with poorer health outcomes, with 
the most robust evidence for deleterious impacts of racial and ethnic discrimination on 
psychological distress and negative mental health outcomes among racial and ethnic 
minorities.1,10,11 
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6.1.2 Intersectional discrimination 
A meta-analysis of research on self-reported discrimination and health published from 1986-
2007 found that most focused on racism (66%), and less commonly on sexism (17%) or 
discrimination against sexual minorities (6%).12 Some studies have explicitly investigated 
discrimination on the bases of multiple social statuses,13-17 however, this appears rare.18,19 
Intersectional research on discrimination and health has been identified as an area in need of 
development.2,18 Crenshaw20 coined intersectionality to describe how Black women’s 
experiences of discrimination were qualitatively unique, rather than merely a combination of 
experiences of white women and Black men. Intersectionality has become a central framework 
for understanding the multiple, interacting, and context-dependent forms of social and health 
advantage or disadvantage that individuals experience on the bases of social status and 
position.21,22  
 Intersectionality scholars are heterogeneous in their ontological and methodological 
orientations.21 Social scientific and population health research approaches tend to apply an 
intercategorical approach to intersectionality, one that takes the critical realist perspective that 
while existing categories of social status and position (e.g., race, gender) are socially constructed 
and provisional categories, they nevertheless reflect real and socially meaningful groupings. As 
applied to the study of discrimination and health, intercategorical intersectionality involves 
examining the potentially interacting impacts of multiple, multidimensional categories of social 
status and position on outcomes of interest.2,21 Intersectionality argues that health inequalities do 
not necessarily increase linearly with each additional marginalized social status, and that the 
study of one form of discrimination or privilege at a time (e.g., racism, sexism), will obscure the 
experiences of groups facing intersecting forms of discrimination.2,22 Moreover, an intersectional 
perspective also suggests that individuals belonging to multiple socially marginalized groups 
may be unable to identify a single basis for any given act of discrimination they experience, 
raising questions as to the validity of survey measures which require participants to do so.23  
6.1.3 Measuring intersectional discrimination 
Corresponding to a remarkable growth in public health and social science research on 
discrimination over the past two decades,1 the set of instruments available to measure 
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discrimination has expanded rapidly. For instance, a 2006 review identified 152 self-report 
instruments for racism alone.24 Despite this proliferation of discrimination measures, few have 
been developed specifically to assess discrimination across multiple social statuses or positions. 
Two exceptions are scales developed by Bastos et al. for the Brazilian context25 and by Bogart et 
al. to evaluate racial/ethnic, sexual orientation, and HIV stigma concurrently.26   
Of the most commonly used and widely validated measures of (racial/ethnic) discrimination,11 
two have particular potential to be used for cross-group discrimination: Krieger et al.’s 
Experiences of Discrimination (EOD)27 and Williams et al.’s Everyday and Major 
Discrimination measures.28 The former asks “"Have you ever experienced discrimination, been 
prevented from doing something, or been hassled or made to feel inferior in any of the following 
situations because of your race, ethnicity, or color?" across 9 domains, but has been adapted to 
include other stem endings (“e.g., “because of your sex”), such as in the 2004–2005 United 
States National Epidemiologic Survey of Alcohol and Related Conditions.17,29 Williams’ 
measures28 inquire about “unfair” treatment in interactions with various institutions or domains 
(major discrimination), or about specific instances of poor or inferior treatment (everyday 
discrimination). Those endorsing any discrimination experiences are asked to indicate the main 
reason they attribute to the experience (or in some adaptations, multiple main reasons15).  
While these extant measures are candidates for use in intersectional analyses, they present 
substantial challenges. First, their items were not developed to tap into the manifestations of 
discrimination across non-dominant social groups. For example, the Everyday and Major 
Discrimination measures28 were designed to ascertain racial discrimination against African-
Americans. Thus, they include items which may be less salient for other racial and non-racial 
minority groups30,31 (e.g., related to perceptions of the respondent as frightening) – and even for 
Black women32 –  and exclude items relevant to a number of discriminated groups (e.g., being 
ostracized in public).  
Measures that employ parallel question sets for each type of discrimination17,26 impose a high 
respondent burden and preclude valid assessment of total discrimination burden because 
respondents may report the same discrimination experience (e.g., being harassed) multiple times 
(e.g., related both to gender and to race). Without the ability to estimate exposure to 
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discrimination overall, researchers are limited either to conduct analyses within subgroups at risk 
of the exposure (e.g., intersecting effects of racial, sexual, and HIV-related discrimination among 
ethnic minority men who have sex with men living with HIV26) or, in broader population 
samples, to analyzing the effect of exposure to any discrimination in combination with the 
number or combination of attributions reported.17  These limitations severely limit ability to 
evaluate the role of self-reported discrimination in mediating health inequities in population 
health research, and to testing hypotheses consistent with scientific knowledge about the impacts 
of cumulative and chronic stressors.33-35     
6.1.4 The present study 
Considering the limitations of existing measures for intersectional population health research 
concerned with the impacts of multiple forms of discrimination, we sought to develop a new 
measure, which we titled the Intersectional Discrimination Index (InDI). The index consists of 
three components which assess anticipated, day-to-day, and major discrimination respectively. 
Considering evidence that perceived discrimination’s deleterious impact is not dependent on the 
grounds it is attributed to,18 and following the approach recommended for evaluation by Bauer,2 
we aimed to develop a single index that can be administered and scored without need for 
attributions to specific grounds. Instead, data on social status and position (i.e., socio-
demographic measures) can be used to compare the experiences and outcomes of groups at 
relevant intersections.   
The InDI was developed and refined through literature review, expert consultation, and pilot 
testing. To evaluate the InDI’s validity and reliability, it was administered to survey panel 
members in Canada and the United States sampled for maximum racial/ethnic and sexual 
diversity, along with socio-demographic, mental health, and substance use measures. A subgroup 
completed a follow-up survey including the InDI and the most comprehensive versions of 
Williams’ Everyday28 and Major36 Discrimination. These data were used to examine 
acceptability and data quality, internal consistency and dimensionality, construct validity 
(including associations with the Williams measures and established health correlates of 
discrimination), and test-retest reliability. Considering the need for a well-developed empirical 
and theoretical basis for validation hypotheses, as well as sufficient sample sizes, these analyses 
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of validity and reliability consider one axis of social status or position at a time (e.g., 
race/ethnicity, sexual orientation). A companion paper (Bauer and Scheim, in preparation) will 
demonstrate the utility of the InDI for intersectional analyses of health outcomes through worked 
examples.  
6.2 Methods
6.2.1 InDI Development 
Development of the InDI began with a narrative review of public health and social scientific 
literature on (a) intersectionality, (b) theoretical models linking stigma, discrimination, and 
mental health, (c) measuring self-reported discrimination, and (d) development of self-report 
measures. Informed by this review, we decided to develop a multidimensional index to reflect 
the nature of discrimination-related stressors, including major or disruptive life events, chronic or 
ongoing stressors, traumatic or violent events (frequently excluded in discrimination measures37), 
as well as anticipatory stress related to expecting future discrimination.18,38 Many items were 
adapted from existing discrimination and victimization measures, while others were generated by 
the investigators to cover manifestation of discrimination not included in extant measures (e.g., 
dissolution of personal relationships). A construct map39 was used to ensure balanced coverage 
of all discrimination domains (e.g., institutional settings,1,40,41 interpersonal relationships,32 and 
chronic slights42) and of discrimination types reflecting various affective bases of prejudice (e.g., 
disgust versus fear). Further detail on item development for each component is provided below.  
To gather input on the draft InDI, we held telephone and videoconference consultations with 
eight experts from Canada, the United States, and Australia, including epidemiologists, 
psychologists, and policy analysts from the Canadian and Ontario Human Rights Commissions. 
After revising item content and wording based on expert feedback, we pilot-tested the second 
version of the InDI with ten graduate students to obtain feedback on item and instruction clarity, 
face validity, and sufficiency of response options. The index was also reviewed for readability 
using the Flesch-Kincaid Grade Level, and wording was revised until a 7th grade level was 
reached. The final index contains the three sub-measures described below: anticipated, day-to-
day, and major discrimination. The InDI is included as Appendix B.  Rather than asking 
respondents to attribute the bases of discriminatory experiences or expectations (i.e., social 
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identities or statuses), the InDI solicits experiences “because of who you are”, with the following 
definition provided at the outset and midway through the questionnaire: 
These questions are about experiences related to who you are. This includes both how you 
describe yourself and how others might describe you. For example, your skin colour, ancestry, 
nationality, religion, gender, sexuality, age, weight, disability or mental health issue, and income. 
Anticipated discrimination. The minority stress framework suggests that the stress and 
vigilance associated with anticipation of discrimination are important contributors to stigma-
related mental health inequities.43,44 Yet, the construct is rarely included in measures of 
discrimination.38 Existing measures tend to either simultaneously evaluate anticipated stigma and 
subsequent behavioural reactions (i.e., include double-barreled questions), inquire only about 
generalized expectations of discrimination against one’s social group, or focus on specific 
concealable stigmas (e.g., mental illness).45,46 Therefore, we developed items to assess 
anticipation of discrimination, as well as expectations of safety and equitable treatment. Items 
were based on the domains covered by the Major Discrimination component. For each of 11 
statements, respondents were asked to indicate agreement on a 5-point Likert-type scale 
(strongly disagree to strongly agree). For example, one item reads: "Because of who I am, I 
might have trouble finding or keeping a job.” To avoid priming respondents to anticipate 
discrimination by recalling past discrimination events, these items were asked first.  
Day-to-day discrimination. This component included 18 items assessing the frequency and 
recentness of day-to-day discrimination (never, lifetime but not past-year, once or twice in the 
past year, many times in the past year). Day-to-day discrimination items were informed by 
Williams’ Everyday Discrimination scale and Sue’s42,47 framework of microaggressions: 
“...everyday verbal, nonverbal, and environmental slights, snubs, or insults, whether intentional 
or unintentional, that communicate hostile, derogatory, or negative messages to target persons 
based solely upon their marginalized group membership.”42 To ensure representation of items 
that reflect both the overlapping and distinct biases and stereotypes that contribute to 
discrimination across non-dominant social groups, we referred to Cuddy et al.’s Stereotype 
Content Model (SCM) and Behaviour from Intergroup Affect and Stereotypes (BIAS) map.48 
The SCM delineates two dimensions on which positive or negative group stereotypes are based –  
warmth and competence.  In turn, the BIAS map predicts affective and behavioural responses to 
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social groups based on their position along each dimension. For example, groups socially 
stereotyped as high in competence but low in warmth tend to be envied, and thus treated with a 
combination of active harm and passive facilitation, whereas groups stereotyped as low on both 
dimensions actively harmed and neglected based on feelings of contempt.  As reporting of day-
to-day discrimination may be particularly susceptible to confounding with current mental health 
status, we tried to avoid items requiring extremely subjective appraisals or comparisons (e.g., 
“people act as if they’re better than you are”). A sample item reads: “Because of who you are, 
have you heard, saw, or read others joking or laughing about you (or people like you)?” 
Major Discrimination. Eleven items measured major events over the lifetime (never, once, or 
more than once). To generate past-year frequencies, respondents endorsing any lifetime 
discrimination were asked whether the specified event had occurred at least once in the past year. 
For utility in monitoring the prevalence of justiciable forms of discrimination,49 and to limit 
confounding with current health status, items referred to specific manifestations of 
discrimination (rather than asking respondents to report “discrimination” per se) and included 
objective end-points where possible (e.g., stopped or arrested by police, rather than ‘harassed’). 
For example, health care discrimination is assessed with: “Because of who you are, has a health 
care provider ever refused you care?” Items related to violence and property damage were 
adapted from measures by Herek50 and the Statistics Canada General Social Survey 
Victimization Survey.51  
6.2.2 Data Collection 
Legerweb was contracted to collect data from a target sample of 3000, split evenly between 
residents of Canada and the United States. Legerweb is a Canadian web survey panel provider 
and builder. Since 2004, they have managed a panel with over 400,000 active members. They 
conduct market research, opinion research, and scientific research for academic clients. Eligible 
participants were Canadian or American residents aged 18+ who participate in English-language 
Legerweb survey panels. Quota sampling was employed with the following targets per country: 
250 in each of six major ethno-racial groups (Middle Eastern, Asian, Black, Indigenous, Latino/
Hispanic, White) and 250 who identify as lesbian, gay, bisexual, or transgender (LGBT, of any 
ethno-racial background). Race/ethnicity demographic questions and a screening question to 
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ascertain LGBT status (“Do you consider yourself lesbian, gay, bisexual, or transgender, or a 
similar identity?") were employed for quota sampling. At baseline, participants completed a 30-
minute questionnaire including the InDI; mental health and substance use measures; and 
indicators of socio-demographics characteristics and targetable attributes (e.g., perceived 
race/ethnicity, apparent disability, wearing religious garb). A random sample of 150 participants 
participated in a 10-15-minute follow-up survey 2-4 weeks after completing the baseline survey. 
The follow-up survey included the InDI, as well as Williams’ Everyday28 and Major36 
Discrimination measures. The Non-Medical Research Ethics Board at the University of Western 
Ontario approved this study (see Appendix E).  
6.2.3 Measures 
Copies of the baseline and follow-up questionnaires are included as Appendices C and D. All 
measures were based on self-report.   
Intersectional Discrimination Index. Responses to anticipated discrimination items were 
scored from 0 (strongly disagree) to 4 (strongly agree). Mean scores (0-4) were calculated for 
individuals who completed at least 9/11 items, with positively worded items reverse-scored. 
Each lifetime major discrimination item was coded as 0 (never), 1 (once), or 2 (more than once), 
for a lifetime major discrimination tally ranging from 0-26. Each past-year major discrimination 
item was coded as 0 (no) or 1 (yes), for a past-year major discrimination tally ranging from 0-13. 
Lifetime day-to-day discrimination was coded as 1 for yes (versus 0 for no) for each item that 
respondents endorsed (lifetime or past-year), for a tally ranging from 0-18. Past-year day-to-day 
discrimination items were coded as 0 for no (never, or not in the past year), 1 for once or twice in 
the past year, and 2 for many times in the past year, for a tally ranging from 0-36. For major and 
day-to-day discrimination, missing values were imputed to “no/never” if respondents had 
completed at least 80% of items; if 20% or more of items were missing, sum scores were not 
calculated.  
Conceptually, major and day-to-day discrimination events are not indicators of a unidimensional 
underlying cause, and are not necessarily expected to be correlated with each other.37 Therefore, 
a priori decision was made to analyze both sub-components as causal indicators (i.e., items that 
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aggregate to form a construct, rather than items that reflect the level of a single underlying 
construct39,52,53), and thus not to subject them to procedures that assume effect indicators (e.g., 
measures of internal consistency, factor analysis). Scores for each of the three components are 
not intended to be summed into a single overall score.  
Attributions. Although attributions to specific grounds are not part of the InDI, a universal 
attribution question was included for exploratory purposes. It asked: “Thinking of all of the times 
that you have been treated unfairly or poorly because of who you are, how often do you think 
each of the following was a reason why others treated you this way?”. An expansive list of 
possible reasons was provided (see Table 6.12), including a write-in option for “other”. For 
clarity, each attribution was proceeded by the word “your” (e.g., “Your mental health or 
substance use disorder”). A four-point response scale included the options “never a reason”, 
“sometimes a reason”, “always a reason”, and “not sure if this was a reason”. In these analyses, 
attributions were dichotomized as sometimes or always a reason versus never or unsure.  
Williams Everyday and Major Discrimination (follow-up survey only). The Williams 
Everyday Discrimination scale (see Items in Appendix D) asks about experiences “in your day-
to-day life”, without specifying a timeframe. It was summed overall (ignoring attributions), with 
each item assigned a score from 0 (never) to almost every day (5) for a total possible range of 45 
points. The Williams Major Discrimination measure includes 9 binary items over a lifetime 
frame, and was scored from 0 (no specified major discrimination event) to 9 (all events). 
Demographics. Participants reported their sex assigned at birth and the gender in which they 
lived in day-to-day life. This information was used to classify respondents as cisgender (non-
transgender) men, cisgender women, transgender women (male birth sex, lives as female, 
sometimes female, or non-binary), and transgender men (female birth sex, lives as male, 
sometimes male, or non-binary). Individuals who were classified as transgender and/or who 
reported a gay, lesbian, or bisexual sexual orientation were classified as LGBT.   
Race/ethnicity was assessed with a check-all-that-apply item, using separate response options for 
each country to reflect differences in ethno-racial categorization. To create consistent and 
mutually exclusive ethno-racial categories across countries, respondents were assigned to 
race/ethnicity categories using the following hierarchical coding sequence: white (white 
race/ethnicity only), Indigenous (any First Nations/Inuit/Métis or Alaska Native/American Indian 
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ancestry), Latino/Hispanic (any Hispanic or Latin American ethnicity), Middle Eastern (any 
Middle Eastern/Arab ethnicity), Black (any Black, African-Canadian, or African-American 
race), and Asian (any East, Southeast, or South Asian ethnicity, or Native Hawaiian/Pacific 
Islander in the United States). These criteria were applied such that individuals were assigned to 
the first category (in the ordered list above) that they endorsed. For instance, someone who 
indicated being Indigenous and Latino was classified as Indigenous. For analyses stratified by 
racial/ethnic minority status, respondents were coded as Indigenous and/or racialized (i.e., of 
color) versus white. Parallel questions ascertained immigration history in Canada and the 
United States, and a binary variable was created to reflect native-born versus immigrant status 
in the respondent’s country of residence.  
A dichotomous item asked participants to indicate if they had a physical, sensory, learning, or 
psychiatric disability. Income-to-needs ratio was calculated by dividing annual household 
income by the number persons supported, in CAD and USD respectively. For regression 
analyses, country-specific income quartiles were calculated, and a single income quartile 
variable (1st to 4th) was created for both countries. Missing values were imputed based on the 
country-specific median income-to-needs ratio. Other demographic and background variables 
included age (continuous), educational attainment, urban/suburban or rural residence, and 
religion.  
Health outcomes. Considering that psychological distress is the outcome most consistently 
associated with self-reported discrimination,1,11,12 as well as the potential for health effects of 
discrimination to vary by group (e.g., greater average impacts on affective disorders and anxiety 
for women, and on substance use for men),54,55 we evaluated the impacts of discrimination on a 
composite outcome including one or more of the following: psychological distress, hazardous 
drinking, and current smoking.  
Psychological distress was measured with the six-item K6 measure developed by Kessler.56 
Items are scored from 0 (never) to 4 (all the time), for a total score of 0-24. The K6 was 
developed to estimate the prevalence of serious mental illness, and has shown good sensitivity 
and excellent specificity in U.S. population samples when dichotomized at a score of 13 or 
above and compared to DSM-IV diagnoses via structured clinical interviews.56,57 Therefore, we 
defined psychological distress as a K6 score greater than or equal to 13.   
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The Alcohol Use Disorders Identification Tool (AUDIT) identified probable hazardous or  
harmful drinking, using the recommended cut-point of 8 or more (of 40 possible points).58,59 
TheAUDIT is a widely-used and well-validated measure, and was found to have high sensitivity 
and specificity when initially validated among primary care patients in six countries.58 Current 
smoking was defined, consistent with the Canadian Community Health Survey and the BRFSS, 
as indicating (1) having smoked at least 100 cigarettes over the lifetime (defined as 4 packs in 
Canada and 5 in the U.S.) and (2) currently smoking daily or occasionally. Childhood physical or 
sexual abuse (before age 16) was included as a potential confounder, classified as yes, no, or 
unsure/rather not say/missing.  
6.2.4 Statistical Analysis 
Dimensionality and internal consistency of anticipated discrimination. For the effect 
indicator subscale (anticipated discrimination), exploratory (EFA) and confirmatory (CFA) 
factor analyses were conducted in MPlus v7.4.60 An a priori decision was made to split the data 
by country, with Canadian respondent data used for EFA, and United States respondent data used 
for CFA. The MLR estimator (maximum likelihood with robust standard errors) was used to 
account for non-normality (platykurtosis) in the outcome distribution and the use of Likert items. 
For EFA, 1 and 2 factor solutions were requested, using Geomin oblique rotation to allow for 
correlated factors. Eigenvalues, factor loadings, and goodness of fit statistics were examined to 
evaluate dimensionality. Goodness of fit for CFA was evaluated using parsimony, incremental, 
and absolute indices (Root Mean Square Error of Approximation, Comparative Fit Index, 
Standardized Mean Square Residual).61 Internal consistency (Cronbach’s alpha) and item-total 
correlations were estimated in SAS 9.4. 
Frequencies. Descriptive statistics stratified by country were calculated in SAS v9.4,62 including 
median and mean item responses and mean scores for anticipated discrimination and item 
endorsement, frequency tally, and proportion reporting any exposure for both day-to-day and 
major discrimination. Data quality, acceptability, and scaling were evaluated by examining 
missing data patterns, maximum endorsement frequencies (to identify floor and ceiling effects), 
and distribution of scores across the full possible range. Attributions were described for the full 
sample, stratified by racial/ethnic minority status (white versus racialized and/or Indigenous) and 
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by LGBT status, with chi-square tests for differences in proportions. 
Construct validity. Known-groups comparisons were conducted to ensure that, as 
hypothesized, members of minority groups report more discrimination than members of majority 
groups. Median scores on each InDI component were calculated for racial/ethnic and sexual/
gender majority and minority groups (white versus racialized and/or Indigenous; LGBT versus 
non-LGBT) and Wilcoxon rank-sum tests were used to identify statistically significant 
differences in medians at p<0.05.   
Next, to determine if InDI scores were associated with well-documented effects of perceived 
discrimination, logistic regression models were fit (separately for each of the three components 
over the lifetime and past year) to estimate associations with the composite variable including 
one or more of the following: psychological distress, hazardous drinking, and smoking.  Models 
were adjusted for age, childhood physical or sexual abuse, and income quartile. Models were fit 
for the full sample, as well as stratified by racial/ethnic minority and LGBT status.  
Finally, for the subgroup of 150 who completed the follow-up survey, day-to-day and major 
discrimination frequency scores on the InDI were compared to the corresponding Williams 
measures. Moderate correlation and agreement were expected, as the InDI was designed to 
capture a wider range of discrimination experiences relative to existing discrimination measures. 
Spearman correlations and their 95% confidence intervals were calculated for both day-to-day 
and major discrimination. In addition, respondents were classified as reporting low, moderate, or 
high discrimination on each measure by splitting each distribution into tertiles. Agreement 
between these classifications for both day-to-day and major discrimination was assessed with the 
kappa statistic. 
Test-retest reliability. Using data from the follow-up survey, test-retest reliability was assessed 
for anticipated discrimination scale scores and lifetime frequencies of both day-to-day and major 
discrimination. Test-retest reliability was quantified using intraclass correlation coefficient 
(ICC) estimates and their 95% confidence intervals. These estimates were obtained using a 
model  adjusted for the number of days between baseline and follow-up surveys, via the ICC9 
SAS Macro.63  
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6.3 Results
6.3.1 Sample Characteristics 
The final baseline sample included 2642 respondents, including 1065 in Canada and 1577 in the 
United States. The follow-up questionnaire included 150 participants, including 83 in Canada 
and 67 in the United States. Demographic characteristics are described in Table 6.1.  
Table 6.1: Demographic characteristics of survey participants, stratified by country 
Baseline Follow-up 
Canada 
(n=1065) 
n (%) 
United 
States 
(n=1577) 
n (%) 
Canada 
(n=83) 
n (%) 
United States 
(n=67) 
n (%) 
Age (median, IQR) 36 (48-27) 44 (57-34) 30 (25-
41) 
49 (36-61) 
Lived gender 
  Cisgender male 
  Cisgender female 
  Trans man or transmasculine 
  Trans woman or transfeminine 
 Missing 
466 (43.8) 
559 (52.5) 
20 (1.9) 
19 (1.8) 
1 (0.1) 
749 (47.5) 
764 (48.5) 
31 (2.0) 
31 (2.0) 
2 (0.1) 
38 (45.8) 
45 (54.2) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
30 (44.8) 
36 (53.7) 
1 (1.5) 
0 (0.0) 
0 (0.0) 
Sexual orientation 
   Straight or heterosexual 
   Bisexual 
   Gay or lesbian 
   Not sure 
   Asexual 
   Missing 
865 (81.2) 
99 (9.3) 
50 (4.7) 
35 (3.3) 
10 (0.9) 
6 (0.6) 
1322 (83.8) 
65 (4.1) 
161 (10.2) 
15 (1.0) 
10 (0.6) 
4 (0.3) 
71 (85.5) 
6 (7.2) 
4 (4.8) 
2 (2.4) 
0 (0.0) 
0 (0.0) 
53 (79.1) 
5 (7.5) 
9 (13.4) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
Lesbian, gay, bisexual, and/or 
transgender 
174 (16.3) 255 (16.2) 10 (12.1) 14 (20.9) 
Race/ethnicity
   White  
   Indigenous 
   Latin American/ Hispanic 
   Middle Eastern 
   Black  
   Asian 
187 (17.6) 
162 (15.2) 
114 (10.7) 
112 (10.5) 
245 (23.0) 
245 (23.0) 
198 (12.6) 
251 (15.9) 
261 (16.6) 
247 (15.7) 
246 (15.6) 
374 (23.7) 
11 (13.3) 
7 (8.4) 
4 (4.8) 
5 (6.0) 
15 (18.1) 
41 (49.4) 
8 (11.9) 
18 (26.9) 
4 (6.0) 
1 (1.5) 
12 (17.9) 
24 (35.8) 
Born in Canada/United States 
  Yes 
   No 
581 (54.6) 
484 (45.4) 
1121 (71.1) 
456 (28.9) 
40 (48.2) 
43 (51.8) 
52 (77.6) 
15 (22.4) 
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Has a disability 
   Yes 
   No 
   Missing 
210 (19.7) 
848 (79.6) 
7 (0.7) 
333 (21.1) 
1236 (78.4) 
8 (0.5) 
15 (18.1) 
68 (81.9) 
0 (0.0) 
16 (23.9) 
51 (76.1) 
0 (0.0) 
Educational attainment 
  High school or less 
  Community college/ trade 
school 
  Some university 
  Bachelor’s degree 
  Graduate degree 
  Missing 
186 (17.5) 
343 (32.2) 
96 (9.0) 
302 (28.4) 
136 (12.8) 
2 (0.2) 
209 (13.3) 
379 (24.0) 
204 (12.9) 
483 (30.6) 
300 (19.0) 
2 (0.1) 
15 (18.1) 
22 (26.5) 
7 (8.4) 
27 (32.5) 
11 (13.3) 
1 (1.2) 
9 (13.4) 
18 (26.9) 
5 (7.5) 
21 (31.3) 
14 (20.9) 
0 (0.0) 
Income-to-needs ratioa 
    Less than $10k 
    $10-19.9k 
    $20-29.9k 
    $30-49.9k 
    $50k or more 
    Missing 
185 (17.4) 
258 (24.2) 
168 (15.8) 
211 (19.8) 
123 (11.6) 
120 (11.3) 
200 (12.7) 
341 (21.6) 
263 (16.7) 
386 (24.5) 
270 (17.1) 
117 (7.4) 
14 (16.9) 
18 (21.7) 
17 (20.5) 
21 (25.3) 
8 (9.6) 
5 (6.0) 
12 (17.9) 
11 (16.4) 
15 (22.4) 
14 (20.9) 
11 (16.4) 
4 (6.0) 
Residence 
  Urban or suburban 
  Rural 
  Missing 
935 (87.8) 
128 (12.0) 
2 (0.2) 
1327 (84.2) 
243 (15.4) 
7 (0.4) 
75 (90.4) 
8 (9.6) 
0 (0.0) 
59 (88.1) 
8 (11.9) 
0 (0.0) 
Religion 
  Christian or Catholic 
  Buddhist 
  Hindu 
  Jewish 
  Muslim 
  Sikh 
  Other or no religion  
  Missing 
523 (49.1) 
23 (2.2) 
29 (2.7) 
6 (0.6) 
92 (8.6) 
15 (1.4) 
376 (35.3) 
1 (0.1) 
904 (57.3) 
56 (3.6) 
54 (3.4) 
33 (2.1) 
146 (9.3) 
0 (0.0) 
382 (24.2) 
2 (0.1) 
38 (46.8) 
5 (6.0) 
3 (3.6) 
1 (1.2) 
7 (8.4) 
4 (4.8) 
25 (30.1) 
0 (0.0) 
33 (49.3) 
3 (4.5) 
2 (3.0) 
2 (3.0) 
0 (0.0) 
0 (0.0) 
27 (40.3) 
0 (0.0) 
a Household income divided by number of persons supported, in Canadian and United States dollars, respectively 
6.3.2 Structure of Anticipated Discrimination 
In initial exploratory factor analyses including Canadian participants who provided anticipated 
discrimination data (n=1063), the two positively worded scale items (“I am confident that I will 
be treated with as much respect as my peers” and “I feel safe in my neighbourhood”) were found 
to have weak loadings (0.337 and 0.277 in the one-factor model, respectively). Loadings 
remained below 0.40 when a two-factor solution was evaluated. In addition, both items had 
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lower item-total correlations (0.30 and 0.26). As these items assess expectations of positive 
treatment and safety, which are conceptually distinct from the absence of anticipated 
discrimination, these items were excluded from further analyses. Results of subsequent 
exploratory factor analyses including the remaining 9 items are presented in Table 6.2. One and 
two-factor solutions were requested. Examination of eigenvalues (5.175 for Factor 1 and 0.741 
for Factor 2) and the scree plot (Figure 6.1) supported a one-factor solution. However, model fit 
was improved from suboptimal (RMSEA=0.091; CFI=0.927) to good (RMSEA=0.06; 
CFI=0.976) when a two-factor solution was applied. Conceptually, items that loaded primarily 
on the first factor pertained to anticipated discrimination in interactions with institutions (e.g., 
health care, employment) while items which loaded primarily on the second pertained to 
anticipated discrimination in interpersonal interactions (e.g., violence and harassment, difficulty 
forming relationships).  
Table 6.2: Exploratory Factor Analysis of Anticipated Discrimination among Canadian 
respondents (n=1063)  
Item One-factor 
model 
loadings 
Two-factor model 
loadings 
1 2 
1. Because of who I am, a doctor or nurse,
or other health care provider might treat me
poorly.
0.72* 0.69* 0.04 
2. Because of who I am, I might have
trouble finding or keeping a job.
0.75* 1.08* -0.31*
3. Because of who I am, I might have
trouble getting an apartment or house
0.80* 0.78* 0.04 
5. I worry about being treated unfairly by a
teacher, supervisor, or employer.
0.72* 0.73* 0.01 
6. I may be denied a bank account, loan, or
mortgage because of who I am.
0.72* 0.51* 0.23* 
8. I worry about being harassed or stopped
by police or security.
0.66* 0.35* 0.34* 
9. Because of who I am, people might try to
attack me physically.
0.74* 0.00 0.83* 
10. I expect to be pointed at, called names,
or harassed when in public.
0.75* 0.01 0.83* 
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11. I fear that I will have a hard time finding
friendship or romance because of who I am.
0.63* 0.30* 0.38* 
Eigenvalue -- 5.175 0.741 
Correlation between factors -- 0.818* 
Root Mean Square Error of Approximation 
(95% CI) 
0.091  
(0.082, 0.102) 
0.06 
(0.050, 0.075) 
Comparative Fit Index 0.927 0.976 
Note: Models fit with Maximum Likelihood Estimator with robust standard errors, with Geomin oblique rotation 
method. Coefficients statistically significant at p<0.05 are indicated with an asterisk. 
Figure 6.1: Scree Plot, Exploratory Factor Analysis of Anticipated Discrimination among 
Canadian respondents (n=1063) 
To validate a two-factor solution, data from participants in the United States who provided 
anticipated discrimination data (n=1577) were subjected to confirmatory factor analysis. A two-
factor solution was requested with original Anticipated Discrimination items 1, 2, 3, 5, 6, and 8 
loading on Factor 1, and items 9-11 loading on Factor 2. Results are shown in Table 6.3.  The 
specified model fit the data well, with all indices showing good-to-ideal fit (RMSEA=0.052; 
CFI=0.980; SMSR=0.020).61 However, the two factors were highly correlated (0.93). 
Cronbach’s alpha coefficient (not shown in tables) for the full 9-item scale was 0.93. Values for 
the institutional (6 items) and interpersonal (3 items) anticipated discrimination subscales were 
0.90 and 0.84, respectively. Item-total correlations with the full 9-item scale ranged from 0.68 to 
0.79.  
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Table 6.3: Confirmatory Factor Analysis of Anticipated Discrimination among United 
States respondents (n=1577)  
Item Factor Loadings 
Factor 1- Institutional Factor 2- Interpersonal 
Unstan-
dardized 
(SE) 
Standar-
dized 
Unstan-
dardized 
(SE) 
Standar-
dized 
1. Because of who I am, a doctor or
nurse, or other health care provider
might treat me poorly.
1.00 (--) 0.81 
2. Because of who I am, I might have
trouble finding or keeping a job.
1.07* (.03) 0.80 
3. Because of who I am, I might have
trouble getting an apartment or house
1.10* (.03) 0.86 
5. I worry about being treated unfairly
by a teacher, supervisor, or employer.
1.02* (.03) 0.78 
6. I may be denied a bank account, loan,
or mortgage because of who I am.
0.99* (.03) 0.79 
8. I worry about being harassed or
stopped by police or security.
0.98* (.03) 0.73 
9. Because of who I am, people might
try to attack me physically.
1.00 (--) 0.83 
10. I expect to be pointed at, called
names, or harassed when in public.
1.03* (.02) 0.86 
11. I fear that I will have a hard time
finding friendship or romance because
of who I am.
0.99* (.03) 0.80 
Standardized correlation between factors 0.93* 
Root Mean Square Error of 
Approximation (90% CI) 
0.052 
(0.043, 0.060) 
Comparative Fit Index 0.980 
Standardized Mean Square Residual 0.020 
Note: Models fit with Maximum Likelihood Estimator with robust standard errors. Coefficients statistically 
significant at p<0.05 are indicated with an asterisk. 
Taken together, these results indicate that the Anticipated Discrimination scale has two 
substantively interpretable factors, Anticipated Institutional Discrimination and Anticipated 
139 
Interpersonal Discrimination. Nevertheless, considering the high inter-factor and item-total 
correlations observed, it is acceptable to create a composite score for the full scale.  
6.3.3 Discrimination Frequencies and Data Quality 
Frequencies for anticipated, day-to-day, and major discrimination are displayed in Tables 6.4 to 
6.7 (Canada) and 6.8 to 6.11 (United States). All items took the full range of possible values in 
both countries. Less than 1.0% of data were missing for almost all items, except for past-year 
major events (range from 0.4%-1.7%), which were measured with a follow-up question after 
respondents indicated experiencing a major discrimination event over the lifetime. As shown in 
Tables 6.4 and 6.8, on average, respondents slightly disagreed that they anticipated 
discrimination (mean score [SD]= 1.5 [0.9] in Canada; 1.4 [1.0] in the United States).  In Tables 
6.5 and 6.9, most respondents reported any day-to-day discrimination over the lifetime (87.8% in 
Canada, 79.1% in the United States), any day-to-day discrimination over the past year (63.4% in 
Canada, 54.1% in the United States), or any major discrimination over the lifetime (70.8% in 
Canada, 62.5% in the United States). In both countries, just under one-third of respondents 
reported major discrimination in the past year (32.9% in Canada, 27.5% in the United States). 
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Table 6.4: Anticipated discrimination* reported on the Intersectional Discrimination Index 
among participants in Canada (n=1065) 
Because of who I am…. 
Median 
(IQR) 
Mean 
(SD) 
[Min, 
Max] 
Missing 
(n) 
A doctor or nurse, or other health care 
provider might treat me poorly. 
1 (0-2) 1.4 (1.2) [0,4] 3 
I might have trouble finding or keeping a job. 2 (1-3) 1.8 (1.3) [0,4] 3 
I might have trouble getting an apartment or 
house. 
1 (1-3) 1.5 (1.2) [0,4] 5 
I worry about being treated unfairly by a 
teacher, supervisor, or employer. 
2 (1-3) 1.8 (1.2) [0,4] 8 
I may be denied a bank account, loan, or 
mortgage. 
1 (0-2) 1.2 (1.1) [0,4] 6 
I worry about being harassed or stopped by 
police or security. 
1 (0-3) 1.5 (1.2) [0,4] 2 
People might try to attack me physically. 1 (0-2) 1.4 (1.2) [0,4] 3 
I expect to be pointed at, called names, or 
harassed when in public. 
1 (0-2) 1.2 (1.1) [0,4] 6 
I fear that I will have a hard time finding 
friendship or romance. 
1 (0-2) 1.4 (1.2) [0,4] 2 
Mean score (range= 0-4)b 1.4 (0.9-2.1) 1.5 (0.9) [0,4] 2 
*0=strongly disagree, 4=strongly agree; higher scores equal stronger agreement
a For participants who completed at least 80% of items.
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Table 6.5: Enacted discrimination reported on the Intersectional Discrimination Index among participants in Canada 
(n=1065) 
Frequency score* 
Median (IQR)  
[Min, Max] 
    Proportion reporting 
any 
n (%) 
Missing 
n (%) 
Day-to-day discrimination, lifetime 
(range=0-18) 
8 (3-14) 
[0, 18] 935 (87.8) 4 (0.4) 
Day-to-day discrimination, past-year 
 (range=0-36) 
2 (0-7) 
[0, 36] 675 (63.4) 4 (0.4) 
Major discrimination, lifetime 
 (range=0-26) 
2 (0-6)    
[0, 26] 754 (70.8) 2 (0.2) 
Major discrimination, past-year 
(range=0-13) 
0 (0-1)  
[0, 13] 350 (32.9) 10 (0.9) 
*Total scores computed for those who completed at least 80% of items.
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Table 6.6: Frequency of day-to-day discrimination reported on the Intersectional Discrimination Index among participants in 
Canada (n= 1065) 
Never 
n (%) 
Lifetime 
only 
n (%) 
Once or 
twice in 
past year 
n (%) 
Many 
times in 
past year 
n (%) 
Missing 
n (%) 
Treated poorly or unfairly by a healthcare provider 707 (66.4) 239 (22.4) 85 (8.0) 33 (3.1) 1 (0.1) 
Treated poorly or unfairly by a teacher or professor 629 (59.1) 333 (31.3) 74 (7.0) 27 (2.5) 2 (0.2) 
Treated poorly or unfairly by a supervisor or employer 502 (47.1) 370 (34.7) 130 (12.2) 58 (5.5) 5 (0.5) 
Treated poorly or unfairly by a coworker or classmate 445 (41.8) 424 (39.8) 119 (11.2) 72 (6.8) 5 (0.5) 
Treated poorly or unfairly by a customer service 
representative 
470 (44.1) 315 (29.6) 185 (17.4) 90 (8.5) 5 (0.5) 
Treated poorly or unfairly by police, border, security 
officer 
665 (62.4) 245 (23.0) 100 (9.4) 49 (4.6) 6 (0.6) 
Treated poorly or unfairly by a transportation provider 708 (66.5) 214 (20.1) 95 (8.9) 44 (4.1) 4 (0.4) 
Treated poorly or unfairly by a landlord 742 (69.7) 208 (19.5) 71 (6.7) 40 (3.8) 4 (0.4) 
Treated poorly or unfairly by a relative or friend 621 (58.3) 254 (23.9) 117 (11.0) 69 (6.5) 4 (0.4) 
Heard, saw, or read others joking or laughing about you 
(or people like you) 
334 (31.4) 374 (35.1) 195 (18.3) 160 (15.0) 2 (0.2) 
Treated as if unfriendly, unhelpful, or rude 491 (46.1) 300 (28.2) 187 (17.6) 83 (7.8) 4 (0.4) 
Called names or heard/saw identity used as an insult 439 (41.2) 344 (32.3) 164 (15.4) 113 (10.6) 5 (0.5) 
Treated as if others are afraid of you 635 (59.6) 235 (22.1) 120 (11.3) 70 (6.6) 5 (0.5) 
Stared or pointed at in public 582 (54.7) 279 (26.2) 129 (12.1) 69 (6.5) 6 (0.6) 
Told that you should think, act, or look more like others 570 (53.5) 271 (25.5) 129 (12.1) 90 (8.5) 5 (0.5) 
Heard that you or people like you don’t belong 548 (51.5) 293 (27.5) 125 (11.7) 94 (8.8) 5 (0.5) 
Asked inappropriate, offensive, or overly personal 
questions 
458 (43.0) 332 (31.2) 173 (16.2) 98 (9.2) 4 (0.4) 
Treated as if you are less smart or capable than others 491 (46.1) 287 (27.0) 173 (16.2) 109 (10.2) 5 (0.5) 
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Table 6.7: Frequency of major discrimination events reported on the Intersectional 
Discrimination Index among participants in Canada (n= 1065) 
Lifetime 
n (%) 
Past year 
n (%) 
Refused health care 
     Missing 
     No 
     Yes 
     Yes, more than once 
 2 (0.2) 
950 (89.2) 
80 (7.5) 
33 (3.1) 
4 (0.4) 
1005 (94.4) 
56 (5.3) 
Fired, dismissed, or turned down for a job post-
interview 
     Missing  
     No 
     Yes 
     Yes, more than once 
3 (0.3) 
666 (62.5) 
243 (22.8) 
153 (14.4) 
11 (1.0) 
930 (87.3) 
124 (11.6) 
Evicted or denied housing 
     Missing 
     No 
     Yes 
     Yes, more than once 
5 (0.5) 
889 (83.5) 
129 (12.1) 
42 (3.9) 
8 (0.8) 
1003 (94.2) 
54 (5.1) 
Unreasonably stopped, searched, or arrested by 
police or security 
     Missing 
     No 
     Yes 
     Yes, more than once 
5 (0.5) 
755 (70.9) 
182 (17.1) 
123 (11.6) 
17 (1.6) 
948 (89.0) 
100 (9.4) 
Unreasonably suspended or expelled from school 
     Missing  
     No 
     Yes 
     Yes, more than once 
    3 (0.3) 
948 (89.0) 
88 (8.3) 
26 (2.4) 
9 (0.9) 
1038 (97.5) 
18 (1.7) 
Unable to open a bank account or get a loan 
    Missing 
     No 
     Yes 
     Yes, more than once 
6 (0.6) 
914 (85.8) 
97 (9.1) 
48 (4.5) 
10 (0.9) 
992 (93.2) 
63 (5.9) 
Had to move to another city, state/province, or 
country 
    Missing 
     No 
     Yes 
     Yes, more than once 
7 (0.7) 
888 (83.4) 
133 (12.5) 
37 (3.5) 
12 (1.1) 
1008 (94.7) 
45 (4.2) 
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Lifetime 
n (%) 
Past year 
n (%) 
Lost a close relationship 
     Missing  
     No 
     Yes 
     Yes, more than once 
4 (0.4) 
719 (67.5) 
213 (20.0) 
129 (12.1) 
9 (0.9) 
923 (86.7) 
133 (12.5) 
Repeatedly harassed at work, school, home, or when 
accessing services 
     Missing 
     No 
     Yes 
     Yes, more than one place 
8 (0.8) 
716 (67.2) 
219 (20.6) 
122 (11.5) 
14 (1.3) 
918 (86.2) 
133 (12.5) 
Threatened with violence 
     Missing 
     No 
     Yes 
     Yes, more than once 
8 (0.8) 
774 (72.7) 
170 (16.0) 
113 (10.6) 
15 (1.4) 
968 (90.1) 
82 (7.7) 
Physically assaulted 
     Missing 
     No 
     Yes 
     Yes, more than once 
5 (0.5) 
774 (72.7) 
177 (16.6) 
109 (10.2) 
16 (1.5) 
987 (92.7) 
62 (5.8) 
Sexually assaulted 
     Missing 
     No 
     Yes 
     Yes, more than once 
6 (0.6) 
823 (77.3) 
129 (12.1) 
107 (10.1) 
12 (1.1) 
995 (93.4) 
58 (5.5) 
Property stolen, vandalized, or damaged 
     Missing 
     No 
     Yes 
     Yes, more than once 
5 (0.5) 
812 (76.2) 
158 (14.8) 
90 (8.5) 
11 (1.0) 
981 (92.1) 
73 (6.9) 
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Table 6.8: Anticipated discrimination* reported on the Intersectional Discrimination Index 
among participants in the United States (n=1577) 
Because of who I am…. 
Median 
(IQR) 
Mean 
(SD) 
[Min, 
Max] 
Missing 
(n) 
A doctor or nurse, or other health care provider 
might treat me poorly. 
1 (0-2) 1.3 (1.2) [0,4] 0 
I might have trouble finding or keeping a job. 1 (0-3) 1.5 (1.3) [0,4] 3 
I might have trouble getting an apartment or 
house. 
1 (0-2) 1.4 (1.2) [0,4] 3 
I worry about being treated unfairly by a 
teacher, supervisor, or employer. 
1 (0-3) 1.6 (1.3) [0,4] 3 
I may be denied a bank account, loan, or 
mortgage. 
1 (0-2) 1.3 (1.2) [0,4] 7 
I worry about being harassed or stopped by 
police or security. 
1 (0-3) 1.5 (1.3) [0,4] 4 
People might try to attack me physically. 1 (0-2) 1.5 (1.3) [0,4] 7 
I expect to be pointed at, called names, or 
harassed when in public. 
1 (0-2) 1.3 (1.3) [0,4] 7 
I fear that I will have a hard time finding 
friendship or romance. 
1 (0-2) 1.3 (1.3) [0,4] 4 
Mean score (range= 0-4)a 1.3 (0.6-2.1) 1.4 (1.0) [0,4] 1 
*0=strongly disagree, 4=strongly agree; higher scores equal stronger agreement
a For participants who completed at least 80% of items. 
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Table 6.9: Enacted discrimination reported on the Intersectional Discrimination Index among participants in the United States 
(n=1577) 
 
 
Frequency score*  
Median (IQR)  
[Min, Max] 
    Proportion reporting 
any 
n (%) 
Missing  
n (%) 
Day-to-day discrimination, lifetime 
(range=0-18) 
7 (1-14) 
[0, 18] 1248 (79.1) 6 (0.4) 
Day-to-day discrimination, past-year 
(range=0-36) 
1 (0-8)   
[0, 36] 853 (54.1) 6 (0.4) 
Major discrimination, lifetime 
(range=0-26) 
2 (0-5)     
[0, 26] 985 (62.5) 7 (0.4) 
Major discrimination, past-year 
(range=0-13) 
0 (0-1) 
[0, 13]   434 (27.5) 20 (1.3) 
  
*Total scores computed for those who completed at least 80% of items.  
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Table 6.10: Frequency of day-to-day discrimination reported on the Intersectional Discrimination Index among participants in 
the United States (n=1577) 
Never 
n (%) 
Lifetime 
only 
n (%) 
Once or 
twice in 
past year 
n (%) 
Many 
times in 
past year 
n (%) 
Missing 
n (%) 
Treated poorly or unfairly by a healthcare provider 1039 (65.9) 303 (19.2) 156 (9.9) 79 (5.0) 0 (0.0) 
Treated poorly or unfairly by a teacher or professor 999 (63.4) 373 (23.7) 150 (9.5) 51 (3.2) 4 (0.3) 
Treated poorly or unfairly by a supervisor or employer 810 (51.4) 477 (30.3) 187 (11.9) 101 (6.4) 2 (0.1) 
Treated poorly or unfairly by a coworker or classmate 757 (48.0) 530 (33.6) 177 (11.2) 111 (7.0) 2 (0.1) 
Treated poorly or unfairly by a customer service 
representative 
786 (49.8) 420 (26.6) 255 (16.2) 106 (6.7) 10 (0.6) 
Treated poorly or unfairly by police, border, security 
officer 
996 (63.2) 308 (19.6) 181 (11.5) 86 (5.5) 6 (0.4) 
Treated poorly or unfairly by a transportation provider 1155 (73.2) 222 (14.1) 134 (8.5) 63 (4.0) 3 (0.2) 
Treated poorly or unfairly by a landlord 1126 (71.4) 263 (16.7) 123 (7.8) 63 (4.0) 2 (0.1) 
Treated poorly or unfairly by a relative or friend 874 (55.4) 394 (25.0) 185 (11.7) 122 (7.7) 2 (0.1) 
Heard, saw, or read others joking or laughing about you 
(or people like you) 
635 (40.3) 480 (30.4) 270 (17.1) 185 (11.7) 7 (0.4) 
Treated as if unfriendly, unhelpful, or rude 792 (50.2) 364 (23.1) 277 (17.6) 137 (8.7) 7 (0.4) 
Called names or heard/saw identity used as an insult 761 (48.3) 433 (27.5) 228 (14.5) 149 (9.5) 6 (0.4) 
Treated as if others are afraid of you 964 (61.1) 306 (19.4) 187 (11.9) 115 (7.3) 5 (0.3) 
Stared or pointed at in public 917 (58.2) 319 (20.2) 184 (11.7) 149 (9.5) 8 (0.5) 
Told that you should think, act, or look more like others 919 (58.3) 341 (21.6) 210 (13.3) 100 (6.3) 7 (0.4) 
Heard that you or people like you don’t belong 905 (57.4) 345 (21.9) 172 (10.9) 145 (9.2) 10 (0.6) 
Asked inappropriate, offensive, or overly personal 
questions 
800 (50.7) 402 (25.5) 219 (13.9) 148 (9.4) 8 (0.5) 
Treated as if you are less smart or capable than others 797 (50.5) 403 (25.6) 227 (14.4) 144 (9.1) 6 (0.4) 
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Table 6.11: Frequency of major discrimination events reported on the Intersectional 
Discrimination Index among participants in the United States (n=1577) 
Lifetime 
n (%) 
Past year 
n (%) 
Refused health care 
     Missing 
     No 
     Yes 
     Yes, more than once 
3 (0.2) 
1369 (86.8) 
148 (9.4) 
57 (3.6) 
11 (0.7) 
1448 (91.8) 
118 (7.5) 
Fired, dismissed, or turned down for a job post-
interview 
     Missing  
     No 
     Yes 
     Yes, more than once 
7 (0.4) 
1090 (69.1) 
298 (18.9) 
182 (11.5) 
18 (1.1) 
1414 (89.7) 
145 (9.2) 
Evicted or denied housing 
     Missing  
     No 
     Yes 
     Yes, more than once 
6 (0.4) 
1341 (85.0) 
165 (10.5) 
65 (4.1) 
15 (1.0) 
1479 (93.8) 
83 (5.3) 
Unreasonably stopped, searched, or arrested by 
police or security 
     Missing 
     No 
     Yes 
     Yes, more than once 
13 (0.8) 
1177 (74.6) 
233 (14.8) 
154 (9.8) 
20 (1.3) 
1419 (90.0) 
138 (8.8) 
Unreasonably suspended or expelled from school 
     Missing 
     No 
     Yes 
     Yes, more than once 
10 (0.6) 
1416 (89.8) 
111 (7.0) 
40 (2.5) 
19 (1.2) 
1503 (95.3) 
55 (3.5) 
Unable to open a bank account or get a loan 
     Missing  
     No 
     Yes 
     Yes, more than once 
12 (0.8) 
1360 (86.2) 
136 (8.6) 
69 (4.4) 
18 (1.1) 
1469 (93.2) 
90 (5.7) 
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Lifetime 
n (%) 
Past year 
n (%) 
Had to move to another city, state/province, or 
country 
     Missing  
     No 
     Yes 
     Yes, more than once 
13 (0.8) 
1364 (86.5) 
141 (8.9) 
59 (3.7) 
20 (1.3) 
1478 (93.7) 
79 (5.0) 
Lost a close relationship 
     Missing  
     No 
     Yes 
     Yes, more than once 
8 (0.5) 
1137 (72.1) 
226 (14.3) 
206 (13.1) 
22 (1.4) 
1405 (89.1) 
150 (9.5) 
Repeatedly harassed at work, school, home, or when 
accessing services 
     Missing  
     No 
     Yes 
     Yes, more than once 
7 (0.4) 
1156 (73.3) 
260 (16.5) 
154 (9.8) 
13 (0.8) 
1406 (89.2) 
158 (10.0) 
Threatened with violence 
     Missing 
     No 
     Yes 
     Yes, more than once 
13 (0.8) 
1242 (78.8) 
187 (11.9) 
135 (8.6) 
26 (1.7) 
1458 (92.5) 
93 (5.9) 
Physically assaulted 
     Missing 
     No 
     Yes 
     Yes, more than once 
9 (0.6) 
1238 (78.5) 
176 (11.2) 
154 (9.8) 
20 (1.3) 
1479 (93.8) 
78 (5.0) 
Sexually assaulted 
     Missing 
     No 
     Yes 
     Yes, more than once 
4 (0.3) 
1293 (82.0) 
150 (9.5) 
130 (8.2) 
11 (0.7) 
1481 (93.9) 
85 (5.4) 
Property stolen, vandalized, or damaged 
     Missing 
     No 
     Yes 
     Yes, more than once 
10 (0.6) 
1180 (74.8) 
253 (16.0) 
134 (8.5) 
24 (1.5) 
1442 (91.4) 
111 (7.0) 
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6.3.4 Attributions 
Among those who had a score greater than 0 on the day-to-day and/or major discrimination 
measure across both countries (n=2254), attributions for discrimination are described in Table 
6.12. Overall, ethnicity (58.2%), race (55.0%), and gender (48.2%) were the most common 
attributions provided. As expected, ethnicity, race, and citizenship or country of origin were 
more common attributions among non-white versus white respondents (all p<0.001). LGBT 
respondents were more likely to attribute discrimination to sexual orientation or transgender 
status (both p<0.001) than non-LGBT respondents. They were also significantly more likely to 
attribute discrimination to age, income, mental health or substance use, disability, or weight.  
Table 6.12: Attributions among those reporting any lifetime discrimination 
Overall 
(n=2254) 
n (%) 
White 
(n=292) 
n (%) 
Non-white 
(n=1962) 
n (%) 
LGBT 
(n=395) 
n (%) 
Non-LGBT 
(n=1853) 
n (%) 
Age 870 (38.6) 114 (39.0) 756 (38.5) 175 (44.3)* 693 (37.4) 
Gender 1087 (48.2) 144 (49.3) 943 (48.1) 238 (60.3)** 847 (45.7) 
Transgender/ gender 
non-conforming 297 (13.2) 37 (12.7) 260 (13.3) 120 (30.4)** 177 (9.6) 
Sexual orientation 463 (20.5) 63 (21.6) 400 (20.4) 267 (67.6)** 196 (10.6) 
Citizenship or 
country of origin 888 (39.4) 68 (23.3)** 820 (41.8) 161 (40.8) 726 (39.2) 
Income 848 (37.6) 111 (38.0) 737 (37.6) 168 (42.5)* 679 (36.6) 
Education 717 (31.8) 83 (28.4)  634 (32.3) 124 (31.4) 591 (31.9) 
Mental health or 
substance use  463 (20.5) 67 (23.0) 396 (20.2) 134 (33.9)** 329 (17.8) 
Disability 420 (18.6) 59 (20.2) 361 (18.4) 101 (25.6)** 319 (17.2) 
Race 1240 (55.0) 65 (22.3)** 1175 (59.9) 227 (57.5) 1011 (54.6) 
Ethnicity 1312 (58.2) 85 (29.1)** 1227 (62.5) 241 (61.0) 1068 (57.6) 
Religion 754 (33.5) 90 (30.8) 664 (33.8) 137 (34.7) 614 (33.1) 
Language 815 (36.2) 93 (31.9) 722 (36.8) 155 (39.2) 657 (35.5) 
Weight 782 (34.7) 116 (39.7) 666 (33.9) 187 (47.3)** 594 (32.0) 
*= p<0.05, compared to cell to the right.  **= p<0.001, compared to cell to the right. 
For the full sample, other attributions written in included those related to appearance or dress 
(n=28), height (n=15), family structure or relationship status (n=10), veteran status (n=4), 
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criminal record (n=3), or having an interracial relationship or family (n=4). Occasionally, write-
in attributions suggested a broader interpretation of the phrase “because of who I am” than 
intended, including political or moral views (n=10), “just because” or similar responses (n=11), 
or the respondent’s intelligence or attractiveness (n=7).  
6.3.5 Known groups comparisons 
Median frequencies for all InDI components were significantly higher among Indigenous or 
racialized individuals, as compared to white individuals, including anticipated discrimination 
(1.4 vs. 1.0, p<0.001), past-year day-to-day discrimination (2.0 vs. 0, p<0.001), lifetime day-to-
day discrimination (8.0 vs. 4.0, p<0.001), past-year major discrimination (0 [IQR=0-1] vs. 0 
[IQR=0-0], p=0.018) and lifetime major discrimination (2.0 vs. 1.0 p=0.004). Similarly, LGBT 
individuals had significantly higher frequencies for all discrimination types as compared to 
cisgender heterosexual individuals (all p<0.001), including anticipated discrimination (1.9 vs. 
1.2), past-year day-to-day discrimination (3.5 vs. 1.0), lifetime day-to-day discrimination (11.0 
vs. 7.0), past-year major discrimination (0 [IQR=0-2] vs. 0 [IQR=0-1]) and lifetime major 
discrimination (4.0 vs. 2.0). 
6.3.6 Associations with health outcomes 
Of 2572 participants who provided complete data on health conditions, 37.9% (n=1001) were 
classified as having a negative mental health or health behaviour outcome based on meeting at 
least one of the following criteria: severe psychological distress (17.0%, n=437), current 
smoking (22.4%, n=577), or hazardous drinking (16.6%, n=428). As shown in Table 6.13, 
greater anticipated, day-to-day (lifetime and past year), and major (lifetime and past-year) 
discrimination were each positively associated with negative mental health or health behaviour 
outcomes after controlling for age, income quartile, and childhood abuse. Results of models 
stratified by race/ethnicity and LGBT minority statuses did not differ appreciably for day-to-day 
or major discrimination (not shown). However, when stratified by race/ethnicity, anticipated 
discrimination was significantly associated with health outcomes among Indigenous or racialized 
respondents (n=2197; AOR for 1-unit change=1.68, 95% CI: 1.52, 1.86), but not white 
respondents (n=373; AOR=1.26, 95% CI: 0.98, 1.63).  
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Table 6.13: Logistic regression of composite mental and behavioural health outcomea on 
InDI components  
ORb for 1-unit 
change (95% CI) 
AORc for 1-unit 
change 
(95% CI) 
Anticipated discrimination, current 
(range=0-4)       [n=2570] 1.86 (1.70, 2.03)* 1.58 (1.44, 1.73)* 
Day-to-day discrimination, lifetime 
(range=0-18)     [n=2564] 1.12 (1.11, 1.14)* 1.10 (1.08, 1.11)* 
Day-to-day discrimination, past-year 
 (range=0-36)    [n=2564] 1.11 (1.09, 1.12)* 1.08 (1.07, 1.10)* 
Major discrimination, lifetime 
 (range=0-26)    [n=2566] 1.17 (1.14, 1.19)* 1.14 (1.11, 1.16)* 
Major discrimination, past-year 
[n=2545] 1.62 (1.51, 1.74)* 1.46 (1.36, 1.56)* (range=0-13)     
a One or more of: severe psychological distress, current smoking, hazardous alcohol use. 
b OR=odds ratio. 
c AOR=adjusted odds ratio; adjusted for age, income quartile, and childhood physical or sexual abuse. 
*p<0.0001
6.3.7 Correlation and agreement with Williams measures 
Frequency scores on the InDI and Williams everyday/day-to-day discrimination components 
(both completed at follow-up) were strongly positively correlated (Spearman’s r=0.83, 95% CI: 
0.77, 0.87). When categorized into low, moderate, or high discrimination based on tertiles, 
agreement between the day-to-day discrimination measures was moderate (weighted 
kappa=0.61, 95% CI: 0.51, 0.71). Twenty-three participants were classified as experiencing 
more day-to-day discrimination on the Williams scale as compared to the InDI, and 23 were 
classified higher on the InDI. For major discrimination, correlation between the two measures 
was also high (Spearman’s r=0.76, 95% CI: 0.69, 0.82), while agreement was moderate 
(weighted kappa=0.56, 95% CI: 0.46, 0.66). Twenty participants were classified as reporting 
greater major discrimination on the Williams measure as compared to the InDI, while 33 
participants reported greater major discrimination on the InDI. 
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6.3.8 Test-retest reliability 
Adjusting for the number of days between baseline and follow-up survey completion (mean=43, 
range=21 to 63), the intra-class correlation coefficient (ICC) for test-retest reliability of 
anticipated discrimination (n=150) was 0.72 (95% CI: 0.63, 0.79). ICCs for lifetime day-to-day 
and major discrimination frequencies (n=149) were 0.78 (95% CI: 0.71, 0.83) and 0.72 (0.63, 
0.79) respectively.  
6.4 Discussion
6.4.1 Prevalence of discrimination 
We developed and evaluated the Intersectional Discrimination Index, which includes measures 
of anticipated, day-to-day, and major discrimination for use in intersectional analyses of 
discrimination and health. Our attribution-free scale of anticipated discrimination is novel, and 
thus comparisons to existing measures were not possible. Moreover, given intentional 
oversampling of racial/ethnic and sexual/gender minorities and lack of weighting to reflect 
population demographics, prevalence estimates should not be over-interpreted. However, we 
note that the proportion of United States respondents reporting lifetime day-to-day or major 
discrimination (79.1% and 62.5%, respectively) are broadly comparable to the results of a 2015 
survey weighted to reflect the U.S. population, in which 68% reported lifetime everyday and 
47% reported lifetime major discrimination on a modified version of the Williams discrimination 
measures.64 Similarly, between-country unadjusted prevalence differences in our sample may 
reflect sociodemographic differences (e.g., the younger average age of Canadian respondents. 
However, the higher prevalence of discrimination reported by Canadians (87.8% lifetime day-to-
day discrimination, 70.8% lifetime major discrimination) warrant further investigation.  
6.4.2 Anticipated discrimination 
After removing two positively-worded items that may have been tapping a different construct 
(anticipation of positive treatment versus the absence of anticipated discrimination), we found 
support for use of the InDI Anticipated Discrimination measure as a unidimensional scale, with a 
similar structure in both Canada and the United States. We also found evidence of construct 
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validity. As hypothesized, anticipated discrimination scores were higher among racial/ethnic and 
sexual/gender minority groups. Anticipated discrimination was associated with negative mental 
and behavioural health outcomes within the full sample, and among racial/ethnic and 
sexual/gender minorities, but not among white respondents as a group. Future research could 
explore the possibility that anticipated discrimination has a stronger impact on health within 
groups that experience a higher level of enacted (day-to-day or major) discrimination. 
6.4.3 Day-to-day and major discrimination 
Known groups comparisons and associations with mental and behavioural health outcomes 
provided evidence of construct validity for both enacted discrimination components of the InDI. 
Both forms of discrimination were reported significantly more often by Indigenous or racialized 
and LGBT persons, versus white and non-LGBT individuals. Consistent with expectations, 
lifetime and past-year reports of both discrimination types were associated with higher odds of 
severe psychological distress, smoking, or hazardous drinking among the full sample, and when 
stratified by racial/ethnic and sexual/gender minority statuses.  
Among the 150 follow-up survey participants, correlation and agreement with the measures 
developed by Williams et al.28 were high, particularly for day-to-day/everyday discrimination. In 
developing the InDI, we aimed to ground discrimination reports in more concrete domains or 
events than previous measures, while also covering a broader range of discrimination types. For 
day-to-day discrimination, it does not appear that the InDI had broader coverage: the number of 
respondents who were in a higher tertile of the response distribution for the Williams measure as 
compared to the InDI was equal to the number who were in a higher tertile for the InDI. In 
contrast, the InDI appeared to tap more major discrimination events than the Williams index. 
Our ability to draw conclusions about the relative performance and content validity of the two 
instrument sets is limited by the small follow-up survey sample.  
6.4.4 Test re-test validity 
Test re-test reliabilities for anticipated, lifetime day-to-day, and lifetime major discrimination 
were high (ICC=0.72-0.78); while not directly comparable, these coefficients are higher than the 
test-retest correlations reported for the Experiences of Discrimination measure by Krieger et al.27 
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While ICCs were adjusted for the number of days between baseline and follow-up, all 
participants completed follow-up at least three weeks after baseline. Thus, these estimates should 
be taken as lower bounds of test-retest reliability.  
6.4.5 Strengths and Limitations 
The development and validation of the InDI had several strengths, as well as limitations, that 
should be noted. To our knowledge, the InDI is the first set of discrimination measures 
developed explicitly to assess the phenomenon across all types or bases of discrimination, taking 
an intersectional approach that does not require respondents to indicate which social status(es) or 
position(s) they believe to have been targeted for discrimination. This evaluation benefited from 
a large binational sample, including neighbouring countries that share important similarities 
(e.g., sociodemographic heterogeneity) as well as differences (e.g., immigration policies and 
patterns 65) that may impact the nature and measurement of discrimination. 
Establishing construct validity requires a theoretical and empirical basis for hypotheses (e.g., 
regarding expected variation in discrimination prevalence and health associations). Therefore, 
these analyses were not structured to evaluate the performance of the measures intersectionally 
(e.g., across groups cross-stratified by multiple sociodemographic variables), nor among specific 
ethno-racial groups or minority populations that have been understudied in the discrimination 
and health literature (e.g., people with disabilities). Considering this preliminary evidence of the 
validity and reliability of the InDI, we plan to conduct further, exploratory analyses to 
investigate its measurement properties across additional axes of social status and position, 
including interactions of multiple non-dominant social statuses.  
Based on concerns about recall of day-to-day discrimination over the long-term, as well as the 
expected low frequencies of past year major discrimination, frequency response options for the 
two components were not aligned. The approximate number of discrimination events (one versus 
two or more) was measured over the past year for day-to-day discrimination, and over the 
lifetime for major discrimination. Nevertheless, examination of the item frequencies for lifetime 
versus past-year day-to-day discrimination suggests some degree of telescoping, with high 
proportions of those indicating lifetime discrimination also indicating past-year discrimination.
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However, this may also reflect the chronic nature of day-to-day discrimination, as a phenomenon 
that often reoccurs with regularity among members of minority groups.42 An optimal timeframe 
for measuring discrimination cannot be identified from existing research, as most measures 
include a single (or unspecified) timeframe, and because the relevant timeframe will vary by type 
of discrimination (e.g., cumulative, lagged, or immediate effects) and health outcome (e.g., 
latency period).24 The InDI could be used to further investigate the temporal relationships 
between discrimination and health, responding to calls for better integration of life course 
frameworks within the field.66 Investigators using the InDI may opt to adapt the response scales 
presented here to fit their research questions and study designs.  
Finally, the InDI and these analyses are subject to similar limitations as all research on self-
reported, perceived discrimination. For instance, reporting of discrimination may be influenced 
by personality traits, response styles, or current mental health status. The current study did not 
examine personality traits or response styles. However, evidence to date indicates that 
associations between reported discrimination and health outcomes persist after control for 
personality traits or styles (particularly social desirability), and longitudinally when 
discrimination is measured prior to health outcomes.18  Further, the construct validity of social 
desirability scales as measures of response style (versus adaptive impression management) has 
been questioned.67  
6.4.6 Conclusion and next steps 
In conclusion, the InDI measures of anticipated, day-to-day, and major discrimination show great 
promise for use in intersectional discrimination research in population health, and potentially in 
other fields (e.g., for social science research interested in monitoring the prevalence of 
discrimination over time). In this bi-national validity and reliability study, the InDI measures 
demonstrated strong construct validity and test-retest reliability. The InDI is substantively novel 
in several respects, including a wider range of manifestations of discrimination than extant 
measures developed from models of racism, and using the stem “because of who you are” in lieu 
of attributions to specific bases of discrimination.  
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To support investigators in selecting discrimination measures, future research should evaluate the 
unique contribution of the InDI as compared to scales currently in common use, particularly 
those initially developed to measure racism in the United States but more recently adapted for 
studies of multiple discrimination types. We have not recommended the use of an overall InDI 
summary score because the appropriate weights to assign to each component are unknown. 
However, future research could also consider the potential for combined scores with empirically-
derived weights. To provide guidance on applications of the InDI, we are preparing a companion 
paper that uses the InDI measures in combination with data on socio-demographic characteristics 
and targetable attributes (e.g., visibility of stigmatized statuses) to conduct intersectional 
analyses of the impacts of discrimination on specific health outcomes. 
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7 Chapter 7: Integrated Discussion 
7.1 Introduction 
This thesis sought to examine the impacts of discrimination on health risk behaviours in 
Ontario’s transgender population, and to develop and evaluate the validity of an intersectional 
index of discrimination for population health research. Specifically, Chapters 2-5 explored 
relationships between self-reported discrimination— alongside other potential determinants of 
transgender health—and HIV-related sexual risk behaviour, heavy episodic drinking, and illicit 
drug use among transgender Ontarians. These chapters drew on data from the Trans PULSE 
Project, a Canadian Institutes of Health Research-funded community-based research project 
which surveyed 433 trans Ontarians in 2009-2010, using respondent-driven sampling. Chapter 6 
described the development of the Intersectional Discrimination Index, and provided initial 
evidence of the index’s reliability and validity in a bi-national sample of 2642 Canadians and 
Americans. This chapter will review key findings and their implications for health and social 
service delivery, and future research.  
7.2 Summary of Key Findings 
7.2.1 HIV-related sexual risk among transgender Ontarians 
7.2.1.1 Transfeminine persons 
In many settings, transfeminine persons who have sex with men are the population most heavily 
impacted by HIV,1 and risk for HIV has been correlated with experiences of discrimination2-4 as 
well as social and medical gender transition.5  Chapter 2 adds to the limited evidence base 
regarding HIV and other sexually transmitted infection risk in broader transfeminine populations, 
particularly outside the United States.6-8 Uniquely, this chapter also considered whether similar 
factors might predict both HIV sexual risk and sexual inactivity. Sexual inactivity was 
approximately twice as common in this population: of those who had ever had sex, 40.8% (95% 
CI: 28.9, 52.6) reported no past-year sex partners while 20.9% (95% CI: 11.7, 30.2) were at high 
HIV/STI-related risk. This contrasts with previous studies of transfeminine persons, which have 
164 
 
often been designed explicitly to address HIV-related sexual risk, and thus have recruited highly 
sexually active samples.1 
Among sexually-experienced transfeminine persons overall, anti-transgender discrimination and 
violence were not independently associated with HIV/STI sexual risk or inactivity, nor were 
indicators of social exclusion (e.g., lack of social or parental support). Rather, a gender transition 
factor—having completed genital surgery—was associated with lower odds of both outcomes, 
relative to low-risk sex.  
In a sensitivity analysis employing a restricted definition of HIV-related sexual risk excluding 
insertive vaginal intercourse, results were more comparable to the extant literature, with lower 
incomes9,10 and experiences of transphobia2-4 being positively associated with sexual risk. This 
suggests that impacts of discrimination and social exclusion on trans people’s sexual health are 
context-dependent. In the U.S. context, one study postulated that differential exposure to early 
trauma and abuse among transfeminine persons attracted to men (who generally “come out” and 
transition at younger ages) may shape their later HIV risk and susceptibility to effects of 
discrimination and violence in adulthood.11 
7.2.1.2 Transmasculine persons 
Relative to their transfeminine counterparts, the sexual health of transmasculine persons has been 
greatly understudied.12 Two recent reviews of the literature on transgender men’s sexual health 
noted that research to date has relied on very small convenience samples, and— related to small 
samples—analytic studies to identify contributors to sexual risk behaviour are lacking.13,14 
Considering the limited potential for sexual transmission of HIV between transmasculine persons 
and cisgender female partners, Chapter 3 focused on HIV-related sexual risk among 
transmasculine persons who identified as sexual minorities (e.g., gay, bisexual, queer), and/or 
who reported sex with men in the past year (T-GBMSM).  
In this group, discrimination and social exclusion were not associated with sexual risk. Factors 
most strongly related to HIV risk among cisgender men who have sex with men— childhood 
sexual abuse,15,16 depression,17 and stimulant use18—were predictive instead. In addition, 
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contrary to findings among transfeminine Ontarians, gender transition was related to higher 
sexual risk, and in this case, it was social rather than medical transition that had an impact.  
7.2.2 Substance use among transgender Ontarians 
Chapters 4 and 5 drew on Trans PULSE and Canadian Community Health Survey data to 
identify predictors of heavy episodic drinking and illicit drug use among trans Ontarians, and 
disparities in relation to the overall provincial population. 
7.2.2.1 Heavy episodic drinking 
As described in Chapter 4, the past-year prevalence of heavy episodic drinking (HED) at least 
monthly was higher among trans persons than expected based on the Ontario population, 
standardized to the trans age distribution. When stratified by gender spectrum, disparities were 
particularly pronounced for transmasculine persons, who had the highest estimated prevalence 
(42.2%). Neither discrimination nor gender transition were associated with heavy episodic 
drinking. In multivariable analyses, transmasculine gender spectrum and engagement in sex 
work were the only predictors of greater HED. The latter finding is consistent with high levels of 
substance use in studies of sex workers,19 however, as employment in sex work was relatively 
uncommon in this population (2.2%), it is unlikely to represent an important contributor to the 
large disparities identified.   
7.2.2.2 Illicit drug use 
Past-year prevalences of both cocaine and amphetamine use were higher among trans Ontarians 
than in the age-standardized Ontario population. By gender spectrum, differences were less 
pronounced than for HED, and varied by substance. Within the trans population, only one gender 
spectrum difference in past-year drug use was detected (transfeminine persons were more likely 
to use crack cocaine). Correlations with past-year use of illicit drugs (associated with higher risk 
of harm to users) within the trans population were complex. Gender transition was not associated 
in bivariable or multivariable models. Both anti-transgender violence and underhousing (an 
indicator of social exclusion) were associated with increased drug use, while transphobia scale 
scores were not. Contrary to expectations of our minority social stress approach, social support 
166 
was positively associated with drug use. Further, when current sex work was added to the 
multivariable model, violence and underhousing were no longer significant predictors of drug 
use, suggesting mediation and/or confounding. This should be cautiously interpreted given the 
small number of sex workers in the sample.  
7.2.3 Implications for understanding impacts of gender affirmation on transgender health 
behaviours 
Guided by minority stress and gender affirmation frameworks, the exploratory analyses in 
Chapters 2-4 considered the relationships between health behaviours and anti-transgender 
discrimination (transphobia) and violence, as well as gender transition, among trans Ontarians. 
This section reflects on the implications of all four chapters for understanding the role of gender 
spectrum and transition on HIV-related sexual risk and substance use. The following section 
(7.2.4) reflects on implications related to discrimination and health risk behaviours.  
Transmasculine persons were significantly more likely than transfeminine persons to report 
heavy episodic drinking monthly or more, but the prevalences of very frequent (weekly or more) 
HED and of illicit drug use did not vary by gender spectrum. While psychopharmacologic and 
neuroendocrine research indicates that cisgender females are more susceptible to substance use 
initiation, dependence, and addiction,20 substance misuse remains heavily concentrated in 
cisgender males.21,22 However, the disparity in substance use between cisgender men and women 
has been declining across recent birth cohorts, and there is no plausible biological (sex-based) 
explanation for this narrowing gap.22  Rather, both cisgender population data and the current 
study indicate that social gender is a salient determinant of substance use behaviour. Studies of 
transgender populations offer a more direct way to disentangle natal sex and gender (i.e., 
biological versus social) effects, which are largely confounded in cisgender populations. As 
discussed in Chapter 5, results in this thesis lend further support to the importance of gender 
identity (as opposed to natal sex) in shaping patterns of substance use. While hormonal transition 
might alter sex-linked patterns of substance use, were biological sex a more salient determinant 
of substance use, we would expect to see higher prevalence of HED and illicit drug use among 
transfeminine persons; this is particularly true considering that less than half were using hormone 
therapy, and most had transitioned within the previous few years.23  
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As postulated by gender affirmation approaches to health risk behaviours among transfeminine 
persons,24,25 it is plausible that some transmasculine persons engage in drinking behaviours 
associated with masculinity as part of affirming gender identity. Qualitative research on the 
motivations underlying health risk behaviours among transmasculine persons is needed to 
contextualize findings of this thesis.   
Gender spectrum differences in HIV-related sexual risk behaviour cannot be directly compared, 
given the different subpopulations studied: all sexually-experienced transfeminine persons versus 
T-GBMSM. In the former group, approximately 1 in 5 had at least one high-risk sexual
encounter in the past year, in the latter group, 1 in 10 did so. While this implies that
transfeminine persons are more likely to engage in HIV-related sexual risk, it is important to
recall that the outcome was defined to include vaginal or anal intercourse to ejaculation (with a
“flesh” penis). Therefore, transfeminine persons had more ways to engage in HIV risk behaviour
than did T-GBMSM (because ~99% could not be the insertive partner in intercourse we defined
as high-risk). Finally, a comprehensive evaluation of gender spectrum differences in HIV risk
behaviour would need to consider the actual HIV/STI risk associated with reported behaviour,
particularly partner characteristics, on which data were not collected.
With respect to social and medical gender transition, no impact on substance use was evident. 
The relationship between transition and sexual risk behaviour varied by gender spectrum. Having 
genital surgery predicted better sexual health outcomes among transfeminine persons (higher 
odds of low-risk sex versus risky sex or inactivity). The negative association with sexual 
inactivity may reflect reduced gender dysphoria as well as enhanced access to sexual partners, 
considering the difficulties transfeminine individuals can face in finding respectful partners.8 
Genital surgery was associated with a 92% reduction in the estimated odds of HIV-related sexual 
risk, while feminizing hormone use was not significantly related. This is consistent with the 
expectation of the gender affirmation framework that those with access to external and internal 
gender affirmation will be less inclined to seek affirmation through sexual interactions, 
potentiating risk behaviour.24 It also suggests that genital surgery is particularly important in this 
regard, which is not surprising given the social emphasis placed on genitalia in defining 
womanhood.26    
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Among transmasculine persons at the time of data collection, genital surgery was extremely 
uncommon (~1%23; 4 of 227 transmasculine participants). In this group, social transition (but not 
hormone therapy) was associated with higher HIV-related sexual risk. This, too, appears 
consistent with the gender affirmation framework: T-GBMSM have reported that following 
social transition, sexual activity with gay and bisexual cisgender men can be an important source 
of gender affirmation for which they are sometimes willing to take health risks.27,28  
7.2.4 Implications for understanding impacts of minority stress on transgender health 
behaviours 
As measured (with a scale including internalized, anticipated, and enacted stigma29), transphobia 
was largely unassociated with the outcomes examined in this thesis, while anti-transgender 
violence was correlated with illicit drug use only. This is in contrast to previous Trans PULSE 
findings of associations between transphobia and both depressive symptomatology30,31 and 
suicidality.32  
This pattern of results could be interpreted to indicate that transphobia is not a key determinant 
of health risk behaviours among trans Ontarians. Across populations, discrimination is more 
consistently associated with psychological distress than with health behaviours.33,34 Yet, 
alternative explanations remain to be explored. First, exposure to some degree of transphobia is 
nearly ubiquitous among trans Ontarians: 98% reported at least one experience.29 Within-group 
analyses cannot detect effects of invariant exposures35,36—in this case, to any discrimination. 
Rather, these thesis analyses asked whether increasing exposure to transphobia predicted risky 
health behaviours within the trans population. Schwartz and Meyer35 argue that social stress 
theory proposes a larger model, in which group disadvantage negatively impacts health directly, 
and mediated by discrimination-related stressors. An ideal test of this model would use between-
groups and mediational analyses “that can capture the workings of stress…[and] its differential 
effect” (p. 1116). To evaluate the effects of discrimination on behavioural health disparities 
identified in this thesis, such a complete test would require discrimination measures that work 
across social groups (so that discrimination can be evaluated as a mediator of disparities). 
Reisner et al. provide a model of such an approach in a paper focused on gender minority 
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disparities in adolescent substance use,37 in which the hypothesized mediator (bullying) was a 
discrimination-related stressor, but measured without attribution to specific social positions.  
It may also be the case that various forms of transphobia are differentially related to mental 
health versus health behaviour outcomes. The Trans PULSE transphobia scale included 11 items. 
Of these, four might be considered major discrimination events following this thesis’ schema: 
being physically assaulted, denied employment, having to move, or being harassed by police. As 
such discrete events can be independent of one another, they should be measured 
comprehensively (i.e., sampling from all domains) and analyzed as an index or checklist rather 
than as a psychometric scale.38-40  
Another three items could be classified as day-to-day discrimination experiences: being made 
fun of, hearing that trans people are not normal, or being objectified or fetishized sexually. The 
remaining four items reflect internalized and/or anticipated stigma: feeling that being trans 
embarrassed one’s family, trying to “pass” as non-trans, worrying about growing old alone, and 
fearing dying young. If, as the social stress and discrimination literatures suggest, categories of 
discrimination stressors are differentially associated with health outcomes,41 combining them 
into a single scale may obscure effects. In addition, these types of discrimination vary in terms of 
duration and chronicity of exposure, and potentially in etiologic period (the lag between 
exposure and consequent health outcome).38,42,43  
At the same time, the distribution of risky health behaviours within trans populations may be 
distributed unevenly based on multiple, intersecting forms of discrimination. Marcellin 
investigated the interacting effects of racism and transphobia on HIV-related sexual risk in her 
thesis.29,44 As previously discussed, this analysis was limited by the fact that the study employed 
transphobia and racism scales with a number of overlapping items. Discrimination that trans 
people may experience due to other social statuses or positions was not assessed. Nevertheless, 
she found that transphobia did predict increased HIV-related risk behaviour, but only among 
Indigenous or racialized trans persons who were exposed to high levels of racism as well. 
Therefore, while we can provisionally conclude that discrimination is more strongly related to 
internalizing mental health conditions than to health behaviours among trans Ontarians, further 
research should employ more comprehensive and intersectional measures of discrimination to 
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test this hypothesis. The Intersectional Discrimination Index developed as part of this thesis is a 
candidate for such a measure.  
7.2.5 Validity and reliability of the Intersectional Discrimination Index 
As described in Chapter 6, the Intersectional Discrimination Index (InDI) was developed through 
a literature review, construct map, and series of expert consultations to measure anticipated, day-
to-day, and major discrimination related to any social status or position. In this thesis, initial 
validity and reliability analyses were conducted with a focus on measurement properties among 
racial/ethnic and sexual/gender minorities, groups for which the body of research on measuring 
discrimination and its health consequences is more developed. Online survey panel members in 
Canada and the United States (n=2642) completed socio-demographic questions, the InDI, and 
measures of mental and behavioural health. No data quality or acceptability concerns were 
identified: missing data did not exceed 1.7% for any variable, and all items took the full range of 
possible values. In test-retest reliability analyses, the InDI components demonstrated strong 
reliability in comparison to other discrimination measures in the literature,45 with intra-cluster 
correlation coefficients between 0.72-0.78.  
After removal of two positively worded items that may have tapped a different construct, factor 
analyses of the Anticipated Discrimination InDI scale found support for two interpretable 
factors: anticipated institutional (6 items) and anticipated interpersonal discrimination (3 items). 
Due to a very high factor inter-correlation (0.93) and high item-total correlations for the full 9-
item scale, use of the overall scale score (rather than subscales) appears suitable.  
Results of known-groups comparisons consistently supported the hypothesis that racial/ethnic 
and sexual/gender minorities would report significantly higher levels of each discrimination type 
relative to the respective majority group (white persons or cisgender heterosexuals). All but one 
of the hypothesized associations between discrimination and health were detected, employing a 
composite mental and behavioral health outcome (1 or more of psychological stress, smoking, 
hazardous drinking). Specifically, in the full sample, day-to-day and major discrimination over 
both the lifetime and the past year, as well as anticipated discrimination, were associated with 
higher odds of reporting one or more of the negative health outcomes. The pattern of results did 
not differ when stratified, except when examining anticipated discrimination stratified by 
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race/ethnicity: among white respondents only, anticipated discrimination was not significantly 
associated with health outcomes. Limited variation in anticipated discrimination, or limited 
salience of anticipated discrimination for members of socially dominant groups, are potential 
explanations for this finding.    
Results of comparisons to the Williams Everyday and Major Discrimination items,46 however, 
were less conclusive with respect to the potential incremental validity of the InDI; Spearman 
correlations between the measures using a lifetime frame were high (0.76 and 0.83). When 
agreement was assessed using tertiles to classify scores as low, moderate, or high, the level of 
agreement was moderate. The InDI demonstrated a slight advantage only for major 
discrimination, by tapping a wider range of discrimination experiences (and thus a greater 
number of experiences).  
Day-to-day discrimination frequencies may depend less on the specific instrument used, as the 
experiences are less discrete and may be more likely to cluster, whether because of 
characteristics associated with being targeted for discrimination, or with perceiving and 
reporting. It is also possible that differences in coverage between the two sets of measures were 
washed out by the combination of the wider scope implied by the Williams item stem (“unfair” 
treatment without reference to social position) and the wider range of discrimination 
manifestations queried by the InDI. These possibilities require further research, as the small 
follow-up sample size (n=150) limited our ability to conduct more in-depth analyses to explore 
the incremental validity of the InDI relative to the Williams measures. Priming may have also 
contributed to the high correlation and agreement observed. While correlations were calculated 
between scores for the InDI completed at baseline and the Williams measures completed at  
follow-up, respondents also completed the InDI a second time (to estimate test-retest 
reliability) immediately preceding the Williams measures.  
7.2.6 Implications for measuring discrimination in population health research 
The development of the InDI was initially motivated by practical and conceptual problems we 
encountered in investigating the impacts of discrimination using Trans PULSE Project data. 
Building on common approaches in the discrimination and health literature, the Trans PULSE 
survey included two discrimination measures—one for racism, and another for transphobia. 
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While the research team was interested in assessing other forms of discrimination, they decided 
that adding yet another scale would not be feasible in the context of a survey that was already 87 
pages long.  
From an intersectional perspective, requiring participants to disaggregate experiences of 
discrimination into those based on race/ethnicity and those based on trans status was 
problematic.47,48 Considering this challenge, and that fact that the two scales included a number 
of parallel items (e.g., being turned down for a job, objectified sexually, harassed by police), it is 
likely that they were “double-counting” some experiences. In addition, as discussed in section 
7.2.4, the scales collapsed multiple dimensions of discrimination (day-to-day, major, anticipated, 
and internalized) that may have differential impacts on health (e.g., for depression versus heavy 
drinking) and etiologic periods.  
The Introduction to this thesis showed that these motivating problems are not unique to Trans 
PULSE, but are common in studies wherein multiple dimensions of discrimination, and/or 
multiple bases of discrimination are of interest. Despite increasing attention to both 
discrimination33,34 and intersectionality49,50 in population health research, there have been few 
attempts to develop universal instruments to measure discrimination, and little conceptual debate 
about the promises and pitfalls of such attempts.51 The InDI was intended to fill this gap by 
explicitly measuring enacted (day-to-day and major) and anticipated discrimination based on 
social position or status—versus generic “unfair treatment” — irrespective of attribution. To this 
end, the item stems ask respondents to report experienced based on “who you are”, defined as: 
“…both how you describe yourself and how others might describe you. For example, your skin 
colour, ancestry, nationality, religion, gender, sexuality, age, weight, disability or mental health 
issue, and income.” 
Although we were concerned that this inclusive stem could encourage reporting of generic (non-
discriminatory) mistreatment, results indicate that almost all respondents interpreted the wording 
as intended. To evaluate this possibility, an overall attribution question was asked of all those 
who reported any discrimination. Only 28 respondents (1.1%) wrote-in an attribution that falls 
outside of our definition of social discrimination (e.g., mistreatment based on personality).   
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Beyond the question stem, a central feasibility question for the InDI was whether the same item 
sets could meaningfully tap discrimination experiences across population groups defined by 
intersecting social positions along lines of race, ethnicity, class, immigration status, gender, 
sexuality, and so on. In developing the InDI, we drew on conceptual models of the functions and 
manifestations of stigma and discrimination52,53 and strove to select a representative set of items. 
This thesis focused on evaluating performance across race, ethnicity, sexuality, and gender 
identity, finding evidence that the measure performed well among both racial/ethnic and 
sexual/gender minority groups.  
In summary, the analyses described in Chapter 6 provide preliminary evidence that the 
Intersectional Discrimination Index can resolve the challenges to intersectional population health 
research on discrimination that motivated its development. Questions remain concerning 
incremental validity relative to existing discrimination measures, and the measures’ validity 
across the full range of non-dominant social statuses and positions. Using the dataset collected 
for this thesis, we will be able to investigate the latter, drawing on information collected 
pertaining to social status and position, as well as targetable attributes (e.g., visible membership 
in a religious minority group, perceived gender non-conformity).  
7.2.7 Implications for prevention and health services 
Findings of Chapters 2-5 have important implications for providers of health and social services 
to trans individuals and communities. First, service providers should take note of the 
heterogeneity of health behaviour risk within trans communities. The disproportionate burden of 
HIV and substance use risks among trans people—including disparities demonstrated in this 
thesis— should be recognized and responded to. However, we estimated that over the previous 
year, 79% of sexually-experienced transfeminine Ontarians and 90% of T-GBMSM were at low 
or no risk of sexually-transmitted HIV, while 67% of trans Ontarians did not drink heavily on a 
regular basis and 88% did not use drugs associated with a high risk of harm to themselves.  
Hence, trans people constitute a “vulnerable” population rather than an “at-risk” population; 
Frohlich and Potvin define the former as a group “at risk of risks” due to social-structural 
conditions, while the latter comprise those individuals at highest risk of a specific health 
outcome.54 Of course, most-at-risk subgroups exist within any vulnerable population; one task of 
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this thesis was to identify such groups in Ontario’s trans population. Since the 1985 publication 
of Geoffrey Rose’s seminal contribution,55 a lively debate has been taking place in the public and 
population health literature regarding the relative merits of disease prevention efforts focused on 
the whole population versus on “high-risk” groups.54,56-58 Neither is necessarily the correct 
approach; rather, over the longer-term, macrostructural conditions and ubiquitous exposures 
must be addressed to shift the population distribution of health while, at the same time, 
implementing interventions to prevent morbidity and mortality in those at highest immediate 
risk.57  
Applying this framework to interventions within the trans population, it becomes apparent that 
supra-individual interventions are required to shift the entire distribution of health in trans 
populations, considering the ubiquity of some degree of social exclusion and the high burden of 
mental health conditions in particular.30-32 However, in the shorter-term, services should 
prioritize prevention of HIV infection and substance use-related harms among the minority of 
trans persons who are currently at-risk. This is particularly the case when delivering services that 
are most appropriate for people already at some risk; for example, a blanket HIV testing 
campaign for transfeminine communities may not be an appropriate use of resources when half 
of the population is not sexually active. Universal approaches can also contribute to stigma by 
labelling entire vulnerable populations as at-risk. Moreover, such universal approaches risk 
worsening inequalities because they rely on individual agency, which is most challenged among 
those at higher risk due to social-structural conditions.54 For example, for trans sex workers (who 
we found to be at elevated risk of potentially hazardous substance use), efforts to promote access 
to substance use services in the trans population at large may be less useful than targeted services 
which address the specific barriers they face.59,60  
In addition to considering the appropriate balance of overall trans population versus high-risk 
prevention strategies, service providers should recognize heterogeneity of trans populations with 
respect to gender spectrum and processes of social and medical gender affirmation, and take an 
individualized approach to prevention, avoiding assumptions. Contrary to the assumption that 
transfeminine persons are primarily impacted by substance use,19 we found that any past-year use 
of illicit drugs did not vary by gender spectrum, while heavy drinking was concentrated among 
transmasculine persons.  
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Providers should be alert to potential changes in health behaviours related to various facets of 
gender affirmation: social and medical, as well as forms not evaluated in the Trans PULSE study 
(e.g., psychological self-affirmation of gender identity61). Among transfeminine persons, genital 
surgery was associated with lower prevalence of sexual risk and inactivity. While this association 
warrants further study, particularly longitudinally, these potential benefits may be considered in 
decision-making processes related to individual treatment plans and health system policies 
regarding access to surgery.  Providers should also note that gender affirmation, while potentially 
health-promoting overall, can also be associated with health risks (e.g., HIV risk behaviour 
among T-GBMSM).  
To address sexual health, physicians and other health care providers who interact with trans 
patients should ensure to take complete sexual histories and to inquire about changes in sexual 
behaviour and related risks, following cultural competence guidelines.62 For transfeminine 
persons, the majority of whom were at HIV/STI risk due to insertive genital sex (i.e., with 
cisgender women or transmasculine persons), sexually transmitted infections screening should be 
considered irrespective of apparent HIV risk. Of course, sexual health extends beyond the 
avoidance of disease, encompassing sexual well-being and pleasure. Primary care providers have 
a role to play in screening and counselling for problems patients may have with achieving 
desired sexual intimacy,63 and our results suggest that such attention is particularly indicated for 
transfeminine individuals. Similarly, brief screening for problematic alcohol use is an evidence-
based primary care intervention64 that should be implemented in trans patient care, considering 
the heavy burden of binge drinking documented in Chapter 4.  
Beyond primary care settings, the results of this thesis have implications for specialized HIV 
prevention and substance use treatment services. Related to HIV prevention among T-GBMSM, 
in previous studies, a preference for accessing services for gay and bisexual men has been 
expressed.29 In this study, key determinants of HIV risk among cisgender gay and bisexual men 
were also associated with such risk among T-GBMSM, lending support to the feasibility of these 
preferences. Given the small size of the population, inclusion within such existing services (e.g., 
those delivered by AIDS Service Organizations across Ontario) may also be more efficient. It is 
likely that T-GBMSM who are primarily attracted to men and who are living in their felt gender 
(particularly if they identify as men) will be most comfortable accessing such services; these 
176 
 
groups were also those found to be at elevated risk of HIV in this study. Service-side barriers to 
inclusion (e.g., lack of inclusive policies or provider practices), however, may limit the ability of 
T-GBMSM to take advantage of prevention programming.65 Results described in Chapters 4 and 
5 indicate need for substance use prevention and treatment for trans sex workers. Flexible, 
mobile or street-based outreach programs with peer involvement have shown effectiveness for 
linking marginalized sex workers with substance use treatment in other settings.60 
7.2.8 Implications for future research 
At present, information on transgender status is not collected in any Statistics Canada surveys, 
including the Canadian Community Health Survey (CCHS), the primary source of data on the 
health status of Canadians. Given this, we evaluated trans-cisgender disparities in substance use 
by comparing respondent-driven sampling survey data from Trans PULSE to CCHS data, 
standardized to the trans population age distribution. While RDS data are theoretically 
generalizable to the networked target population, this generalizability rests on assumptions that 
may not be met in practice.66 Measurement and survey mode differences are further threats to the 
validity of our estimated prevalence differences. Ultimately, better understanding of the health of 
the trans population in Canada, and disparities with cisgender Canadians, will require inclusion 
of measures to assess sex assigned at birth and gender identity and/or lived gender in population 
health surveys.67 In the United States, some population-based surveys and surveillance systems 
have begun collecting and reporting data on trans status, and the results are confirming some 
disparities hypothesized based on convenience and respondent-driven sampling data, while 
challenging others.68-70 
To consider the impact of discrimination as a predictor of poor health outcomes within the trans 
population, future research should employ measures of discrimination that disaggregate its 
various dimensions, which may have different antecedents, and consequences for health. To 
consider discrimination as a potential mediator of disparities with cisgender populations, surveys 
which include both cisgender and trans populations (including but not limited to population-
based surveys) will need to include cross-group discrimination measures, such as the InDI.  
The results of this thesis also raise the intriguing possibility that discrimination is a less salient 
predictor of trans health risk behaviours in Canada, as compared to the United States. In a recent 
177 
 
24-country survey of public opinion on transgender issues, Canada had the third-highest score in 
support of trans rights, while the United States ranked 8th. In 2012, gender identity and 
expression were added as protected grounds under the Ontario Human Rights Code. As of March 
2017, such protections formally exist in nine provinces and one territory, with legislation 
pending in The Yukon, New Brunswick, and federally.71 While Trans PULSE study data predate 
these legal changes, these advances nonetheless reflect a social climate that is more favorable to 
trans people, as compared to the United States, where the right of trans people to use the 
washroom that aligns with their gender identity continues to be a contentious subject of public 
policy debate and legal struggle.72 In the United States, “structural stigma”, including negative 
public opinion as well as laws and policies that marginalize sexual and gender minorities, has 
been associated with poor health outcomes among sexual and gender minority adults and 
adolescents.73-75 Thankfully, variation in legal protections based on gender identity, expression, 
and sexuality within Canada is likely insufficient for such multi-level analyses. However, cross-
national research would offer novel opportunities to examine relationships between trans human 
rights policy and legislation, experiences of discrimination, and health outcomes.  
The development and validation of the Intersectional Discrimination Index also raises several 
intriguing questions for future research. In addition to assessing incremental validity against the 
Williams Everyday and Major Discrimination46 measures in larger samples, comparisons could 
be made with other measures that have been used to evaluate discrimination across groups, such 
as Krieger’s Experiences of Discrimination scale.45 Further, while this thesis provided initial 
evidence of English-language validity and reliability in Canada and the United States, validation 
of translated versions (particularly French and Spanish) and validation or adaptation for other 
country contexts would increase the InDI’s utility for comparative research and multilingual 
population health surveys. Also, while measuring discrimination for its own sake is important 
(e.g., to monitor trends in discrimination), we developed the InDI with the intent to study the 
effects of discrimination on mental and behavioural health, and their roles as mediators of health 
inequalities. Thus, we are preparing a companion paper to Chapter 6 which will demonstrate the 
use of the InDI for such analyses, with an intersectional analytic approach.  
Finally, the unadjusted descriptive results in Chapter 6 indicate that reports of discrimination 
were higher among Canadian respondents, contrary to expectations. This may be an artifact of 
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demographic differences, particularly the younger median age of Canadian participants. The data 
collected as part of this thesis can also be used to determine whether cross-national differences 
are artefactual, or robust to adjustment for demographic differences. If self-reported 
discrimination is indeed more prevalent among Canadians than among demographically-similar 
Americans, this would not necessarily conflict with the observation that Canada appears to offer 
a more hospitable social environment for trans persons and other minority groups. Rather, 
Canadians may perceive more discrimination precisely because a more hospitable climate 
contributes to a greater expectation of fair treatment, and higher sensitivity to violations of this 
expectation. A higher prevalence of perceived discrimination also need not translate into a 
stronger relationship between discrimination and health outcomes. Temporal changes in 
discrimination also warrant investigation, as the current political climate in the United States has 
been associated with concerns about persistent and rising discrimination across multiple bases 
(e.g., race, gender, religion)76 and increases in hate-motivated violence.77 These unfolding events 
make evident the timeliness and urgency of research on discrimination and health. 
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PLEASE NOTE: 
  
  
This copy of the survey is for informational use only.  Please do not fill out and submit this 
copy of the survey.  
  
  
To collect information from surveys, Trans PULSE is using a method called "respondent-driven 
sampling."  This strategy requires that once completed, people that have been invited to 
participate pass the survey along to other people they know and who are eligible to complete 
it also.  You should only fill out and submit the survey if you have been approached to do so.  
The reason for this is that this method allows us to produce more accurate statistics.  
Following this, the information produced from this method of collection will be considered 
more reliable by policymakers and other stakeholders. 
  
  
Please feel free to read over this copy of the survey.  If you have any questions or comments, 
do not hesitate to contact us at  or email us at 
Fo
r In
for
ma
tio
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ly 
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Introduction 
Thank you so much for taking the time to answer the questions in this survey.  The results will go a long way to 
help promote equality for trans communities in Ontario and beyond.  We greatly appreciate your contribution. 
This survey will eventually be completed by 1000 trans-identified people and people of trans experience across 
Ontario.  We've chosen particular kinds of questions to make sure that the results are useful to trans 
communities, meaningful to us, and able to affect our lives for the better.   
Why is this survey important? 
This survey is important because it is driven and owned by community members who want to improve our 
quality of life. It's essential to be able to have every voice heard and to have the real experiences of what it is 
like to be trans or to transition in Ontario in order for services to change and to understand how the health of 
our community is affected by the problems and challenges thrown our way.  
Where did the questions on this survey come from?   
Some of the questions in this survey were designed by members of our communities, and other questions come 
from existing surveys so we can compare our results to theirs.  This will enhance the success of our study in 
creating change and improving things for us.   
We know that some of the questions on the survey may seem very straightforward and basic.  What's really 
unique about this survey is that we've written many questions that relate to our real lives.  For example, the 
supports in our lives, how we feel about ourselves, the health issues that concern us, and our experiences with 
services. Understanding these issues can help us promote change for trans communities.  This survey is also 
important because trans people across Ontario told us these issues were meaningful.  
What will come of the results of this survey? 
The survey itself is not the final step of our project. Once we've collected the surveys from you and analysed the 
information, we will be talking to 60 to 80 trans people in more detail to help us understand our results.  Input 
from trans people is so important to make sure results are interpreted from our perspective. We will ensure that 
the results of this study do not sit on a shelf somewhere, but rather are put into action to improve our health 
and well-being. 
We realize that this survey is long, but we appreciate the time you are taking to fill it out.  Please feel free to 
save it and come back to it at a later time.  Also, if you have more to say on any of the topics we cover, there is 
space at the end of the survey for you to tell us your thoughts. 
A note on the following term: 
“trans, trans-identified or trans experience” -  these phrases are used in different places in the survey and 
in the articles and information created by the Trans PULSE Project more generally.  Identities and labels are 
important parts of our lives and how we think about ourselves. At the same time, it's difficult to use a single term 
to cover all people who are trans, transgendered, cross-dressers, transsexual, genderqueer, or those who have 
transitioned and identify simply as `women' or `men.'  So, we've decided to use these phrases as a means of 
including all trans people, with an understanding that some people may not always identify as trans at all times 
and stages in their life.
Provincial Survey 
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A. One question (or three) before you begin… 
A1.   If you were asked to complete this survey at your doctor's or therapist's office, would you have done it?
Yes
Likely yes
Likely not
No
A2.   If you were asked to complete this survey at a trans or LGBT community event, would you have   
          done it?
Yes
Likely yes
Likely not
No
A3.   In the past 12 months, have you …   (Please check all that apply)
Been a client of a psychiatrist or psychologist who sees many trans clients
Been a patient of a doctor or clinic where many trans patients go 
Attended a trans support group 
Gone to trans-specific nights at a bar or club
Been a member of a LGBT student group
Gone to an event at a LGBT community centre
Been a member of a LGBT religious group
Been a client at a gender-identity clinic 
None of the above 
This study uses new ways to reach more trans people than traditional surveys that are given out at 
doctors' offices or at clubs or support groups.  We want to know how well our method works.   We 
would like to know whether or not you might have completed the survey in one of these other places, 
if we'd done this differently.
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B. About You
B1.  How old are you?  
Male
Female
Yes
No
Unsure
B2.  What was your assigned sex at birth?
B3.  Have you been diagnosed with a medically-recognized intersex condition?
B4.  Which of the following describes your present gender identity?  (Please check all that apply)
These first questions are meant to give you a chance to tell us some basic information about yourself.
Years old
Boy or Man
Girl or Woman
FTM
MTF
Trans Boy or Trans Man
Trans Girl or Trans Woman
Feel like a girl sometimes
Feel like a boy sometimes
T Girl
She-male
Two-spirit
Intersex
Crossdresser
Genderqueer
Bi-gender
Other, please specify:
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B5.  Which of the following reflect your ethno-racial background? (Please check all that apply)
Aboriginal (First Nations, Métis or Inuit)
Latin American  (e.g. Argentina, Mexico, Nicaragua)
East Asian (e.g. China, Japan, Korea, Taiwan)
Indo-Caribbean (e.g. Guyanese with origins in India) 
South Asian (e.g. India, Sri Lanka, Pakistan) 
Middle Eastern (e.g. Egypt, Iran, Israel, Saudi Arabia) 
South East Asian (e.g. Vietnam, Malaysia, Philippines) 
White Canadian or White American 
White European (e.g. England, Greece, Sweden, Russia) 
Black Canadian or African-American 
Black African (e.g. Ghana, Kenya, Somalia) 
Other, please specify:
B6.  How do you identify your own ethno-racial background?
Please specify:
B7.  Are you perceived or treated as a person of colour?
Yes
No
B8.  What is your first language?
Please specify:
B9.   What languages are most often spoken in your home?
First language:
Second language:
Third language:
B10.   What country were you born in?
Canada
Other, please specify:
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B12. Are you...?
B13.  What is your status in Canada?
First Nations
Métis
Inuit
None of the above
B14.  Are you currently enrolled in elementary school, middle school, high school, college, trade school, or 
university?
Yes, full-time 
Yes, part-time 
No
B15.  At this point, what level of education have you completed (in Canada or any other country)?
Did not graduate from high school
High school graduate 
Some college or trade school
College or trade school graduate 
Some university 
University - bachelor's degree
University - graduate or professional degree
I don't know 
B11. How long have you been living in Canada? 
Years Months
Canadian Citizen
Permanent resident/landed
Refugee
Refugee Claimant / PRRA / Judicial Review
Work permit / temporary work papers
Visitor permit
Student permit
Undocumented / Non-status / Without papers
I don't know
Other, please specify:
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B16.   When you were a child, what was the religious or faith practice of your family?  (Please check all that 
apply)
Aboriginal Spirituality 
Agnostic 
Anglican 
Atheist 
Bahá'í
Buddhist
Catholic
Hindu
Jewish 
Mennonite
Amish
Islamic
Protestant Christian 
Sikh
Unitarian 
No religion 
Other, please specify:
B17.  How religious or faith-based was your upbringing?
1 
not at all
2 
a bit
3 
somewhat
4 
fairly
5 
quite
6 
extremely 
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B18.  What is your current religious or faith practice? (Please check all that apply)
Aboriginal Spirituality 
Agnostic 
Anglican 
Atheist 
Bahá'í
Buddhist
Catholic
Hindu
Jewish 
Mennonite
Amish
Islamic
Protestant Christian 
Sikh
Unitarian 
No religion 
Other, please specify: 
B19.  Right now, how religious or spiritual are you?
1 
not at all
2 
a bit
3 
somewhat
4 
fairly
5 
quite
6 
extremely 
B20.   What are the first three digits of your postal code?
B21. Do you live on a reserve?
Yes
No
The first three digits of my postal code are:
I don't know my postal code
I don't have a postal code, as I don't have a home right now
I don't have a postal code, as I am in the military
I don't have a postal code, as I am in the prison system
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B22.   How do you currently identify?  (Please check all that apply)
Bisexual
Gay
Lesbian
Asexual 
Pansexual 
Queer
Straight or heterosexual 
Two-Spirit
Not sure or questioning 
Other, please specify: 
B23.  Are you attracted to…? (Please check all that apply)
Trans men
Non-trans men
Trans women 
Non-trans women 
Genderqueer or bigendered people 
None of the above 
Other, please specify: 
Although a lot of health costs are covered by health insurance, there is still a relationship between our 
health and our incomes. Please know that, like all other information you have provided, these answers 
will be kept confidential.
B24.  What is your best estimate of the total income, before taxes and deductions, of all household  
           members from all sources in the past 12 months?
Less than $5,000.00
$5,000 to less than $10,000
$10,000 to less than $15,000
$15,000 to less than $30,000
$30,000 to less than $40,000
$40,000 to less than $50,000
$50,000 to less than $60,000
$60,000 to less than $80,000
$80,000 to less than $100,000
$100,000 or more
I don't know 
I'd rather not say 
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B25.  Including yourself, how many people were being supported on this household income? Please include 
everyone who is being supported, including those who may live outside of Canada.  
We recognize that, as a community, we work in all types of fields. When we talk about work and 
income, we are talking about all types of income-generating activity, both formal and informal 
employment.  This includes not only jobs, but income earned through activities ranging from public 
speaking to sex work to child care.
B26.  From which of the following sources did your household receive any income in the past 12   
           months?  (Please check all that apply)  
Wages and salaries
Income from self-employment
Dividends and interest (e.g. on bonds, savings)
Employment Insurance (E.I.)
Worker's compensation
Benefits from Canada or Quebec Pension Plan
Retirement pensions, superannuation and annuities
Old Age Security and Guaranteed Income Supplement
Child Tax Benefit 
Provincial or municipal social assistance or welfare (including Ontario Works or Ontario Disability 
Support Program-ODSP)
Child support 
Alimony
None
Other (e.g. rental income, scholarships, parental support), please specify:
Number of people
Will Rowe 
Will Rowe is a member of the provincial Community Engagement Team which guides the Trans PULSE Project. 
Will is a former lesbian feminist turned tranny poststructuralist. He has been active for over 20 years within 
queer communities of Guelph, K-W, Toronto and Hamilton where he has resided for the past five years. He will 
be attending MAC in the fall of '08 to complete his MSW. Will currently co-facilitates Hamilton's trans peer 
support group and HIFY's Rainbow Youth Drop-in. He is a step-parent of two daughters and the grandparent of 
four grandsons. Will enjoys spending time at home with his partner (and their dog) gardening, completing 
home renovations and reading critical theory. 
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B27.  What is your best estimate of your total personal income, before taxes and other deductions,  
           from all sources in the past 12 months? 
Less than $5,000.00
$5,000 to less than $10,000
$10,000 to less than $15,000
$15,000 to less than $30,000
$30,000 to less than $40,000
$40,000 to less than $50,000
$50,000 to less than $60,000
$60,000 to less than $80,000
$80,000 to less than $100,000
$100,000 or more
I don't know 
I'd rather not say 
B28.  If you have socially or medically transitioned and are living in your felt gender, what is your best estimate 
of the highest annual personal income you earned, before taxes and other deductions, from all sources 
before you transitioned?
Less than $5,000.00
$5,000 to less than $10,000
$10,000 to less than $15,000
$15,000 to less than $30,000
$30,000 to less than $40,000
$40,000 to less than $50,000
$50,000 to less than $60,000
$60,000 to less than $80,000
$80,000 to less than $100,000
$100,000 or more
I don't know 
I'd rather not say 
Not applicable, I have not transitioned
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B29.  Are you currently living with any of the following? (Please check all that apply)
Labelled with an intellectual disability 
Learning disability
Autism, Aspergers or neuro-diverse spectrum 
Mental health disability (including depression) 
As a survivor of the psychiatric system 
Blind, low vision or visual impairment 
Physical or mobility disability 
Chronic pain 
Chronic illness
None of the above 
B30.  Are you?
Deaf
Deafened
Hard of hearing 
None of the above 
B31.  What is your current relationship status?
Single and not dating
Single and dating 
In a monogamous relationship 
In a non-monogamous (open) relationship 
In a polyamorous (multiple people) relationship 
B32.  What is your legal marital status right now?
Never married 
Separated
Divorced
Widowed
Living common-law
Married
Communication disability (use of augmentative or alternative communication)
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Years old
B34.   Are you currently living in your felt gender? 
Yes, full-time 
Yes, part-time 
No
B35.   If yes, at what age did you begin living in your felt gender?
Yes
No
B33.  About how old were you when you first became aware that your own sense of your gender did not match 
your body or physical appearance?   
B37.   Have you asked any of the following people to call you by a different name or pronoun, one which reflects 
your gender identity? 
B36.   In your day-to-day life, do you use a different name or pronoun from the one that you were given at birth, 
one that better reflects your gender identity?
Have done Plan to do Do not plan 
on doing
Not 
applicable
My parent(s)
My sibling(s)
My spouse(s) or partner(s)
My child(ren)
My extended family
My roommates
My trans friends
My non-trans friends
My church/temple/mosque
My cultural community
My co-workers
My employer
My supervisor/boss
My teachers
My school
My classmates
Years old
Not applicable
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B38.  Have you legally changed your name to reflect your current gender identity?
Yes (skip to question B40)
No
B39.    If No, do you want to?
Yes
No
B40.   For the following forms of legal identification, are you listed as “male” or “female?”
B41.   Do your academic transcripts accurately reflect your current name and gender identity?
Yes
No
Not applicable 
B42.   Can you get letters of reference (for jobs, school, etc.) that accurately reflect your current name and 
gender identity?
Yes
No
Not applicable
Male Female I don't have 
this/ 
not relevant
Driver's license
Ontario Birth certificate
OHIP card (health card)
Non-Ontario birth certificate
Canadian passport
Other (non-Canadian) passport
Certificate of Indian status card
Canadian citizenship card
Canadian permanent resident card
Canadian armed forces card
“Bring your ID” Card/age of majority card
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B43.  Which of the following applies to your current situation regarding hormones and/or surgery?   
B44.  If you started or completed a medical transition, how old were you when you began?
B45.  Why is changing your body important to you? (Please check all that apply)
Years old
Not applicable
Nael Bhanji 
Nael is a half East-Indian, half Arab, queer, transguy who has spent most of his life in Kenya and now resides in Toronto, 
Ontario. A graduate student at the Women and Gender Studies Institute at the University of Toronto, he is passionate about 
queer, transgender, post-colonial and diasporic theory. When not in nerd-mode, he is also partial to crosswords, safaris, film 
festivals, soccer, basketball and warm socks. Nael is a member of the provincial Community Engagement Team which guides 
the Trans PULSE Project.
I have medically transitioned (hormones and/or surgery)
I am in the process of medically transitioning
I am planning to transition, but have not begun
I am not planning to medically transition
The concept of "transitioning" does not apply to me
I am not sure whether I am going to medically transition
For my self-esteem
For my mental well-being
For my safety
For employment reasons
To be comfortable in my own body
My work depends directly on my body presentation
It's not important to me
Other, please specify:
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C. Overall Health Care
In the next few sections, we would like to learn about your experiences with finding competent and respectful 
health care and social services.   
  
This first care-related section deals with overall health care.
C1. Do you have Ontario Health Insurance Program (OHIP) coverage?
Yes
No
C2. The following four questions refer to health care broadly, not just trans-related care.
C3.  During the past 12 months, was there ever a time when you felt that you needed health care but didn't  
         receive it?
Yes
No
Excellent Good Fair Poor
Overall, how would you rate the availability of health 
care services in Ontario?
Overall, how would you rate the quality of the health 
care services available in Ontario?
Overall, how would you rate the availability of health 
care services in your community?
Overall, how would you rate the quality of the health 
care services available in your community?
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C4.   For each type of service listed in Column 1, please indicate if you have needed the service in the past 12   
         months.  If you did not need it, please go on to the next line (i.e. next service). 
Column 1: 
Service Column 2 Column 3 Column 4
In the past 12 
months, have 
you needed this 
service?
If yes, were you able 
to obtain this service?
Use the list of options on page 20 to indicate the top 
reason(s) you were unable to obtain this service
Addictions services
Emergency services
General health care 
services  
Sexual health care
Trans-related 
hormonal therapy
Trans-related 
surgery of any kind
If you check Yes for any service(s) in Column 2, please indicate whether you were able to obtain this service in 
Column 3. If you check No, please indicate the reason(s) you were unable to obtain this service in Column 4 by 
choosing from the options in the list. 
Yes No
NoYes
NoYes
NoYes
NoYes
NoYes












We know this next section takes more time than others in the survey, but we appreciate your effort in 
answering these important questions.  
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
#1
#2
#3
#1
#2
#3
#1
#2
#3
#1
#2
#3
#1
#2
#3
#1
#2
#3
202
Page 18 of 87
Column 1: 
Service Column 2 Column 3 Column 4
In the past 12 
months, have 
you needed this 
service?
If yes, were you able 
to obtain this service?
Use the list of options on page 20 to indicate the top 
reason(s) you were unable to obtain this service
Trans-related 
electrolysis
Trans-related 
speech therapy
HIV or sexually-
transmitted 
infections testing
Sexual health 
information
Pap smears
Breast exams
Mammograms
NoYes
NoYes
NoYes
NoYes
NoYes










Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
NoYes
NoYes




Yes
No
Yes
No
#1
#2
#3
#1
#2
#3
#1
#2
#3
#1
#2
#3
#1
#2
#3
#1
#2
#3
#1
#2
#3
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Column 1: 
Service Column 2 Column 3 Column 4
In the past 12 
months, have 
you needed this 
service?
If yes, were you able 
to obtain this service?
Use the list of options on page 20 to indicate the top 
reason(s) you were unable to obtain this service
Prostate exams
Fertility Services
AIDS service 
organizations
Shelter and hostel
Sexual assault 
centres
Mental health care 
services for 
reasons other than 
being trans
Trans-related 
mental health 
services
NoYes
NoYes
NoYes
NoYes
NoYes










Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
NoYes
NoYes




Yes
No
Yes
No
#1
#2
#3
#1
#2
#3
#1
#2
#3
#1
#2
#3
#1
#2
#3
#1
#2
#3
#1
#2
#3
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Column 1: 
Service Column 2 Column 3 Column 4
In the past 12 
months, have 
you needed this 
service?
If yes, were you able 
to obtain this service?
Use the list below to indicate the  
reason(s) you were unable to obtain this service
Adoption services NoYes Yes
No
 #1
#2
#3
1. I don't know if this service is available in my area 
2. The service is not available in my area 
3. I didn't meet the requirements 
4. The service or program was full 
5. The waiting time was too long  
6. I don't have coverage for this service 
7. I cannot afford to pay for it 
8. I was denied approval for this service  
9. The staff are insensitive or hostile to trans people  
10. Other patients or clients might be insensitive or hostile to me 
11. I have difficulties accepting my own trans status 
12. There were not appropriate bathrooms 
13. This service did not accommodate my disability 
14. There were language problems  
15. I was afraid my immigration status would be revealed 
16. I found these services to be culturally insensitive 
17. The service provider might be racist 
18. I have pre-existing mental health conditions 
19. I have pre-existing physical health concerns 
20. I haven't gotten around to it 
21. I didn't know where to go  
22. I had problems with transportation  
23. I was not able to find child care  
24. I had personal or family responsibilities  
25. I dislike doctors or am afraid of them 
26. There was too much stigma around this service 
27. There is too much stigma because I'm a sex worker 
28. I didn't want my HIV+ status to be revealed 
29. Other (please specify):  
 
205
Page 21 of 87
C6.  While living in Ontario, what is the furthest distance you have ever traveled for trans-related physical or 
mental health care?
C7.  How far did you travel to get to your most recent appointment for trans-related physical or mental health  
         care?
C5. Do you trust in doctor-patient confidentiality when it comes to receiving trans-related care?
Completely
Mostly
Not much
Not at all
Within my city, town or township
To another city or town in Ontario.  How far away by car?
To another province.  Please specify:
To another country.  Please specify:
I have never received trans-related health care.
Hours Minutes
Within my city, town or township
To another city or town in Ontario.  How far away by car?
To another province.  Please specify:
To another country.  Please specify:
I have never received trans-related health care.
Hours Minutes
Liz James 
Liz James is a 2-Spirited Transsexual Warrior Born in Toronto.  A graduate from the school of Hard Knox. 
Having once been a Prostitute, Bank robber, Heroin/Cocaine addict, and thus ending up in Federal Prison for 
5 years. Fast forwarding to the present day: Raven has discovered her First Nation 2-Spirit heritage. 
Obtained Sex re-assignment surgery, and turned over a new leaf. She has returned to school in order to 
better help her community.  Liz is a member of the provincial Community Engagement Team which guides 
the Trans PULSE Project.
206
Page 22 of 87
D. Emergency Care
D1.  Have you ever avoided going to the emergency room when you needed care because you are trans?
Yes
No
I have never needed emergency care
D2.  Have you ever used emergency room services presenting in your felt gender?
Yes
No (skip to Section E)
D3.  For each of the following, has an emergency care provider ever…? (Please check all that apply)
Refused to see you or ended care because you were trans
Used hurtful or insulting language about trans identity or experience
Refused to discuss or address trans-related health concerns
Told you that you were not really trans
Discouraged you from exploring your gender
Told you they don't know enough about trans-related care to provide it
Belittled or ridiculed you for being trans
Thought the gender listed on your ID or forms was a mistake
Refused to examine parts of your body because you're trans
None of the above
D4.  Have you ever had to educate an emergency care provider regarding your needs as a trans person?
Yes, provided a lot of education
Yes, provided some education
Yes, provided a little education
No
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E. Family Medicine
E1.   Do you have a regular family doctor?
Yes (skip to Question E2)
No
E1a.   If no, have you ever tried to get a family doctor and not been able to?
Yes (skip to Question E5)
No (skip to Question E5)
E2.  Does your current family doctor know about your trans identity or experience?
Yes
No
I'm not sure
E3.  How comfortable are you discussing your trans status and trans-specific health care needs with your  
         family doctor? (Please check only ONE response)
Very uncomfortable
Uncomfortable
Comfortable
Very comfortable
E4.  How knowledgeable is your family doctor about trans-specific health care needs? (Please check only ONE   
        response)
Not at all knowledgeable 
Somewhat knowledgeable
Knowledgeable
Very knowledgeable
Very uncomfortable
Uncomfortable
Comfortable
Very comfortable
E5.   How comfortable would you be discussing your trans status and/or trans-related health care needs with  
          a doctor you did not know? (Please check only ONE response)
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Yes
No
E6.  Do you use walk-in clinics as your primary source of health care?
E7.  If yes, how comfortable are you discussing your trans status and/or trans-related health care needs with a   
         doctor at a walk in clinic? (Please check only ONE response)
Very uncomfortable
Uncomfortable
Comfortable
Very comfortable
E8.  For each of the following, has a family doctor ever…? (Please check all that apply)
Refused to see you or ended care because you were trans
Used hurtful or insulting language about trans identity or experience
Refused to discuss or address trans-related health concerns
Told you that you were not really trans
Discouraged you from exploring your gender
Told you they don't know enough about trans-related care to provide it
Belittled or ridiculed you for being trans
Thought the gender listed on your ID or forms was a mistake
Refused to examine parts of your body because you're trans
None of the above
Not applicable, I have never used this service
E9.   Have you ever had to educate a family doctor regarding your needs as a trans person?
Yes, provided a lot of education
Yes, provided some education
Yes, provided a little education
No
 Tyson Purdy-Smith 
Tyson Purdy-Smith is a member of the provincial Community Engagement Team which guides the Trans 
PULSE Project. Tyson is a 21-year-old transman from Halifax, Nova Scotia. He has been a singer all his life 
and an amateur actor since he was 13. He lives in an attic decorated with Les Miserables memorabilia and 
black-and-white abstract art. He likes poofy white shirts and multicoloured hand-knit socks. He really likes 
it when people who've read his bio-blurb offer to buy him bubble tea.
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E10.  For each of the following, has a walk in clinic doctor ever…? (Please check all that apply)
Refused to see you or ended care because you were trans
Used hurtful or insulting language about trans identity or experience
Refused to discuss or address trans-related health concerns 
Told you that you were not really trans
Discouraged you from exploring your gender
Told you they don't know enough about trans-related care to provide it
None of the above
Not applicable, I have never used this service
E11.  Have you ever had to educate a walk-in clinic doctor regarding your needs as a trans person?
Yes, provided a lot of education
Yes, provided some education
Yes, provided a little education
No
Belittled or ridiculed you for being trans
Thought the gender listed on your ID or forms was a mistake
Refused to examine parts of your body because you're trans
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F. General Mental Health Care
People use mental health care services for a variety of reasons.  This section asks only about 
experiences in seeking mental health care for reasons other than your gender identity.  Section G will 
ask about mental health care related to gender identity or transition.
Yes
No (skip to Section G)
F2.  I received mental health care for the following: (Please check all that apply)
Depression
Anxiety disorders (panic attacks, post traumatic stress disorder)
Addictions
Bipolar disorder
Schizophrenia
Borderline personality disorder
Stress
Anger management
Grieving or bereavement
Eating disorders
Relationship issues
Suicidal thoughts
Couples/Relationship counselling
Dissociative identity disorders (e.g. multiple personality disorder)
Other, please specify:
F3.  Who did you see or talk to? (Please check all that apply)
Family doctor or general practitioner
Psychiatrist
Psychologist
Nurse
Social worker or counsellor
Aboriginal Elder
Religious or spiritual leader
Support group
Other, please specify:
F1.   Have you ever used mental health care services for reasons other than being trans, while presenting in  
         your felt gender?
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F4.   For each of the following, when seeing a mental health provider for reasons other than being trans, has a  
         mental health provider ever…? (Please check all that apply)
Refused to see you or ended care because you were trans
Used hurtful or insulting language about trans identity or experience
Refused to discuss or address trans-related health concerns
Told you that you were not really trans
Discouraged you from exploring your gender
Told you they don't know enough about trans-related care to provide it
Belittled or ridiculed you for being trans
Thought the gender listed on your ID or forms was a mistake
None of the above
F5.  When seeing a mental health provider for reasons other than being trans, have you ever had to educate   
         that mental health provider regarding your needs as a trans person?
Yes, provided a lot of education
Yes, provided some education
Yes, provided a little education
No
F6.  In the past 12 months, have you used mental health care services for reasons other than being trans?
Yes
No (skip to Section G)
F7.  Whom did you see or talk to in the past 12 months? (Please check all that apply)
Family doctor or general practitioner
Psychiatrist
Psychologist
Nurse
Social worker or counsellor
Aboriginal Elder
Religious or spiritual leader
Support group
Other, please specify:
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F8.  In the last 12 months, how satisfied were you with your experience(s) with mental health care providers?
Very satisfied
Satisfied
Neither satisfied nor dissatisfied
Dissatisfied
Very dissatisfied
Caleb Nault 
Caleb is a white, 24 year old, queer-identified trans guy who is currently completing his MA in Sociology at 
York University. He is a member of the provincial Community Engagement Team which guides the Trans 
PULSE Project. Caleb comes from a family of truck drivers and loves to travel (by bike during the summer, 
and grudgingly by transit in the winter). His current research interests include the negotiation of trans 
subjectivity and the autobiographical imperative, social determinants of health for trans people, theorizing 
the body, autoethnographic research methods, and anti-psychiatry, madness, and whiteness studies. He 
currently lives in Parkdale with his amazing partner, Megan, and their cat, Chandler.
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G. Trans-related Mental Health Care
G1.  Have you ever used mental health services related to your trans identity or experience? 
 
Yes   
No  (Skip to Section H)
G2.  Whom did you see or talk to? (Please check all that apply) 
 
Family doctor or general practitioner
Psychiatrist
Psychologist
Nurse
Social worker or counsellor
Aboriginal Elder
Religious or spiritual leader
Support group
Other, please specify:
G3.  At what age did you first see a mental health care provider to discuss your trans identity or experience? 
 
G4.    Thinking back to your overall experiences discussing your needs as a trans person with a mental health 
care provider, how satisfied were you with your experience? 
 
Years old
Very satisfied
Satisfied
Equally satisfied and dissatisfied
Dissatisfied
Very dissatisfied
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G5.  Thinking back to your most recent experience discussing your needs as a trans person with a mental health 
care provider, how satisfied were you with your experience? 
 
G6.  For each of the following, when you used mental health care services related to your trans identity, has a 
mental health care provider ever…? (Please check all that apply) 
 
Refused to see you or ended care because you were trans
Used hurtful or insulting language about trans identity or experience
Refused to discuss or address trans-related health concerns
Told you that you were not really trans
Discouraged you from exploring your gender
Told you they don't know enough about trans-related care to provide it
Belittled or ridiculed you for being trans
Thought the gender listed on your ID or forms was a mistake
None of the above
G7.  When using mental health care services related to your trans identity, have you ever had to educate your 
mental health provider regarding your needs as a trans person? 
 
G8.  In the past 12 months, have you used mental health care services related to your trans identity or 
experience? 
 
Very satisfied
Satisfied
Equally satisfied and dissatisfied
Dissatisfied
Very dissatisfied
Yes, provided a lot of education
Yes, provided some education
Yes, provided a little education
No
Yes
No (skip to Section H)
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G9.  Whom did you see or talk to in the past 12 months? (Please check all that apply) 
 
Family doctor or general practitioner
Psychiatrist
Psychologist
Nurse
Social worker or counsellor
Aboriginal Elder
Religious or spiritual leader
Support group
Other, please specify:
Matt Lundie 
Matt is an Ottawa-area FTM who has been involved in the Ottawa queer communities for the past 10 
years and is a member of the GBQ Trans Mens' Working Group. Currently a public servant working in 
an unrelated field, Matt's experience includes facilitating workshops for various community-driven 
initiatives, volunteering for the Ottawa Men's Survey, OASIS (a drop-in centre for street active and at-
risk people), the Ottawa Police Liaison Committee, and the GLBT Cultural Competence Project.
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H. HIV and Sexually Transmitted Infections 
H1. In your lifetime, have you been diagnosed with any of the following?  (Please check all that apply) 
 
Gonorrhoea (the clap)
Chlamydia 
Genital herpes
Syphilis
HPV (Genital or anal warts)
Hepatitis B
Hepatitis C
I have not been diagnosed with any of these
H2. In the past 12 months, have you been diagnosed with any of the following?  (Please check all that apply) 
 
Gonorrhoea (the clap)
Chlamydia
Genital Herpes
Syphilis
HPV (Genital or anal warts)
Hepatitis B
Hepatitis C
I have not been diagnosed with any of these
I'd rather not say
I'd rather not say
Abnormal Pap test (cervical HPV)
Abnormal Pap test (cervical HPV)
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H3.  Have you ever not gotten tested, or delayed getting tested for HIV for any of these reasons? (Please check 
all that apply) 
 
I hadn't had sex recently, so I didn't believe I needed to get tested
I always had safer sex, so I didn't believe I needed to get tested
I felt healthy, so I didn't believe I needed to get tested
I didn't know where to get anonymous testing
I didn't want my partner to know I got tested
I didn't want other people to know I got tested
I was afraid I might be HIV positive
The HIV testing staff are/have been hostile or insensitive to me
I don't believe I'm at risk
I didn't want my insurance company to know my HIV status
I always used clean needles so I didn't believe I needed to get tested
I have delayed getting tested, or not gotten tested for other reasons (please specify): 
H5.  When was your most recent HIV test?  
 
H4.  Have you ever had an HIV test?  
 
It was not important to me to get tested
Yes
No (skip to Question H6)
Less than 6 months ago
6 months to less than 1 year ago
1 to less than 2 years ago
2 or more years ago
Evana Ortigoza  
My name is Evana Ortigoza. I was 
born in Maracaibo, Venezuela on 
January 28 1965. My family sent me 
away at the age of 12 to Spain and I 
studied a marketing degree and 
Ballet from the University of 
Barcelona. When I came to Canada 
in 1994 I danced with the National 
Ballet of Canada for 4 years. I am 
currently an Outreach Worker at The 
519 Community Centre working with 
trans women who are working in the 
sex-trade in downtown Toronto. I 
also help to coordinate the weekly 
Meal Trans Drop-In for low-income 
trans people. I am forever grateful 
for the opportunity to work with 
other trans people and to improve 
my own life. Evana is a member of 
the provincial Community 
Engagement Team which guides the 
Trans PULSE Project.
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H6.  Why have you gone to get an HIV test? (Please check all that apply) 
 
Someone suggested I should be tested
I felt I had unsafe sex
I had sex with someone who I knew was HIV positive
I had sex with someone who I suspected was HIV positive
I shared needles or drug-using equipment
I thought I might have been exposed at work
I just wanted to find out if I was infected or not
It was part of a routine medical check-up, or for hospitalization or surgical procedure
I was feeling sick
I had been sexually assaulted
I had to for life insurance coverage
I had to for immigration
I was concerned I could give HIV to someone
No particular reason
Don't know
Some other reason (please specify):  
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I. HIV-Related Care
I1.   Are you….?
I2.  When did you find out that you are HIV positive?
I3.  Of the following options, which best describes the way you most likely became HIV positive? (Please check 
only ONE response) 
 
I4.  Do you currently have a doctor who regularly treats you for your HIV-related needs? 
 
HIV Positive
HIV Negative (skip to Section J)
I don't know (skip to Section J)
I would rather not say (skip to Section J)
Year Month
I don't know
Unprotected sex
Broken condom or other failed barrier
Sharing needles or other drug-using equipment
Sharing needles while injecting hormones or silicone
Received tainted blood product
Sexually assaulted or raped
Needle stick as a health care worker
Tattoo or piercing
Born with HIV
Other, please specify:
Yes
No
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I5.  For each of the following, has the doctor(s) who provides your HIV care ever…?  (Please check all that apply)
 
Refused to see you or ended care because you were trans
Used hurtful or insulting language about trans identity or experience
Refused to discuss or address trans-related health concerns
Told you that you were not really trans
Discouraged you from exploring your gender
Told you they don't know enough about trans-related care to provide it
Belittled or ridiculed you for being trans
Thought the gender listed on your ID or forms was a mistake
Refused to examine parts of your body because you're trans
None of the above
I have never seen a doctor for HIV-related needs
I6.    Have you ever had to educate the doctor who provides your HIV care regarding your needs as a trans 
person? 
 
I7.  Are you currently taking any medications to treat HIV/AIDS?  
 
I8. Are you currently taking trans-related hormones with your HIV medications? 
I9. Does the doctor who prescribed your HIV medications know you also take hormones?  
 
Yes, provided a lot of education
Yes, provided some education
Yes, provided a little education
No
Yes
No (skip to Section J)
Yes
No (skip to Section J)
Yes
No
I don't know
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I10. Did the doctor discuss any possible interactions between the hormones and the HIV medications, or the 
effects of HIV on hormonal levels in your body?  
 
Yes
No
I don't recall
Catherine Purdie 
Catherine refers to herself as a "grass roots, low key influencer" and takes advantage of every opportunity to 
participate in speaking events to educate the public that transgender people have a lot to offer society. 
Before retiring in October 2007 she worked in senior management at a financial institution where she 
developed a strong background in technology and senior management, and took pride in developing many 
other leaders and leading large projects. She now spends her time actively involved in several GLBT and 
non-GLBT organizations in the Ottawa area and pursuing her hobby of writing and photography. Catherine is 
a member of the Trans PULSE's provincial Community Engagement Team.
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J. Gender-Related Hormones
J1.  What is your primary source of information regarding hormones? 
 
J2.  Do you feel you have enough information about hormones for gender transition or gender confirmation? 
 
J3. Do you have prescription drug coverage of any kind? 
 
J4.  Whether or not you are now taking them, do you have prescription drug coverage for hormones?  
 
Family
Friends
Internet / Websites
Trans community people and organizations
Doctor (GP, Specialist)
Medical Journals 
Other(s), please specify:
Yes
No
Not Sure
I do not need information on hormones
Yes, through the province (Ontario Drug Benefits or Trillium Drug Program)
Yes, through employer- or school-provided insurance
Yes, through parent's insurance
Yes, through private insurance I have purchased
Yes, through having Aboriginal status
Yes, through the military
Yes, through the federal prison system
No
Yes
No
Not sure
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J5. Have you ever tried to get a prescription for hormones and not been able to?  
 
J6.  Have you ever taken hormones for trans-related reasons? 
 
J6a.  If you have never taken hormones, which best describes your situation?  
 
If you have never taken any hormones, please skip to Section K
Yes
No
I have never tried to get a prescription for hormones
Yes (skip to Question J7)
No 
Not planning on taking hormones
Still deciding if taking hormones is right for me
Can't find a doctor to prescribe hormones
Other, please specify:
Devi McCallion  
Devi is an enthused seventeen year old transwoman who's modest, yet lustrous personality doesn't 
particularly shine through the medium of a short bio written in third person. When she's not pretending to be 
the type of person to regularly use the world lustrous, Devi dedicates time to local peer outreach groups and 
fussily contributes to her ever-growing song writing catalogue. After years spent particularly muted as a 
home-schooled youth in a small town, she's doing her best to make up for lost time by propelling herself 
deeply into what she believes to be a more responsible level of social activism.
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J7.  In the following table, please specify whether you have ever taken any of the listed hormones, the 
year you started taking each type of hormone(s), and the total amount of time you have been on each 
hormone, excluding any breaks. 
J8.  From which source(s) have you ever received your hormones? (Please check all that apply) 
 
Family doctor or GP
Specialist (e.g. endocrinologist)
Internet pharmacy 
Friend or relative
Street/strangers
Herbals or supplements
Veterinary sources 
Column 1 Column 2 Column 3 Column 4
Hormones Have you 
ever taken 
the hormone
(s) listed in 
Column 1? 
If you check `yes' for 
any hormone in 
Column 2, please state 
the year you first 
started taking the 
hormone(s)
If you check `yes' for any 
hormone in Column 2, please 
state the total amount of time 
you've been on the  
hormone(s), excluding any 
breaks
Progesterone
Estrogen
Testosterone blockers/ anti-androgens  
Testosterone
Puberty blockers  
Other, please specify: 
 
Other, please specify: 
 







Year
Year
Year
Year
Year
Year
Year
Years Months
Years Months
Years Months
Years Months
Years Months
Years Months
Months
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Other(s), please specify:
Years
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J9.  Do you currently take hormones?  
 
J10.  Which hormone(s) are you currently taking? (Please check all that apply) 
 
Progesterone 
Estrogen
Anti-androgens / Testosterone blockers
Testosterone
Puberty blockers
Other(s), please specify:
J11.  From which source(s) do you currently get your hormones? (Please check all that apply) 
 
Family doctor or GP
Specialist (e.g. endocrinologist)
Internet pharmacy 
Friend or relative
Street/strangers
Herbals or supplements
Veterinary sources
Other(s), please specify:
J12. Have you ever received blood tests to monitor the effect of hormones on your body?
J13. Do you take hormones by injection? 
 
Yes, under medical supervision
Yes, without medical supervision
No (skip to Section K)
Yes, I receive regular blood tests
Yes, but not regularly
No
I'm not sure whether blood tests were done
Yes
No (skip to Section K)
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J14. Where do you get your syringes or needles?  (Check all that apply) 
 
Pharmacy
Doctor's office
Friends
Needle exchange
Street
Other(s), please specify:
J15.  Have you ever been in a situation where you had to use a needle or syringe to inject your hormones that 
had been used before by someone else? 
 
J16.  Do you think you have enough knowledge about how to safely inject hormones? 
 
Yes
No
Don't know
Yes
No
Don't know
227
Page 43 of 87
K. Surgery and Body Modifications
K1.  For each of the following procedures, please indicate which applies to you:
Don't  
want/need Considering Want Have had
Year had or 
started
Number of revisions 
(follow-up surgeries)
Orchiectomy (removal of testicles)
Vaginoplasty (SRS/GRS; making a 
vagina)
Hysterectomy (removal of uterus)
Oophorectomy (removal of ovaries)
Metaoidioplasty (releasing the 
clitoris)
Urethral lengthening
Testicular Implants (creating 
testicles)
Phalloplasty (making a penis) 
Breast Augmentation (making 
breasts bigger)
Breast Reduction (making breasts 
smaller)
Mastectomy or Chest Reconstruction 
(`top surgery')
Facial Surgeries (feminization/
masculinization)
Vocal Chord Surgery (making voice 
higher)
Facial Hair Removal (laser or 
electrolysis)
Adams Apple Shave
Hair Transplants
Other, please specify:
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K3.  Have you ever performed any of the above procedures on yourself? 
 
K3a.  If so, please tell us what you did:
K4.  Have you ever injected silicone? 
 
K5.  In the past 12 months, how many times have you injected silicone? 
 
K6. Have you ever been in a situation where you had to use a needle or syringe to inject silicone that had been 
used before by someone else? 
 
K2.  How much money have you spent out-of-pocket on hormones, silicone and any of the above procedures? 
 
None
$1  to less than $1,000
$1,000 to less than $2,500
$2,500 to less than $5,000
$5,000 to less than $10,000
$10,000 to less than $20,000
$20,000 to less than $50,000
$50,000 to less than $100,000
$100,000 or more 
Yes
No
Yes
No (skip to Section L)
None
1
2
3
4
5
More than 5 times
Yes
No
Don't know
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L. Making Money
L1. Do you currently have any of the following assets?  (Please check all that apply) 
 
Retirement savings (RRSPs, RIFs, or pension from employer)
GICs, stocks, or mutual funds outside of RRSPs
Home you own
Rental property (residential or commercial)
Car that is owned outright
None of the above
Other assets, please specify:
L2. Do you currently have any of the following debts?  (Please check all that apply) 
 
Credit card debt
Line of credit
Mortgage
Loan debt (e.g. car loan, medical loan, student loan)
None of the above
Other, please specify:
L3.  Has being trans affected your credit history? 
 
Yes, for the better
Yes, for the worse
No
Michelle Le-Claire 
Michelle is a trans-activist who is actively involved in fighting for Trans Human Rights. She is the Executive 
elected as Commissioner of Advocacy and Equity on the Board of Directors Executive Committee for the 
Students' Association of George Brown College. It is there that she is earning her SSW diploma as a full 
time student, and has intentions to further her education through attaining her MSW degree. She also co-
facilitates Trans Youth Toronto at The 519, is part of THRIVE!-TS/TG Housing and Employment Program at 
the Fred Victor Centre, a Programming Committee Member for Egale's Gender Variance Conference, and 
volunteers for many other not-for-profit organizations. Her key interests are fighting oppression and 
advocating for trans communities, in particularly, gender variant and/or trans youth. Michelle is a member 
of Trans PULSE's provincial Community Engagement Team, helping to guide the Project.
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L4. Which of the following describes your employment situation? (Check all that apply) 
 
Employed in a permanent full-time position (35 hours or more per week)
Employed in a permanent part-time position (less than 35 hours per week)
Employed on contract full-time (35 hours or more per week as a temporary or casual worker)
Employed on contract part-time (less than 35 hours per week as a temporary or casual worker)
Self-employed full-time (35 hours or more per week)
Self-employed part-time (less than 35 hours per week)
On leave from work
Not employed (not a student, retired, or disabled)
Student
Retired
Receiving disability (ODSP)
Receiving Employment Insurance (EI)
Receiving General Social Assistance (welfare or workfare)
L5. About how many hours a week do you usually work at your job or business? If you usually work extra hours, 
paid or unpaid, please include these hours.  
 
L6. How many jobs do you currently have?   
 
L7. How long have you been in your current job (if you work multiple jobs, respond based on the longest job you 
currently have)?   
 
Hours
Number of jobs
Months Years
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L8. What type of paid work do you do right now (Check all that apply)?  
 
No paid work
Accounting/Finance/Insurance/Banking
Administrative/Clerical
Aesthetics/Hair/Make-up
Agriculture, Forestry, & Fishing
Arts, Entertainment, and Media
Automotive/Motor Vehicle
Building Construction/Skilled Trades
Business
Computer Services/Hardware/Software
Consulting Services
Counselling 
Creative/Design
Customer Support/Client Care
Drug Trade
Editorial/Writing
Education/Training
Electronics
Engineering
Escort work
Food Services/Hospitality/Travel/Tourism
Government and Policy
Healthcare/medicine
Legal services/law
Manufacturing
Military
Nonprofit
Personal Care and Service
Printing/Editing/Writing
Research/academia
Retail/Sales
Science/biotechnology
Sex Work 
Sports and Recreation/Fitness
Other, please specify:
232
Page 48 of 87
L9. How satisfied are you with your job or main activity?  
 
L10. Right now, do you work in the field/job you would like to be working in?  
 
L10a. Why are you not working in the field/job you would like to be working in? (Please check all 
 that apply) 
 
There are no jobs available in my field
Do not have necessary education/training
Education/training earned in another country is not recognized as equivalent in Canada
Fear of discrimination for being trans
Previous experiences of discrimination for being trans
Employers do not accommodate my disability 
Disability 
Other, please specify: 
L10b. What is the one main reason why you are not working in the field/job you would like to be   
             working in?
Very satisfied
Satisfied
Neither satisfied nor dissatisfied
Dissatisfied
Very dissatisfied
Yes (skip to Question L11)
No
There are no jobs available in my field
Do not have necessary education/training
Education/training earned in another country is not recognized as equivalent in Canada
Fear of discrimination for being trans
Previous experiences of discrimination for being trans
Other forms of discrimination
Employers do not accommodate my disability 
Other, please specify: 
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L11.  Have you ever done sex work or exchanged sex for money or other resources (e.g. shelter, drugs, food)? 
 
L11a.  If yes, what were your reasons for doing so? (Please check all that apply) 
 
It paid well
It was necessary to pay for living expenses
It was necessary to pay for transition-related expenses (e.g. surgery, hormones)
To be part of a community
To affirm my gender identity
It made me feel attractive
None of the above
L11b. How would you describe your experience with sex work? 
 
L12.  When applying for a job, have you ever not provided references from a previous job because of your trans 
identity or experience? 
 
L13.  Have you ever declined a job offer due to a lack of a trans-positive work environment?
Yes
No (skip to Question L12)
Entirely positive
Mostly positive
An equal mix of positive and negative
Mostly negative
Entirely negative
Yes
No
Yes
No
L14. Do you believe you've ever been turned down for a job because you are trans? 
 
Yes
No
Unsure
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L15.  If you medically and/or socially transitioned in the workplace, how often were your employers and 
coworkers accepting during this period of time? 
 
L16. Have you ever been fired, constructively dismissed, or laid off because of your trans identity or gender 
expression? 
 
Always
Very frequently
Occasionally
About half the time
Rarely
Very rarely
Never
Yes
No
Not sure
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L17.   Please rank your monthly expenses from most important to least important, with 1 being the most 
important.  
  
 Designate all items that are not expenses for you because you don't have them or they are paid by 
someone else as not applicable ("NA"):
Rent or home payment 
Groceries
Hormones
Other prescription drugs
Alcohol and/or recreational drugs
Saving for surgery
Transportation-related expenses
Hair removal
Saving money for education
Paying off money borrowed for education (student loan)
Paying off money borrowed for surgery or other gender-related medical care
Paying off other debt
Clothing
Vacation
Entertainment
Providing for my children
Sending money home to family
Saving money for retirement
Saving money for other purposes
Legal expenses
Counselling
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M. Living and Eating
M1. Which of the following statements best describes the food eaten in your household in the past 12 months? (Choose ONE) 
M2.  Was that often true, sometimes true, or never true in the past 12 months?  
 
M3.  Which best describes your current housing situation?  
 
You and your household always had enough of the kinds of food you wanted to eat
You and your household had enough to eat, but not always the kinds of food you wanted
Sometimes you and your household did not have enough to eat
Often you and your household didn't have enough to eat
Don't know
Often true
Sometimes true
Never true
Don't know
I own a house
I rent a house
I own an apartment or condo
I rent an apartment or condo
I live in housing on a Reserve
I live on a Metis Settlement
I live in an Inuit Hamlet
I live in subsidized or public housing
I live in a group home
I live in a long-term care facility
I live with my parents or family
I live in a seniors home or retirement home
I live in a boarding school
I live in a student residence
I live in a self-contained room in a motel or boarding house
I couch-surf or stay at a friend's house
I am squatting
I live on the street
I live in a rehabilitation facility
I live in military housing
I live in a prison
Other, please specify:
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M4.  In the past 5 years, how many different places have you lived?   
 
M5.  How long have you been in your current dwelling? 
 
M6. Have you ever moved to a different city or town for your own safety because you were trans? 
 
M7. Have you ever moved to a different city or town to be closer to trans-related services you needed? 
 
M8.  Have you ever been asked or told to leave your parent's or other guardian's house (where you were   
          living) for being trans? 
 
M9.  Have you ever been asked or told to leave your home by your spouse or partner (who you were living with) 
for being trans? 
 
M10.  Has being trans affected your rental history? 
 
Number of places
Years Months
Yes
No
Yes
No
Yes
No
I was not out as trans while living with parents/family
Yes
No
I have never been out as trans while living with a partner or spouse
Yes, for the better
Yes, for the worse
No
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M11.  Considering your income, how difficult is it for you to meet your monthly housing-related costs?  Housing 
costs include rent, mortgage, property taxes and utilities only. 
 
M12.  Have you ever lost housing or a housing opportunity due to your trans status or gender expression?
M13. Are you worried that you will lose your housing because of your trans status or gender expression? 
 
M14.  Have you ever accessed a shelter as a trans person? 
 
M14a.  As a trans person, did you feel safe at the shelter? 
 
M14b.  At the shelter, did you experience hostility or verbal harassment because of your trans status 
or gender expression? 
 
M14c.  At the shelter, did you experience physical harassment or violence because of your trans 
status or gender expression? 
 
Very difficult
Fairly difficult
A little difficult
Not difficult at all
I don't know
I'd rather not say
Yes
No
Unsure
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No (skip to Question M15)
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M15.  Have you ever been refused access to a shelter because of your trans status or gender expression? 
 
M16.  Have you avoided accessing a shelter due to transphobia? 
 
These next few questions are about your history of homelessness.  By homeless we mean that you 
don't have a fixed, regular, and adequate night-time residence or you stay in a shelter, welfare hotel, 
transitional program or any place not usually used for sleeping, such as streets, cars, movie theatres, 
abandoned buildings, etc.  People living in jail are not considered homeless.
M17.  Based on the above definition, have you ever been homeless while presenting in your felt gender? 
 
M18.  Are you currently homeless?  
 
M19.  Thinking about your most recent or current episode of homelessness, where did you sleep or where are 
you sleeping? 
 
Yes
No (skip to Question M20)
Yes
No
In a shelter 
Outside on the street
In a motel or hotel
Outside in parks
With a friend or friends 
In a car
With a family member 
Other, please specify: 
Yes
No
I have never attempted to access a shelter
Yes
No
I have never attempted to access a shelter
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M20.  Have you ever spent any time in a jail, presenting as your felt gender? 
 
M20a.  Were you in a jail appropriate to your felt gender? 
 
M20b.  As a trans person, did you usually feel safe in jail? 
 
M20c.  In jail, did you experience hostility or verbal harassment in jail because of your trans status or 
gender expression? 
 
M20d.  In jail, did you experience physical harassment or violence because of your trans status or 
gender expression? 
 
M21.  In the past twelve months, have you spent any time in a jail?
Yes, both federal and provincial
Yes, federal
Yes, provincial
No (skip to Section N)
Yes
No
Some of the time
Yes, both federal and provincial
Yes, federal
Yes, provincial
No
Yes
No
Yes
No
Yes
No
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N. Your Life Experiences
Next are some questions about the support that is available to you.
N1.   About how many close friends and close relatives do you have, that is, people you feel at ease with and  
          can talk to about what is on your mind?
Number of close friends
N2. How often is each of the following kinds of support available to you if you need it:
None of 
the time
A little of 
the time
Some of 
the time
Most of the 
time
All of the 
time
Someone to help you if you were confined to bed?
Someone you can count on to listen to you when you 
need to talk?
Someone to give you advice about a crisis?
Someone to take you to the doctor if you needed it?
Someone who shows you love and affection?
Someone to have a good time with?
Someone to give you information in order to help you 
understand a situation?
Someone to confide in or talk to about yourself or your 
problems?
Someone who hugs you?
Someone to get together with for relaxation?
Someone to prepare your meals if you were unable to 
do it yourself?
Someone whose advice you really want?
Someone to do things with to help you get your mind 
off things?
Someone to help with daily chores if you were sick?
Someone to share your most private worries and fears 
with?
Someone to turn to for suggestions about how to deal 
with a personal problem?
Someone to do something enjoyable with?
Someone who understands your problems?
Someone to love you and make you feel wanted?
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N3. How often do people you encounter perceive you as a person of colour?
Always
Very frequently
Occasionally
About half the time
Rarely
Very rarely
Never
N4. For each of the following, please indicate how often you've had this experience.
N5.  How accepting of ethno-racial diversity is the trans community?
Completely accepting
Mostly accepting
Somewhat accepting
Slightly accepting
Not at all accepting
Never Once or 
twice
Sometimes Many times
1. As you were growing up, how often were made fun of or called 
names because of your race or ethnicity?
2. As you were growing up, how often were you hit or beaten up 
because of your race or ethnicity?
3. As an adult, how often were you made fun of or called names 
because of your race or ethnicity?
4. How often were you treated rudely or unfairly because of your 
race or ethnicity? 
5. How often have you experienced some form of police harassment 
because of your race or ethnicity?  
6. How often have you been turned down for a job because of your 
race or ethnicity?  
7. How often have been uncomfortable in trans spaces because of 
your race or ethnicity?
8. How often have had difficulty finding lovers because of your race 
or ethnicity?
9. How often have you been objectified sexually because of your 
race or ethnicity?
10. In sexual relationships, how often do you find that partners pay 
more attention to your race or ethnicity than to who you are as a 
person? 
243
Page 59 of 87
N6.   How accepting of gender diversity is your ethno-racial community?
Completely accepting
Mostly accepting
Somewhat accepting
Slightly accepting
Not at all accepting
N7. How often do people you encounter know you are trans without being told so?
Always
Very frequently
Occasionally
About half the time
Rarely
Very rarely
Never
N8.  In general, do you want people to know you're trans without being told?
Yes
No
Don't care
N9. Never Once or 
Twice
Sometimes Many times
How often have you been made fun of or called names for being trans?
How often have you been hit or beaten up for being trans?
How often have you heard that trans people are not normal? 
How often have you been objectified or fetishized sexually because 
you're trans?
How often have you felt that being trans hurt and embarrassed your 
family?
How often have you had to try to pass as non-trans to be accepted? 
How often do you suspect you have been turned down for a job 
because of your trans identity?
How often have you had to move away from your family or friends 
because you're trans? 
How often have you experienced some form of police harassment for 
being trans? 
How often do you worry about growing old alone?
How often do you fear you will die young?
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Questions N10 to N15 are intended for those who have begun social transition or re living in their felt 
gender.  If this does not apply to you, please skip to Question N16.
N10.   In general, how supportive of your gender identity or expression are the following people? (Please  
             check one for each)
N11.  Since starting your transition and/or coming out as trans, has the number of people you would call  
           "close friends"…?
Increased a lot
Increased somewhat
Stayed about the same
Decreased somewhat
Decreased a lot
Not at all 
supportive
Not very 
supportive
Somewhat 
supportive
Very 
supportive
Not 
applicable 
My parent(s)
My sibling(s)
My spouse(s) or partner(s)
My child(ren)
My extended family
My roommates
My trans friends
My non-trans friends
My church/temple/mosque
My cultural community
My co-workers
My employer
My supervisor/boss
My teachers
My school
My classmates
N12.  Since transitioning or identifying as trans, has your quality of life...? (please check only one)
Gotten a lot better
Gotten somewhat better
Stayed the same
Gotten somewhat worse
Gotten a lot worse
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N13.  Have you ever experienced the following because you're trans or because of your gender expression? 
(Please check all that apply)
Silent harassment (e.g. being stared at, being whispered about)
Verbal harassment 
Physical intimidation and threats
Physical violence (e.g. being hit, kicked or punched)
Sexual harassment (e.g. cat calling, being propositioned)
Sexual assault (e.g. unwanted sexual touching or sexual activity)
N14. If you experienced physical violence and/or sexual assaults, did you report the incident to the police?
N15.  Have you ever avoided any of the following situations because of a fear of being harassed, being read as  
            trans, or being outed? (please check all that apply)
Public transit 
Grocery store or pharmacy
Malls or clothing stores
Travelling abroad
Clubs or social groups
Gyms
Church/synagogue/temple or other religious institution
Public washrooms
Public spaces (e.g. parks)
Restaurants or bars
Cultural or community centres
None of the above
Schools
Treanor Mahood-Greer 
Treanor has many life experiences: 
per was a pig farmer, a prospector 
and now a social worker with a 
master's degree. Per is also an artist 
and an activist who maintains hir 
self-efficacy and balance by having 
JOHN WAYNE and Johnny Cash in hir 
life. Per attempts to help people 
understand gender theory through a 
trans-spiritual lens, by bringing 
together per's experiences from 
working in the bush, per's love of art 
and nature, and spirituality, and hir 
transgendered status. Per wants to 
create praxis, which becomes 
informed action not just dialogue in 
order to make a difference in this 
gendered world. Treanor is a 
member of the Community 
Engagement Team which guides the 
Trans PULSE Project.
Yes
No
I have never experienced physical violence and/or sexual assaults
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If you have begun or completed a transition or come out as your felt gender, skip to N21.
N16.     If you have not transitioned or come out, how supportive of your gender identity or expression do 
               you expect the following people will be? (Please check one for each)
N17.    After you begin your transition or come out as trans, do you expect the number of people you would  
              call "close friends" to…?
Increase a lot
Increase somewhat
Stay about the same
Decrease somewhat
Decrease a lot
Not at all 
supportive
Not very 
supportive
Somewhat 
supportive
Very 
supportive
Not 
applicable 
My parent(s)
My sibling(s)
My spouse(s) or partner(s)
My child(ren)
My extended family
My roommates
My trans friends
My non-trans friends
My church/temple/mosque
My cultural community
My co-workers
My employer
My supervisor/boss
My teachers
My school
My classmates
N18.  After you begin your transition or come out as trans, do you expect your quality of life will…?
Get a lot better
Get somewhat better
Stay the same
Get somewhat worse
Get a lot worse
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N19.  Do you expect that you will experience the following because you're trans or because of your gender 
expression?  (Check all that apply)
Silent harassment (e.g. being stared at, being whispered about) 
Verbal harassment
Physical intimidation and threats
Physical violence (e.g. being hit, kicked or punched)
Sexual harassment (e.g. cat calling, being propositioned)
Sexual assault (e.g. unwanted sexual touching or sexual activity)
N20.  Do you expect that you will avoid any of the following situations because of a fear of being harassed, 
being read as trans, or being outed? (please check all that apply)
Public transit
Grocery store or pharmacy
Malls or clothing stores
Schools
Travelling abroad
Clubs or social groups
Gyms
Church/synagogue/temple or other religious institution
Public washrooms
Public spaces (e.g. parks)
Restaurants or bars
Cultural or community centres
None of the above
Silent harassment (e.g. being stared at, being whispered about)
N21.  Do you personally know of other trans people who have experienced the following because they're trans or 
because of their gender expression? (please check all that apply)
Verbal harassment
Physical intimidation and threats
Physical violence (e.g. being hit, kicked or punched)
Sexual harassment (e.g. cat calling, being propositioned)
Sexual assault (e.g. unwanted sexual touching or sexual activity)
Committed suicide
Been killed
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N22. How would you describe your sense of belonging to your local community?
Very strong
Somewhat strong
Somewhat weak
Very weak
N23. How important is having a strong `trans community' to you?
Very important
Somewhat important
Neutral
Not too important
Not important at all
N24. Are you a member of any voluntary organizations or associations?
Trans or LGBT 
Organization
Other 
organization
No
School groups
Religious social groups
Community centers
Support groups
Ethnic or cultural associations
Social, civic or fraternal clubs
Other groups 
N25. How often did you participate in meetings or activities of these groups in the past 12 months?  (If you 
belong to many, just think of the ones in which you are most active)
At least once a week
At least once a month
At least 3 or 4 times a year
At least once a year
Not at all
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The following questions relate to the sensitive issues of childhood sexual, physical and emotional 
abuse.  If you need to speak to someone immediately regarding your childhood experiences, please 
contact the Abuse Victim Hotline at 1-877-448-8678.  
  
These next questions are about experiences before age 16. If you've had any such experiences, they 
may be difficult to discuss and we appreciate your willingness to answer these questions. 
N26.  Before age 16, did you ever experience something sexual that you did not want, that felt inappropriate,  
           or was at any time perceived as hurtful?  Unwanted sexual experiences could include such things as  
           watching someone having sex, touching someone or having them touch you sexually, or some other  
           type of sexual activity including oral, anal, or vaginal intercourse or mutual masturbation.
Yes
No (skip to Question N27)
Don't know (skip to Question N27)
I'd rather not answer (skip to Question N27)
N26a.  In the above experience(s), what was the relationship of the person(s) to you? 
N26b. How old were you the first time this happened? 
Years old
N27.   Before age 16, were you ever pushed, grabbed, shoved, kicked, punched or physically attacked in some 
other way? 
Yes
No (skip to Question N28)
Don't know (skip to Question N28)
I'd rather not answer (skip to Question N28)
N27a. In the above experience(s), what was the relationship of the person(s) to you? 
N27b.  How old were you the first time this happened to you?
Years old
250
Page 66 of 87
N28.   Before age 16, were you shamed, belittled, humiliated, or emotionally manipulated?
Yes
No (skip to Section O)
Don't know (skip to Section O)
I'd rather not say (skip to Section O)
N28a. In the above experience(s), what was the relationship of the person(s) to you?
N28b.  How old were you the first time this happened to you?
Years old
Adrian Edgar 
Adrian is a transguy in med school with a background in cross-cultural health, ethics, and Native studies. 
He does a lot of health activism but enjoys 'Peace through Health' and queer/trans health advocacy the 
most. Adrian worked on the Transgender Health Program's trans health survey in Vancouver last summer, 
and volunteered with Camp Ten Oaks for queer kids and kids with queer families the two summers before 
that. He is strongly committed to increasing community-based health services for Aboriginal people and 
Nations, and people in conflict with the law. Adrian is going to be a palliative care doctor and will work to 
increase understanding and respect for the needs and dignity of trans people at the end of their lives.
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O.  Parenting
O1.  Would you like to have or adopt a child in the future?
Yes
No
Undecided/Unsure
O2.  Before medically transitioning, did your health care provider discuss the possibility of retaining sperm, eggs, or fertilized 
embryos for future fertility treatments?
Yes
No
This does not apply to me
O3.  Are you a parent, whatever this means to you?
Yes
No (skip to Section P)
O4.  Which of the following describe your relationship to your children? (Check all that apply)
I am a step parent
I am a biological parent
I am an adoptive parent
I am a foster parent
I am an intentional non-biological parent
I am partnered with a biological parent of the child(ren)
I am partnered with a step parent of the child(ren)
I am partnered with an adoptive parent of the child(ren)
I am partnered with a foster parent of the child(ren)
I am partnered with an intentional non-biological parent of the child(ren)
Other, please specify:
O5.  Which of the following describes the legal custody status of your children?
I have sole custody
I have shared custody
I am an access parent
I am a supervised access parent
I have no legal access to my children
My children are adults
Other, please specify:
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O6.  Have you ever lost or had custody reduced due to being trans?
Yes, lost custody
Yes, had custody reduced
No
O7.  How satisfied are you with your current custody arrangement?
Completely satisfied
Mostly satisfied
Mostly dissatisfied
Completely dissatisfied
O8.  Do you see your children less due to being trans?
Yes
No
Unsure
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P. Sexual Activity and Sexual Health
In this section, we'd like to ask you questions about sex, specifically, who you're having sex with, what types of 
sex you're having, if any, and how you feel about your sex life and sexuality.  We understand that these can be 
sensitive topics but we wanted to include these questions because sex and relationships can be important parts 
of our lives and can have a big impact on how we feel about ourselves.   
  
We're asking you to please recall your sexual experiences over the last year and your lifetime.  By “sex partners,” 
please include everyone you've had sexual contact with, even once, including anal, oral, or genital sex. 
P1.  Over your lifetime, how many sex partners have you had?
Number of people
I have not yet had sex (skip to Section Q)
P2. In your lifetime, who have your sex partners been? (Please check all that apply)
Trans men
Non-trans men
Trans women
Non-trans women
Genderqueer persons
Unknown
Other, please specify: 
P3.  In the past 12 months, how many sex partners have you had?
Number of people
I have not had sex in the past 12 months 
P4. In the past 12 months, who have your partners been? (Please check all that apply)
Trans men
Non-trans men
Trans women
Non-trans women
Genderqueer persons
Unknown
Other, please specify:
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We all have different ways we talk about our bodies, and different words to refer to our tender parts. The 
following questions ask about your sexual experiences in the past 12 months.  We will use this information 
responsibly. Whatever you're doing, we hope you're having a good time! 
  
Since we cannot make assumptions about body parts, we won't.  As a result, questions ask specifically 
about body parts, fluids and behaviours.  If you are unwilling to share this information, please skip to 
Question P11.
P5.  In the past 12 months, have you received oral sex from anyone?
Yes
No  (skip to Question P6)
P5a.  In the past 12 months, while receiving oral sex, how often did your partner(s) get your sex fluids 
or menstrual blood in their mouth(s)? 
Every time
Most times
About half the time 
Less than half the time 
Never 
P5b. Who was your partner(s) in this activity? (Please check all that apply) 
Spouse/long-term lover
Regular sex partner 
One time or occasional sex partner 
Regular partner who I pay (cash, drugs, shelter) for sex
Regular partner who pays me (cash, drugs, shelter) for sex
One time or occasional partner who I pay (cash, drugs, shelter) for sex
One time or occasional partner who pays me (cash, drugs, shelter) for sex 
P6.  In the past 12 months, have you given anyone oral sex?
Yes
No  (skip to Question P7)
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P6a.  In the past 12 months, while performing oral sex, how often did you get sex fluids or menstrual 
blood in your mouth?
Every time
Most times
About half the time 
Less than half the time 
Never 
P6b.  Who was your partner(s) in this activity? (check all that apply)
Spouse/long-term lover
Regular sex partner
One time or occasional sex partner
Regular partner who I pay (cash, drugs, shelter) for sex
Regular partner who pays me (cash, drugs, shelter) for sex
One time or occasional partner who I pay (cash, drugs, shelter) for sex
One time or occasional partner who pays me (cash, drugs, shelter) for sex
P7.   In the past 12 months, have you been the receptive partner in anal sex?
Yes
No  (skip to Question P8)
P7a.  Which of the following did your partner(s) use for penetration? (Check all that apply)
Flesh genitals
Silicone or latex
Fingers or hands 
P7b.  In the past 12 months, while receiving anal sex, how often did your partner(s) ejaculate inside 
        you (without a condom)?
Every time
Most times
About half the time 
Less than half the time 
Never 
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P7c.  Who was your partner(s) in this activity? (Check all that apply)
Spouse/long-term lover
Regular sex partner
One time or occasional sex partner
Regular partner who I pay (cash, drugs, shelter) for sex
Regular partner who pays me (cash, drugs, shelter) for sex
One time or occasional partner who I pay (cash, drugs, shelter) for sex
One time or occasional partner who pays me (cash, drugs, shelter) for sex
P8.    In the past 12 months, have you been the insertive partner in anal sex?
Yes
No  (skip to Question P9)
P8a.  Which of the following did you use for penetration? (check all that apply)
Flesh genitals
Silicone or latex
Fingers or hands 
P8b.  In the past 12 months, as the insertive partner in anal sex, how often did you ejaculate inside 
         your partner's ass (without a condom)?
Every time
Most times
About half the time 
Less than half the time 
Never 
P8c.  Who was your partner(s) in this activity? (please check all that apply)
Spouse/long-term lover
Regular sex partner
One time or occasional sex partner
Regular partner who I pay (cash, drugs, shelter) for sex
Regular partner who pays me (cash, drugs, shelter) for sex
One time or occasional partner who I pay (cash, drugs, shelter) for sex
One time or occasional partner who pays me (cash, drugs, shelter) for sex
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P9.   In the past 12 months, have you been the receptive partner in genital sex (i.e. vaginal or front hole sex)?
Yes
No  (skip to Question P10)
P9a.  Which of the following did your partner(s) use for penetration? (check all that apply)
Flesh genitals
Silicone or latex
Fingers or hands 
P9b. In the past 12 months, while being the receptive partner in genital sex, how often did your partner 
ejaculate inside you (without a condom)?
Every time
Most times
About half the time 
Less than half the time 
Never 
P9c.  Who was your partner(s) in this activity? (please check all that apply)
Spouse/long-term lover
Regular sex partner
One time or occasional sex partner
Regular partner who I pay (cash, drugs, shelter) for sex
Regular partner who pays me (cash, drugs, shelter) for sex
One time or occasional partner who I pay (cash, drugs, shelter) for sex
One time or occasional partner who pays me (cash, drugs, shelter) for sex
P10.  In the past 12 months, have you been the insertive partner in genital sex (i.e. vaginal or front hole sex)? 
Yes
No  (skip to Question P11)
P10a.  Which of the following did you use for penetration? (please check all that apply) 
Flesh genitals
Silicone or latex
Fingers or hands 
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P10b.  In the past 12 months, while being the insertive partner in genital sex, how often did you ejaculate 
inside your partner (without a condom)?
Every time
Most times
About half the time 
Less than half the time 
Never 
P10c.  Who was your partner(s) in this activity? (please check all that apply)
Spouse/long-term lover
Regular sex partner
One time or occasional sex partner
Regular partner who I pay (cash, drugs, shelter) for sex
Regular partner who pays me (cash, drugs, shelter) for sex
One time or occasional partner who I pay (cash, drugs, shelter) for sex
One time or occasional partner who pays me (cash, drugs, shelter) for sex
P11.  In the past 12 months, have you ever had sex while drunk or high?
Yes
No
P12.  Do you have a spouse or long term sexual partner?
Yes
No  (skip to Question P13)
P12a.  How often do you and your spouse or long-term sexual partner use condoms or other protective   
            barriers (dental dam, latex glove, plastic wrap) during sex that involves sex fluids? Check ONE  
            only: 
Always
Most of the time
Sometimes 
Rarely 
Never 
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P12b.  Has your spouse or long-term sex partner been tested for HIV since their last risk activity? 
P12c.  If your spouse or long-term sex partner has been tested for HIV, they are: 
P12d.  Has your spouse or long-term sex partner been tested for other sexually transmitted infections   
             (such as gonorrhea and chlamydia) since their last risk activity? 
P13. When you think about using protection with a partner (for example, a condom, dental dam, glove, or plastic 
wrap), how certain are you that you could use protection in the following scenarios?   A `7' means that 
you're absolutely certain you could do what the question asks; a `1' means you're absolutely certain that 
you couldn't do what the question asks. 
Not at all 
Certain 
1
  
  
2
  
  
3
  
  
4
  
  
5
  
  
6
Absolutely 
Certain 
7
I can ask a new partner to use a protective barrier 
I can ask a partner I haven't been using protective barriers 
with to start using them
I can refuse sex when I don't have a protective barrier 
available
I can get a partner to use a protective barrier, even if I'm 
drunk or high
I can get a partner to use a protective barrier, even if they 
don't want to.
I can ask a partner who truly sees me as the gender I know 
myself to be to use a protective barrier
I can ask a non-trans partner to use a protective barrier 
I can ask a trans partner to use a protective barrier 
The same HIV status than I am
A different HIV status than I am
I don't know as I don't know what the results of their test were
I don't know as I haven't been tested
I don't want to say
Not applicable
Yes
No
I'm not sure
Not applicable
Yes
No
I'm not sure
Not applicable
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P14. Please read each item and decide to what extent it is characteristic of you. Give each item a rating of how 
much it applies to you by using the following scale:
P15. When I think about having sex, I worry… 
Not at all Slightly Somewhat Moderately Very
I feel anxious when I think about the sexual 
aspects of my life.
I worry about the sexual aspects of my life.
Thinking about the sexual aspects of my life often 
leaves me with an uneasy feeling.
I am satisfied with the status of my own sexual 
fulfillment.
The sexual aspects of my life are personally 
gratifying to me.
The sexual aspects of my life are satisfactory, 
compared to most people's.
I am satisfied with the sexual aspects of my life.
I am satisfied with the way my sexual needs are 
currently being met.
I am afraid of becoming sexually involved with 
another person.
I have a fear of sexual relationships.
I am fearful of engaging in sexual activity.
I don't have much fear about engaging in sex.
Not at all Slightly Somewhat Moderately Very
That other people think my body is unattractive 
That there are very few people who would want to 
have sex with me
About my physical safety
About feeling ashamed about my body
That once I'm naked, people will not see me as 
the gender I am
That people only want to have sex with me 
because I'm trans
That I can't have the sex I want until I have  
a(nother) surgery 
P16.  If you have transitioned or come out as trans, has the quality of your sex life changed?
Yes, for the better
Yes, for the worse
No, it has not changed 
Not applicable 
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Q. Emotional Well-being
Q1.  In general, would you say your mental health is…?    
Excellent
Very good
Good
Fair
Poor
I don't know 
Q2.  How satisfied are you with your life in general?   
Q3.  Thinking about the amount of stress in your life, would you say that most days are…? 
Very satisfied 
Satisfied 
Neither satisfied nor dissatisfied  
Dissatisfied 
Very dissatisfied 
I don't know 
Not at all stressful  
Not very stressful  
A bit stressful   
Quite a bit stressful  
Extremely stressful  
I don't know 
Q4.  Have you ever been diagnosed with any of the following:
Anxiety disorders (e.g. panic attacks, post-traumatic stress disorder)
Schizophrenia
Bipolar disorder
Major depression
Dissociative identity disorders (multiple personality disorder)
Borderline personality disorder
Other major mental health disorder, please specify:
None of the above
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Q5.  Have you ever been diagnosed with any of the following:
Anorexia nervosa 
Bulimia nervosa
Exercise bulimia
Binge eating disorder 
None of the above 
Q6.  Below is a list of the ways you might have felt or behaved. Please tell us how often you have felt this way 
during the past week. 
Rarely or 
none of the 
time 
(less than 
1 day)
Some or a 
little of the 
time (1-2 
days)
Occasionally 
or a 
moderate 
amount of 
time 
(3-4 days)
Most or all 
of 
the time 
(5-7 
days)
1. I was bothered by things that usually don't bother me.
2. I did not feel like eating; my appetite was poor.
3. I felt that I could not shake off the blues even with help 
from my family or friends.
4. I felt I was just as good as other people.
5. I had trouble keeping my mind on what I was doing.
6. I felt depressed.
7. I felt that everything I did was an effort.
8. I felt hopeful about the future.
9. I thought my life had been a failure.
10. I felt fearful.
11. My sleep was restless.
12. I was happy.
13. I talked less than usual.
14. I felt lonely.
15. People were unfriendly.
16. I enjoyed life.
17. I had crying spells.
18. I felt sad.
19. I felt that people dislike me.
20. I could not get “going.”
During the past week
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Q7.  How much do you agree with the following statements?
Strongly 
Agree Agree Disagree
Strongly 
Disagree
On the whole, I am satisfied with myself.
At times, I think I am no good at all.
I feel that I have a number of good qualities.
I am able to do things as well as most other people.
I feel I do not have much to be proud of. 
I certainly feel useless at times.
I'm a person of worth, at least on an equal plane with others.
I wish I could have more respect for myself.
All in all, I am inclined to feel that I am a failure.
I take a positive attitude toward myself.
The following questions relate to the sensitive issue of suicide.  If you need to 
speak to someone immediately regarding suicide, please contact the National 
Suicide Prevention Lifeline at 1-800-273-8255.
Q8.  Have you ever seriously considered committing suicide or taking your own life?  
Yes
No (skip to Section R)  
Q8a.  If yes, was this related to your being trans?
Yes
No 
Q8b.  If yes, has this happened in the past 12 months? 
Yes
No 
Q9.  Have you ever attempted to commit suicide or tried taking your own life? 
Yes
No (skip to Section R)  
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Q9a.  If yes, did this happen in the past 12 months? 
Yes
No 
Q9b.  Did you see or talk to a health professional following your attempt to commit suicide? 
Yes
No 
Q9c.  How old were you when you first attempted suicide or tried taking your own life? 
Years Old
Mason McColl 
  
Mason is a 22-year old 
fluid transmasculine 
queer radical living in 
Peterborough, who is 
actively involved in 
gender politics, anti-
poverty work and sex-
positive activism. 
Mason works as a 
community organizer, 
group builder and 
policy changer. He is 
passionate about 
everything, specifically 
kids, education, 
solidarity, and most of 
all, his dog Lily.
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R. Cigarettes, Drugs and Alcohol
R1. In your lifetime, have you smoked a total of 100 or more cigarettes (about 4 packs)?  
Yes
No (skip to Question R4)  
R2.  At the present time, do you smoke cigarettes daily, occasionally or not at all? 
Daily
Occasionally 
Not at all
R3. Over your life, how long have you smoked in total?
The next few questions ask about your alcohol consumption.   
When we use the word `drink' it means: 
   -  one (1) bottle or can of beer or a glass of draft 
   -  one (1) glass of wine or a wine cooler 
   -  one (1) drink or cocktail with 1 ½  ounces of liquor.
R4.  During the past 12 months, have you had a drink of beer, wine, liquor or any other alcoholic beverage? 
Yes
No (skip to Question R12)  
R5. During the past 12 months, how often did you drink alcoholic beverages? 
Never
Less than once a month 
Once a month 
2 to 3 times a month 
Once a week 
2 to 3 times a week 
4 to 6 times a week 
Every day 
Years Months
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R6. How often in the past 12 months have you had 5 or more drinks on one occasion? 
More than once a week 
Once a week 
2 to 3 times a month 
Once a month 
Less than once a month 
Never
R7. Have you ever felt you should cut down on your drinking?
Yes
No
R8. Have people annoyed you by criticising your drinking?
Yes
No
R9. Have you ever felt bad or guilty about your drinking?
Yes
No
R10. Have you ever had a drink first thing in the morning to steady your nerves or get rid of a hangover?
Yes
No
R11.  Is your current drinking a problem for you?
Yes
Sometimes 
No
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R12.  In the past 12 months, which of the following have you used? (Please check all that apply) 
Marijuana or hashish 
Poppers or nitrites, including ampules 
Crack 
Cocaine
Crystal meth
Other amphetamine
PCP (angel dust)
Special K 
GHB (G)
LSD (acid)
Opium
Heroin
Ecstasy
Prescription narcotics, other than for medical use (Percocet, Oxycontin)
Other, please specify:
None of the above    (skip to Section S) 
R13.   Is your current drug use a problem for you?
Yes
Sometimes 
No
R14.  Overall, has this experience of using drugs been: 
Completely positive 
Mostly positive 
Equally positive and negative 
Mostly negative 
Completely negative 
None of the above, it's neither positive nor negative 
R15.  In the past 12 months, have you ever injected drugs for reasons other than medical use?
Yes
No (skip to Section S)
R16.  If yes, in the past 12 months, have you ever been in a situation where you had to use needles or drug-
using equipment that someone had used before?
Yes
No
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S. General Health Concerns
Research on trans people has rarely been concerned with our general health.  We'd like to ask you 
some questions about your health overall, to help us better understand our communities' health 
issues. 
S1.  To start, in general, would you say your health is…? 
Excellent
Very good
Good
Fair
Poor
I don't know 
S2.  Compared to one year ago, how would you say your health is now?   
Much better now
Somewhat better now
About the same 
Somewhat worse now
Much worse now 
I don't know 
S3. Are you usually pain-free or physically comfortable? 
Yes (skip to Question S6)
No
I don't know
S4. How would you describe the usual intensity of your pain or discomfort?  
Mild
Moderate 
Severe
I don't know
S5. How many activities does your pain or discomfort prevent? 
I don't know 
Most
Some 
A few
None
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S6.   Have you been diagnosed with the following health conditions?  If yes, please include the year of 
diagnosis.
Yes Year of diagnosis:
Allergies
Asthma
Breast cancer
Cervical cancer
Chronic fatigue syndrome
Diabetes
Elevated liver enzymes
Elevated prolactin levels
Endometrial cancer
Endometrial hyperplasia
Fibromyalgia
Gall stones
Heart attack
High blood pressure
High cholesterol
Pulmonary embolism 
(blood clot in the lung)
Osteoporosis
Ovarian cancer
Penile cancer
Polycystic ovary syndrome
Prostate cancer
Sleep apnea (stopped 
breathing during sleep)
Stroke
Yes Year of diagnosis:
Testicular cancer
Thyroid condition
Uterine cancer
Vaginal cancer
Venous thrombosis (blood 
clot in the leg)
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T. Strategies for Information and Action
What is the best way to make the results of this study available to trans communities (for example, posters or 
pamphlets)? 
What types of actions do you think we should undertake using the results of this study?
What sort of education or policy changes would you like to see as a result of this study?
Now that you've finished the survey, is there anything else you'd like to let us know?
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Appendix B: The Intersectional Discrimination Index (InDI) 
These questions are about experiences related to who you are. This includes both how you describe yourself and 
how others might describe you. For example, your skin colour, ancestry, nationality, religion, gender, sexuality, age, 
weight, disability or mental health issue, and income.  
Strongly 
disagree 
Disagree  Neither 
agree nor 
disagree  
Agree Strongly 
agree 
1. Because of who I am, a doctor or nurse,
or other health care provider might treat
me poorly.
2. Because of who I am, I might have
trouble finding or keeping a job.
3. Because of who I am, I might have
trouble getting an apartment or house
4. I am confident that I will be treated with 
as much respect as my peers.*
5. I worry about being treated unfairly by a
teacher, supervisor, or employer.
6. I may be denied a bank account, loan, or 
mortgage because of who I am.
7. I feel safe in my neighbourhood.*
8. I worry about being harassed or stopped
by police or security.
9. Because of who I am, people might try
to attack me physically.
10. I expect to be pointed at, called names,
or harassed when in public.
11. I fear that I will have a hard time finding 
friendship or romance because of who I
am.
* Deleted from final version of InDI based on results of factor analyses.
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Because of who you are, have you… 
 Never  Yes, but not in 
the past year 
Yes, once or twice 
in the past year 
Yes, many 
times in the 
past year 
1. Been treated poorly or unfairly by a  
a. ….Health care provider 
b. …Teacher or professor 
c. …Supervisor or employer 
d. …Coworker or classmate 
e. …Sales clerk, receptionist, or other 
customer service representative 
f. …Police officer, border guard, 
security officer 
g. Transportation provider (e.g., bus or 
taxi driver) 
h. …Landlord 
i. …Relative or friend 
    
2. Heard, saw, or read others joking or laughing 
about you (or people like you) 
    
3. Been treated as if you are unfriendly, 
unhelpful, or rude 
    
4. Been called names or heard/saw your identity 
used as an insult 
    
5. Been treated as if others are afraid of you     
6. Been stared or pointed at in public      
7. Been told that you should think, act, or look 
more like others  
    
8. Heard that you or people like you don’t 
belong  
    
9. Asked inappropriate, offensive, or overly 
personal questions 
    
10. Been treated as if you are less smart or 
capable than others 
    
 
As a reminder, we are interested in experiences related to who you are. This includes both how you describe 
yourself and how others might describe you. For example, your skin colour, ancestry, nationality, religion, gender, 
sexuality, age, weight, disability or mental health issue, and income.  
11. Because of who you are, has a health care provider ever refused you care? 
 
  Never 
  Once  
  More than once 
 
11b. [If once or more] Has this happened to you in the past 12 months?    Yes    No    
 
12. Because of who you are, have you ever been fired or dismissed from a job, or been turned down for a job that you 
interviewed for? 
 
  Never 
  Once  
  More than once 
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12b. [If once or more] Has this happened to you in the past 12 months?    Yes    No   
      
13. Because of who you are, have you ever been evicted or denied housing? 
 
  Never 
  Once  
  More than once 
 
13b. [If once or more] Has this happened to you in the past 12 months?    Yes    No  
      
14. Because of who you are, have you ever been unreasonably stopped and questioned, searched, or arrested by police 
or security? 
 
  Never 
  Once  
  More than once 
 
14b. [If once or more] Has this happened to you in the past 12 months?    Yes    No  
     
15. Because of who you are, have you ever been unreasonably expelled or suspended from school? 
 
  Never 
  Once  
  More than once 
 
15b. [If once or more] Has this happened to you in the past 12 months?    Yes    No  
 
16. Because of who you are, have you ever been unable to open a bank account, cash a cheque, or get a loan? 
  
      Never 
   Once  
   More than once 
 
16b. [If once or more] Has this happened to you in the past 12 months?    Yes    No  
 
17. Because of who you are, have you ever had to move to another neighbourhood, town, city, state, province, or 
country? 
 
  Never 
  Once  
  More than once 
 
17b. [If once or more] Has this happened to you in the past 12 months?    Yes    No   
    
18. Because of who you are, have you ever lost a close relationship (e.g., with a family member, friend, or partner)? 
 
  Never 
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  Once  
  More than once 
 
18b. [If once or more] Has this happened to you in the past 12 months?    Yes    No  
     
19. Because of who you are, have you ever been repeatedly harassed at work or school, where you live, or when 
accessing services? 
 
  No 
  Yes—in one place  
  Yes—in more than one place 
 
19b. [If yes]  Has this happened to you in the past 12 months?    Yes    No    
    
20. Because of who you are, have you ever been threatened with a physical or sexual attack? 
 
  Never 
  Once 
  More than once 
 
20b. [If once or more] Has this happened to you in the past 12 months?    Yes    No  
   
21. Because of who you are, have you ever been physically attacked (e.g., spit on, had objects thrown at you, hit, 
punched, pushed or grabbed, beaten)? 
 
  Never 
  Once  
  More than once 
 
          21b. [If once or more] Has this happened to you in the past 12 months?    Yes    No  
       
22. Because of who you are, have you ever been made to engage in sexual activity, or been touched in a sexual way, 
that you didn’t want? 
 
  Never 
  Once  
  More than once 
 
           22b. [If once or more] Has this happened to you in the past 12 months?    Yes    No   
     
23. Because of who you are, have you ever had someone take, damage, or vandalize your property? 
 
  Never 
  Once  
  More than once 
 
           23b. [If once or more] Has this happened to you in the past 12 months?    Yes    No 
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Appendix C: Understanding Social Experiences and Health Baseline Survey
IFOLLOW - IFOLLOW - SHOW ALL 
The following questions will determine whether or not you are eligible to participate in the survey. If you choose to 
skip any of these questions, you will not be able to participate. 
AGENUM - AGENUM 
How old are you? 
jQuery(function() { jQuery('&#160; years old').insertAfter(jQuery('#AGENUM')); });  .questionarea { margin-
bottom: -5px; } .questiontitle{ display : none; } 
Q2 - Q2 - ASK ALL 
What country do you live in? 
 Canada (1) 
 United States (2) 
 Other (96) 
Q5CAN - Q5CAN - ASK IF Q2=1(Canada) 
Which one or more of the following best describes your racial, ethnic, and cultural background? 
 White (1)
 Aboriginal or Indigenous (First Nations, Métis, or Inuit) (2)
 East Asian (Chinese, Japanese, Korean) (3)
 South Asian (for example, East Indian, Pakistani, Sri Lankan) (4)
 Southeast Asian (for example, Filipino, Thai, Indonesian, Vietnamese) (5)
 Black or African Canadian (6)
 Latin American (7)
 Middle Eastern (for example, Egyptian, Iranian, Lebanese) (8)
Q5US - Q5US - ASK IF Q2=2(USA) 
Which one or more of the following best describes your racial, ethnic, and cultural background? 
 White (1)
 Hispanic or Latino/a (2)
 Black or African American (3)
 American Indian or Alaska Native (4)
 East Asian (Chinese, Japanese, Korean) (5)
 South Asian (for example, Asian Indian, Pakistani, Sri Lankan) (6)
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 Southeast Asian (for example, Filipino, Thai, Indonesian, Vietnamese) (7)
 Native Hawaiian or Pacific Islander (8)
 Middle Eastern (for example, Egyptian, Iranian, Lebanese) (9)
Q74 - Q74 - ASK ALL 
Do you consider yourself lesbian, gay, bisexual, or transgender, or a similar identity? 
 Yes (1) 
 No (2) 
Q9Q19 - Q9Q19 - ASK ALL 
These questions are about experiences related to who you are. This includes both how you describe yourself and 
how others might describe you. For example, your skin ^f('Q2').any('1')?"colour":"color"^, ancestry, nationality, 
religion, gender, sexuality, age, weight, disability or mental health issue, and income. 
Strongly 
disagree (1) 
Disagree 
(2) 
Neither agree 
nor disagree (3) 
Agree 
(4) 
Strongly 
agree (5) 
Because of who I am, a doctor or nurse, or 
other health care provider might treat me 
poorly. (1) 
     
Because of who I am, I might have trouble 
finding or keeping a job. (2)      
Because of who I am, I might have trouble 
getting an apartment or house (3)      
I am confident that I will be treated with as 
much respect as my peers. (4)      
I worry about being treated unfairly by a 
teacher, supervisor, or employer. (5)      
I may be denied a bank account, loan, or 
mortgage because of who I am. (6)      
I feel safe in my neighbourhood. (7)      
I worry about being harassed or stopped by 
police or security. (8)      
Because of who I am, people might try to 
attack me physically. (9)      
I expect to be pointed at, called names, or 
harassed when in public. (10)      
I fear that I will have a hard time finding 
friendship or romance because of who I am. 
(11) 
     
Q20 - Q20 - ASK ALL 
Because of who you are, have you... 
Never 
(1) 
Yes, but not in 
the past year 
(2) 
Yes, once or 
twice in the past 
year (3) 
Yes, many times 
in the past year 
(4) 
Been treated poorly or unfairly by a health care 
provider (20a)     
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Never 
(1) 
Yes, but not in 
the past year 
(2) 
Yes, once or 
twice in the past 
year (3) 
Yes, many times 
in the past year 
(4) 
Been treated poorly or unfairly by a teacher or 
professor (20b)     
Been treated poorly or unfairly by a supervisor 
or employer (20c)     
Been treated poorly or unfairly by a coworker or 
classmate (20d)     
Been treated poorly or unfairly by a sales clerk, 
receptionist, or other customer service 
representative (20e) 
    
Been treated poorly or unfairly by a police 
officer, border guard, security officer (20f)     
Been treated poorly or unfairly by a 
transportation provider (e.g., bus or taxi driver) 
(20g) 
    
Been treated poorly or unfairly by a landlord 
(20h)     
Been treated poorly or unfairly by a relative or 
friend (20i)     
Q21Q29 - Q21Q29 - ASK ALL 
Because of who you are, have you... 
 
 Never 
(1) 
Yes, but not in 
the past year (2) 
Yes, once or twice 
in the past year (3) 
Yes, many times 
in the past year (4) 
&nbsp; (b)     
Heard, saw, or read others joking or 
laughing about you (or people like you) 
(21) 
    
Been treated as if you are unfriendly, 
unhelpful, or rude (22)     
Been called names or heard/saw your 
identity used as an insult (23)     
Been treated as if others are afraid of you 
(24)     
Been stared or pointed at in public (25)     
Been told that you should think, act, or 
look more like others (26)     
Heard that you or people like you don’t 
belong (27) 
    
Asked inappropriate, offensive, or overly 
personal questions (28)     
Been treated as if you are less smart or 
capable than others (29)     
     
IQ30 - IQ30 - ASK ALL 
As a reminder, we are interested in experiences related to who you are. This includes both how you describe 
yourself and how others might describe you. For example, your skin ^f('Q2').any('1')?"colour":"color"^, ancestry, 
nationality, religion, gender, sexuality, age, weight, disability or mental health issue, and income. 
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 Q30 - Q30 - ASK ALL 
Because of who you are, has a health care provider ever refused you care? 
 
 Never (1) 
 Once (2) 
 More than once (3) 
Q30B - Q30B - ASK IF Q30=2,3(once or more) 
Has this happened to you in the past 12 months? 
#placeholder_Q30B .questiontitle { display:none; } 
 Yes (1) 
 No (2) 
Q31 - Q31 - ASK ALL 
Because of who you are, have you ever been fired or dismissed from a job, or been turned down for a job that you 
interviewed for? 
 
 Never (1) 
 Once (2) 
 More than once (3) 
Q31B - Q31B - ASK IF Q31=2,3(once or more) 
Has this happened to you in the past 12 months? 
#placeholder_Q31B .questiontitle { display:none; } 
 Yes (1) 
 No (2) 
Q32 - Q32 - ASK ALL 
Because of who you are, have you ever been evicted or denied housing? 
 
 Never (1) 
 Once (2) 
 More than once (3) 
Q32B - Q32B - ASK IF Q32=2,3(once or more) 
Has this happened to you in the past 12 months? 
#placeholder_Q32B .questiontitle { display:none; } 
 Yes (1) 
 No (2) 
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Q33 - Q33 - ASK ALL 
Because of who you are, have you ever been unreasonably stopped and questioned, searched, or arrested by police 
or security? 
 
 Never (1) 
 Once (2) 
 More than once (3) 
Q33B - Q33B - ASK IF Q33=2,3(once or more) 
Has this happened to you in the past 12 months? 
#placeholder_Q33B .questiontitle { display:none; } 
 Yes (1) 
 No (2) 
Q34 - Q34 - ASK ALL 
Because of who you are, have you ever been unreasonably expelled or suspended from school? 
 
 Never (1) 
 Once (2) 
 More than once (3) 
Q34B - Q34B - ASK IF Q34=2,3(once or more) 
Has this happened to you in the past 12 months? 
#placeholder_Q34B .questiontitle { display:none; } 
 Yes (1) 
 No (2) 
Q35 - Q35 - ASK ALL 
Because of who you are, have you ever been unable to open a bank account, cash a 
^f('Q2').any('1')?"cheque":"check"^, or get a loan? 
 
 Never (1) 
 Once (2) 
 More than once (3) 
Q35B - Q35B - ASK IF Q35=2,3(once or more) 
Has this happened to you in the past 12 months? 
#placeholder_Q35B .questiontitle { display:none; } 
 Yes (1) 
 No (2) 
Q36 - Q36 - ASK ALL 
Because of who you are, have you ever had to move to another neighbourhood, town, city, state, province, or 
country? 
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 Never (1) 
 Once (2) 
 More than once (3) 
Q36B - Q36B - ASK IF Q36=2,3(once or more) 
Has this happened to you in the past 12 months? 
#placeholder_Q36B .questiontitle { display:none; } 
 Yes (1) 
 No (2) 
Q37 - Q37 - ASK ALL 
Because of who you are, have you ever lost a close relationship (e.g., with a family member, friend, or partner)? 
 
 Never (1) 
 Once (2) 
 More than once (3) 
Q37B - Q37B - ASK IF Q37=2,3(once or more) 
Has this happened to you in the past 12 months? 
#placeholder_Q37B .questiontitle { display:none; } 
 Yes (1) 
 No (2) 
Q38 - Q38 - ASK ALL 
Because of who you are, have you ever been repeatedly harassed at work or school, where you live, or when 
accessing services? 
 
 No (1) 
 Yes — in one place (2) 
 Yes — in more than one place (3) 
Q38B - Q38B - ASK IF Q38=2,3(once or more) 
Has this happened to you in the past 12 months? 
#placeholder_Q38B .questiontitle { display:none; } 
 Yes (1) 
 No (2) 
Q39 - Q39 - ASK ALL 
Because of who you are, have you ever been threatened with a physical or sexual attack? 
 
 Never (1) 
 Once (2) 
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 More than once (3) 
Q39B - Q39B - ASK IF Q39=2,3(once or more) 
Has this happened to you in the past 12 months? 
#placeholder_Q39B .questiontitle { display:none; } 
 Yes (1) 
 No (2) 
Q40 - Q40 - ASK ALL 
Because of who you are, have you ever been physically attacked (e.g., spit on, had objects thrown at you, hit, 
punched, pushed or grabbed, beaten)? 
 
 Never (1) 
 Once (2) 
 More than once (3) 
Q40B - Q40B - ASK IF Q40=2,3(once or more) 
Has this happened to you in the past 12 months? 
#placeholder_Q40B .questiontitle { display:none; } 
 Yes (1) 
 No (2) 
Q41 - Q41 - ASK ALL 
Because of who you are, have you ever been made to engage in sexual activity, or been touched in a sexual way, that 
you didn’t want? 
 
 Never (1) 
 Once (2) 
 More than once (3) 
Q41B - Q41B - ASK IF Q41=2,3(once or more) 
Has this happened to you in the past 12 months? 
#placeholder_Q41B .questiontitle { display:none; } 
 Yes (1) 
 No (2) 
Q42 - Q42 - ASK ALL 
Because of who you are, have you ever had someone take, damage, or vandalize your property? 
 
 Never (1) 
 Once (2) 
 More than once (3) 
282
Q42B - Q42B - ASK IF Q42=2,3(once or more) 
Has this happened to you in the past 12 months? 
#placeholder_Q42B .questiontitle { display:none; } 
 Yes (1) 
 No (2) 
Q43 - Q43 - If >NEVER to any of 20-42 
Thinking of all of the times that you have been treated unfairly or poorly because of who you are, how often do you 
think each of the following was a reason why others treated you this way? 
 
 Never a 
reason 
(1) 
Sometimes a 
reason (2) 
Always a 
reason (3) 
Not sure if 
this was a 
reason (4) 
Your age (1)     
Your gender (2)     
Your transgender or gender non-conforming status (3)     
Your sexual orientation (being gay, lesbian, bisexual, or 
straight) (4)     
Your citizenship status or country of origin (5)     
Your income (6)     
Your level of education (7)     
Your mental health issue or substance use disorder (8)     
Your physical disability (9)     
Your race (skin ^f('Q2').any('1')?"colour":"color"^) (10)     
Your ethnicity (cultural background or ancestry) (11)     
Your religion (12)     
Your language (e.g., accent, how you speak 
English^f('Q2').any('1') ? " or French" : ""^, other 
language spoken) (13) 
    
Your weight (14)     
Another reason, please specify (96)____________     
PROV - PROV - ASK IF Q2=1(CANADA) 
What PROVINCE/TERRITORY do you live in? 
 
 British Columbia (BC) 
 Alberta (AB) 
 Saskatchewan (SK) 
 Manitoba (MB) 
 Ontario (ON) 
 Quebec (QC) 
 New Brunswick (NB) 
 Nova Scotia (NS) 
 Prince Edward Island (PE) 
 Newfoundland (NF) 
 Northwest Territories (NT) 
 Yukon (YK) 
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 Nunavut (NU) 
USSTATE - USSTATE - ASK IF Q2=2(USA) 
What STATE do you live in? 
 
 Alabama (1) 
 Alaska (2) 
 Arizona (3) 
 Arkansas (4) 
 California (5) 
 Colorado (6) 
 Connecticut (7) 
 Delaware (8) 
 District of Columbia (9) 
 Florida (10) 
 Georgia (11) 
 Hawaii (12) 
 Idaho (13) 
 Illinois (14) 
 Indiana (15) 
 Iowa (16) 
 Kansas (17) 
 Kentucky (18) 
 Louisiana (19) 
 Maine (20) 
 Maryland (21) 
 Massachusetts (22) 
 Michigan (23) 
 Minnesota (24) 
 Mississippi (25) 
 Missouri (26) 
 Montana (27) 
 Nebraska (28) 
 Nevada (29) 
 New Hampshire (30) 
 New Jersey (31) 
 New Mexico (32) 
 New York (33) 
 North Carolina (34) 
 North Dakota (35) 
 Ohio (36) 
 Oklahoma (37) 
 Oregon (38) 
 Pennsylvania (39) 
 Rhode Island (40) 
 South Carolina (41) 
 South Dakota (42) 
 Tennessee (43) 
 Texas (44) 
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 Utah (45) 
 Vermont (46) 
 Virginia (47) 
 Washington (48) 
 West Virginia (49) 
 Wisconsin (50) 
 Wyoming (51) 
 I prefer not to answer (99) 
Q4 - Q4 - ASK ALL 
What is the language you most often speak at home? 
 
 English (1) 
 French (2) 
 Other (96) 
Q6CAN - Q6CAN - ASK IF Q2=1(Canada) 
How do other people usually classify you in this country? 
(Please choose one or two responses) 
 White (1) 
 Aboriginal or Indigenous to Canada (First Nations, Métis, or Inuit) (2) 
 East Asian (Chinese, Japanese, Korean) (3) 
 South Asian (for example, East Indian, Pakistani, Sri Lankan) (4) 
 Southeast Asian (for example, Filipino, Thai, Indonesian, Vietnamese) (5) 
 Black or African Canadian (6) 
 Latin American (7) 
 Middle Eastern (for example, Egyptian, Iranian, Lebanese) (8) 
 Not sure (98) 
Q44CAN - Q44CAN - ASK IF Q2=1(Canada) 
Which of the following best describes you? 
 
 Born a citizen of CANADA (1) 
 Immigrated to CANADA when I was 16 or younger (2) 
 Immigrated to CANADA when I was 17 or older (3) 
 Living temporarily in CANADA (4) 
Q6US - Q6US - ASK IF Q2=2(USA) 
How do other people usually classify you in this country? 
(Please choose one or two responses) 
 White (1) 
 Hispanic or Latino/a (2) 
 Black or African American (3) 
 American Indian or Alaska Native (4) 
 East Asian (Chinese, Japanese, Korean) (5) 
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 South Asian (for example, Asian Indian, Pakistani, Sri Lankan) (6) 
 Southeast Asian (for example, Filipino, Thai, Indonesian, Vietnamese) (7) 
 Native Hawaiian or Pacific Islander (8) 
 Middle Eastern (for example, Egyptian, Iranian, Lebanese) (9) 
 Not sure (98) 
Q44US - Q44US - ASK IF Q2=2(USA) 
Which of the following best describes you? 
 
 Born a citizen of THE UNITED STATES (1) 
 Immigrated to THE UNITED STATES when I was 16 or younger (2) 
 Immigrated to THE UNITED STATES when I was 17 or older (3) 
 Living temporarily in THE UNITED STATES (4) 
Q44BCAN - Q44BCAN - ASK IF Q44CAN = NOT born a citizen(2,3,4) 
In total, how many years have you lived in CANADA? 
jQuery(function() { jQuery('&#160;year(s)').insertAfter(jQuery('#Q44BCAN')); }); 
 
Q44BUS - Q44BUS - ASK IF Q44US = NOT born a citizen(2,3,4) 
In total, how many years have you lived in THE UNITED STATES? 
jQuery(function() { jQuery('&#160;year(s)').insertAfter(jQuery('#Q44BUS')); }); 
 
Q45 - Q45 - ASK ALL 
How do you define yourself in terms of religion or spirituality? 
(Please choose one) 
 Anglican (1) 
 Protestant Christian (2) 
 Catholic (3) 
 Other Christian (not Protestant, Anglican, or Catholic) (4) 
 Buddhist (5) 
 Hindu (6) 
 Jewish (7) 
 Muslim (8) 
 Sikh (9) 
 Agnostic (10) 
 Atheist (11) 
 None of the above (97) 
Q46 - Q46 - ASK ALL 
Do you wear clothing or accessories associated with your faith? (e.g., head covering, head scarf, face veil, turban, 
jewellery with religious symbols) 
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(Please choose one) 
 Yes — most of the time (1) 
 Yes — only for prayers, holidays, or special events (2) 
 No (3) 
Q47 - Q47 - ASK ALL 
Which of the following best describes where you currently live? 
 
 Urban or suburban (1) 
 Rural (2) 
Q48 - Q48 - ASK ALL 
What was your sex assigned at birth (e.g., on your birth certificate)? 
 
 Male (1) 
 Female (2) 
Q49 - Q49 - ASK ALL 
In what gender do you live your day-to-day life? 
 
 Male (1) 
 Female (2) 
 Sometimes male, sometimes female (3) 
 Non-binary, or something other than male or female (4) 
Q7 - Q7 - ASK ALL 
Which of the following best describes you? 
(Please choose one) 
 Straight or heterosexual (1) 
 Bisexual (2) 
 Gay or lesbian (3) 
 Not sure (4) 
 Asexual (not sexually attracted to others) (5) 
Q8 - Q8 - ASK ALL 
How often have other people thought you were lesbian, gay, bisexual, or transgender? (Regardless of how you 
identify) 
 
 Never (1) 
 Once or twice (2) 
 Sometimes (3) 
 Most of the time (4) 
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Q50 - Q50 - ASK ALL 
Do you have any of the following:   Blindness or severe visual impairment 
 Deafness or hard of hearing 
 A long-lasting condition that substantially limits one or more basic physical activities, such as walking, climbing 
stairs, or lifting 
 A long-lasting physical, mental, or emotional condition that increases the difficulty of learning, remembering, 
concentrating, or interacting with others 
 
 Yes (1) 
 No (2) 
Q51 - Q51 - ASK IF Q50=1(yes) 
When you meet people for the first time, do they classify you as having a disability, mental health condition, or 
chronic illness- without being told? 
 
 No, never (1) 
 Yes, some of the time (2) 
 Yes, most or all of the time (3) 
Q52 - Q52 - ASK ALL 
Has a doctor or other health care provider ever told you that you have a mental health disorder (e.g., bipolar 
disorder, borderline personality disorder, schizophrenia), not including dysthymia, depression, or anxiety? 
 
 Yes (1) 
 No (2) 
Q53 - Q53 - ASK ALL 
What is the highest level of education you have completed? 
 
 Did not graduate from high school (1) 
 High school diploma (2) 
 Some ^f('Q2').any('1')?"":"community "^college or trade school (3) 
 ^f('Q2').any('1')?"College ":"Community college "^or trade school diploma (4) 
 Some university (5) 
 University bachelor’s degree (6) 
 University graduate degree (7) 
Q54 - Q54 - ASK ALL 
In the past year, what was the main source of income for your household? 
 
 Employment (wages and salaries) (1) 
 Self-employment or small business (2) 
 Investments or savings (3) 
 Unemployment insurance or worker’s compensation (4) 
 Government retirement pension or Social Security for retirement (5) 
288
 Retirement pension from employer (6) 
 Social assistance or disability benefits (7) 
 Student loans or scholarships (8) 
 I'd rather not say (99) 
Q55 - Q55 - ASK ALL 
What is your best estimate of the total income, before taxes and deductions, of all    household members from all 
sources in the past 12 months? 
 
 Less than $10,000 (1) 
 $10,000 to less than $15,000 (2) 
 $15,000 to less than $30,000 (3) 
 $30,000 to less than $40,000 (4) 
 $40,000 to less than $50,000 (5) 
 $50,000 to less than $60,000 (6) 
 $60,000 to less than $80,000 (7) 
 $80,000 to less than $100,000 (8) 
 $100,000 to less than $150,000 (9) 
 More than $150,000 (10) 
 I don't know (98) 
 I'd rather not say (99) 
Q55B - Q55B - ASK ALL 
Including yourself, how many adults and children living in the household were being supported on this income? 
 
 
Q56 - Q56 - ASK ALL 
Before age 16, did you ever experience something sexual that you did not want, that felt inappropriate, or was at any 
time perceived as hurtful? 
 
 Yes (1) 
 No (2) 
 I don’t know (8) 
 I'd rather not say (9) 
Q57 - Q57 - ASK ALL 
Before age 16, were you ever pushed, grabbed, shoved, kicked, punched or physically attacked by an adult? 
 
 Yes (1) 
 No (2) 
 I don’t know (8) 
 I'd rather not say (9) 
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Q58A - Q58A - ASK ALL 
In your lifetime, have you smoked more than 100 cigarettes (about ^f('Q2').any('1')?"4":"5"^ packs)? 
 
 Yes (1) 
 No (2) 
Q58B - Q58B - ASK IF Q58A=1(yes) 
At the present time, how often do you smoke cigarettes? 
 
 Daily (1) 
 Occasionally (2) 
 Not at all (3) 
Q59 - Q59 - ASK ALL 
The following questions ask about how you have been feeling during the past 30 days. For each question, please 
check the box that best describes how often you had this feeling.  
 
 During the past 30 days, about how often did you feel... 
 
 All of the 
time (1) 
Most of  the 
time (2) 
Some of  the 
time (3) 
A little of the 
time (4) 
None of the 
time (97) 
...nervous (1)      
...hopeless (2)      
...restless or fidgety (3)      
...so depressed that nothing could 
cheer you up (4)      
...that everything was an effort 
(5)      
...worthless (6)      
Q60A - Q60A - ASK ALL 
How often do you have a drink containing alcohol? 
 
 Never (1) 
 Monthly or less (2) 
 2 to 4 times a month (3) 
 2 to 3 times a week (4) 
 4 or more times a week (5) 
Q60B - Q60B - ASK IF Q60A = NOT NEVER 
How many drinks containing alcohol do you have on a typical day when you are drinking? 
 
 1 or 2 (1) 
 3 or 4 (2) 
 5 or 6 (3) 
290
 7, 8, or 9 (4) 
 10 or more (5) 
Q60C - Q60C - ASK IF Q60A = NOT NEVER 
How often do you have six or or more drinks on one occasion? 
 
 Never (1) 
 Less than monthly (2) 
 Monthly (3) 
 Weekly (4) 
 Daily or almost daily (5) 
Q60D - Q60D - ASK IF (Q60A = NOT NEVER) AND (Q60B=2,3,4,5 OR Q60D=2,3,4,5) 
How often during the last year have you found that you were not able to stop drinking once you had started? 
 
 Never (1) 
 Less than monthly (2) 
 Monthly (3) 
 Weekly (4) 
 Daily or almost daily (5) 
Q60E - Q60E - ASK IF (Q60A = NOT NEVER) AND (Q60B=2,3,4,5 OR Q60D=2,3,4,5) 
How often during the last year have you failed to do what was normally expected from you because of drinking? 
 
 Never (1) 
 Less than monthly (2) 
 Monthly (3) 
 Weekly (4) 
 Daily or almost daily (5) 
Q60F - Q60F - ASK IF (Q60A = NOT NEVER) AND (Q60B=2,3,4,5 OR Q60D=2,3,4,5) 
How often during the last year have you needed a first drink in the morning to get yourself going after a heavy 
drinking session? 
 
 Never (1) 
 Less than monthly (2) 
 Monthly (3) 
 Weekly (4) 
 Daily or almost daily (5) 
Q60G - Q60G - ASK IF (Q60A = NOT NEVER) AND (Q60B=2,3,4,5 OR Q60D=2,3,4,5) 
How often during the last year have you had a feeling of guilt or remorse after drinking? 
 
 Never (1) 
 Less than monthly (2) 
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 Monthly (3) 
 Weekly (4) 
 Daily or almost daily (5) 
Q60H - Q60H - ASK IF (Q60A = NOT NEVER) AND (Q60B=2,3,4,5 OR Q60D=2,3,4,5) 
How often during the last year have you been unable to remember what happened the night before because you had 
been drinking? 
 
 Never (1) 
 Less than monthly (2) 
 Monthly (3) 
 Weekly (4) 
 Daily or almost daily (5) 
Q60I - Q60I - ASK ALL 
Have you or someone else been injured as a result of your drinking? 
 
 No (1) 
 Yes, but not in the last year (2) 
 Yes, during the last year (3) 
Q60J - Q60J - ASK ALL 
Has a relative or friend or a doctor or another health worker been concerned about your drinking or suggested you 
cut down? 
 
 No (1) 
 Yes, but not in the last year (2) 
 Yes, during the last year (3) 
Q61A - Q61A - ASK ALL 
The following items ask about anxiety and fear. For each item, please select the answer that best describes your 
experience over the past week. 
.questionarea {     margin-bottom: -10px;  } 
 Never (1) Rarely (2) Occasionally (3) Frequently (4) Constantly (5) 
How often do you feel anxious? (1)      
Q61B - Q61B - ASK ALL 
 
 
 I never feel 
anxious (1) 
Mild 
(2) 
Moderate 
(3) 
Severe 
(4) 
Extreme 
(5) 
When you feel anxious, how intense or severe 
is your anxiety? (1)      
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Q61C - Q61C - ASK ALL 
Never 
(1) 
Rarely 
(2) 
Occasionally 
(3) 
Frequently 
(4) 
All the 
time (5) 
How often do you avoid situations, places, 
objects, or activities because of anxiety or fear? 
(1) 
    
Q61D - Q61D - ASK ALL 
Not at 
all (1) 
Mild 
(2) 
Moderate 
(3) 
Severe 
(4) 
Extreme 
(5) 
How much does anxiety or fear interfere with your ability 
to do the things you need to do at work, at school, or at 
home? (1) 
    
Q61E - Q61E - ASK ALL 
Not at 
all (1) 
Mild 
(2) 
Moderate 
(3) 
Severe 
(4) 
Extreme 
(5) 
How much does anxiety or fear interfere with your 
social life and relationships? (1)     
Q62 - Q62 - ASK ALL 
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Appendix D: Understanding Social Experiences and Health (InDI) Follow-up Survey
Q9Q19 - Q9Q19 - ASK ALL 
These questions are about experiences related to who you are. This includes both how you describe yourself and 
how others might describe you. For example, your skin ^f('Q2').any('1')?"colour":"color"^, ancestry, nationality, 
religion, gender, sexuality, age, weight, disability or mental health issue, and income. 
Strongly 
disagree (1) 
Disagree 
(2) 
Neither agree 
nor disagree (3) 
Agree 
(4) 
Strongly 
agree (5) 
Because of who I am, a doctor or nurse, or 
other health care provider might treat me 
poorly. (1) 
     
Because of who I am, I might have trouble 
finding or keeping a job. (2)      
Because of who I am, I might have trouble 
getting an apartment or house (3)      
I am confident that I will be treated with as 
much respect as my peers. (4)      
I worry about being treated unfairly by a 
teacher, supervisor, or employer. (5)      
I may be denied a bank account, loan, or 
mortgage because of who I am. (6)      
I feel safe in my neighbourhood. (7)      
I worry about being harassed or stopped by 
police or security. (8)      
Because of who I am, people might try to 
attack me physically. (9)      
I expect to be pointed at, called names, or 
harassed when in public. (10)      
I fear that I will have a hard time finding 
friendship or romance because of who I am. 
(11) 
     
Q20 - Q20 - ASK ALL 
Because of who you are, have you... 
Never 
(1) 
Yes, but not in 
the past year 
(2) 
Yes, once or 
twice in the past 
year (3) 
Yes, many times 
in the past year 
(4) 
Been treated poorly or unfairly by a health care 
provider (20a)     
Been treated poorly or unfairly by a teacher or 
professor (20b)     
Been treated poorly or unfairly by a supervisor 
or employer (20c)     
Been treated poorly or unfairly by a coworker or 
classmate (20d)     
Been treated poorly or unfairly by a sales clerk, 
receptionist, or other customer service 
representative (20e) 
    
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Never 
(1) 
Yes, but not in 
the past year 
(2) 
Yes, once or 
twice in the past 
year (3) 
Yes, many times 
in the past year 
(4) 
Been treated poorly or unfairly by a police 
officer, border guard, security officer (20f)    
Been treated poorly or unfairly by a 
transportation provider (e.g., bus or taxi driver) 
(20g) 
   
Been treated poorly or unfairly by a landlord 
(20h)    
Been treated poorly or unfairly by a relative or 
friend (20i)    
Q21Q29 - Q21Q29 - ASK ALL 
Because of who you are, have you... 
Never 
(1) 
Yes, but not in 
the past year (2) 
Yes, once or twice 
in the past year (3) 
Yes, many times 
in the past year (4) 
&nbsp; (b) 
Heard, saw, or read others joking or 
laughing about you (or people like you) 
(21) 
   
Been treated as if you are unfriendly, 
unhelpful, or rude (22)    
Been called names or heard/saw your 
identity used as an insult (23)    
Been treated as if others are afraid of you 
(24)    
Been stared or pointed at in public (25)    
Been told that you should think, act, or 
look more like others (26)    
Heard that you or people like you don’t 
belong (27) 
   
Asked inappropriate, offensive, or overly 
personal questions (28)    
Been treated as if you are less smart or 
capable than others (29)    
   
IQ30 - IQ30 - ASK ALL 
As a reminder, we are interested in experiences related to who you are. This includes both how you describe 
yourself and how others might describe you. For example, your skin ^f('Q2').any('1')?"colour":"color"^, ancestry, 
nationality, religion, gender, sexuality, age, weight, disability or mental health issue, and income. 
Q30 - Q30 - ASK ALL 
Because of who you are, has a health care provider ever refused you care? 
 Never (1) 
 Once (2) 
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 More than once (3) 
Q30B - Q30B - ASK IF Q30=2,3(once or more) 
Has this happened to you in the past 12 months? 
#placeholder_Q30B .questiontitle { display:none; } 
 Yes (1) 
 No (2) 
Q31 - Q31 - ASK ALL 
Because of who you are, have you ever been fired or dismissed from a job, or been turned down for a job that you 
interviewed for? 
 
 Never (1) 
 Once (2) 
 More than once (3) 
Q31B - Q31B - ASK IF Q31=2,3(once or more) 
Has this happened to you in the past 12 months? 
#placeholder_Q31B .questiontitle { display:none; } 
 Yes (1) 
 No (2) 
Q32 - Q32 - ASK ALL 
Because of who you are, have you ever been evicted or denied housing? 
 
 Never (1) 
 Once (2) 
 More than once (3) 
Q32B - Q32B - ASK IF Q32=2,3(once or more) 
Has this happened to you in the past 12 months? 
#placeholder_Q32B .questiontitle { display:none; } 
 Yes (1) 
 No (2) 
Q33 - Q33 - ASK ALL 
Because of who you are, have you ever been unreasonably stopped and questioned, searched, or arrested by police 
or security? 
 
 Never (1) 
 Once (2) 
 More than once (3) 
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Q33B - Q33B - ASK IF Q33=2,3(once or more) 
Has this happened to you in the past 12 months? 
#placeholder_Q33B .questiontitle { display:none; } 
 Yes (1) 
 No (2) 
Q34 - Q34 - ASK ALL 
Because of who you are, have you ever been unreasonably expelled or suspended from school? 
 
 Never (1) 
 Once (2) 
 More than once (3) 
Q34B - Q34B - ASK IF Q34=2,3(once or more) 
Has this happened to you in the past 12 months? 
#placeholder_Q34B .questiontitle { display:none; } 
 Yes (1) 
 No (2) 
Q35 - Q35 - ASK ALL 
Because of who you are, have you ever been unable to open a bank account, cash a 
^f('Q2').any('1')?"cheque":"check"^, or get a loan? 
 
 Never (1) 
 Once (2) 
 More than once (3) 
Q35B - Q35B - ASK IF Q35=2,3(once or more) 
Has this happened to you in the past 12 months? 
#placeholder_Q35B .questiontitle { display:none; } 
 Yes (1) 
 No (2) 
Q36 - Q36 - ASK ALL 
Because of who you are, have you ever had to move to another neighbourhood, town, city, state, province, or 
country? 
 
 Never (1) 
 Once (2) 
 More than once (3) 
Q36B - Q36B - ASK IF Q36=2,3(once or more) 
Has this happened to you in the past 12 months? 
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#placeholder_Q36B .questiontitle { display:none; } 
 Yes (1) 
 No (2) 
Q37 - Q37 - ASK ALL 
Because of who you are, have you ever lost a close relationship (e.g., with a family member, friend, or partner)? 
 
 Never (1) 
 Once (2) 
 More than once (3) 
Q37B - Q37B - ASK IF Q37=2,3(once or more) 
Has this happened to you in the past 12 months? 
#placeholder_Q37B .questiontitle { display:none; } 
 Yes (1) 
 No (2) 
Q38 - Q38 - ASK ALL 
Because of who you are, have you ever been repeatedly harassed at work or school, where you live, or when 
accessing services? 
 
 No (1) 
 Yes — in one place (2) 
 Yes — in more than one place (3) 
Q38B - Q38B - ASK IF Q38=2,3(once or more) 
Has this happened to you in the past 12 months? 
#placeholder_Q38B .questiontitle { display:none; } 
 Yes (1) 
 No (2) 
Q39 - Q39 - ASK ALL 
Because of who you are, have you ever been threatened with a physical or sexual attack? 
 
 Never (1) 
 Once (2) 
 More than once (3) 
Q39B - Q39B - ASK IF Q39=2,3(once or more) 
Has this happened to you in the past 12 months? 
#placeholder_Q39B .questiontitle { display:none; } 
 Yes (1) 
 No (2) 
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Q40 - Q40 - ASK ALL 
Because of who you are, have you ever been physically attacked (e.g., spit on, had objects thrown at you, hit, 
punched, pushed or grabbed, beaten)? 
 
 Never (1) 
 Once (2) 
 More than once (3) 
Q40B - Q40B - ASK IF Q40=2,3(once or more) 
Has this happened to you in the past 12 months? 
#placeholder_Q40B .questiontitle { display:none; } 
 Yes (1) 
 No (2) 
Q41 - Q41 - ASK ALL 
Because of who you are, have you ever been made to engage in sexual activity, or been touched in a sexual way, that 
you didn’t want? 
 
 Never (1) 
 Once (2) 
 More than once (3) 
Q41B - Q41B - ASK IF Q41=2,3(once or more) 
Has this happened to you in the past 12 months? 
#placeholder_Q41B .questiontitle { display:none; } 
 Yes (1) 
 No (2) 
Q42 - Q42 - ASK ALL 
Because of who you are, have you ever had someone take, damage, or vandalize your property? 
 
 Never (1) 
 Once (2) 
 More than once (3) 
Q42B - Q42B - ASK IF Q42=2,3(once or more) 
Has this happened to you in the past 12 months? 
#placeholder_Q42B .questiontitle { display:none; } 
 Yes (1) 
 No (2) 
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Q43 - Q43 - If >NEVER to any of 20-42 
Thinking of all of the times that you have been treated unfairly or poorly because of who you are, how often do you 
think each of the following was a reason why others treated you this way? 
jQuery(function() { jQuery('Your').appendTo(jQuery('#Q43_header0')); }); 
 Never a 
reason 
(1) 
Sometimes a 
reason (2) 
Always a 
reason (3) 
Not sure if 
this was a 
reason (4) 
Age (1)     
Gender (2)     
Transgender or gender non-conforming status (3)     
Sexual orientation (being gay, lesbian, bisexual, or 
straight) (4)     
Citizenship status or country of origin (5)     
Income (6)     
Level of education (7)     
Mental health issue or substance use disorder (8)     
Physical disability (9)     
Race (skin ^f('Q2').any('1')?"colour":"color"^) (10)     
Ethnicity (cultural background or ancestry) (11)     
Religion (12)     
Language (e.g., accent, how you speak 
English^f('Q2').any('1') ? " or French" : ""^, other 
language spoken) (13) 
    
Weight (14)     
Another reason, please specify (96)____________     
Q63 - Q63 - ASK ALL 
We know that these questions may seem repetitive, but we appreciate your patience in filling them out.   
 
 In your day-to-day life, how often do any of the following things happen to you? 
 
 
Never 
(1) 
Less than 
once a year 
(2) 
A few 
times a 
year (3) 
A few times 
a month (4) 
At least 
once a 
week (5) 
Almost 
everyday (6) 
You are treated with less 
courtesy than other people are. 
(1) 
      
You are treated with less 
respect than other people are. 
(2) 
      
You receive poorer service than 
other people at restaurants or 
stores. (3) 
      
People act as if they think you 
are not smart. (4)       
People act as if they are afraid 
of you. (5)       
People act as if they think you 
are dishonest. (6)       
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Never 
(1) 
Less than 
once a year 
(2) 
A few 
times a 
year (3) 
A few times 
a month (4) 
At least 
once a 
week (5) 
Almost 
everyday (6) 
People act as if they’re better 
than you are. (7) 
      
You are called names or 
insulted. (8)       
You are threatened or harassed. 
(9)       
Q64 - Q64 - ASK ALL 
What do you think was the reason (or reasons) for these experiences? Your... 
(check all that apply) 
 Age (1) 
 Gender (2) 
 Transgender or gender non-conforming status (3) 
 Sexual orientation (being gay, lesbian, bisexual, or straight) (4) 
 Citizenship status or country of origin (5) 
 Income (6) 
 Level of education (7) 
 Mental health issue or substance use (8) 
 Physical disability (9) 
 Race (skin ^f('Q2').any('1')?"colour":"color"^) (10) 
 Ethnicity (cultural background or ancestry) (11) 
 Religion (12) 
 Language (e.g., accent, how you speak English or French, other language spoken) (13) 
 Weight (14) 
 Another reason, please specify (96)____________ 
IEND - IEND 
In the following questions, we are interested in the way other people have treated you or your beliefs about how 
other people have treated you. Have any of the following ever happened to you: 
 
Q65A - Q65A - ASK ALL 
At any time in your life, have you ever been unfairly fired? 
 
 Yes (1) 
 No (2) 
Q65B - Q65B - ASK IF Q65A=1(yes) 
What do you think was the reason (or reasons) for this experience? Your... 
(check all that apply)  #placeholder_Q65B .questiontitle { display:none; } 
 Age (1) 
 Gender (2) 
 Transgender or gender non-conforming status (3) 
 Sexual orientation (being gay, lesbian, bisexual, or straight) (4) 
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 Citizenship status or country of origin (5) 
 Income (6) 
 Level of education (7) 
 Mental health issue or substance use (8) 
 Physical disability (9) 
 Race (skin ^f('Q2').any('1')?"colour":"color"^) (10) 
 Ethnicity (cultural background or ancestry) (11) 
 Religion (12) 
 Language (e.g., accent, how you speak English^f('Q2').any('1') ? " or French" : ""^, other language spoken) (13) 
 Weight (14) 
 Another reason, please specify (96)____________ 
Q66A - Q66A - ASK ALL 
For unfair reasons, have you ever not been hired for a job? 
 
 Yes (1) 
 No (2) 
Q66B - Q66B - ASK IF Q66A=1(yes) 
What do you think was the reason (or reasons) for this experience? Your... 
(check all that apply)  #placeholder_Q66B .questiontitle { display:none; } 
 Age (1) 
 Gender (2) 
 Transgender or gender non-conforming status (3) 
 Sexual orientation (being gay, lesbian, bisexual, or straight) (4) 
 Citizenship status or country of origin (5) 
 Income (6) 
 Level of education (7) 
 Mental health issue or substance use (8) 
 Physical disability (9) 
 Race (skin ^f('Q2').any('1')?"colour":"color"^) (10) 
 Ethnicity (cultural background or ancestry) (11) 
 Religion (12) 
 Language (e.g., accent, how you speak English^f('Q2').any('1') ? " or French" : ""^, other language spoken) (13) 
 Weight (14) 
 Another reason, please specify (96)____________ 
Q67A - Q67A - ASK ALL 
Have you ever been unfairly denied a promotion? 
 
 Yes (1) 
 No (2) 
Q67B - Q67B - ASK IF Q67A=1(yes) 
What do you think was the reason (or reasons) for this experience? Your... 
302
(check all that apply)  #placeholder_Q67B .questiontitle { display:none; } 
 Age (1) 
 Gender (2) 
 Transgender or gender non-conforming status (3) 
 Sexual orientation (being gay, lesbian, bisexual, or straight) (4) 
 Citizenship status or country of origin (5) 
 Income (6) 
 Level of education (7) 
 Mental health issue or substance use (8) 
 Physical disability (9) 
 Race (skin ^f('Q2').any('1')?"colour":"color"^) (10) 
 Ethnicity (cultural background or ancestry) (11) 
 Religion (12) 
 Language (e.g., accent, how you speak English^f('Q2').any('1') ? " or French" : ""^, other language spoken) (13) 
 Weight (14) 
 Another reason, please specify (96)____________ 
Q68A - Q68A - ASK ALL 
Have you ever been unfairly stopped, searched, questioned, physically threatened or abused by the police? 
 
 Yes (1) 
 No (2) 
Q68B - Q68B - ASK IF Q68A=1(yes) 
What do you think was the reason (or reasons) for this experience? Your... 
(check all that apply)  #placeholder_Q68B .questiontitle { display:none; } 
 Age (1) 
 Gender (2) 
 Transgender or gender non-conforming status (3) 
 Sexual orientation (being gay, lesbian, bisexual, or straight) (4) 
 Citizenship status or country of origin (5) 
 Income (6) 
 Level of education (7) 
 Mental health issue or substance use (8) 
 Physical disability (9) 
 Race (skin ^f('Q2').any('1')?"colour":"color"^) (10) 
 Ethnicity (cultural background or ancestry) (11) 
 Religion (12) 
 Language (e.g., accent, how you speak English^f('Q2').any('1') ? " or French" : ""^, other language spoken) (13) 
 Weight (14) 
 Another reason, please specify (96)____________ 
Q69A - Q69A - ASK ALL 
Have you ever been unfairly discouraged by a teacher or advisor from continuing your education? 
 
 Yes (1) 
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 No (2) 
Q69B - Q69B - ASK IF Q69A=1(yes) 
What do you think was the reason (or reasons) for this experience? Your... 
(check all that apply)  #placeholder_Q69B .questiontitle { display:none; } 
 Age (1)
 Gender (2)
 Transgender or gender non-conforming status (3)
 Sexual orientation (being gay, lesbian, bisexual, or straight) (4)
 Citizenship status or country of origin (5)
 Income (6)
 Level of education (7)
 Mental health issue or substance use (8)
 Physical disability (9)
 Race (skin ^f('Q2').any('1')?"colour":"color"^) (10)
 Ethnicity (cultural background or ancestry) (11)
 Religion (12)
 Language (e.g., accent, how you speak English^f('Q2').any('1') ? " or French" : ""^, other language spoken) (13)
 Weight (14)
 Another reason, please specify (96)____________
Q70A - Q70A - ASK ALL 
Have you ever been unfairly prevented from moving into a neighborhood because the landlord or a realtor refused to 
sell or rent you a house or apartment? 
 Yes (1) 
 No (2) 
Q70B - Q70B - ASK IF Q70A=1(yes) 
What do you think was the reason (or reasons) for this experience? Your... 
(check all that apply)  #placeholder_Q70B .questiontitle { display:none; } 
 Age (1)
 Gender (2)
 Transgender or gender non-conforming status (3)
 Sexual orientation (being gay, lesbian, bisexual, or straight) (4)
 Citizenship status or country of origin (5)
 Income (6)
 Level of education (7)
 Mental health issue or substance use (8)
 Physical disability (9)
 Race (skin ^f('Q2').any('1')?"colour":"color"^) (10)
 Ethnicity (cultural background or ancestry) (11)
 Religion (12)
 Language (e.g., accent, how you speak English^f('Q2').any('1') ? " or French" : ""^, other language spoken) (13)
 Weight (14)
 Another reason, please specify (96)____________
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Q71A - Q71A - ASK ALL 
Have you ever moved into a neighborhood where neighbors made life difficult for you or your family? 
 
 Yes (1) 
 No (2) 
Q71B - Q71B - ASK IF Q71A=1(yes) 
What do you think was the reason (or reasons) for this experience? Your... 
(check all that apply)  #placeholder_Q71B .questiontitle { display:none; } 
 Age (1) 
 Gender (2) 
 Transgender or gender non-conforming status (3) 
 Sexual orientation (being gay, lesbian, bisexual, or straight) (4) 
 Citizenship status or country of origin (5) 
 Income (6) 
 Level of education (7) 
 Mental health issue or substance use (8) 
 Physical disability (9) 
 Race (skin ^f('Q2').any('1')?"colour":"color"^) (10) 
 Ethnicity (cultural background or ancestry) (11) 
 Religion (12) 
 Language (e.g., accent, how you speak English^f('Q2').any('1') ? " or French" : ""^, other language spoken) (13) 
 Weight (14) 
 Another reason, please specify (96)____________ 
Q72A - Q72A - ASK ALL 
Have you ever been unfairly denied a bank loan? 
 
 Yes (1) 
 No (2) 
Q72B - Q72B - ASK IF Q72A=1(yes) 
What do you think was the reason (or reasons) for this experience? Your... 
(check all that apply)  #placeholder_Q72B .questiontitle { display:none; } 
 Age (1) 
 Gender (2) 
 Transgender or gender non-conforming status (3) 
 Sexual orientation (being gay, lesbian, bisexual, or straight) (4) 
 Citizenship status or country of origin (5) 
 Income (6) 
 Level of education (7) 
 Mental health issue or substance use (8) 
 Physical disability (9) 
 Race (skin ^f('Q2').any('1')?"colour":"color"^) (10) 
 Ethnicity (cultural background or ancestry) (11) 
 Religion (12) 
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 Language (e.g., accent, how you speak English^f('Q2').any('1') ? " or French" : ""^, other language spoken) (13) 
 Weight (14) 
 Another reason, please specify (96)____________ 
Q73A - Q73A - ASK ALL 
Have you ever received service from someone such as a plumber or car mechanic that was worse than what other 
people get? 
 
 Yes (1) 
 No (2) 
Q73B - Q73B - ASK IF Q73A=1(yes) 
What do you think was the reason (or reasons) for this experience? Your... 
(check all that apply)  #placeholder_Q73B .questiontitle { display:none; } 
 Age (1) 
 Gender (2) 
 Transgender or gender non-conforming status (3) 
 Sexual orientation (being gay, lesbian, bisexual, or straight) (4) 
 Citizenship status or country of origin (5) 
 Income (6) 
 Level of education (7) 
 Mental health issue or substance use (8) 
 Physical disability (9) 
 Race (skin ^f('Q2').any('1')?"colour":"color"^) (10) 
 Ethnicity (cultural background or ancestry) (11) 
 Religion (12) 
 Language (e.g., accent, how you speak English^f('Q2').any('1') ? " or French" : ""^, other language spoken) (13) 
 Weight (14) 
 Another reason, please specify (96)____________ 
MessComplete - MessComplete 
Thank you, you have completed the survey.  
 
^f('REDIRTXT')^ 
 
MessScreened - MessScreened 
^f('REDIRTXT')^  
 
^f('SMODE').any('3') ? "THIS LINE APPEARS ONLY IN TEST MODE: : " + f('INTCODE').value() : ""^ 
^f('SMODE').any('3') ? " - " + f('INTCODE').valueLabel() : ""^ 
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	Appendix F: Letters of Invitation, Understanding Social Experiences and Health 
 
 
	
Survey	Code:	AC14727_093_5FR.8524.77893	
Survey	Length:	40 minutes	
Reward:	$4 or	8 Air	Miles 
	
Dear	$+FIRSTNAME+$	$+LASTNAME+$,		
A	new	online	survey	is	now	available,	Understanding	Social	Experiences	and	Health.	It	
will	only	take	40	minutes	of	your	time	and	give	you	$6.50	or	13	Air	Miles	if	you	meet	the	
criteria	to	answer	the	survey.	You	have	until	CHOOSE	CLOSING	DATE	to	participate	in	
this	survey.	Please	see	the	link	for	more	information	about	this	survey.	
 
~	PARTICIPATE!	~ 
 
 
+	Get	chances	for	our	monthly	draw 
Remember	that	for	every	survey	conducted,	you	get	chances	for	our	monthly	draw	in	addition	to	earning	
your	rewards.	The	monthly	draw	includes:	2	prizes	of	$	1,000	in	cash,	a	prize	of	$	100	in	cash,	a	prize	of	
1,000	miles	of	Airmiles	rewards	and	a	prize	of	an	iPad. 
 
Can	I	answer	this	survey	from	a	mobile	device?	Yes	or	No 
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Thank	you	for	your	participation!
Questions or trouble with the survey? Call us at or  
If you are not able to open the link to complete the survey , please copy and paste the following link into your web browser : 
https://legerweb.com/sid.asp?CODESURVEY=AC14727_093_5FR.8524.77893&L=FR&LMID=POR2012641461417216213 
Unsubscribe | About Us | Privacy | Facebook | Twitter | Contact Us
© 2016 Legerweb.com. All Rights Reserved. 
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Survey	Code:	AC14727_093_5FR.8524.77893	
Survey	Length:	15 minutes	
Reward:	$2 or	4 Air	Miles 
	
Dear	$+FIRSTNAME+$	$+LASTNAME+$,		
A	new	online	survey	is	now	available,	Understanding	Social	Experiences	and	Health.	It	
will	only	take	15	minutes	of	your	time	and	give	you	$2	or	4	Air	Miles	if	you	meet	the	
criteria	to	answer	the	survey.	You	have	until	CHOOSE	CLOSING	DATE	to	participate	in	
this	survey.	Please	see	the	link	for	more	information	about	this	survey.	
 
~	PARTICIPATE!	~ 
 
 
+	Get	chances	for	our	monthly	draw 
Remember	that	for	every	survey	conducted,	you	get	chances	for	our	monthly	draw	in	addition	to	earning	
your	rewards.	The	monthly	draw	includes:	2	prizes	of	$	1,000	in	cash,	a	prize	of	$	100	in	cash,	a	prize	of	
1,000	miles	of	Airmiles	rewards	and	a	prize	of	an	iPad. 
 
Can	I	answer	this	survey	from	a	mobile	device?	Yes	or	No 
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Thank	you	for	your	participation! 
 
Questions or trouble with the survey? Call us at or  
 
If you are not able to open the link to complete the survey , please copy and paste the following link into your web browser : 
https://legerweb.com/sid.asp?CODESURVEY=AC14727_093_5FR.8524.77893&L=FR&LMID=POR2012641461417216213 
 
Unsubscribe | About Us | Privacy | Facebook | Twitter | Contact Us 
  
© 2016 Legerweb.com. All Rights Reserved. 
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Appendix G: Letters of Information and Consent, Understanding Social Experiences and Health 
Study	Title:	Understanding	Social	Experiences	and	Health	
Principal	Investigator	
Greta	Bauer,	Associate	Professor		
Epidemiology	&	Biostatistics	
Schulich	School	of	Medicine	&	Dentistry	
Western	University	
London,	Ontario,	Canada	
Invitation	to	Participate	
You	are	being	invited	to	participate	in	this	research	study	about	social	discrimination	(i.e.,	being	treated	
differently	because	of	who	you	are)	and	health	because	you	are	a	Legerweb	member.	You	do	not	need	
to	have	experienced	social	discrimination	to	participate.		
Why	is	this	study	being	done?	
The	purpose	of	this	study	is	to	develop	better	ways	of	asking	people	about	how	they	are	treated	in	
society,	and	to	increase	our	understanding	of	how	this	treatment	affects	health.		
How	long	will	you	be	in	this	study?	
The	survey	you	are	being	asked	to	participate	in	today	takes	30-40	minutes	to	complete.	If	you	complete	
today’s	survey,	you	may	be	contacted	in	one	to	two	weeks	and	invited	to	complete	a	15-minute	follow-
up	survey.		
What	are	the	study	procedures?	
If	you	are	eligible	and	agree	to	participate,	you	will	be	asked	to	answer	some	survey	questions	about	
who	you	are	(demographics),	experiences	of	unfair	treatment	related	to	who	you	are,	and	some	aspects	
of	your	current	health.		
What	are	the	risks	and	harms	of	participating	in	this	study?	
There	are	no	known	or	anticipated	risks	associated	with	participating	in	this	study.	It	is	possible	that	you	
may	be	uncomfortable	with	some	of	the	questions,	or	that	they	may	cause	distress	by	recalling	difficult	
memories	or	experiences.	You	are	welcome	to	skip	any	questions	you	do	not	wish	to	answer.	If	you	
need	to	speak	with	someone	about	your	feelings	after	completing	the	survey,	please	visit	
http://www.yourlifecounts.org/need-help/crisis-lines	to	find	a	distress	line	in	your	area.	
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	What	are	the	benefits	of	participating	in	this	study?	
You	may	not	directly	benefit	from	participating	in	this	study	but	information		
gathered	may	provide	benefits	to	society	as	a	whole	which	include	more	knowledge	about	how	unfair	
treatment	impacts	health.		
Can	participants	choose	to	leave	the	study?	
If	you	decide	to	withdraw	from	the	study	(by	exiting	the	webpage),	the	information	that	was	collected	
prior	to	you	leaving	the	study	may	still	be	used.		No	new	information	will	be	collected	without	your	
permission.	
How	will	participant	information	be	kept	confidential?		
All	survey	data	collected	will	remain	confidential.	If	the	results	are	published,	your	name	will	not	be	
used.	Contact	or	personal	information	that	you	have	provided	Legerweb	will	not	be	stored	together	with	
other	information	you	provide	about	yourself.			
Representatives	of	The	University	of	Western	Ontario	Non-Medical	Research	Ethics	Board	may	require	
access	to	your	study-related	records	to	monitor	the	conduct	of	the	research.	Data	will	be	retained	for	
five	years	following	the	end	of	the	study.	
Are	participants	compensated	to	be	in	this	study?	
Yes.	Legerweb	will	compensate	you	with	$6.50	or	13	Air	Miles	for	participating.		
What	are	the	rights	of	participants?	
Your	participation	in	this	study	is	voluntary.	You	may	decide	not	to	be	in	this	study.		Even	if	you	consent	
to	participate	you	have	the	right	to	not	answer	individual	questions	or	to	withdraw	from	the	study	at	
any	time.		Your	relationship	with	Legerweb	will	not	be	affected	should	you	decide	to	withdraw	from	this	
study.	You	do	not	waive	any	legal	rights	by	consenting	to	this	study.	
Who	do	participants	contact	for	questions?	
If	you	have	technical	questions	or	questions	about	compensation,	please	contact	Legerweb.	For	other	
questions	about	this	specific	research	study,	please	contact	Ayden	Scheim	at	 	or	
		
If	you	have	any	questions	about	your	rights	as	a	research	participant	or	the	conduct	of	this	study,	you	
may	contact	The	Office	of	Human	Research	Ethics	 ,	email:	 	
Consent		
Completion	of	the	survey	is	indication	of	your	consent	to	participate.	
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Study	Title:	Understanding	Social	Experiences	and	Health	
	
Principal	Investigator	
Greta	Bauer,	Associate	Professor		
Epidemiology	&	Biostatistics	
Schulich	School	of	Medicine	&	Dentistry	
Western	University	
London,	Ontario,	Canada	
	
	
Invitation	to	Participate	
You	are	being	invited	to	participate	in	this	follow-up	survey	about	social	discrimination	(i.e.,	being	
treated	differently	because	of	who	you	are)	and	health	because	in	the	past	two	weeks,	you	participated	
in	the	initial	survey	for	this	research	project.	You	do	not	need	to	have	experienced	social	discrimination	
to	participate.	
Why	is	this	study	being	done?	
The	purpose	of	this	study	is	to	develop	better	ways	of	asking	people	about	how	they	are	treated	in	
society,	and	to	increase	our	understanding	of	how	this	treatment	affects	health.		
How	long	will	you	be	in	this	study?		
The	survey	you	are	being	asked	to	participate	in	today	takes	about	15	minutes	to	complete.		
What	are	the	study	procedures?	
If	you	agree	to	participate,	you	will	be	asked	to	answer	some	survey	questions	about	experiences	of	
unfair	treatment	related	to	who	you	are.	
What	are	the	risks	and	harms	of	participating	in	this	study?	
There	are	no	known	or	anticipated	risks	associated	with	participating	in	this	study.	It	is	possible	that	you	
may	be	uncomfortable	with	some	of	the	questions,	or	that	they	may	cause	distress	by	recalling	difficult	
memories	or	experiences.	You	are	welcome	to	skip	any	questions	you	do	not	wish	to	answer.	If	you	
need	to	speak	with	someone	about	your	feelings	after	completing	the	survey,	please	visit	
http://www.yourlifecounts.org/need-help/crisis-lines	to	find	a	distress	line	in	your	area.	
What	are	the	benefits	of	participating	in	this	study?	
You	may	not	directly	benefit	from	participating	in	this	study	but	information		
gathered	may	provide	benefits	to	society	as	a	whole	which	include	more	knowledge	about	how	unfair	
treatment	impacts	health.		
Can	participants	choose	to	leave	the	study?	
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	If	you	decide	to	withdraw	from	the	study	(by	exiting	the	webpage),	the	information	that	was	collected	
prior	to	you	leaving	the	study	may	still	be	used.		No	new	information	will	be	collected	without	your	
permission.	
How	will	participant	information	be	kept	confidential?		
All	survey	data	collected	will	remain	confidential.	If	the	results	are	published,	your	name	will	not	be	
used.	Contact	or	personal	information	that	you	have	provided	Legerweb	will	not	be	stored	together	with	
other	information	you	provide	about	yourself.			
Representatives	of	The	University	of	Western	Ontario	Non-Medical	Research	Ethics	Board	may	require	
access	to	your	study-related	records	to	monitor	the	conduct	of	the	research.	Data	will	be	retained	for	
five	years	following	the	end	of	the	study.		
Are	participants	compensated	to	be	in	this	study?	
Yes.	Legerweb	will	compensate	you	with	$2	or	4	Air	Miles	for	participating.	
What	are	the	rights	of	participants?	
Your	participation	in	this	study	is	voluntary.	You	may	decide	not	to	be	in	this	study.		Even	if	you	consent	
to	participate	you	have	the	right	to	not	answer	individual	questions	or	to	withdraw	from	the	study	at	
any	time.	Your	relationship	with	Legerweb	will	not	be	affected	should	you	decide	to	withdraw	from	this	
study.		You	do	not	waive	any	legal	rights	by	consenting	to	this	study.		
Who	do	participants	contact	for	questions?	
If	you	have	technical	questions	or	questions	about	compensation,	please	contact	Legerweb.	For	other	
questions	about	this	specific	research	study,	please	contact	Ayden	Scheim	at	 	or	
		
If	you	have	any	questions	about	your	rights	as	a	research	participant	or	the	conduct	of	this	study,	you	
may	contact	The	Office	of	Human	Research	Ethics	 	email:	 	
Consent		
Completion	of	the	survey	is	indication	of	your	consent	to	participate.	
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